data_1pxe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pxe _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 1.633 ' HZ3' ' CD ' ' A' ' 19' ' ' LYS 0.789 0.4 OUTLIER . . . . . 1 N--CA 0.861 -29.895 1 N-CA-C 129.976 7.028 . . . . 4.62 129.976 . . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 1.098 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 48.9 t -86.73 -22.85 0.29 Allowed Pre-proline 2 C--O 1.002 -11.945 1 CA-C-O 130.826 5.108 . . . . 0.88 112.712 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 1.098 ' HD2' ' N ' ' A' ' 20' ' ' CYS 0.288 14.8 Cg_exo -52.21 81.69 0.02 OUTLIER 'Trans proline' 3 C--N 1.0 -17.806 2 O-C-N 105.253 -8.341 . . . . 3.39 121.264 -178.869 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 1.559 HG21 ' CB ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -92.84 167.62 14.05 Favored Pre-proline 2 C--N 1.143 -8.406 0 CA-C-N 114.023 -1.444 . . . . 2.54 114.559 -179.675 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.423 ' HD2' ' CG2' ' A' ' 22' ' ' THR . 27.9 Cg_exo -43.77 -21.96 0.39 Allowed 'Trans proline' 2 C--O 1.084 -7.205 0 C-N-CA 123.532 2.821 . . . . 1.88 113.082 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.691 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -107.49 -54.83 0.64 Allowed Glycine 3 C--O 1.083 -9.328 0 O-C-N 118.409 -2.682 . . . . 1.34 114.177 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 42.4 t -54.72 155.18 4.38 Favored 'General case' 1 C--N 1.198 -5.98 1 O-C-N 115.373 -4.604 . . . . 0.63 110.856 -179.69 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 1.01 ' OD2' ' CB ' ' A' ' 26' ' ' ASP . 26.5 t0 -102.11 -40.26 6.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.061 0.458 . . . . 1.58 111.494 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 48.43 4.72 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.626 -0.797 . . . . 0.45 111.636 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.416 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -154.66 113.67 3.65 Favored 'General case' 1 C--O 1.05 -9.428 0 CA-C-O 124.055 1.883 . . . . 1.33 110.621 -179.6 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 1.011 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 113.11 29.37 3.04 Favored Glycine 2 C--N 1.162 -9.094 1 O-C-N 113.307 -5.871 . . . . 0.99 113.099 179.66 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 1.011 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 11.51 -167.24 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.377 0 O-C-N 119.95 -1.912 . . . . 0.37 112.885 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 1.023 HG11 ' CB ' ' A' ' 31' ' ' VAL . 14.1 p -59.73 -32.59 49.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.415 0.894 . . . . 1.13 113.415 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 1.591 ' HG1' ' CB ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.18 8.07 7.9 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.85 -0.531 . . . . 1.89 111.259 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.35 15.0 62.88 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.645 -0.788 . . . . 0.49 111.163 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.007 HD13 ' CG ' ' A' ' 34' ' ' LEU . 15.7 mt -101.96 3.98 39.52 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.266 0.555 . . . . 1.37 110.379 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.711 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.2 160.23 36.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.387 -0.824 . . . . 0.86 109.387 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.536 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 9.8 Cg_endo -72.69 46.66 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.573 1.515 . . . . 0.99 111.239 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.0 m170 89.65 -177.65 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.697 -0.853 . . . . 0.67 108.697 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 1.281 ' C ' ' CA ' ' A' ' 39' ' ' ARG . 42.1 p-80 -133.08 19.62 4.08 Favored 'General case' 1 C--O 0.634 -31.304 1 CA-C-O 176.774 26.988 . . . . 1.18 110.38 178.696 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 1.552 ' HG2' ' CD ' ' A' ' 39' ' ' ARG . 22.3 mtt180 -1.92 10.1 0.0 OUTLIER 'General case' 2 C--N 0.573 -33.156 3 O-C-N 8.928 -71.108 . . . . 5.86 118.508 177.803 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 1.413 ' OG ' ' CA ' ' A' ' 40' ' ' SER . 7.9 p -173.82 30.46 0.01 OUTLIER 'General case' 2 N--CA 1.318 -7.064 0 N-CA-C 118.899 2.925 . . . . 2.53 118.899 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 1.41 HD21 ' CG ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER 87.76 -43.86 0.03 OUTLIER 'General case' 1 C--O 0.833 -20.858 0 CA-C-O 127.14 3.353 . . . . 2.82 116.281 179.143 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 1.431 ' HG ' ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER -35.48 -25.78 0.01 OUTLIER 'General case' 1 C--N 0.987 -15.179 3 O-C-N 100.76 -13.713 . . . . 2.12 111.608 179.396 . . . . . . . . 5 4 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . -123.6 -88.99 0.87 Allowed Glycine 1 C--N 1.248 -4.333 0 O-C-N 120.365 -1.46 . . . . 0.49 110.731 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.711 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.1 t 48.9 109.8 0.01 OUTLIER Pre-proline 0 C--O 1.191 -1.977 0 CA-C-N 115.366 -0.417 . . . . 0.74 111.167 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.676 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 42.6 Cg_endo -96.83 18.45 0.56 Allowed 'Trans proline' 0 C--O 1.169 -2.926 0 C-N-CA 123.821 3.014 . . . . 1.5 115.383 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.668 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 33.9 m-70 -94.18 -83.09 0.34 Allowed 'General case' 1 C--N 1.207 -5.605 0 O-C-N 118.876 -2.39 . . . . 0.92 111.734 -177.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 1.622 ' HZ3' ' CE ' ' A' ' 47' ' ' LYS 0.273 0.6 OUTLIER 67.59 62.14 0.44 Allowed 'General case' 2 CA--C 1.316 -8.043 0 N-CA-C 118.336 2.717 . . . . 3.99 118.336 179.938 . . . . . . . . 5 4 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 1.34 ' OD1' ' CB ' ' A' ' 48' ' ' ASP 0.322 1.5 t0 -135.94 6.9 3.17 Favored 'General case' 2 N--CA 1.275 -9.215 1 CA-C-O 129.55 4.5 . . . . 3.5 120.243 178.955 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 1.618 ' HD3' ' CG ' ' A' ' 49' ' ' ARG . 2.2 ptt180 56.53 87.27 0.06 Allowed 'General case' 2 C--O 0.679 -28.96 2 O-C-N 114.286 -5.259 . . . . 5.94 118.085 179.431 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 1.579 HG21 ' CB ' ' A' ' 50' ' ' VAL . 1.9 t 142.54 -113.12 0.0 OUTLIER Pre-proline 3 C--N 0.943 -17.065 4 O-C-N 90.607 -20.058 . . . . 3.38 115.5 177.269 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.354 ' HB2' ' CD ' ' A' ' 52' ' ' PRO 0.445 2.2 Cg_endo -56.64 -139.95 0.0 OUTLIER 'Trans proline' 4 C--N 0.752 -30.857 3 O-C-N 93.03 -14.774 . . . . 3.89 126.842 -179.35 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 1.354 ' CD ' ' HB2' ' A' ' 51' ' ' PRO . 1.6 Cg_endo -62.47 79.13 0.1 Allowed 'Trans proline' 2 C--N 1.129 -11.013 0 O-C-N 118.441 -1.4 . . . . 2.18 114.319 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 1.404 ' HG3' ' CB ' ' A' ' 53' ' ' GLU . 3.8 mp0 -151.55 -103.64 0.06 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.33 -0.857 . . . . 2.29 111.665 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 1.002 HG22 ' CB ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -132.82 2.16 1.55 Allowed 'Isoleucine or valine' 1 C--O 1.142 -4.586 0 CA-C-O 118.712 -0.661 . . . . 1.31 109.583 -179.712 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.56 ' CD2' ' CB ' ' A' ' 55' ' ' LEU . 1.1 tp . . . . . 2 CA--C 1.351 -6.69 1 CA-C-O 136.579 7.847 . . . . 3.16 117.136 -178.959 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 3.4 mttt . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 121.22 0.533 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.702 ' O ' ' N ' ' A' ' 22' ' ' THR . 50.9 t -74.68 -36.64 2.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.335 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 72.4 Cg_exo -48.56 73.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.931 1.754 . . . . 0.0 111.822 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.702 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -79.53 172.99 8.46 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.323 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 94.9 Cg_exo -41.84 -28.15 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.191 1.927 . . . . 0.0 111.31 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.539 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -94.73 -70.35 1.09 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.095 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 22.7 t -50.97 159.39 0.58 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.891 0.346 . . . . 0.0 110.95 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -109.76 -41.61 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 92.53 60.55 1.22 Allowed Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.42 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.72 129.38 8.46 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.249 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.689 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.16 22.36 32.7 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.125 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.738 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 23.42 -160.9 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 123.436 0.695 . . . . 0.0 112.585 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.524 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.5 p -62.25 -33.41 58.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' CG2' ' CD1' ' A' ' 34' ' ' LEU . 2.4 t -133.89 21.76 3.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.412 0.551 . . . . 0.0 111.415 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.31 16.84 44.32 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.493 ' CD1' ' CG2' ' A' ' 32' ' ' THR . 20.5 mt -99.48 4.53 46.09 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.14 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.738 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.41 157.45 58.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.444 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.1 Cg_endo -70.96 47.11 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.427 1.418 . . . . 0.0 111.041 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.513 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 5.1 m80 88.47 -179.39 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.958 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 52.9 p-80 -130.61 104.14 7.03 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.188 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.494 ' O ' ' HB3' ' A' ' 40' ' ' SER . 4.5 mtt180 -71.16 -1.85 13.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.718 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.588 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 72.7 p 175.03 61.1 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 43' ' ' GLY . 0.5 OUTLIER 76.93 -161.3 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.398 178.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.437 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER 64.57 -2.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 41' ' ' LEU . . . -147.27 -98.32 0.21 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.958 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.5 t 52.9 105.87 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.571 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.627 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 93.3 Cg_endo -90.6 34.89 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.142 2.562 . . . . 0.0 114.367 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.808 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.8 m-70 -121.12 -92.07 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.961 -0.695 . . . . 0.0 112.507 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 75.25 67.74 0.08 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.26 0.482 . . . . 0.0 111.192 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB3' ' OE1' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -151.63 18.52 0.71 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.913 0.387 . . . . 0.0 111.012 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.508 ' O ' ' OE1' ' A' ' 53' ' ' GLU . 6.2 ptt-85 50.74 -177.64 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.605 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 70.2 t 26.72 -85.38 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.144 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 69.0 Cg_exo -46.34 168.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.269 0 CA-C-N 120.709 1.289 . . . . 0.0 111.872 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.539 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 7.6 Cg_endo -49.85 96.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.425 2.083 . . . . 0.0 112.173 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.808 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 3.8 mp0 -154.62 -102.43 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.478 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -147.58 19.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.995 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.562 ' HB2' ' N ' ' A' ' 50' ' ' VAL . 15.3 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.284 0.564 . . . . 0.0 111.018 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.497 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.044 0.449 . . . . 0.0 110.027 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.661 ' O ' ' N ' ' A' ' 22' ' ' THR . 16.7 t -77.14 -54.78 1.48 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.158 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 9.7 Cg_endo -53.09 70.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.072 1.848 . . . . 0.0 112.051 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.661 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -110.4 -177.45 0.46 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.997 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 22' ' ' THR . 83.9 Cg_exo -46.86 -18.75 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.719 1.613 . . . . 0.0 112.691 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.92 12.44 52.92 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.884 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 26' ' ' ASP . 41.7 t -153.65 162.81 40.92 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.854 0.327 . . . . 0.0 110.57 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 25.4 t0 -103.94 -41.94 5.72 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.975 0.417 . . . . 0.0 109.883 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.531 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 86.79 54.21 2.69 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.944 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -156.75 131.79 9.06 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.362 -0.419 . . . . 0.0 111.487 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.6 21.29 34.73 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.425 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.9 t-80 24.36 -159.19 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 122.996 0.518 . . . . 0.0 112.189 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 43' ' ' GLY . 10.5 p -70.03 -34.51 59.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.435 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 10.7 p -116.72 6.53 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.204 -0.31 . . . . 0.0 111.557 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 65.03 14.4 58.95 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.812 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 18.8 mt -102.58 1.77 35.26 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.739 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.14 158.32 41.34 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.373 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.9 Cg_endo -71.32 46.43 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.457 1.438 . . . . 0.0 111.329 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m170 89.11 -179.44 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.957 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 51.5 p-80 -130.73 108.52 9.94 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.875 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -56.06 -22.83 29.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.668 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.497 ' HB3' ' CB ' ' A' ' 19' ' ' LYS . 4.4 p 168.61 86.83 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.571 ' C ' ' H ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER 79.24 -170.79 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.502 0.191 . . . . 0.0 110.511 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.475 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 68.7 m 66.35 -8.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 41' ' ' LEU . . . -145.99 -101.3 0.3 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.957 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 55.24 104.92 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.615 -0.293 . . . . 0.0 111.246 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.607 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 70.3 Cg_endo -92.16 34.72 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.13 2.554 . . . . 0.0 114.207 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.652 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 11.2 m-70 -122.16 -83.02 0.66 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.356 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.547 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 71.92 65.17 0.14 Allowed 'General case' 0 N--CA 1.461 0.119 0 O-C-N 122.156 -0.34 . . . . 0.0 111.199 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -152.81 15.79 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.401 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.467 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 2.6 ttm180 43.67 -169.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.671 ' HB ' ' CD ' ' A' ' 51' ' ' PRO . 88.7 t 37.45 -91.07 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.114 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.671 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 10.1 Cg_endo -54.09 -175.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.254 1.303 . . . . 0.0 112.109 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 27.6 Cg_exo -62.19 95.84 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.283 1.988 . . . . 0.0 111.536 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.652 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 19.4 mp0 -152.11 -103.23 0.05 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.929 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.547 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -136.14 7.94 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 50' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 121.151 0.5 . . . . 0.0 110.965 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 121.249 0.547 . . . . 0.0 111.899 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 22' ' ' THR . 49.5 t -72.13 -26.58 0.86 Allowed Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 71.9 Cg_exo -50.51 74.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.558 1.505 . . . . 0.0 112.388 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -83.78 172.54 9.0 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 88.1 Cg_exo -44.49 -27.93 2.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.243 1.962 . . . . 0.0 111.839 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . -97.42 -69.1 0.97 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.357 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 24.0 t -46.04 157.52 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 111.716 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -112.51 -30.72 7.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.81 58.75 2.08 Favored Glycine 0 CA--C 1.506 -0.512 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.452 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.403 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -161.51 128.67 4.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.426 -0.887 . . . . 0.0 109.738 -179.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.979 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.62 50.33 3.6 Favored Glycine 0 C--O 1.219 -0.801 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.03 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.979 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 -12.3 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.428 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 13.1 p -52.39 -37.36 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.888 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.448 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 17.9 p -114.02 -7.28 13.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.819 0.342 . . . . 0.0 110.156 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.79 80.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.448 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 12.1 mt -97.06 1.38 50.05 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.702 0.763 . . . . 0.0 109.163 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.74 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -110.33 161.21 25.46 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.771 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 74.2 Cg_endo -76.63 49.32 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.261 1.308 . . . . 0.0 111.265 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.3 m170 90.46 -176.4 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.574 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 48.3 p-80 -134.98 -53.96 0.8 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.511 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 39.96 33.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.463 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 41' ' ' LEU . 28.3 p -143.95 -68.46 0.33 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.792 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.468 ' CB ' ' O ' ' A' ' 40' ' ' SER . 0.4 OUTLIER 157.72 -52.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.548 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.3 p -41.55 -30.32 0.21 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.796 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' CYS . . . -100.41 -106.06 2.79 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.542 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.0 t 49.77 108.07 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.954 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.734 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 9.2 Cg_endo -96.29 2.0 2.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.143 2.562 . . . . 0.0 113.373 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.641 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 47.1 m-70 -70.2 -80.29 0.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.623 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 0.2 OUTLIER 53.82 61.72 2.95 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.455 0.645 . . . . 0.0 110.853 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.551 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.16 -6.25 12.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.902 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 0.4 OUTLIER 47.81 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.721 ' HB ' ' CD ' ' A' ' 51' ' ' PRO . 88.8 t 107.44 -81.76 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.351 1.061 . . . . 0.0 110.518 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.721 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 12.7 Cg_endo -56.41 -171.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.767 1.645 . . . . 0.0 111.115 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.524 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 25.1 Cg_exo -65.83 108.63 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.224 1.949 . . . . 0.0 111.768 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.641 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 2.0 pm0 -158.84 -103.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.487 HG12 ' SG ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -120.52 -8.73 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.949 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 11.4 mmtm . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.154 0.502 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.6 t -88.48 -42.08 0.47 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.355 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 74.2 Cg_exo -48.35 76.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.991 1.794 . . . . 0.0 112.212 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -90.63 175.64 3.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.67 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.549 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 64.6 Cg_exo -40.57 -27.97 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 112.622 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.637 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -93.8 -72.96 1.2 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.542 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -46.13 158.8 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 111.499 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -103.64 -37.52 7.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.791 0.329 . . . . 0.0 110.901 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 85.04 40.9 7.79 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.665 ' CG2' ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -158.16 62.44 0.45 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.864 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 176.59 57.24 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.624 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.5 t-80 -37.92 173.91 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.372 0.606 . . . . 0.0 112.298 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.594 ' HA ' ' HB3' ' A' ' 45' ' ' PRO . 13.6 p -48.44 -33.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.519 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.45 ' OG1' ' CG ' ' A' ' 34' ' ' LEU . 7.9 p -122.84 -1.79 8.86 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.155 -0.341 . . . . 0.0 110.16 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.57 15.63 64.28 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.45 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 23.7 mt -99.93 6.07 45.22 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.948 0.88 . . . . 0.0 108.747 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.583 ' CD2' ' CE1' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.42 155.96 46.45 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.165 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.493 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 3.0 Cg_exo -73.48 51.39 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.658 1.572 . . . . 0.0 110.574 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.504 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 6.3 m170 89.47 -174.36 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.523 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 26.5 p-80 -130.5 124.69 32.53 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.323 0.582 . . . . 0.0 111.121 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -54.47 -35.67 63.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.404 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 23.0 p 169.43 84.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.424 HD22 HG23 ' A' ' 54' ' ' ILE . 7.6 mt 75.04 -8.33 1.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -53.06 -27.21 18.85 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.382 0.611 . . . . 0.0 109.376 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.428 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -133.15 -77.17 0.11 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 54' ' ' ILE . 4.6 t 26.81 92.58 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.624 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 6.2 Cg_endo -105.16 2.46 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.448 3.432 . . . . 0.0 112.959 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.654 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 92.6 m-70 -37.19 -57.39 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.74 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.647 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 6.0 mttt -175.1 -62.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.263 0.554 . . . . 0.0 110.626 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 26.1 t70 132.03 -14.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.032 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 3.5 ttp180 -70.59 145.95 50.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.318 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . 1.7 p -42.15 -46.37 10.44 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.725 ' O ' ' N ' ' A' ' 53' ' ' GLU . 7.6 Cg_endo -49.15 178.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.769 1.646 . . . . 0.0 111.235 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.637 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 4.1 Cg_endo -46.21 69.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.661 2.241 . . . . 0.0 112.845 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.725 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.5 mt-10 -145.11 -106.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.501 ' CG1' ' HA ' ' A' ' 48' ' ' ASP . 0.8 OUTLIER -126.41 -6.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.727 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.556 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 4.8 mmtp . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.397 0.618 . . . . 0.0 111.742 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 22' ' ' THR . 51.0 t -87.94 -35.21 0.44 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.957 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 94.8 Cg_exo -44.45 73.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.268 1.979 . . . . 0.0 112.803 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -81.17 171.66 11.68 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.162 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 96.2 Cg_exo -41.08 -28.51 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.394 2.063 . . . . 0.0 111.891 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -96.44 -64.1 0.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.195 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.6 t -56.15 158.58 3.93 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.836 0.35 . . . . 0.0 111.272 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -110.46 -35.73 5.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.608 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 89.23 56.48 1.92 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.856 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.8 OUTLIER -158.96 131.46 6.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.985 -0.607 . . . . 0.0 111.082 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 94.94 20.6 27.93 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.246 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.737 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 23.2 -163.21 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 123.647 0.779 . . . . 0.0 112.798 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 13.8 p -63.23 -33.68 62.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.421 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.3 t -130.05 18.25 5.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.016 -0.427 . . . . 0.0 111.348 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.97 15.22 48.74 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.351 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.421 HD12 ' CG2' ' A' ' 32' ' ' THR . 18.7 mt -97.88 4.85 49.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 120.99 0.424 . . . . 0.0 110.068 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.737 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.8 158.05 58.14 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.877 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.3 Cg_exo -71.37 46.83 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.8 1.667 . . . . 0.0 111.078 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 6.6 m170 91.9 -176.24 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.673 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 26.9 p-80 -128.42 121.7 29.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.281 0.562 . . . . 0.0 110.528 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.41 -29.22 67.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.202 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 39' ' ' ARG . 24.1 p 175.51 73.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.5 OUTLIER 78.84 -15.54 0.75 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 178.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -22.99 1.29 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.226 0.536 . . . . 0.0 109.894 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.628 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.52 -82.6 0.15 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.673 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 47.76 110.08 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 114.874 -0.663 . . . . 0.0 111.315 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.604 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 14.6 Cg_endo -102.69 30.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.492 2.795 . . . . 0.0 113.179 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.801 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 67.3 m-70 -98.18 -90.87 0.27 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.68 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 40.0 mmtt -161.07 -74.77 0.06 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 110.988 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.68 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 22.7 t0 158.21 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.073 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.465 ' C ' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -56.42 129.56 41.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.258 -179.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 2.4 t -29.83 -50.66 0.32 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.92 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.9 Cg_exo -51.67 -170.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.24 1.96 . . . . 0.0 111.873 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 74.9 Cg_exo -50.47 64.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.679 2.253 . . . . 0.0 113.645 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.801 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.9 mm-40 -139.7 -106.21 0.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 119.918 -0.087 . . . . 0.0 111.091 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.587 HG21 ' SG ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -129.69 -21.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.916 -0.49 . . . . 0.0 111.547 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.469 ' O ' ' CD2' ' A' ' 55' ' ' LEU . 4.7 tt . . . . . 0 CA--C 1.533 0.318 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.8 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 111.547 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' THR . 42.5 t -89.5 -41.46 0.43 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.06 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.8 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 85.6 Cg_exo -43.37 81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.418 2.078 . . . . 0.0 112.96 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -91.97 171.6 7.55 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.204 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.4 Cg_endo -47.5 -27.71 7.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.892 1.728 . . . . 0.0 110.368 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.583 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -91.3 -67.62 1.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.751 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -53.39 154.84 3.15 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.23 -40.16 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.027 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 83.65 44.25 6.94 Favored Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.109 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.435 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -155.64 129.96 8.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.146 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 99.59 19.45 20.27 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.43 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.714 ' CG ' ' HA3' ' A' ' 43' ' ' GLY . 1.6 t-80 24.19 -157.0 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 123.462 0.705 . . . . 0.0 112.261 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.6 p -66.27 -33.68 65.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.478 ' CG2' ' CD1' ' A' ' 34' ' ' LEU . 2.1 t -132.47 21.49 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.484 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.6 15.02 45.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.604 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' CD1' ' CG2' ' A' ' 32' ' ' THR . 17.4 mt -98.95 3.83 47.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.987 0.422 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.68 161.4 44.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.259 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.543 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.5 Cg_exo -72.29 45.07 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.041 1.828 . . . . 0.0 111.629 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.0 m170 90.58 -176.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.844 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 31.3 p-80 -129.49 120.35 25.26 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.159 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.528 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.22 -17.66 63.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.267 -178.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.672 ' HB2' ' HA ' ' A' ' 19' ' ' LYS . 35.3 t 173.83 68.73 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.454 ' CD2' HG21 ' A' ' 54' ' ' ILE . 0.3 OUTLIER 78.5 -12.87 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.09 -29.53 0.91 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.411 0.624 . . . . 0.0 109.401 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.714 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.83 -77.77 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.088 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.844 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 51.23 109.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.587 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 76.1 Cg_endo -94.07 22.49 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.914 2.409 . . . . 0.0 113.98 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.671 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.6 m-70 -105.29 -93.32 0.36 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.432 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 74.48 69.08 0.09 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.556 0.616 . . . . 0.0 111.472 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.596 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -136.17 8.38 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.071 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 48' ' ' ASP . 1.0 OUTLIER 55.5 38.73 30.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.074 0.464 . . . . 0.0 111.984 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 48' ' ' ASP . 5.8 t -142.72 143.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 12.7 Cg_exo -27.01 -59.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.56 2.84 . . . . 0.0 113.677 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 70.5 Cg_endo -73.46 57.61 3.58 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.48 2.12 . . . . 0.0 113.69 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.671 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 20.2 mp0 -164.88 -102.29 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.519 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.9 0.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.914 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.456 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 12.7 tp . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.906 0.384 . . . . 0.0 111.205 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.485 ' HB2' ' N ' ' A' ' 41' ' ' LEU . 47.4 t -104.28 67.61 0.13 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.27 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.494 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 85.5 Cg_endo -78.9 75.22 5.15 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.927 1.752 . . . . 0.0 113.272 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' A' ' 25' ' ' CYS . 91.7 m -87.34 145.19 37.15 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 22' ' ' THR . 61.2 Cg_exo -36.93 -27.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.726 2.284 . . . . 0.0 112.987 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.501 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -144.15 -9.95 0.38 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.996 -1.097 . . . . 0.0 114.74 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.617 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 23.6 t -48.09 151.78 0.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.811 1.306 . . . . 0.0 110.712 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -102.76 -44.06 5.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.795 0.331 . . . . 0.0 111.301 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 55.65 1.52 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.657 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.71 129.74 8.69 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.66 -0.77 . . . . 0.0 110.557 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.825 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 93.78 23.75 22.39 Favored Glycine 0 C--O 1.226 -0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.222 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.825 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 t-80 17.72 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.05 0.94 . . . . 0.0 113.179 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 43' ' ' GLY . 9.5 p -63.88 -33.31 61.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.417 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 12.0 p -117.65 0.23 12.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.866 0.303 . . . . 0.0 110.837 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 69.27 13.66 67.78 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.098 -1.049 . . . . 0.0 110.649 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.417 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 16.9 mt -101.06 3.5 41.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.218 0.532 . . . . 0.0 109.77 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.766 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.51 159.46 36.82 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.101 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 60.5 Cg_endo -73.34 47.69 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.329 1.352 . . . . 0.0 110.872 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.1 m170 91.36 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.651 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 34.7 p-80 -132.75 -51.18 0.91 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.402 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 36.73 28.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.646 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 2.2 p -158.03 5.01 0.12 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.485 ' N ' ' HB2' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 82.26 -23.61 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.1 p -48.89 -27.01 2.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.115 0.484 . . . . 0.0 110.164 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -124.71 -88.84 0.79 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.651 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.3 t 52.72 111.62 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.513 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 30' ' ' HIS . 28.8 Cg_endo -98.95 14.4 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.204 2.603 . . . . 0.0 113.45 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.674 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 38.1 m-70 -86.72 -72.97 0.48 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.487 ' H ' ' CG1' ' A' ' 54' ' ' ILE . 0.6 OUTLIER 50.29 62.13 2.83 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.082 0.468 . . . . 0.0 111.644 -179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.609 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 5.9 t70 -141.44 9.75 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.606 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.45 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 1.9 ptt180 59.96 -170.73 0.14 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.278 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HB ' ' CD ' ' A' ' 51' ' ' PRO . 56.4 t 23.65 -80.2 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 124.972 1.309 . . . . 0.0 114.156 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.598 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 9.1 Cg_endo -50.88 176.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.669 1.579 . . . . 0.0 112.056 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 44.3 Cg_exo -56.79 77.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.14 1.894 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.674 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.9 mm-40 -132.32 -105.62 0.26 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.487 ' CG1' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -145.99 18.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.581 ' HB2' ' N ' ' A' ' 50' ' ' VAL . 2.6 tm? . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.38 0.61 . . . . 0.0 111.615 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.826 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 5.3 mmtt . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 121.665 0.745 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 35.2 t -72.16 -35.78 3.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.53 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 88.6 Cg_exo -47.05 82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.987 1.791 . . . . 0.0 112.796 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -87.44 177.79 2.54 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.517 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 72.1 Cg_exo -41.7 -23.71 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.314 2.009 . . . . 0.0 112.775 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.513 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -105.14 -67.06 0.69 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.446 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 39.1 t -46.75 155.11 0.27 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.637 0.718 . . . . 0.0 110.749 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -107.9 -43.39 4.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 110.784 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.21 61.49 0.98 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.962 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -154.35 131.09 10.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.2 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.671 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 89.86 22.59 35.61 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.217 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.746 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 t-80 23.37 -158.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.448 0.699 . . . . 0.0 112.279 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 8.7 p -64.84 -35.83 76.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.446 ' CG2' ' CD1' ' A' ' 34' ' ' LEU . 1.4 t -129.85 21.01 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.438 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.08 16.2 39.73 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.193 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' CD1' ' CG2' ' A' ' 32' ' ' THR . 25.5 mt -97.3 2.57 50.86 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 110.048 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.746 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -121.52 158.19 54.47 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.602 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.556 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.17 45.74 0.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.741 1.627 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m170 89.97 179.44 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.951 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.6 p-80 -124.89 -52.85 1.66 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.705 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.43 ' CG ' ' HG2' ' A' ' 21' ' ' PRO . 47.3 ttt180 45.35 19.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.889 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.826 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -165.24 23.06 0.05 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.425 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 77.83 -161.07 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 71.77 -53.14 0.69 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.552 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -96.9 -91.17 1.86 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.951 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.88 108.7 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.259 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.573 ' N ' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -90.4 27.12 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.074 2.516 . . . . 0.0 114.431 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.773 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 19.2 m-70 -111.61 -76.0 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.982 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.773 ' HG2' ' O ' ' A' ' 46' ' ' HIS . 1.6 ptpt 53.8 68.59 0.82 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 110.917 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.809 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 2.2 t70 -132.74 10.58 4.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.432 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.809 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER 50.23 50.73 18.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.297 0.57 . . . . 0.0 112.229 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.435 ' CG1' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -149.16 153.55 38.02 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.643 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 79.6 Cg_exo -38.52 -56.38 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.769 1.646 . . . . 0.0 112.782 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 72.9 Cg_endo -73.44 56.37 3.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.678 2.252 . . . . 0.0 114.098 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 30.8 mp0 -162.84 -104.33 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.873 0.368 . . . . 0.0 110.985 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.574 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -131.85 4.56 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.702 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.794 -178.791 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 1.7 mmtm . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.185 0.517 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 22' ' ' THR . 41.9 t -55.16 -41.84 92.81 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.387 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 76.9 Cg_exo -43.05 77.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.367 2.045 . . . . 0.0 112.984 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.629 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -82.96 176.03 4.22 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.137 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 80.7 Cg_exo -46.9 -22.84 2.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.925 1.75 . . . . 0.0 111.663 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 52' ' ' PRO . . . -103.11 -69.22 0.8 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.904 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.9 t -42.1 150.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.043 0.422 . . . . 0.0 111.7 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -101.71 -47.14 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.38 53.44 1.07 Allowed Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.511 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.71 125.74 5.4 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.006 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.721 ' O ' ' CA ' ' A' ' 33' ' ' GLY . . . 111.25 -10.35 28.88 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.096 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.9 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 46.94 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.702 -0.881 . . . . 0.0 111.823 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.882 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.8 p -50.97 -31.6 10.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 9.5 p -116.47 4.28 13.29 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.574 1.079 . . . . 0.0 112.036 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.721 ' CA ' ' O ' ' A' ' 29' ' ' GLY . . . 71.57 17.38 76.38 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.351 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 32' ' ' THR . 3.2 mt -124.29 8.62 8.49 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.9 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -107.09 167.21 9.77 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.336 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 57.1 Cg_endo -72.12 37.63 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.263 1.309 . . . . 0.0 110.884 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m170 89.34 179.26 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.935 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.0 p-80 -128.68 -50.33 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.727 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HG3' ' CG ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER 40.95 27.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.422 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.552 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 2.4 m -174.09 18.98 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' A' ' 43' ' ' GLY . 0.9 OUTLIER 76.33 -171.86 0.09 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.305 0.502 . . . . 0.0 110.36 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 18.8 m 73.28 -18.06 0.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 41' ' ' LEU . . . -130.48 -94.33 0.68 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.935 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.5 t 55.77 121.62 0.01 OUTLIER Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.709 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.599 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 72.5 Cg_endo -95.21 24.97 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.006 2.471 . . . . 0.0 113.857 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.612 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 11.1 m-70 -115.8 -95.46 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 78.62 67.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.346 0.521 . . . . 0.0 112.209 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.447 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 51.0 t0 -139.24 10.54 2.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.374 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 27.11 43.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.79 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 96.0 t -157.65 -57.32 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.207 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.4 Cg_endo -96.42 -179.41 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.198 2.599 . . . . 0.0 111.171 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 9.3 Cg_endo -50.88 84.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 121.977 1.785 . . . . 0.0 110.736 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.612 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.2 mt-10 -140.37 -96.85 0.15 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -146.43 25.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 7.6 tt . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.607 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.702 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.717 0.294 . . . . 0.0 111.324 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.614 ' N ' ' HA ' ' A' ' 40' ' ' SER . 48.8 t -111.6 68.8 0.77 Allowed Pre-proline 0 C--N 1.334 -0.067 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 94.9 Cg_endo -88.9 71.98 2.12 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.857 1.705 . . . . 0.0 111.123 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.525 ' HB ' ' H ' ' A' ' 25' ' ' CYS . 2.1 m -81.99 141.8 47.54 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.284 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.69 -21.6 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.217 1.944 . . . . 0.0 111.869 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' C ' ' HB3' ' A' ' 52' ' ' PRO . . . -123.15 -37.23 0.61 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.622 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.525 ' H ' ' HB ' ' A' ' 22' ' ' THR . 13.0 t -44.4 152.13 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.868 0.834 . . . . 0.0 111.046 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -108.47 -34.36 6.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.31 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 39' ' ' ARG . . . 83.63 54.83 2.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.211 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -157.8 127.43 5.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.443 -0.879 . . . . 0.0 110.154 -179.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.782 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 95.78 24.52 15.28 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.978 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.782 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 17.71 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.921 0.889 . . . . 0.0 113.049 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 43' ' ' GLY . 7.8 p -67.9 -35.57 72.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.41 ' CG2' HG12 ' A' ' 31' ' ' VAL . 11.5 p -113.62 -3.96 13.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.328 -0.233 . . . . 0.0 110.637 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 72.96 12.62 79.12 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.4 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 13.7 mt -101.35 5.0 42.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 109.942 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.689 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.97 164.34 17.01 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.565 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 2.8 Cg_exo -74.09 45.21 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.945 1.763 . . . . 0.0 110.884 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m170 87.54 179.25 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.797 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 47.4 p-80 -129.23 -53.08 1.19 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.195 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.702 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 45.42 20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.607 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.614 ' HA ' ' N ' ' A' ' 20' ' ' CYS . 1.4 p -143.21 -53.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER 157.6 -53.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.03 0.377 . . . . 0.0 111.459 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.407 ' N ' HD13 ' A' ' 41' ' ' LEU . 56.6 p -33.2 -36.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.235 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.567 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -104.48 -98.91 2.54 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.797 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.8 t 55.0 109.04 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.262 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.1 Cg_endo -95.01 24.65 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.903 2.402 . . . . 0.0 113.7 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.766 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 15.6 m-70 -107.13 -76.84 0.61 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.793 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.766 ' HG2' ' O ' ' A' ' 46' ' ' HIS . 4.4 pttt 54.07 66.23 1.29 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.492 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 1.5 t0 -131.34 -10.52 3.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.498 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER 53.21 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.972 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 28.0 t 99.55 -68.94 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.452 1.101 . . . . 0.0 110.449 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.972 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 2.9 Cg_exo -73.92 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.818 1.679 . . . . 0.0 110.498 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.615 ' HD2' ' CB ' ' A' ' 51' ' ' PRO . 44.1 Cg_endo -67.11 99.32 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.8 1.667 . . . . 0.0 111.647 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 21.8 mp0 -152.2 -103.16 0.05 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.64 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.52 7.74 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.516 ' HB2' ' H ' ' A' ' 50' ' ' VAL . 3.0 tt . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.884 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.798 0.332 . . . . 0.0 111.318 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.552 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 16.7 t -110.18 33.27 0.1 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 97.0 Cg_endo -77.35 80.03 3.01 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.484 1.456 . . . . 0.0 111.732 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.473 ' HB ' ' H ' ' A' ' 25' ' ' CYS . 1.1 m -85.97 142.14 36.13 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.017 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 22' ' ' THR . 98.1 Cg_exo -43.43 -30.19 2.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.188 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.578 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -112.44 -26.61 4.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.965 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -51.83 144.18 11.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -82.27 -46.77 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.34 23.72 77.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.568 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.587 ' CG2' ' O ' ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.48 43.95 1.29 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.388 0.614 . . . . 0.0 110.671 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.869 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -170.55 29.81 0.13 Allowed Glycine 0 C--O 1.22 -0.772 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.325 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.869 ' O ' ' O ' ' A' ' 29' ' ' GLY . 3.1 t-80 15.64 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 10.3 p -59.01 -21.1 18.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.591 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 3.2 p -132.37 6.77 4.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.017 0.826 . . . . 0.0 110.216 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 64.18 18.62 62.95 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.7 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 32' ' ' THR . 9.3 mt -117.06 10.42 13.93 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.687 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -113.39 171.4 4.38 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.003 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 35' ' ' TYR . 2.7 Cg_exo -74.89 43.3 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.971 1.781 . . . . 0.0 112.01 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.525 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.8 m80 85.11 -176.37 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.25 0.547 . . . . 0.0 110.405 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.918 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 29.4 p-80 -152.01 153.71 34.57 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.601 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mtt180 -149.22 38.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.082 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.563 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 60.3 p -170.42 20.54 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' CD2' HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER 77.42 -36.84 0.24 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.46 0.573 . . . . 0.0 112.195 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 41' ' ' LEU . 64.6 m -36.46 -35.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.193 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.496 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.1 -93.05 2.26 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.981 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.918 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.1 t 48.67 111.08 0.01 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 115.256 -0.472 . . . . 0.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.577 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.9 Cg_endo -86.4 18.39 1.58 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.951 2.434 . . . . 0.0 113.943 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.719 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 9.3 m-70 -105.0 -89.33 0.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.466 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.508 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER 77.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 178.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.68 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 1.4 t70 -146.13 24.9 1.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.259 0.552 . . . . 0.0 109.812 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 34.23 43.12 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.95 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 48' ' ' ASP . 6.7 m -135.99 153.78 77.18 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.681 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.467 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 27.9 Cg_exo -27.33 -48.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.039 3.159 . . . . 0.0 113.822 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.578 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 96.7 Cg_endo -92.62 39.06 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.406 2.071 . . . . 0.0 114.461 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.719 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 8.8 mm-40 -144.42 -102.39 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.558 HG12 ' SG ' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -128.9 3.71 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -178.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.2 tp . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.464 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 22.5 mttt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 121.367 0.603 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.691 ' O ' ' N ' ' A' ' 22' ' ' THR . 48.1 t -56.21 -40.51 85.28 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.59 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.633 ' HD3' ' HA ' ' A' ' 39' ' ' ARG . 86.2 Cg_exo -48.51 72.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.118 1.879 . . . . 0.0 112.678 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.691 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -81.14 173.49 7.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.552 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 4.6 Cg_exo -37.5 -27.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.752 2.301 . . . . 0.0 112.644 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' THR . . . -97.28 -75.81 1.26 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.914 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 34.2 t -39.5 156.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.055 0.455 . . . . 0.0 112.212 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.77 -36.96 6.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.82 57.99 1.55 Allowed Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.126 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.64 135.46 9.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.808 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 90.68 21.75 35.96 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.452 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.718 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 21.63 -158.61 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.396 0.679 . . . . 0.0 112.448 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.487 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 6.9 p -70.73 -34.52 56.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.444 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 5.9 p -117.46 5.81 12.53 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.025 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.54 13.76 61.31 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.132 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.444 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 19.8 mt -101.63 2.56 38.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.714 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.25 158.78 40.33 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.335 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.6 Cg_endo -71.9 48.26 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.354 1.37 . . . . 0.0 111.302 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.55 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.1 m170 90.2 -179.33 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.903 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 33.1 p-80 -129.33 -55.07 1.18 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.426 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.633 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 91.4 mtt-85 41.92 30.5 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 38.3 t -155.12 -1.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.657 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 82.73 -35.78 0.09 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.0 p -39.77 -37.34 0.52 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.241 0.543 . . . . 0.0 110.485 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.49 -90.69 2.09 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.903 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 59.1 112.24 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.859 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.5 Cg_endo -92.31 27.08 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.013 2.475 . . . . 0.0 114.105 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.699 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.8 m-70 -114.7 -74.91 0.6 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.025 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.685 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 54.61 65.48 1.49 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.92 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t70 -133.88 -7.06 2.76 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.718 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.568 ' O ' ' O ' ' A' ' 48' ' ' ASP . 0.1 OUTLIER 48.69 135.22 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.927 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 33.6 t 96.21 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.551 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.927 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 4.7 Cg_exo -76.95 -167.51 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.646 1.564 . . . . 0.0 110.706 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 24.9 Cg_exo -64.93 100.74 0.36 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 121.989 1.793 . . . . 0.0 112.28 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.699 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 26.3 mp0 -155.85 -104.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.687 HG12 ' SG ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -132.36 11.15 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.195 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' HB2' ' H ' ' A' ' 50' ' ' VAL . 17.7 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.369 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.722 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.048 0 CA-C-O 121.142 0.496 . . . . 0.0 111.854 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.685 ' O ' ' N ' ' A' ' 22' ' ' THR . 52.3 t -88.72 -32.96 0.4 Allowed Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 49.9 Cg_exo -38.47 76.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.229 1.953 . . . . 0.0 113.31 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -84.77 170.21 14.24 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.11 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 9.3 Cg_endo -52.58 -19.22 9.85 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.285 1.99 . . . . 0.0 112.207 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' A' ' 51' ' ' PRO . . . -108.95 -51.0 0.7 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.483 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.3 t -51.74 156.27 1.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.339 0.569 . . . . 0.0 110.304 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -98.75 -42.9 7.0 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.23 53.69 2.44 Favored Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.919 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.19 131.57 9.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.922 -0.639 . . . . 0.0 111.162 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.71 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 92.66 20.87 33.03 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.439 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.768 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t-80 22.08 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.527 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.6 p -61.76 -33.69 58.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.434 ' CG2' ' CD1' ' A' ' 34' ' ' LEU . 1.5 t -132.4 19.94 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.268 0.485 . . . . 0.0 111.475 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.17 16.75 49.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.176 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.434 ' CD1' ' CG2' ' A' ' 32' ' ' THR . 22.3 mt -99.57 3.9 45.6 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.227 0.537 . . . . 0.0 110.055 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.768 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.75 158.49 51.8 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.822 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.15 44.33 0.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.945 1.763 . . . . 0.0 111.268 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.9 m170 93.01 -175.63 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.917 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 43.2 p-80 -141.09 140.27 34.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.434 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 9.3 mtt180 -131.82 33.06 4.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.722 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 38.6 p -165.42 12.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.4 OUTLIER 81.31 -32.63 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.525 0.602 . . . . 0.0 111.633 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -39.78 -31.44 0.11 Allowed 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.208 0.528 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.532 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -109.57 -92.81 2.22 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.917 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.37 108.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 115.151 -0.524 . . . . 0.0 111.089 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.565 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 97.3 Cg_endo -87.53 23.21 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.85 2.366 . . . . 0.0 114.084 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.652 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 14.4 m-70 -110.56 -96.47 0.41 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.571 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' CB ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.98 68.09 0.1 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.962 0.801 . . . . 0.0 110.492 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.519 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -133.64 9.32 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.443 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? 60.96 42.41 12.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.108 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.445 ' O ' ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -152.94 148.6 20.48 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.43 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 50.7 Cg_exo -36.66 -58.18 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.36 2.04 . . . . 0.0 113.044 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.745 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 13.5 Cg_exo -69.0 62.03 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.077 1.851 . . . . 0.0 112.6 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.652 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 18.8 mp0 -166.58 -102.65 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.008 0.433 . . . . 0.0 110.559 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.519 HG22 HD12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -117.09 -32.05 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 11.8 tp . . . . . 0 N--CA 1.466 0.334 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.509 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.694 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.5 mmmm . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 121.32 0.581 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.49 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 34.0 t -113.77 41.31 0.24 Allowed Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 41.1 Cg_endo -89.68 81.33 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.946 1.764 . . . . 0.0 113.296 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.603 HG21 ' CB ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -96.53 152.64 38.74 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.787 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -44.34 -25.1 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . -101.92 -51.54 1.08 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.603 ' CB ' HG21 ' A' ' 22' ' ' THR . 47.9 t -51.1 148.53 4.37 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.053 0.926 . . . . 0.0 110.311 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -96.06 -46.18 6.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 92.63 42.72 4.41 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.429 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -152.94 131.35 12.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.566 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.755 ' O ' ' N ' ' A' ' 33' ' ' GLY . . . 103.62 -4.15 46.65 Favored Glycine 0 C--O 1.219 -0.842 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.453 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.925 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 46.77 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.494 -1.004 . . . . 0.0 111.494 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.463 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 8.1 p -52.28 -32.32 15.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.44 ' OG1' HD13 ' A' ' 34' ' ' LEU . 2.5 t -133.35 21.53 4.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.512 1.051 . . . . 0.0 112.499 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.755 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 66.58 15.68 64.38 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.264 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD13 ' OG1' ' A' ' 32' ' ' THR . 8.9 mt -112.2 6.85 19.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.925 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -117.85 163.14 25.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.054 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 Cg_endo -71.52 42.25 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.505 1.47 . . . . 0.0 111.388 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 2.2 m170 90.73 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 122.921 0.488 . . . . 0.0 109.896 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.714 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 35.5 p-80 -137.66 -54.74 0.67 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.436 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 15.9 mtt180 41.14 25.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.622 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 83.3 p -162.34 17.42 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.462 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 76.36 -33.1 0.21 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 85.5 p -38.62 -31.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.873 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.609 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -122.85 -84.15 0.67 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.714 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 45.96 112.32 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 114.865 -0.667 . . . . 0.0 111.013 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.7 Cg_endo -93.59 12.82 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.737 ' HB3' ' CD ' ' A' ' 53' ' ' GLU . 18.7 m-70 -92.08 -69.63 0.73 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.859 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HA ' HG13 ' A' ' 54' ' ' ILE . 1.7 ptpt 51.01 62.14 2.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.587 ' CB ' ' HG3' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -135.03 14.44 3.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.137 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.52 38.86 0.95 Allowed 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.354 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.556 HG23 ' HG3' ' A' ' 53' ' ' GLU . 2.5 m -130.7 153.46 81.56 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.541 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.508 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 87.7 Cg_exo -27.05 -46.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.988 3.125 . . . . 0.0 114.487 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 86.6 Cg_endo -98.43 46.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.877 2.385 . . . . 0.0 114.543 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.737 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 14.4 mm-40 -149.44 -98.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.648 HG12 ' SG ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -129.64 5.36 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.612 0.365 . . . . 0.0 110.248 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 50' ' ' VAL . 4.0 tt . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.581 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 11.4 mmtt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.374 0.607 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.3 t -72.8 -35.3 2.89 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.017 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 63.5 Cg_exo -37.57 77.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.682 2.255 . . . . 0.0 113.705 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -82.93 173.88 6.88 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -46.99 -20.22 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.46 2.106 . . . . 0.0 112.265 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.46 -58.27 0.55 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.696 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 37.7 t -54.77 156.75 3.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.985 0.422 . . . . 0.0 111.693 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.03 -43.41 6.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.117 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.26 34.5 23.23 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.769 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.558 ' CG2' ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -142.13 45.49 1.66 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.492 0.663 . . . . 0.0 110.68 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.956 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -178.58 57.81 0.09 OUTLIER Glycine 0 C--O 1.217 -0.944 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.775 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.956 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -12.82 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.177 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.492 ' C ' ' HB3' ' A' ' 45' ' ' PRO . 10.0 p -56.25 -31.51 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.492 ' OG1' HD13 ' A' ' 34' ' ' LEU . 1.5 t -131.93 7.44 4.36 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.871 -0.518 . . . . 0.0 110.53 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.18 64.79 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.096 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.492 HD13 ' OG1' ' A' ' 32' ' ' THR . 38.0 mt -93.66 1.05 56.72 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.666 0.746 . . . . 0.0 109.331 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.669 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -116.01 156.86 46.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.286 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 59.2 Cg_endo -73.22 50.87 1.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.32 1.347 . . . . 0.0 111.604 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.583 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.3 m170 92.13 -176.67 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.558 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 27.4 p-80 -132.25 121.28 23.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.8 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.51 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.8 OUTLIER -59.74 -28.28 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.639 -178.098 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 0.8 OUTLIER 173.83 71.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 HD23 ' CG2' ' A' ' 54' ' ' ILE . 0.3 OUTLIER 79.88 -17.75 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.694 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.02 1.04 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.273 0.558 . . . . 0.0 109.788 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.649 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -128.93 -85.47 0.45 Allowed Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.58 ' O ' ' O ' ' A' ' 43' ' ' GLY . 1.8 t 44.46 113.49 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.68 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.638 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 4.8 Cg_endo -101.61 1.28 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.808 3.005 . . . . 0.0 113.252 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.66 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 22.5 m-70 -75.53 -92.03 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.145 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.604 ' HG3' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 63.71 65.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.091 -0.381 . . . . 0.0 111.935 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.495 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 7.2 t0 -129.63 -6.21 4.64 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.371 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.482 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 64.2 ttt-85 58.34 118.46 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.809 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 24.7 t 99.23 -72.43 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.886 0.874 . . . . 0.0 112.598 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.809 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 29.8 Cg_endo -74.4 -179.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.135 1.223 . . . . 0.0 111.955 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 60.9 Cg_exo -53.2 98.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.208 1.939 . . . . 0.0 112.478 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.66 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.1 mp0 -149.76 -105.03 0.07 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.604 HD12 ' HG3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -118.39 -15.68 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.754 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.729 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.1 mttp . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.294 0.568 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.592 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -66.32 164.43 30.82 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.613 ' CG ' ' HA ' ' A' ' 54' ' ' ILE . 37.3 Cg_exo -25.18 -70.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.501 3.468 . . . . 0.0 114.06 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.585 ' OG1' ' HD2' ' A' ' 23' ' ' PRO . 0.6 OUTLIER -163.83 176.12 2.39 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.151 -178.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.585 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 81.4 Cg_exo -46.9 -27.56 5.95 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.949 1.766 . . . . 0.0 111.081 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -46.95 -57.36 6.95 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.711 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 42.3 t -55.91 157.6 4.31 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -84.06 -39.1 19.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.703 0.287 . . . . 0.0 111.311 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' HA2' ' NE2' ' A' ' 38' ' ' HIS . . . 69.3 43.91 68.23 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.29 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.2 133.64 16.5 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.782 -0.709 . . . . 0.0 111.017 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.623 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 88.61 24.9 31.75 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.926 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.2 t-80 24.55 -156.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.311 0.644 . . . . 0.0 112.07 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 15.0 p -70.11 -34.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.434 ' CG2' ' CD1' ' A' ' 34' ' ' LEU . 1.5 t -127.01 18.95 7.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.373 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.39 14.71 42.6 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.299 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.434 ' CD1' ' CG2' ' A' ' 32' ' ' THR . 21.1 mt -96.4 1.62 51.91 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.278 0.561 . . . . 0.0 110.172 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.797 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.52 156.82 55.31 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.734 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.8 Cg_exo -70.91 45.41 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.86 1.707 . . . . 0.0 111.72 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 6.1 m170 95.72 -173.52 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.887 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 28.6 p-80 -140.31 -48.91 0.45 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.766 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.479 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 42.22 22.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.217 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 52.6 p -163.48 17.13 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 77.84 -7.53 1.81 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.045 0.384 . . . . 0.0 111.765 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -53.63 -22.87 9.54 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.536 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -146.15 -72.61 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.887 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.9 t 53.26 112.0 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.012 -0.594 . . . . 0.0 111.163 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.603 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 57.4 Cg_endo -98.16 35.51 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.234 2.623 . . . . 0.0 114.362 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.683 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 18.7 m-70 -118.88 -99.83 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.249 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.49 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.9 69.83 0.11 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-N 118.633 0.651 . . . . 0.0 110.243 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -136.33 10.81 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.155 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 49' ' ' ARG . 1.4 ttt85 57.18 43.96 23.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.175 0.512 . . . . 0.0 111.737 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.509 ' CG1' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -141.86 152.85 63.43 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.527 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 3.6 Cg_exo -35.28 -58.64 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.767 2.311 . . . . 0.0 112.817 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.67 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 94.3 Cg_endo -79.85 65.79 8.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.605 2.203 . . . . 0.0 113.764 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.711 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.5 mp0 -163.15 -101.93 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 112.22 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.613 ' HA ' ' CG ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -165.16 29.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 pt? . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.001 -178.537 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 22' ' ' THR . 30.2 t -81.31 -34.97 0.75 Allowed Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 75.9 Cg_exo -44.34 82.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.138 1.892 . . . . 0.0 113.091 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -89.63 173.79 5.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.889 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 3.6 Cg_endo -45.51 -23.13 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.615 2.21 . . . . 0.0 112.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.492 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -106.32 -61.35 0.6 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.62 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.5 t -50.95 158.82 0.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.681 0.241 . . . . 0.0 111.071 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -108.42 -29.42 8.83 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.81 44.24 7.86 Favored Glycine 0 CA--C 1.503 -0.664 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.411 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 1.1 m -153.75 129.87 10.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.72 -1.24 . . . . 0.0 108.947 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.879 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.31 59.45 1.74 Allowed Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.431 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.879 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.5 t-80 -24.09 -167.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.879 1.272 . . . . 0.0 113.783 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.472 ' C ' ' HB3' ' A' ' 45' ' ' PRO . 10.9 p -51.51 -32.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.505 ' CG2' HD12 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -129.24 1.73 5.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.963 0.347 . . . . 0.0 110.326 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.89 13.94 78.66 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.505 HD12 ' CG2' ' A' ' 32' ' ' THR . 43.6 mt -95.13 2.01 54.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.834 0.826 . . . . 0.0 109.398 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.706 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.24 160.53 33.78 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.15 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 73.7 Cg_endo -75.71 49.18 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.161 1.241 . . . . 0.0 111.359 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.5 m170 91.03 -176.65 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 44.8 p-80 -136.26 134.78 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.538 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -111.71 15.65 20.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 41' ' ' LEU . 49.7 p -172.76 28.05 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.535 HD23 ' CG2' ' A' ' 54' ' ' ILE . 0.2 OUTLIER 78.59 -24.31 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.57 0.623 . . . . 0.0 111.784 178.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -42.27 -28.48 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.547 . . . . 0.0 109.894 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.607 ' O ' ' O ' ' A' ' 44' ' ' CYS . . . -112.15 -90.51 1.93 Allowed Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.607 ' O ' ' O ' ' A' ' 43' ' ' GLY . 3.7 t 41.61 112.26 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 115.248 -0.476 . . . . 0.0 110.898 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.727 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 3.3 Cg_endo -99.88 1.18 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.489 2.793 . . . . 0.0 113.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.727 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 38.7 m-70 -72.53 -77.22 0.1 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.32 -177.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' A' ' 46' ' ' HIS . 0.0 OUTLIER 50.96 65.07 1.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.666 ' CB ' ' HG3' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -127.41 -2.49 6.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 176.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.493 ' C ' ' HD2' ' A' ' 51' ' ' PRO . 7.8 ttt180 55.4 116.91 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.668 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 20.3 t 98.56 -62.12 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.668 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.5 Cg_endo -79.22 -179.2 5.21 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.624 1.549 . . . . 0.0 111.944 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 51.7 Cg_exo -54.32 80.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.012 1.808 . . . . 0.0 111.842 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.727 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 23.6 mm-40 -135.84 -107.3 0.21 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.138 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.546 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -108.3 -24.01 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.428 ' HB2' ' OG1' ' A' ' 22' ' ' THR . 5.9 mt . . . . . 0 N--CA 1.467 0.417 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.779 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.589 ' HB3' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.44 -0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 111.278 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.72 ' H ' ' HA ' ' A' ' 40' ' ' SER . 20.8 t -112.83 -42.03 0.08 OUTLIER Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.558 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.599 ' HD3' ' HA ' ' A' ' 40' ' ' SER . 98.6 Cg_exo -46.18 92.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.268 1.979 . . . . 0.0 113.795 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.538 ' HB ' HD21 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -124.04 171.76 6.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.472 178.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 93.2 Cg_exo -45.49 89.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.26 1.973 . . . . 0.0 112.24 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.724 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . 134.67 -60.87 0.64 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.861 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.9 t -48.78 151.63 1.16 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -103.89 -45.7 4.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.666 0.269 . . . . 0.0 111.648 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 84.41 47.85 5.27 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.74 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.637 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -157.0 120.08 4.08 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.041 -0.579 . . . . 0.0 110.934 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 97.03 24.8 12.15 Favored Glycine 0 C--O 1.223 -0.549 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.63 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.737 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.3 t-80 21.78 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 1.06 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 8.4 p -60.14 -35.63 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.049 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.489 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 8.3 p -119.45 6.24 11.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.092 -0.38 . . . . 0.0 111.73 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.23 14.61 62.0 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.733 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.489 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 13.6 mt -106.03 3.67 28.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.375 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.697 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.18 161.04 33.26 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' CG ' ' A' ' 37' ' ' HIS . 6.5 Cg_exo -71.87 47.54 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.589 1.526 . . . . 0.0 110.857 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.637 ' HB3' ' HA ' ' A' ' 28' ' ' THR . 0.3 OUTLIER 78.11 174.08 0.18 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.967 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 49.9 p-80 -123.9 -43.16 2.13 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.607 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.73 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 40.15 23.97 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.9 179.084 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.73 ' OG ' ' O ' ' A' ' 39' ' ' ARG . 58.0 m 145.57 30.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.724 0.64 . . . . 0.0 112.109 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 38' ' ' HIS . 12.0 mt -126.88 -179.42 4.82 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.101 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.3 p -73.94 -1.87 21.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.565 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -71.28 -96.28 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 1.06 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 3.6 t 66.55 124.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 56.3 Cg_endo -99.35 22.63 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.295 2.663 . . . . 0.0 113.908 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.595 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 18.6 m-70 -105.31 -84.3 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.697 -178.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HG3' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 70.94 68.68 0.18 Allowed 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.831 -0.543 . . . . 0.0 110.339 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -116.01 -8.47 11.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.022 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.427 ' O ' HG12 ' A' ' 50' ' ' VAL . 8.6 mmp_? 65.17 38.23 6.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.235 0.541 . . . . 0.0 111.118 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -158.4 170.93 8.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.159 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 84.6 Cg_exo -41.32 -46.89 5.63 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.25 1.967 . . . . 0.0 114.179 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.724 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 66.3 Cg_endo -86.35 84.21 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.391 2.061 . . . . 0.0 115.182 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER 172.62 -100.55 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.339 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.642 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -122.54 -8.68 8.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.435 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.538 HD21 ' HB ' ' A' ' 22' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.035 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 39' ' ' ARG . 23.9 mmtt . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' ' N ' ' A' ' 22' ' ' THR . 44.2 t -80.28 -45.05 1.41 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.497 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 6.7 Cg_endo -51.71 70.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.801 1.668 . . . . 0.0 111.754 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.749 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 82.8 p -98.85 175.57 2.4 Favored Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.749 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -47.07 -21.75 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.509 1.473 . . . . 0.0 110.928 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' GLU . . . -100.52 20.01 50.13 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.935 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.1 t -163.79 158.89 20.65 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.041 0.421 . . . . 0.0 111.631 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.82 -44.78 6.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 77.59 39.67 24.85 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.888 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.612 ' CG2' ' O ' ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.51 46.81 1.29 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.359 0.599 . . . . 0.0 111.315 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.977 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -177.76 48.97 0.1 OUTLIER Glycine 0 C--O 1.218 -0.867 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.79 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.977 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 -6.33 -179.39 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.583 ' C ' ' HB3' ' A' ' 45' ' ' PRO . 10.2 p -54.88 -25.48 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.405 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 21.3 p -125.73 -3.31 7.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.51 66.32 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.405 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 14.2 mt -99.49 2.73 45.2 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.472 0.653 . . . . 0.0 109.404 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.657 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -113.23 157.23 41.58 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 57.2 Cg_endo -71.97 51.31 1.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.22 1.28 . . . . 0.0 111.234 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.573 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.0 m170 90.24 -176.01 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.481 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 26.2 p-80 -130.07 119.52 23.22 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.824 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.495 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -51.85 -30.96 25.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.6 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 6.4 t 160.96 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 O-C-N 123.054 0.221 . . . . 0.0 111.329 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HG ' ' C ' ' A' ' 40' ' ' SER . 2.2 mt 78.35 -27.41 0.17 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -49.64 -23.87 1.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.344 179.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.541 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -133.49 -88.03 0.33 Allowed Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.528 ' O ' ' O ' ' A' ' 43' ' ' GLY . 1.2 t 42.71 109.72 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.522 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.694 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -102.54 -2.29 0.35 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.795 2.997 . . . . 0.0 113.288 -179.324 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.658 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 44.3 m-70 -63.64 -80.01 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.765 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 12.2 pttt 57.25 57.1 4.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.46 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -120.17 -10.82 9.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.573 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 20.0 ttp180 46.66 48.24 14.49 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.726 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -159.61 -57.72 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 120.64 0.257 . . . . 0.0 110.71 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.726 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 21.2 Cg_endo -97.03 -171.99 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.933 3.089 . . . . 0.0 110.217 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.681 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 12.5 Cg_endo -56.5 79.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.25 1.3 . . . . 0.0 110.737 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.658 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.0 OUTLIER -124.16 -107.75 0.33 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.813 -178.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.5 ' CG1' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -140.58 13.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 110.328 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.573 ' HB3' ' HA ' ' A' ' 49' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.095 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 120.892 0.377 . . . . 0.0 110.746 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.7 t -118.15 26.61 0.11 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 28.5 Cg_endo -62.9 69.97 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.088 1.192 . . . . 0.0 112.181 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 20' ' ' CYS . 21.7 m -80.33 135.88 53.5 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.443 ' HD2' HG23 ' A' ' 22' ' ' THR . 97.4 Cg_exo -42.33 -26.51 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 111.667 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.658 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -103.76 -50.33 1.03 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.887 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.502 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 46.2 t -42.81 155.33 0.05 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.487 0.644 . . . . 0.0 111.228 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -101.77 -34.88 9.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 81.15 38.21 15.96 Favored Glycine 0 CA--C 1.502 -0.75 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.654 ' CG2' ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -159.57 62.85 0.38 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.85 -1.175 . . . . 0.0 108.572 -179.17 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 177.99 54.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.608 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.608 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.8 t-80 -37.52 176.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 45' ' ' PRO . 13.1 p -47.0 -30.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.502 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.44 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 15.0 p -126.63 -2.52 6.7 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.074 -0.391 . . . . 0.0 109.966 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.82 14.94 66.14 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 15.5 mt -100.96 4.7 42.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.715 0.769 . . . . 0.0 109.119 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -111.48 159.53 32.73 Favored Pre-proline 0 N--CA 1.448 -0.548 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.142 179.472 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 37' ' ' HIS . 61.1 Cg_endo -73.21 49.08 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.222 1.282 . . . . 0.0 111.113 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.518 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.6 m170 88.64 -173.97 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.514 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 29.6 p-80 -139.26 -50.94 0.52 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.335 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.497 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.1 OUTLIER 41.05 20.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.506 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 4.8 p -161.09 18.27 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 40' ' ' SER . 2.7 mt 71.62 5.72 5.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.892 0.314 . . . . 0.0 111.576 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.478 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 12.9 m -67.97 -4.43 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.455 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -156.92 -72.29 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.436 ' SG ' ' CG2' ' A' ' 54' ' ' ILE . 4.7 t 20.31 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.066 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.608 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 3.4 Cg_endo -105.7 5.88 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.703 3.602 . . . . 0.0 112.097 178.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.746 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 86.1 m-70 -39.01 -67.85 0.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.982 -177.135 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.704 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER 54.62 69.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.568 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -127.82 -8.79 5.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.563 179.629 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.637 ' C ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER 46.02 33.23 1.59 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.173 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.637 HG22 ' C ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -171.37 -75.33 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.624 177.834 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.526 ' CD ' HG21 ' A' ' 50' ' ' VAL . 49.9 Cg_endo -67.8 178.1 3.66 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 111.581 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.658 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 2.0 Cg_endo -41.77 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.364 2.043 . . . . 0.0 111.576 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.746 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.9 OUTLIER -150.1 -110.75 0.06 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.633 ' H ' ' CG ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -146.85 11.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.049 0.939 . . . . 0.0 108.883 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.7 tp . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.953 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 1.644 ' HA ' ' CG ' ' A' ' 16' ' ' ARG 1.061 0.0 OUTLIER . . . . . 3 C--O 0.325 -47.601 2 N-CA-C 145.341 12.719 . . . . 8.22 145.341 . . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 1.587 ' HA ' ' CG ' ' A' ' 17' ' ' GLU 0.919 5.8 mt-10 97.52 -113.15 0.0 OUTLIER 'General case' 4 C--O 0.156 -56.472 5 O-C-N 61.523 -38.236 . . . . 7.1 144.321 -179.8 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 1.609 ' HB3' ' CA ' ' A' ' 18' ' ' SER 0.769 73.6 m -83.22 166.22 18.76 Favored 'General case' 4 C--O 0.255 -51.25 4 CA-C-N 169.722 23.874 . . . . 4.99 126.912 179.236 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 1.633 ' HZ3' ' CD ' ' A' ' 19' ' ' LYS 0.789 0.4 OUTLIER -129.05 -177.85 4.39 Favored 'General case' 2 N--CA 0.861 -29.895 4 O-C-N 83.215 -24.678 . . . . 4.62 129.976 179.947 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 1.098 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 48.9 t -86.73 -22.85 0.29 Allowed Pre-proline 2 C--O 1.002 -11.945 1 CA-C-O 130.826 5.108 . . . . 0.88 112.712 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 1.098 ' HD2' ' N ' ' A' ' 20' ' ' CYS 0.288 14.8 Cg_exo -52.21 81.69 0.02 OUTLIER 'Trans proline' 3 C--N 1.0 -17.806 2 O-C-N 105.253 -8.341 . . . . 3.39 121.264 -178.869 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 1.559 HG21 ' CB ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -92.84 167.62 14.05 Favored Pre-proline 2 C--N 1.143 -8.406 0 CA-C-N 114.023 -1.444 . . . . 2.54 114.559 -179.675 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.423 ' HD2' ' CG2' ' A' ' 22' ' ' THR . 27.9 Cg_exo -43.77 -21.96 0.39 Allowed 'Trans proline' 2 C--O 1.084 -7.205 0 C-N-CA 123.532 2.821 . . . . 1.88 113.082 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.691 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -107.49 -54.83 0.64 Allowed Glycine 3 C--O 1.083 -9.328 0 O-C-N 118.409 -2.682 . . . . 1.34 114.177 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 42.4 t -54.72 155.18 4.38 Favored 'General case' 1 C--N 1.198 -5.98 1 O-C-N 115.373 -4.604 . . . . 0.63 110.856 -179.69 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 1.01 ' OD2' ' CB ' ' A' ' 26' ' ' ASP . 26.5 t0 -102.11 -40.26 6.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.061 0.458 . . . . 1.58 111.494 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 48.43 4.72 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.626 -0.797 . . . . 0.45 111.636 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.416 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -154.66 113.67 3.65 Favored 'General case' 1 C--O 1.05 -9.428 0 CA-C-O 124.055 1.883 . . . . 1.33 110.621 -179.6 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 1.011 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 113.11 29.37 3.04 Favored Glycine 2 C--N 1.162 -9.094 1 O-C-N 113.307 -5.871 . . . . 0.99 113.099 179.66 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 1.011 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 11.51 -167.24 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.377 0 O-C-N 119.95 -1.912 . . . . 0.37 112.885 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 1.023 HG11 ' CB ' ' A' ' 31' ' ' VAL . 14.1 p -59.73 -32.59 49.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.415 0.894 . . . . 1.13 113.415 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 1.591 ' HG1' ' CB ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.18 8.07 7.9 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.85 -0.531 . . . . 1.89 111.259 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.35 15.0 62.88 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.645 -0.788 . . . . 0.49 111.163 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.007 HD13 ' CG ' ' A' ' 34' ' ' LEU . 15.7 mt -101.96 3.98 39.52 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.266 0.555 . . . . 1.37 110.379 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.711 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.2 160.23 36.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.387 -0.824 . . . . 0.86 109.387 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.536 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 9.8 Cg_endo -72.69 46.66 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.573 1.515 . . . . 0.99 111.239 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.0 m170 89.65 -177.65 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.697 -0.853 . . . . 0.67 108.697 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 1.281 ' C ' ' CA ' ' A' ' 39' ' ' ARG . 42.1 p-80 -133.08 19.62 4.08 Favored 'General case' 1 C--O 0.634 -31.304 1 CA-C-O 176.774 26.988 . . . . 1.18 110.38 178.696 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 1.552 ' HG2' ' CD ' ' A' ' 39' ' ' ARG . 22.3 mtt180 -1.92 10.1 0.0 OUTLIER 'General case' 2 C--N 0.573 -33.156 3 O-C-N 8.928 -71.108 . . . . 5.86 118.508 177.803 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 1.413 ' OG ' ' CA ' ' A' ' 40' ' ' SER . 7.9 p -173.82 30.46 0.01 OUTLIER 'General case' 2 N--CA 1.318 -7.064 0 N-CA-C 118.899 2.925 . . . . 2.53 118.899 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 1.497 ' CD2' ' CG ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 87.76 -43.86 0.03 OUTLIER 'General case' 1 C--O 0.833 -20.858 0 CA-C-O 127.14 3.353 . . . . 2.82 116.281 179.143 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 1.431 ' HG ' ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER -35.48 -25.78 0.01 OUTLIER 'General case' 1 C--N 0.987 -15.179 3 O-C-N 100.76 -13.713 . . . . 2.12 111.608 179.396 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . -123.6 -88.99 0.87 Allowed Glycine 1 C--N 1.248 -4.333 0 O-C-N 120.365 -1.46 . . . . 0.49 110.731 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.711 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.1 t 48.9 109.8 0.01 OUTLIER Pre-proline 0 C--O 1.191 -1.977 0 CA-C-N 115.366 -0.417 . . . . 0.74 111.167 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.676 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 42.6 Cg_endo -96.83 18.45 0.56 Allowed 'Trans proline' 0 C--O 1.169 -2.926 0 C-N-CA 123.821 3.014 . . . . 1.5 115.383 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.668 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 33.9 m-70 -94.18 -83.09 0.34 Allowed 'General case' 1 C--N 1.207 -5.605 0 O-C-N 118.876 -2.39 . . . . 0.92 111.734 -177.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.622 ' HZ3' ' CE ' ' A' ' 47' ' ' LYS 0.273 0.6 OUTLIER 67.59 62.14 0.44 Allowed 'General case' 2 CA--C 1.316 -8.043 0 N-CA-C 118.336 2.717 . . . . 3.99 118.336 179.938 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 1.34 ' OD1' ' CB ' ' A' ' 48' ' ' ASP 0.322 1.5 t0 -135.94 6.9 3.17 Favored 'General case' 2 N--CA 1.275 -9.215 1 CA-C-O 129.55 4.5 . . . . 3.5 120.243 178.955 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 1.618 ' HD3' ' CG ' ' A' ' 49' ' ' ARG . 2.2 ptt180 56.53 87.27 0.06 Allowed 'General case' 2 C--O 0.679 -28.96 2 O-C-N 114.286 -5.259 . . . . 5.94 118.085 179.431 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 1.579 HG21 ' CB ' ' A' ' 50' ' ' VAL . 1.9 t 142.54 -113.12 0.0 OUTLIER Pre-proline 3 C--N 0.943 -17.065 4 O-C-N 90.607 -20.058 . . . . 3.38 115.5 177.269 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.354 ' HB2' ' CD ' ' A' ' 52' ' ' PRO 0.445 2.2 Cg_endo -56.64 -139.95 0.0 OUTLIER 'Trans proline' 4 C--N 0.752 -30.857 3 O-C-N 93.03 -14.774 . . . . 3.89 126.842 -179.35 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 1.354 ' CD ' ' HB2' ' A' ' 51' ' ' PRO . 1.6 Cg_endo -62.47 79.13 0.1 Allowed 'Trans proline' 2 C--N 1.129 -11.013 0 O-C-N 118.441 -1.4 . . . . 2.18 114.319 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 1.404 ' HG3' ' CB ' ' A' ' 53' ' ' GLU . 3.8 mp0 -151.55 -103.64 0.06 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.33 -0.857 . . . . 2.29 111.665 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 1.028 ' O ' ' N ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -132.82 2.16 1.55 Allowed 'Isoleucine or valine' 1 C--O 1.142 -4.586 0 CA-C-O 118.712 -0.661 . . . . 1.31 109.583 -179.712 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.56 ' CD2' ' CB ' ' A' ' 55' ' ' LEU . 1.1 tp -17.71 -10.43 0.0 OUTLIER 'General case' 2 CA--C 1.351 -6.69 1 CA-C-O 136.579 7.847 . . . . 3.16 117.136 -178.959 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 1.456 ' HB1' ' C ' ' A' ' 56' ' ' ALA 0.933 . . -133.42 6.5 3.82 Favored 'General case' 4 C--N 0.889 -19.454 4 N-CA-C 148.576 13.917 . . . . 3.83 148.576 -179.721 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 1.497 ' CG ' ' CD2' ' A' ' 41' ' ' LEU 0.336 0.0 OUTLIER -54.0 -163.71 0.0 OUTLIER 'General case' 4 C--O 0.462 -40.357 2 O-C-N 106.839 -9.913 . . . . 5.04 106.539 -179.973 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 1.631 ' HE1' ' CD2' ' A' ' 58' ' ' HIS 0.687 14.0 m170 -89.94 -36.3 15.08 Favored 'General case' 4 C--O 0.411 -43.074 5 CA-C-O 158.019 18.057 . . . . 6.54 131.318 -179.485 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.55 ' HG2' ' CB ' ' A' ' 59' ' ' GLU 0.529 2.0 mt-10 -116.75 -35.92 4.04 Favored 'General case' 4 C--N 0.551 -34.113 4 O-C-N 40.191 -51.568 . . . . 5.66 109.746 -179.892 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 1.527 HD22 ' CB ' ' A' ' 60' ' ' ASN 0.766 1.4 m-20 -124.13 105.32 9.44 Favored 'General case' 4 C--N 0.702 -27.572 5 O-C-N 84.301 -23.999 . . . . 6.72 135.775 179.894 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 1.615 HG22 ' CG1' ' A' ' 61' ' ' VAL 0.443 27.1 m -84.19 152.64 3.74 Favored 'Isoleucine or valine' 4 C--N 0.761 -25.01 3 O-C-N 92.275 -19.016 . . . . 3.83 114.079 179.982 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 1.551 HD23 ' CB ' ' A' ' 62' ' ' LEU 0.402 7.5 tt 57.19 -40.67 0.04 OUTLIER 'General case' 4 C--O 0.433 -41.914 2 CA-C-O 137.146 8.117 . . . . 4.44 108.571 179.82 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 1.556 ' HG3' ' CE ' ' A' ' 63' ' ' LYS 0.751 4.7 tttm . . . . . 4 C--O 0.55 -35.739 4 O-C-N 70.002 -32.936 . . . . 6.94 118.484 179.828 . . . . . . . . 4 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 18' ' ' SER . 0.7 OUTLIER -132.83 65.62 1.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 3.4 t 85.34 -14.84 0.55 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.851 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 3.4 mttt 57.82 156.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.22 0.533 . . . . 0.0 111.364 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.702 ' O ' ' N ' ' A' ' 22' ' ' THR . 50.9 t -74.68 -36.64 2.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.335 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 72.4 Cg_exo -48.56 73.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.931 1.754 . . . . 0.0 111.822 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.702 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -79.53 172.99 8.46 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.323 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 94.9 Cg_exo -41.84 -28.15 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.191 1.927 . . . . 0.0 111.31 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.539 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -94.73 -70.35 1.09 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.095 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 22.7 t -50.97 159.39 0.58 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.891 0.346 . . . . 0.0 110.95 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -109.76 -41.61 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 92.53 60.55 1.22 Allowed Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.42 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.72 129.38 8.46 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.249 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.689 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.16 22.36 32.7 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.125 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.738 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 23.42 -160.9 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 123.436 0.695 . . . . 0.0 112.585 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.524 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.5 p -62.25 -33.41 58.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' CG2' ' CD1' ' A' ' 34' ' ' LEU . 2.4 t -133.89 21.76 3.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.412 0.551 . . . . 0.0 111.415 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.31 16.84 44.32 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' CD1' ' CG2' ' A' ' 32' ' ' THR . 20.5 mt -99.48 4.53 46.09 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.14 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.738 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.41 157.45 58.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.444 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.1 Cg_endo -70.96 47.11 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.427 1.418 . . . . 0.0 111.041 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.513 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 5.1 m80 88.47 -179.39 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.958 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 52.9 p-80 -130.61 104.14 7.03 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.188 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.494 ' O ' ' HB3' ' A' ' 40' ' ' SER . 4.5 mtt180 -71.16 -1.85 13.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.718 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.588 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 72.7 p 175.03 61.1 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.531 HD23 ' HG3' ' A' ' 57' ' ' MET . 0.5 OUTLIER 76.93 -161.3 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.398 178.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.437 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER 64.57 -2.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 41' ' ' LEU . . . -147.27 -98.32 0.21 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.958 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.5 t 52.9 105.87 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.571 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.627 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 93.3 Cg_endo -90.6 34.89 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.142 2.562 . . . . 0.0 114.367 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.808 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.8 m-70 -121.12 -92.07 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.961 -0.695 . . . . 0.0 112.507 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 75.25 67.74 0.08 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.26 0.482 . . . . 0.0 111.192 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB3' ' OE1' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -151.63 18.52 0.71 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.913 0.387 . . . . 0.0 111.012 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.602 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 6.2 ptt-85 50.74 -177.64 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.605 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 70.2 t 26.72 -85.38 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.144 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 69.0 Cg_exo -46.34 168.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.269 0 CA-C-N 120.709 1.289 . . . . 0.0 111.872 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.539 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 7.6 Cg_endo -49.85 96.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.425 2.083 . . . . 0.0 112.173 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.808 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 3.8 mp0 -154.62 -102.43 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.491 HG22 ' HG3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -147.58 19.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.995 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.562 ' HB2' ' N ' ' A' ' 50' ' ' VAL . 15.3 tp -46.92 -29.0 1.8 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.284 0.564 . . . . 0.0 111.018 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' CG2' ' A' ' 22' ' ' THR . . . -109.67 42.61 1.46 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.276 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.531 ' HG3' HD23 ' A' ' 41' ' ' LEU . 9.8 ttt -66.03 -80.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.482 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 57' ' ' MET . 33.7 p80 173.64 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.012 0.434 . . . . 0.0 110.488 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 9.7 tt0 -133.92 -40.22 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.546 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.88 40.01 1.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.773 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.0 m -71.81 158.7 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.741 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.602 ' HA ' ' HB3' ' A' ' 49' ' ' ARG . 6.9 mp 62.52 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.897 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.924 0.392 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 62.05 113.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.524 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 p 63.81 115.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.603 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.497 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -90.32 -176.27 4.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.044 0.449 . . . . 0.0 110.027 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.661 ' O ' ' N ' ' A' ' 22' ' ' THR . 16.7 t -77.14 -54.78 1.48 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.158 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 9.7 Cg_endo -53.09 70.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.072 1.848 . . . . 0.0 112.051 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.661 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -110.4 -177.45 0.46 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.997 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 22' ' ' THR . 83.9 Cg_exo -46.86 -18.75 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.719 1.613 . . . . 0.0 112.691 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.92 12.44 52.92 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.884 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 26' ' ' ASP . 41.7 t -153.65 162.81 40.92 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.854 0.327 . . . . 0.0 110.57 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 25.4 t0 -103.94 -41.94 5.72 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.975 0.417 . . . . 0.0 109.883 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.531 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 86.79 54.21 2.69 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.944 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -156.75 131.79 9.06 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.362 -0.419 . . . . 0.0 111.487 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.6 21.29 34.73 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.425 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.9 t-80 24.36 -159.19 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 122.996 0.518 . . . . 0.0 112.189 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 43' ' ' GLY . 10.5 p -70.03 -34.51 59.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.435 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 10.7 p -116.72 6.53 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.204 -0.31 . . . . 0.0 111.557 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 65.03 14.4 58.95 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.812 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 18.8 mt -102.58 1.77 35.26 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.739 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.14 158.32 41.34 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.373 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.9 Cg_endo -71.32 46.43 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.457 1.438 . . . . 0.0 111.329 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m170 89.11 -179.44 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.957 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 51.5 p-80 -130.73 108.52 9.94 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.875 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -56.06 -22.83 29.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.668 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.497 ' HB3' ' CB ' ' A' ' 19' ' ' LYS . 4.4 p 168.61 86.83 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.571 ' C ' ' H ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER 79.24 -170.79 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.502 0.191 . . . . 0.0 110.511 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.475 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 68.7 m 66.35 -8.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 41' ' ' LEU . . . -145.99 -101.3 0.3 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.957 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 55.24 104.92 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.615 -0.293 . . . . 0.0 111.246 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.607 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 70.3 Cg_endo -92.16 34.72 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.13 2.554 . . . . 0.0 114.207 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.652 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 11.2 m-70 -122.16 -83.02 0.66 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.356 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.547 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 71.92 65.17 0.14 Allowed 'General case' 0 N--CA 1.461 0.119 0 O-C-N 122.156 -0.34 . . . . 0.0 111.199 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -152.81 15.79 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.401 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.467 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 2.6 ttm180 43.67 -169.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.671 ' HB ' ' CD ' ' A' ' 51' ' ' PRO . 88.7 t 37.45 -91.07 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.114 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.671 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 10.1 Cg_endo -54.09 -175.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.254 1.303 . . . . 0.0 112.109 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 27.6 Cg_exo -62.19 95.84 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.283 1.988 . . . . 0.0 111.536 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.652 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 19.4 mp0 -152.11 -103.23 0.05 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.929 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.547 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -136.14 7.94 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 50' ' ' VAL . 0.8 OUTLIER -46.58 -30.11 2.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.151 0.5 . . . . 0.0 110.965 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -47.83 -29.65 3.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.153 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.435 ' HG2' ' CD2' ' A' ' 41' ' ' LEU . 40.4 mtp -61.66 102.77 0.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.913 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.97 -34.24 71.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -67.02 -53.82 27.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -136.15 96.28 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.025 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 35.6 m -76.3 151.84 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.261 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.456 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 0.7 OUTLIER 83.76 -24.42 0.16 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.855 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.824 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 120.71 0.291 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -75.68 154.16 36.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.003 0.43 . . . . 0.0 111.806 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.76 129.28 39.8 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.508 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -143.97 -52.02 0.32 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.249 0.547 . . . . 0.0 111.899 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 22' ' ' THR . 49.5 t -72.13 -26.58 0.86 Allowed Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 71.9 Cg_exo -50.51 74.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.558 1.505 . . . . 0.0 112.388 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -83.78 172.54 9.0 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 88.1 Cg_exo -44.49 -27.93 2.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.243 1.962 . . . . 0.0 111.839 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . -97.42 -69.1 0.97 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.357 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 24.0 t -46.04 157.52 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 111.716 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -112.51 -30.72 7.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.81 58.75 2.08 Favored Glycine 0 CA--C 1.506 -0.512 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.452 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.403 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -161.51 128.67 4.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.426 -0.887 . . . . 0.0 109.738 -179.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.979 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.62 50.33 3.6 Favored Glycine 0 C--O 1.219 -0.801 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.03 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.979 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 -12.3 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.428 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 13.1 p -52.39 -37.36 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.888 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.448 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 17.9 p -114.02 -7.28 13.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.819 0.342 . . . . 0.0 110.156 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.79 80.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.448 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 12.1 mt -97.06 1.38 50.05 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.702 0.763 . . . . 0.0 109.163 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.74 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -110.33 161.21 25.46 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.771 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 74.2 Cg_endo -76.63 49.32 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.261 1.308 . . . . 0.0 111.265 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.3 m170 90.46 -176.4 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.574 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 48.3 p-80 -134.98 -53.96 0.8 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.511 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 39.96 33.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.463 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 41' ' ' LEU . 28.3 p -143.95 -68.46 0.33 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.792 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.468 ' CB ' ' O ' ' A' ' 40' ' ' SER . 0.4 OUTLIER 157.72 -52.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.548 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.3 p -41.55 -30.32 0.21 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.796 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' CYS . . . -100.41 -106.06 2.79 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.542 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.0 t 49.77 108.07 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.954 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.734 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 9.2 Cg_endo -96.29 2.0 2.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.143 2.562 . . . . 0.0 113.373 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.641 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 47.1 m-70 -70.2 -80.29 0.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.623 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 0.2 OUTLIER 53.82 61.72 2.95 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.455 0.645 . . . . 0.0 110.853 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.551 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.16 -6.25 12.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.902 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 0.4 OUTLIER 47.81 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.721 ' HB ' ' CD ' ' A' ' 51' ' ' PRO . 88.8 t 107.44 -81.76 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.351 1.061 . . . . 0.0 110.518 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.721 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 12.7 Cg_endo -56.41 -171.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.767 1.645 . . . . 0.0 111.115 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.524 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 25.1 Cg_exo -65.83 108.63 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.224 1.949 . . . . 0.0 111.768 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.641 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 2.0 pm0 -158.84 -103.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.487 HG12 ' SG ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -120.52 -8.73 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.504 ' C ' ' H ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 42.07 27.1 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.949 -179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.3 -24.36 0.16 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.504 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER 68.16 -81.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.59 0.233 . . . . 0.0 111.109 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -83.58 -46.96 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.66 -170.45 1.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -110.77 102.53 11.06 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.851 0.357 . . . . 0.0 111.217 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.418 ' CG1' HG23 ' A' ' 50' ' ' VAL . 6.8 t 68.79 127.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.554 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 49' ' ' ARG . 17.0 tp 75.21 -80.38 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.646 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.784 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.865 0.364 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -148.97 -79.32 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.528 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.07 131.29 54.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.175 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 11.4 mmtm -97.66 -170.07 1.94 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.154 0.502 . . . . 0.0 111.391 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.6 t -88.48 -42.08 0.47 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.355 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 74.2 Cg_exo -48.35 76.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.991 1.794 . . . . 0.0 112.212 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -90.63 175.64 3.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.67 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.549 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 64.6 Cg_exo -40.57 -27.97 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 112.622 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.637 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -93.8 -72.96 1.2 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.542 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -46.13 158.8 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 111.499 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -103.64 -37.52 7.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.791 0.329 . . . . 0.0 110.901 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 85.04 40.9 7.79 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.665 ' CG2' ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -158.16 62.44 0.45 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.864 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 176.59 57.24 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.624 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.5 t-80 -37.92 173.91 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.372 0.606 . . . . 0.0 112.298 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.594 ' HA ' ' HB3' ' A' ' 45' ' ' PRO . 13.6 p -48.44 -33.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.519 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.45 ' OG1' ' CG ' ' A' ' 34' ' ' LEU . 7.9 p -122.84 -1.79 8.86 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.155 -0.341 . . . . 0.0 110.16 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.57 15.63 64.28 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.45 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 23.7 mt -99.93 6.07 45.22 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.948 0.88 . . . . 0.0 108.747 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.583 ' CD2' ' CE1' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.42 155.96 46.45 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.165 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.493 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 3.0 Cg_exo -73.48 51.39 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.658 1.572 . . . . 0.0 110.574 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.504 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 6.3 m170 89.47 -174.36 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.523 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 26.5 p-80 -130.5 124.69 32.53 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.323 0.582 . . . . 0.0 111.121 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -54.47 -35.67 63.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.404 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 23.0 p 169.43 84.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.587 HD23 ' CG ' ' A' ' 57' ' ' MET . 7.6 mt 75.04 -8.33 1.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -53.06 -27.21 18.85 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.382 0.611 . . . . 0.0 109.376 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.428 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -133.15 -77.17 0.11 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 54' ' ' ILE . 4.6 t 26.81 92.58 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.624 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 6.2 Cg_endo -105.16 2.46 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.448 3.432 . . . . 0.0 112.959 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.654 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 92.6 m-70 -37.19 -57.39 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.74 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.647 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 6.0 mttt -175.1 -62.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.263 0.554 . . . . 0.0 110.626 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 26.1 t70 132.03 -14.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.032 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 3.5 ttp180 -70.59 145.95 50.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.318 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . 1.7 p -42.15 -46.37 10.44 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.725 ' O ' ' N ' ' A' ' 53' ' ' GLU . 7.6 Cg_endo -49.15 178.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.769 1.646 . . . . 0.0 111.235 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.637 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 4.1 Cg_endo -46.21 69.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.661 2.241 . . . . 0.0 112.845 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.725 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.5 mt-10 -145.11 -106.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.501 ' CG1' ' HA ' ' A' ' 48' ' ' ASP . 0.8 OUTLIER -126.41 -6.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 0.8 OUTLIER 53.13 26.3 4.86 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.727 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 48' ' ' ASP . . . 61.91 22.06 12.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.563 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.587 ' CG ' HD23 ' A' ' 41' ' ' LEU . 20.7 mtt 65.34 -73.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.865 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.11 -177.86 3.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.77 -28.25 3.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.574 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 55' ' ' LEU . 83.7 m-20 -61.01 171.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.722 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 61' ' ' VAL . 18.5 m -134.62 137.06 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' CB ' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER 63.34 176.63 0.16 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.712 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 tptp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.883 179.751 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.029 0.442 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -141.52 -60.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.126 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -137.46 174.77 10.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.527 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.556 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 4.8 mmtp -129.91 179.04 6.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.397 0.618 . . . . 0.0 111.742 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 22' ' ' THR . 51.0 t -87.94 -35.21 0.44 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.957 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 94.8 Cg_exo -44.45 73.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.268 1.979 . . . . 0.0 112.803 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -81.17 171.66 11.68 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.162 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 96.2 Cg_exo -41.08 -28.51 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.394 2.063 . . . . 0.0 111.891 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -96.44 -64.1 0.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.195 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.6 t -56.15 158.58 3.93 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.836 0.35 . . . . 0.0 111.272 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -110.46 -35.73 5.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.608 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 89.23 56.48 1.92 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.856 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.8 OUTLIER -158.96 131.46 6.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.985 -0.607 . . . . 0.0 111.082 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 94.94 20.6 27.93 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.246 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.737 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 23.2 -163.21 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 123.647 0.779 . . . . 0.0 112.798 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 13.8 p -63.23 -33.68 62.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.421 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.3 t -130.05 18.25 5.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.016 -0.427 . . . . 0.0 111.348 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.97 15.22 48.74 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.351 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.421 HD12 ' CG2' ' A' ' 32' ' ' THR . 18.7 mt -97.88 4.85 49.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 120.99 0.424 . . . . 0.0 110.068 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.737 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.8 158.05 58.14 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.877 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.3 Cg_exo -71.37 46.83 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.8 1.667 . . . . 0.0 111.078 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 6.6 m170 91.9 -176.24 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.673 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 26.9 p-80 -128.42 121.7 29.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.281 0.562 . . . . 0.0 110.528 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.41 -29.22 67.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.202 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 39' ' ' ARG . 24.1 p 175.51 73.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.5 OUTLIER 78.84 -15.54 0.75 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 178.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -22.99 1.29 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.226 0.536 . . . . 0.0 109.894 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.628 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.52 -82.6 0.15 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.673 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 47.76 110.08 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 114.874 -0.663 . . . . 0.0 111.315 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.604 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 14.6 Cg_endo -102.69 30.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.492 2.795 . . . . 0.0 113.179 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.801 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 67.3 m-70 -98.18 -90.87 0.27 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.68 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 40.0 mmtt -161.07 -74.77 0.06 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 110.988 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.68 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 22.7 t0 158.21 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.073 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.807 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -56.42 129.56 41.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.258 -179.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 2.4 t -29.83 -50.66 0.32 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.92 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.9 Cg_exo -51.67 -170.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.24 1.96 . . . . 0.0 111.873 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 74.9 Cg_exo -50.47 64.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.679 2.253 . . . . 0.0 113.645 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.801 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.9 mm-40 -139.7 -106.21 0.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 119.918 -0.087 . . . . 0.0 111.091 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.587 HG21 ' SG ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -129.69 -21.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.916 -0.49 . . . . 0.0 111.547 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.495 ' HG ' HG22 ' A' ' 61' ' ' VAL . 4.7 tt 56.24 14.65 1.61 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' HIS . . . 45.17 25.87 0.21 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 mtp 44.36 -87.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.496 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' ALA . 11.3 p80 -124.98 165.22 18.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.727 0.298 . . . . 0.0 110.593 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 58.84 99.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.029 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.9 t30 60.59 167.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.495 HG22 ' HG ' ' A' ' 55' ' ' LEU . 11.2 p -168.87 166.56 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.431 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.807 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 2.2 tt 62.9 123.94 0.01 OUTLIER 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.48 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.09 175.04 8.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.868 0.366 . . . . 0.0 111.162 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -163.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.296 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.8 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -143.5 173.96 11.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 111.547 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' THR . 42.5 t -89.5 -41.46 0.43 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.06 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.8 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 85.6 Cg_exo -43.37 81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.418 2.078 . . . . 0.0 112.96 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -91.97 171.6 7.55 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.204 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.4 Cg_endo -47.5 -27.71 7.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.892 1.728 . . . . 0.0 110.368 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.583 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -91.3 -67.62 1.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.751 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -53.39 154.84 3.15 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.23 -40.16 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.027 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 83.65 44.25 6.94 Favored Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.109 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.435 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -155.64 129.96 8.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.146 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 99.59 19.45 20.27 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.43 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.714 ' CG ' ' HA3' ' A' ' 43' ' ' GLY . 1.6 t-80 24.19 -157.0 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 123.462 0.705 . . . . 0.0 112.261 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.6 p -66.27 -33.68 65.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.478 ' CG2' ' CD1' ' A' ' 34' ' ' LEU . 2.1 t -132.47 21.49 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.484 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.6 15.02 45.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.604 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' CD1' ' CG2' ' A' ' 32' ' ' THR . 17.4 mt -98.95 3.83 47.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.987 0.422 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.68 161.4 44.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.259 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.543 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.5 Cg_exo -72.29 45.07 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.041 1.828 . . . . 0.0 111.629 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.0 m170 90.58 -176.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.844 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 31.3 p-80 -129.49 120.35 25.26 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.159 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.528 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.22 -17.66 63.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.267 -178.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.672 ' HB2' ' HA ' ' A' ' 19' ' ' LYS . 35.3 t 173.83 68.73 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.454 ' CD2' HG21 ' A' ' 54' ' ' ILE . 0.3 OUTLIER 78.5 -12.87 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.09 -29.53 0.91 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.411 0.624 . . . . 0.0 109.401 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.714 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.83 -77.77 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.088 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.844 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 51.23 109.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.587 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 76.1 Cg_endo -94.07 22.49 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.914 2.409 . . . . 0.0 113.98 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.671 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.6 m-70 -105.29 -93.32 0.36 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.432 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 74.48 69.08 0.09 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.556 0.616 . . . . 0.0 111.472 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.596 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -136.17 8.38 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.071 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 48' ' ' ASP . 1.0 OUTLIER 55.5 38.73 30.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.074 0.464 . . . . 0.0 111.984 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 48' ' ' ASP . 5.8 t -142.72 143.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 12.7 Cg_exo -27.01 -59.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.56 2.84 . . . . 0.0 113.677 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 70.5 Cg_endo -73.46 57.61 3.58 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.48 2.12 . . . . 0.0 113.69 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.671 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 20.2 mp0 -164.88 -102.29 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.519 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.9 0.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.914 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.616 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . 12.7 tp -47.6 -16.4 0.07 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' CB ' HG22 ' A' ' 22' ' ' THR . . . -37.54 -60.72 0.67 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.451 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 70.1 mmm -98.94 -163.85 1.08 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.576 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -127.37 -36.24 2.12 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.647 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -45.31 -91.52 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.112 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.26 51.11 1.59 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.284 0.564 . . . . 0.0 109.564 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.616 ' CG1' ' HA ' ' A' ' 55' ' ' LEU . 67.3 t -120.19 167.74 13.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.892 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.435 ' N ' ' CG1' ' A' ' 61' ' ' VAL . 2.0 mp 60.88 19.61 9.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.723 0.297 . . . . 0.0 110.778 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.908 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.842 0.353 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -95.8 85.2 4.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.2 t -149.92 167.47 26.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -163.27 -174.33 3.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.205 179.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.485 ' HB2' ' N ' ' A' ' 41' ' ' LEU . 47.4 t -104.28 67.61 0.13 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.27 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.494 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 85.5 Cg_endo -78.9 75.22 5.15 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.927 1.752 . . . . 0.0 113.272 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' A' ' 25' ' ' CYS . 91.7 m -87.34 145.19 37.15 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 22' ' ' THR . 61.2 Cg_exo -36.93 -27.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.726 2.284 . . . . 0.0 112.987 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -144.15 -9.95 0.38 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.996 -1.097 . . . . 0.0 114.74 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.617 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 23.6 t -48.09 151.78 0.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.811 1.306 . . . . 0.0 110.712 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -102.76 -44.06 5.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.795 0.331 . . . . 0.0 111.301 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 55.65 1.52 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.657 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.71 129.74 8.69 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.66 -0.77 . . . . 0.0 110.557 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.825 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 93.78 23.75 22.39 Favored Glycine 0 C--O 1.226 -0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.222 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.825 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 t-80 17.72 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.05 0.94 . . . . 0.0 113.179 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 43' ' ' GLY . 9.5 p -63.88 -33.31 61.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.417 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 12.0 p -117.65 0.23 12.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.866 0.303 . . . . 0.0 110.837 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 69.27 13.66 67.78 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.098 -1.049 . . . . 0.0 110.649 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.417 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 16.9 mt -101.06 3.5 41.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.218 0.532 . . . . 0.0 109.77 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.766 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.51 159.46 36.82 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.101 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 60.5 Cg_endo -73.34 47.69 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.329 1.352 . . . . 0.0 110.872 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.1 m170 91.36 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.651 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 34.7 p-80 -132.75 -51.18 0.91 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.402 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 36.73 28.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.646 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 2.2 p -158.03 5.01 0.12 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.626 HD22 ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 82.26 -23.61 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.1 p -48.89 -27.01 2.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.115 0.484 . . . . 0.0 110.164 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -124.71 -88.84 0.79 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.651 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.3 t 52.72 111.62 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.513 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 30' ' ' HIS . 28.8 Cg_endo -98.95 14.4 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.204 2.603 . . . . 0.0 113.45 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.674 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 38.1 m-70 -86.72 -72.97 0.48 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.487 ' H ' ' CG1' ' A' ' 54' ' ' ILE . 0.6 OUTLIER 50.29 62.13 2.83 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.082 0.468 . . . . 0.0 111.644 -179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.609 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 5.9 t70 -141.44 9.75 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.606 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.488 ' CB ' ' HA ' ' A' ' 62' ' ' LEU . 1.9 ptt180 59.96 -170.73 0.14 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.278 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HB ' ' CD ' ' A' ' 51' ' ' PRO . 56.4 t 23.65 -80.2 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 124.972 1.309 . . . . 0.0 114.156 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.598 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 9.1 Cg_endo -50.88 176.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.669 1.579 . . . . 0.0 112.056 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 44.3 Cg_exo -56.79 77.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.14 1.894 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.674 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.9 mm-40 -132.32 -105.62 0.26 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.512 HG21 ' HG3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -145.99 18.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.581 ' HB2' ' N ' ' A' ' 50' ' ' VAL . 2.6 tm? -40.65 -32.41 0.21 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.38 0.61 . . . . 0.0 111.615 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 22' ' ' THR . . . -99.14 58.65 1.12 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.541 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.626 ' HA ' HD22 ' A' ' 41' ' ' LEU . 1.5 ttt -102.21 171.25 7.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.847 0.356 . . . . 0.0 110.884 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -117.14 -20.2 9.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.384 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -106.64 -52.17 2.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.708 0.289 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -131.93 77.17 1.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.206 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 57' ' ' MET . 28.5 m -70.25 148.13 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.488 ' HA ' ' CB ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER 69.28 -66.33 0.26 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.907 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.947 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.777 0.322 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.23 -173.46 3.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.963 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.9 m -134.28 176.58 8.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.826 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 5.3 mmtt -80.03 131.75 35.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.665 0.745 . . . . 0.0 111.181 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 35.2 t -72.16 -35.78 3.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.53 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 88.6 Cg_exo -47.05 82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.987 1.791 . . . . 0.0 112.796 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -87.44 177.79 2.54 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.517 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 72.1 Cg_exo -41.7 -23.71 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.314 2.009 . . . . 0.0 112.775 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.513 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -105.14 -67.06 0.69 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.446 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 39.1 t -46.75 155.11 0.27 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.637 0.718 . . . . 0.0 110.749 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -107.9 -43.39 4.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 110.784 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.21 61.49 0.98 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.962 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -154.35 131.09 10.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.2 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.671 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 89.86 22.59 35.61 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.217 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.746 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 t-80 23.37 -158.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.448 0.699 . . . . 0.0 112.279 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 8.7 p -64.84 -35.83 76.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.446 ' CG2' ' CD1' ' A' ' 34' ' ' LEU . 1.4 t -129.85 21.01 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.438 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.08 16.2 39.73 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.193 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' CD1' ' CG2' ' A' ' 32' ' ' THR . 25.5 mt -97.3 2.57 50.86 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 110.048 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.746 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -121.52 158.19 54.47 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.602 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.556 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.17 45.74 0.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.741 1.627 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m170 89.97 179.44 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.951 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.6 p-80 -124.89 -52.85 1.66 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.705 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.43 ' CG ' ' HG2' ' A' ' 21' ' ' PRO . 47.3 ttt180 45.35 19.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.889 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.826 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -165.24 23.06 0.05 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.425 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 77.83 -161.07 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 71.77 -53.14 0.69 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.552 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -96.9 -91.17 1.86 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.951 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.88 108.7 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.259 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.573 ' N ' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -90.4 27.12 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.074 2.516 . . . . 0.0 114.431 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.773 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 19.2 m-70 -111.61 -76.0 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.982 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.773 ' HG2' ' O ' ' A' ' 46' ' ' HIS . 1.6 ptpt 53.8 68.59 0.82 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 110.917 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.809 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 2.2 t70 -132.74 10.58 4.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.432 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.844 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER 50.23 50.73 18.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.297 0.57 . . . . 0.0 112.229 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.435 ' CG1' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -149.16 153.55 38.02 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.643 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 79.6 Cg_exo -38.52 -56.38 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.769 1.646 . . . . 0.0 112.782 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 72.9 Cg_endo -73.44 56.37 3.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.678 2.252 . . . . 0.0 114.098 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 30.8 mp0 -162.84 -104.33 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.873 0.368 . . . . 0.0 110.985 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.574 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -131.85 4.56 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.702 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.489 ' HA ' ' CB ' ' A' ' 62' ' ' LEU . 2.5 tt -39.25 -30.92 0.07 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.794 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' CB ' ' HB ' ' A' ' 22' ' ' THR . . . -64.51 -42.3 95.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.237 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.497 ' HB3' ' CG2' ' A' ' 61' ' ' VAL . 1.9 tmm? -58.71 173.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.603 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.544 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 5.6 m170 -134.41 -173.13 3.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.806 0.336 . . . . 0.0 111.459 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 58' ' ' HIS . 33.8 mm-40 75.37 -86.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.412 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -119.62 64.76 0.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.106 0.479 . . . . 0.0 110.904 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.497 ' CG2' ' HB3' ' A' ' 57' ' ' MET . 33.5 m -158.18 -172.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.633 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.844 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER 42.58 -165.46 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.919 0.39 . . . . 0.0 111.742 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.941 0.401 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.19 159.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.344 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.81 125.58 25.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.944 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 1.7 mmtm -112.93 -78.34 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.185 0.517 . . . . 0.0 110.622 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 22' ' ' THR . 41.9 t -55.16 -41.84 92.81 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.387 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 76.9 Cg_exo -43.05 77.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.367 2.045 . . . . 0.0 112.984 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.629 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -82.96 176.03 4.22 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.137 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 80.7 Cg_exo -46.9 -22.84 2.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.925 1.75 . . . . 0.0 111.663 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 52' ' ' PRO . . . -103.11 -69.22 0.8 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.904 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.9 t -42.1 150.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.043 0.422 . . . . 0.0 111.7 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -101.71 -47.14 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.38 53.44 1.07 Allowed Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.511 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.71 125.74 5.4 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.006 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.721 ' O ' ' CA ' ' A' ' 33' ' ' GLY . . . 111.25 -10.35 28.88 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.096 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.9 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 46.94 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.702 -0.881 . . . . 0.0 111.823 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.882 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.8 p -50.97 -31.6 10.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 9.5 p -116.47 4.28 13.29 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.574 1.079 . . . . 0.0 112.036 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.721 ' CA ' ' O ' ' A' ' 29' ' ' GLY . . . 71.57 17.38 76.38 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.351 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 32' ' ' THR . 3.2 mt -124.29 8.62 8.49 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.9 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -107.09 167.21 9.77 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.336 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 57.1 Cg_endo -72.12 37.63 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.263 1.309 . . . . 0.0 110.884 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m170 89.34 179.26 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.935 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.0 p-80 -128.68 -50.33 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.727 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HG3' ' CG ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER 40.95 27.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.422 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.552 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 2.4 m -174.09 18.98 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' A' ' 43' ' ' GLY . 0.9 OUTLIER 76.33 -171.86 0.09 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.305 0.502 . . . . 0.0 110.36 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 18.8 m 73.28 -18.06 0.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 41' ' ' LEU . . . -130.48 -94.33 0.68 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.935 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.5 t 55.77 121.62 0.01 OUTLIER Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.709 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.599 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 72.5 Cg_endo -95.21 24.97 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.006 2.471 . . . . 0.0 113.857 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.612 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 11.1 m-70 -115.8 -95.46 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 78.62 67.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.346 0.521 . . . . 0.0 112.209 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.447 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 51.0 t0 -139.24 10.54 2.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.374 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 27.11 43.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.79 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 96.0 t -157.65 -57.32 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.207 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.4 Cg_endo -96.42 -179.41 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.198 2.599 . . . . 0.0 111.171 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 9.3 Cg_endo -50.88 84.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 121.977 1.785 . . . . 0.0 110.736 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.612 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.2 mt-10 -140.37 -96.85 0.15 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -146.43 25.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 7.6 tt -48.82 -18.8 0.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.607 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.424 ' CB ' ' CG2' ' A' ' 22' ' ' THR . . . -133.6 54.77 1.93 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.367 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.477 ' HG2' HD22 ' A' ' 41' ' ' LEU . 8.2 tmm? -61.37 -76.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.871 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -121.37 -73.42 0.65 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.727 0.298 . . . . 0.0 110.991 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -75.2 -67.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 61' ' ' VAL . 1.4 m-20 176.32 147.15 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 61' ' ' VAL . 15.8 m 44.25 105.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.484 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 49' ' ' ARG . 0.3 OUTLIER 68.78 -171.34 0.18 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.982 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 tttp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.853 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 mmp_? . . . . . 0 C--O 1.231 0.098 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.85 37.24 4.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.226 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' HD22 ' A' ' 41' ' ' LEU . 2.7 m -95.82 159.9 14.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.578 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.702 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -108.79 -166.56 1.13 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.324 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.614 ' N ' ' HA ' ' A' ' 40' ' ' SER . 48.8 t -111.6 68.8 0.77 Allowed Pre-proline 0 C--N 1.334 -0.067 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 94.9 Cg_endo -88.9 71.98 2.12 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.857 1.705 . . . . 0.0 111.123 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.525 ' HB ' ' H ' ' A' ' 25' ' ' CYS . 2.1 m -81.99 141.8 47.54 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.284 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.69 -21.6 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.217 1.944 . . . . 0.0 111.869 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' C ' ' HB3' ' A' ' 52' ' ' PRO . . . -123.15 -37.23 0.61 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.622 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.525 ' H ' ' HB ' ' A' ' 22' ' ' THR . 13.0 t -44.4 152.13 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.868 0.834 . . . . 0.0 111.046 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -108.47 -34.36 6.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.31 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 39' ' ' ARG . . . 83.63 54.83 2.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.211 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -157.8 127.43 5.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.443 -0.879 . . . . 0.0 110.154 -179.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.782 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 95.78 24.52 15.28 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.978 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.782 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 17.71 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.921 0.889 . . . . 0.0 113.049 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 43' ' ' GLY . 7.8 p -67.9 -35.57 72.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.41 ' CG2' HG12 ' A' ' 31' ' ' VAL . 11.5 p -113.62 -3.96 13.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.328 -0.233 . . . . 0.0 110.637 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 72.96 12.62 79.12 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.4 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 13.7 mt -101.35 5.0 42.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 109.942 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.689 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.97 164.34 17.01 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.565 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 2.8 Cg_exo -74.09 45.21 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.945 1.763 . . . . 0.0 110.884 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m170 87.54 179.25 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.797 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 47.4 p-80 -129.23 -53.08 1.19 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.195 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.702 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 45.42 20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.607 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.614 ' HA ' ' N ' ' A' ' 20' ' ' CYS . 1.4 p -143.21 -53.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER 157.6 -53.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.03 0.377 . . . . 0.0 111.459 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.407 ' N ' HD13 ' A' ' 41' ' ' LEU . 56.6 p -33.2 -36.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.235 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.567 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -104.48 -98.91 2.54 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.797 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.8 t 55.0 109.04 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.262 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.1 Cg_endo -95.01 24.65 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.903 2.402 . . . . 0.0 113.7 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.766 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 15.6 m-70 -107.13 -76.84 0.61 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.793 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.766 ' HG2' ' O ' ' A' ' 46' ' ' HIS . 4.4 pttt 54.07 66.23 1.29 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.492 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 1.5 t0 -131.34 -10.52 3.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.498 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER 53.21 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.972 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 28.0 t 99.55 -68.94 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.452 1.101 . . . . 0.0 110.449 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.972 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 2.9 Cg_exo -73.92 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.818 1.679 . . . . 0.0 110.498 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.615 ' HD2' ' CB ' ' A' ' 51' ' ' PRO . 44.1 Cg_endo -67.11 99.32 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.8 1.667 . . . . 0.0 111.647 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 21.8 mp0 -152.2 -103.16 0.05 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.64 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.52 7.74 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.516 ' HB2' ' H ' ' A' ' 50' ' ' VAL . 3.0 tt -46.78 -26.58 0.98 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.884 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.433 ' HB3' ' OG1' ' A' ' 22' ' ' THR . . . -53.19 -46.74 69.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.54 82.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -46.38 -29.38 1.66 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.419 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.52 -51.01 7.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -103.73 57.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.343 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.1 m -81.23 146.92 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.891 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 49' ' ' ARG . 0.4 OUTLIER 67.51 -66.94 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.884 0.374 . . . . 0.0 111.189 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tptt . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.813 -179.763 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.897 0.38 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.25 157.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.9 p -75.89 151.36 37.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -122.02 -26.87 4.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 111.318 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.552 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 16.7 t -110.18 33.27 0.1 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 97.0 Cg_endo -77.35 80.03 3.01 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.484 1.456 . . . . 0.0 111.732 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.545 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 1.1 m -85.97 142.14 36.13 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.017 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 22' ' ' THR . 98.1 Cg_exo -43.43 -30.19 2.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.188 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.578 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -112.44 -26.61 4.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.965 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -51.83 144.18 11.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -82.27 -46.77 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.34 23.72 77.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.568 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.587 ' CG2' ' O ' ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.48 43.95 1.29 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.388 0.614 . . . . 0.0 110.671 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.869 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -170.55 29.81 0.13 Allowed Glycine 0 C--O 1.22 -0.772 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.325 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.869 ' O ' ' O ' ' A' ' 29' ' ' GLY . 3.1 t-80 15.64 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 10.3 p -59.01 -21.1 18.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.591 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 3.2 p -132.37 6.77 4.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.017 0.826 . . . . 0.0 110.216 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 64.18 18.62 62.95 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.7 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 32' ' ' THR . 9.3 mt -117.06 10.42 13.93 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.687 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -113.39 171.4 4.38 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.003 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 35' ' ' TYR . 2.7 Cg_exo -74.89 43.3 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.971 1.781 . . . . 0.0 112.01 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.525 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.8 m80 85.11 -176.37 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.25 0.547 . . . . 0.0 110.405 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.918 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 29.4 p-80 -152.01 153.71 34.57 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.601 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mtt180 -149.22 38.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.082 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.563 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 60.3 p -170.42 20.54 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' CD2' HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER 77.42 -36.84 0.24 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.46 0.573 . . . . 0.0 112.195 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 41' ' ' LEU . 64.6 m -36.46 -35.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.193 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.496 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.1 -93.05 2.26 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.981 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.918 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.1 t 48.67 111.08 0.01 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 115.256 -0.472 . . . . 0.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.9 Cg_endo -86.4 18.39 1.58 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.951 2.434 . . . . 0.0 113.943 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.719 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 9.3 m-70 -105.0 -89.33 0.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.466 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.508 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER 77.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 178.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.68 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 1.4 t70 -146.13 24.9 1.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.259 0.552 . . . . 0.0 109.812 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.516 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 0.1 OUTLIER 34.23 43.12 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.95 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 48' ' ' ASP . 6.7 m -135.99 153.78 77.18 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.681 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.467 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 27.9 Cg_exo -27.33 -48.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.039 3.159 . . . . 0.0 113.822 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.578 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 96.7 Cg_endo -92.62 39.06 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.406 2.071 . . . . 0.0 114.461 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.719 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 8.8 mm-40 -144.42 -102.39 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.558 HG12 ' SG ' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -128.9 3.71 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -178.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.2 tp -53.85 -15.58 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HB2' ' N ' ' A' ' 22' ' ' THR . . . -31.2 -61.77 0.19 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.64 146.88 52.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.476 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.38 142.2 29.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.563 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 73.89 -61.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.654 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -68.85 83.44 0.3 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 110.512 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 49' ' ' ARG . 21.0 m -83.04 139.92 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.208 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.48 -66.73 0.22 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.968 0.414 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.781 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.766 0.317 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.22 -33.77 63.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.5 p -160.84 116.83 2.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 22.5 mttt -99.99 -73.64 0.63 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.367 0.603 . . . . 0.0 111.064 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.691 ' O ' ' N ' ' A' ' 22' ' ' THR . 48.1 t -56.21 -40.51 85.28 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.59 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.633 ' HD3' ' HA ' ' A' ' 39' ' ' ARG . 86.2 Cg_exo -48.51 72.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.118 1.879 . . . . 0.0 112.678 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.691 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -81.14 173.49 7.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.552 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 4.6 Cg_exo -37.5 -27.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.752 2.301 . . . . 0.0 112.644 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' THR . . . -97.28 -75.81 1.26 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.914 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 34.2 t -39.5 156.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.055 0.455 . . . . 0.0 112.212 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.77 -36.96 6.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.82 57.99 1.55 Allowed Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.126 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.64 135.46 9.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.808 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 90.68 21.75 35.96 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.452 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.718 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 21.63 -158.61 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.396 0.679 . . . . 0.0 112.448 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.487 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 6.9 p -70.73 -34.52 56.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.444 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 5.9 p -117.46 5.81 12.53 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.025 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.54 13.76 61.31 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.132 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.444 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 19.8 mt -101.63 2.56 38.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.714 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.25 158.78 40.33 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.335 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.6 Cg_endo -71.9 48.26 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.354 1.37 . . . . 0.0 111.302 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.55 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.1 m170 90.2 -179.33 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.903 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 33.1 p-80 -129.33 -55.07 1.18 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.426 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.633 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 91.4 mtt-85 41.92 30.5 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 38.3 t -155.12 -1.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.657 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 82.73 -35.78 0.09 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.0 p -39.77 -37.34 0.52 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.241 0.543 . . . . 0.0 110.485 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.49 -90.69 2.09 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.903 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 59.1 112.24 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.859 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.5 Cg_endo -92.31 27.08 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.013 2.475 . . . . 0.0 114.105 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.699 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.8 m-70 -114.7 -74.91 0.6 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.025 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.685 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 54.61 65.48 1.49 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.92 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t70 -133.88 -7.06 2.76 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.718 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.568 ' O ' ' O ' ' A' ' 48' ' ' ASP . 0.1 OUTLIER 48.69 135.22 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.927 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 33.6 t 96.21 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.551 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.927 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 4.7 Cg_exo -76.95 -167.51 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.646 1.564 . . . . 0.0 110.706 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 24.9 Cg_exo -64.93 100.74 0.36 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 121.989 1.793 . . . . 0.0 112.28 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.699 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 26.3 mp0 -155.85 -104.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.687 HG12 ' SG ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -132.36 11.15 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.195 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' HB2' ' H ' ' A' ' 50' ' ' VAL . 17.7 tp -45.64 -25.64 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.369 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.18 -48.15 71.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.442 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.521 ' HG3' ' HB3' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -52.22 108.16 0.27 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.54 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -66.19 136.69 56.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.745 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.9 25.38 12.03 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.081 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -157.38 48.99 0.43 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.985 0.421 . . . . 0.0 110.77 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.432 ' HB ' ' CB ' ' A' ' 49' ' ' ARG . 29.6 m -60.87 156.01 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.123 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER 42.2 40.08 1.62 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.266 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 tptm . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.127 179.411 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.743 0.306 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.79 39.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -178.68 153.86 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.722 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -168.4 145.74 4.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.142 0.496 . . . . 0.0 111.854 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.685 ' O ' ' N ' ' A' ' 22' ' ' THR . 52.3 t -88.72 -32.96 0.4 Allowed Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 49.9 Cg_exo -38.47 76.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.229 1.953 . . . . 0.0 113.31 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -84.77 170.21 14.24 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.11 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 9.3 Cg_endo -52.58 -19.22 9.85 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.285 1.99 . . . . 0.0 112.207 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' A' ' 51' ' ' PRO . . . -108.95 -51.0 0.7 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.483 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.3 t -51.74 156.27 1.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.339 0.569 . . . . 0.0 110.304 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -98.75 -42.9 7.0 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.23 53.69 2.44 Favored Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.919 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.19 131.57 9.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.922 -0.639 . . . . 0.0 111.162 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.71 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 92.66 20.87 33.03 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.439 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.768 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t-80 22.08 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.527 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.6 p -61.76 -33.69 58.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.434 ' CG2' ' CD1' ' A' ' 34' ' ' LEU . 1.5 t -132.4 19.94 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.268 0.485 . . . . 0.0 111.475 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.17 16.75 49.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.176 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.434 ' CD1' ' CG2' ' A' ' 32' ' ' THR . 22.3 mt -99.57 3.9 45.6 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.227 0.537 . . . . 0.0 110.055 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.768 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.75 158.49 51.8 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.822 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.15 44.33 0.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.945 1.763 . . . . 0.0 111.268 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.9 m170 93.01 -175.63 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.917 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 43.2 p-80 -141.09 140.27 34.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.434 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 9.3 mtt180 -131.82 33.06 4.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.722 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 38.6 p -165.42 12.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 57' ' ' MET . 0.4 OUTLIER 81.31 -32.63 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.525 0.602 . . . . 0.0 111.633 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -39.78 -31.44 0.11 Allowed 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.208 0.528 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.532 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -109.57 -92.81 2.22 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.917 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.37 108.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 115.151 -0.524 . . . . 0.0 111.089 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.565 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 97.3 Cg_endo -87.53 23.21 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.85 2.366 . . . . 0.0 114.084 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.652 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 14.4 m-70 -110.56 -96.47 0.41 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.571 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' CB ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.98 68.09 0.1 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.962 0.801 . . . . 0.0 110.492 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.519 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -133.64 9.32 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.443 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.921 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 3.5 mpp_? 60.96 42.41 12.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.108 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.445 ' O ' ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -152.94 148.6 20.48 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.43 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 50.7 Cg_exo -36.66 -58.18 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.36 2.04 . . . . 0.0 113.044 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.745 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 13.5 Cg_exo -69.0 62.03 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.077 1.851 . . . . 0.0 112.6 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.652 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 18.8 mp0 -166.58 -102.65 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.008 0.433 . . . . 0.0 110.559 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.519 HG22 HD12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -117.09 -32.05 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 11.8 tp 31.24 32.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.509 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 54' ' ' ILE . . . 172.0 29.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.531 ' HA ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -82.2 125.14 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.561 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 57.16 -163.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.05 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -93.33 42.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.797 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.7 50.92 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.328 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 56' ' ' ALA . 8.1 m -42.86 132.71 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.711 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.921 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 2.3 mp 44.77 34.29 1.15 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.052 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.15 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.938 0.399 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.47 -168.55 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.608 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.26 12.16 21.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.694 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.5 mmmm 71.38 172.67 0.31 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.32 0.581 . . . . 0.0 111.269 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.49 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 34.0 t -113.77 41.31 0.24 Allowed Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 41.1 Cg_endo -89.68 81.33 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.946 1.764 . . . . 0.0 113.296 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.628 ' HB ' ' CA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -96.53 152.64 38.74 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.787 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -44.34 -25.1 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . -101.92 -51.54 1.08 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.603 ' CB ' HG21 ' A' ' 22' ' ' THR . 47.9 t -51.1 148.53 4.37 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.053 0.926 . . . . 0.0 110.311 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -96.06 -46.18 6.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 92.63 42.72 4.41 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.429 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -152.94 131.35 12.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.566 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.755 ' O ' ' N ' ' A' ' 33' ' ' GLY . . . 103.62 -4.15 46.65 Favored Glycine 0 C--O 1.219 -0.842 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.453 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.925 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 46.77 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.494 -1.004 . . . . 0.0 111.494 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.463 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 8.1 p -52.28 -32.32 15.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.44 ' OG1' HD13 ' A' ' 34' ' ' LEU . 2.5 t -133.35 21.53 4.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.512 1.051 . . . . 0.0 112.499 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.755 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 66.58 15.68 64.38 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.264 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD13 ' OG1' ' A' ' 32' ' ' THR . 8.9 mt -112.2 6.85 19.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.925 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -117.85 163.14 25.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.054 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 Cg_endo -71.52 42.25 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.505 1.47 . . . . 0.0 111.388 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 2.2 m170 90.73 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 122.921 0.488 . . . . 0.0 109.896 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.714 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 35.5 p-80 -137.66 -54.74 0.67 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.436 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 15.9 mtt180 41.14 25.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.622 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 83.3 p -162.34 17.42 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.506 ' CD1' ' HG3' ' A' ' 57' ' ' MET . 0.6 OUTLIER 76.36 -33.1 0.21 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 85.5 p -38.62 -31.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.873 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.609 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -122.85 -84.15 0.67 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.714 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 45.96 112.32 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 114.865 -0.667 . . . . 0.0 111.013 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.7 Cg_endo -93.59 12.82 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.737 ' HB3' ' CD ' ' A' ' 53' ' ' GLU . 18.7 m-70 -92.08 -69.63 0.73 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.859 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HA ' HG13 ' A' ' 54' ' ' ILE . 1.7 ptpt 51.01 62.14 2.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.587 ' CB ' ' HG3' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -135.03 14.44 3.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.137 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.52 38.86 0.95 Allowed 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.354 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG23 ' HG3' ' A' ' 53' ' ' GLU . 2.5 m -130.7 153.46 81.56 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.541 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.508 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 87.7 Cg_exo -27.05 -46.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.988 3.125 . . . . 0.0 114.487 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 86.6 Cg_endo -98.43 46.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.877 2.385 . . . . 0.0 114.543 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.737 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 14.4 mm-40 -149.44 -98.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.648 HG12 ' SG ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -129.64 5.36 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.612 0.365 . . . . 0.0 110.248 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 50' ' ' VAL . 4.0 tt -56.48 -13.46 2.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.628 ' CA ' ' HB ' ' A' ' 22' ' ' THR . . . -42.71 -57.51 2.71 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.506 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -63.12 115.64 4.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.003 0.43 . . . . 0.0 111.182 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -78.3 -34.13 48.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.801 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -61.3 -52.26 65.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.69 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.03 92.82 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.7 m -66.8 173.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.18 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 tt 62.41 -80.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.822 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.934 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.911 0.386 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.58 178.33 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.655 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.3 m -91.85 20.57 5.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.581 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 11.4 mmtt 62.73 167.93 0.13 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.374 0.607 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.3 t -72.8 -35.3 2.89 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.017 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 63.5 Cg_exo -37.57 77.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.682 2.255 . . . . 0.0 113.705 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -82.93 173.88 6.88 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -46.99 -20.22 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.46 2.106 . . . . 0.0 112.265 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.46 -58.27 0.55 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.696 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 37.7 t -54.77 156.75 3.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.985 0.422 . . . . 0.0 111.693 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.03 -43.41 6.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.117 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.26 34.5 23.23 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.769 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.558 ' CG2' ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -142.13 45.49 1.66 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.492 0.663 . . . . 0.0 110.68 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.956 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -178.58 57.81 0.09 OUTLIER Glycine 0 C--O 1.217 -0.944 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.775 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.956 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -12.82 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.177 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.492 ' C ' ' HB3' ' A' ' 45' ' ' PRO . 10.0 p -56.25 -31.51 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.492 ' OG1' HD13 ' A' ' 34' ' ' LEU . 1.5 t -131.93 7.44 4.36 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.871 -0.518 . . . . 0.0 110.53 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.18 64.79 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.096 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.492 HD13 ' OG1' ' A' ' 32' ' ' THR . 38.0 mt -93.66 1.05 56.72 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.666 0.746 . . . . 0.0 109.331 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.669 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -116.01 156.86 46.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.286 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 59.2 Cg_endo -73.22 50.87 1.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.32 1.347 . . . . 0.0 111.604 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.583 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.3 m170 92.13 -176.67 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.558 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 27.4 p-80 -132.25 121.28 23.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.8 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.51 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.8 OUTLIER -59.74 -28.28 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.639 -178.098 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 0.8 OUTLIER 173.83 71.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD23 ' CG2' ' A' ' 54' ' ' ILE . 0.3 OUTLIER 79.88 -17.75 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.694 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.02 1.04 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.273 0.558 . . . . 0.0 109.788 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.649 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -128.93 -85.47 0.45 Allowed Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.58 ' O ' ' O ' ' A' ' 43' ' ' GLY . 1.8 t 44.46 113.49 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.68 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.638 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 4.8 Cg_endo -101.61 1.28 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.808 3.005 . . . . 0.0 113.252 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.66 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 22.5 m-70 -75.53 -92.03 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.145 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.604 ' HG3' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 63.71 65.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.091 -0.381 . . . . 0.0 111.935 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.495 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 7.2 t0 -129.63 -6.21 4.64 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.371 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.487 ' HG3' HG12 ' A' ' 61' ' ' VAL . 64.2 ttt-85 58.34 118.46 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.809 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 24.7 t 99.23 -72.43 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.886 0.874 . . . . 0.0 112.598 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.809 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 29.8 Cg_endo -74.4 -179.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.135 1.223 . . . . 0.0 111.955 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 60.9 Cg_exo -53.2 98.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.208 1.939 . . . . 0.0 112.478 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.66 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.1 mp0 -149.76 -105.03 0.07 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.604 HD12 ' HG3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -118.39 -15.68 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.754 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 57' ' ' MET . 14.3 mt 34.06 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 61' ' ' VAL . . . 55.45 2.03 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.543 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER 70.25 -65.92 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.734 0.302 . . . . 0.0 111.649 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -109.67 143.03 40.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.18 0.514 . . . . 0.0 112.328 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 33.84 -88.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.377 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -48.48 167.63 0.03 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.188 0.518 . . . . 0.0 112.152 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 14.6 p -127.9 155.28 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.163 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HB3' ' HG3' ' A' ' 49' ' ' ARG . 0.3 OUTLIER 83.58 5.48 0.78 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 63' ' ' LYS . 10.6 tptm . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.129 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.891 0.377 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -73.67 159.32 33.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 p -68.7 178.07 2.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.447 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.1 mttp -86.65 -174.94 5.23 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.294 0.568 . . . . 0.0 111.08 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.592 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -66.32 164.43 30.82 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.613 ' CG ' ' HA ' ' A' ' 54' ' ' ILE . 37.3 Cg_exo -25.18 -70.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.501 3.468 . . . . 0.0 114.06 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.585 ' OG1' ' HD2' ' A' ' 23' ' ' PRO . 0.6 OUTLIER -163.83 176.12 2.39 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.151 -178.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.585 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 81.4 Cg_exo -46.9 -27.56 5.95 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.949 1.766 . . . . 0.0 111.081 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -46.95 -57.36 6.95 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.711 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 42.3 t -55.91 157.6 4.31 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -84.06 -39.1 19.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.703 0.287 . . . . 0.0 111.311 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' HA2' ' NE2' ' A' ' 38' ' ' HIS . . . 69.3 43.91 68.23 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.29 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.2 133.64 16.5 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.782 -0.709 . . . . 0.0 111.017 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.623 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 88.61 24.9 31.75 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.926 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.2 t-80 24.55 -156.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.311 0.644 . . . . 0.0 112.07 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 15.0 p -70.11 -34.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.434 ' CG2' ' CD1' ' A' ' 34' ' ' LEU . 1.5 t -127.01 18.95 7.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.373 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.39 14.71 42.6 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.299 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.434 ' CD1' ' CG2' ' A' ' 32' ' ' THR . 21.1 mt -96.4 1.62 51.91 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.278 0.561 . . . . 0.0 110.172 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.797 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.52 156.82 55.31 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.734 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.8 Cg_exo -70.91 45.41 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.86 1.707 . . . . 0.0 111.72 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 6.1 m170 95.72 -173.52 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.887 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 28.6 p-80 -140.31 -48.91 0.45 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.766 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.479 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 42.22 22.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.217 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 52.6 p -163.48 17.13 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 77.84 -7.53 1.81 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.045 0.384 . . . . 0.0 111.765 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -53.63 -22.87 9.54 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.536 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -146.15 -72.61 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.887 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.9 t 53.26 112.0 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.012 -0.594 . . . . 0.0 111.163 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.603 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 57.4 Cg_endo -98.16 35.51 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.234 2.623 . . . . 0.0 114.362 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.683 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 18.7 m-70 -118.88 -99.83 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.249 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HG2' ' CA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 73.9 69.83 0.11 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-N 118.633 0.651 . . . . 0.0 110.243 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -136.33 10.81 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.155 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 49' ' ' ARG . 1.4 ttt85 57.18 43.96 23.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.175 0.512 . . . . 0.0 111.737 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.509 ' CG1' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -141.86 152.85 63.43 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.527 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 3.6 Cg_exo -35.28 -58.64 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.767 2.311 . . . . 0.0 112.817 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.67 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 94.3 Cg_endo -79.85 65.79 8.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.605 2.203 . . . . 0.0 113.764 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.711 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.5 mp0 -163.15 -101.93 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 112.22 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.613 ' HA ' ' CG ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -165.16 29.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.431 ' HA ' HG23 ' A' ' 61' ' ' VAL . 2.7 pt? -48.81 -32.42 8.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.001 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 21' ' ' PRO . . . -114.91 64.47 0.68 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.729 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.486 ' HA ' ' CD2' ' A' ' 41' ' ' LEU . 19.6 ttp -89.63 154.77 19.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.553 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -23.8 6.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.449 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -123.09 87.14 2.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.882 0.373 . . . . 0.0 111.793 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 61.03 160.46 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 55' ' ' LEU . 2.1 p -91.26 151.01 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.465 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 49' ' ' ARG . 4.7 tt 62.31 148.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.924 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' CA ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.043 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.818 0.342 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.32 155.01 41.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.036 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 39' ' ' ARG . 2.2 p -87.59 165.41 15.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.366 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.85 -26.74 2.39 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 22' ' ' THR . 30.2 t -81.31 -34.97 0.75 Allowed Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 75.9 Cg_exo -44.34 82.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.138 1.892 . . . . 0.0 113.091 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -89.63 173.79 5.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.889 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 3.6 Cg_endo -45.51 -23.13 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.615 2.21 . . . . 0.0 112.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.492 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -106.32 -61.35 0.6 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.62 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.5 t -50.95 158.82 0.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.681 0.241 . . . . 0.0 111.071 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -108.42 -29.42 8.83 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.81 44.24 7.86 Favored Glycine 0 CA--C 1.503 -0.664 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.411 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 1.1 m -153.75 129.87 10.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.72 -1.24 . . . . 0.0 108.947 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.879 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.31 59.45 1.74 Allowed Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.431 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.879 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.5 t-80 -24.09 -167.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.879 1.272 . . . . 0.0 113.783 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.472 ' C ' ' HB3' ' A' ' 45' ' ' PRO . 10.9 p -51.51 -32.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.505 ' CG2' HD12 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -129.24 1.73 5.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.963 0.347 . . . . 0.0 110.326 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.89 13.94 78.66 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.505 HD12 ' CG2' ' A' ' 32' ' ' THR . 43.6 mt -95.13 2.01 54.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.834 0.826 . . . . 0.0 109.398 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.706 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.24 160.53 33.78 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.15 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 73.7 Cg_endo -75.71 49.18 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.161 1.241 . . . . 0.0 111.359 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.5 m170 91.03 -176.65 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 44.8 p-80 -136.26 134.78 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.538 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.518 ' HB3' ' HA ' ' A' ' 18' ' ' SER . 7.0 mtt180 -111.71 15.65 20.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 41' ' ' LEU . 49.7 p -172.76 28.05 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.535 HD23 ' CG2' ' A' ' 54' ' ' ILE . 0.2 OUTLIER 78.59 -24.31 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.57 0.623 . . . . 0.0 111.784 178.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -42.27 -28.48 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.547 . . . . 0.0 109.894 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.607 ' O ' ' O ' ' A' ' 44' ' ' CYS . . . -112.15 -90.51 1.93 Allowed Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.607 ' O ' ' O ' ' A' ' 43' ' ' GLY . 3.7 t 41.61 112.26 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 115.248 -0.476 . . . . 0.0 110.898 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.727 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 3.3 Cg_endo -99.88 1.18 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.489 2.793 . . . . 0.0 113.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.727 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 38.7 m-70 -72.53 -77.22 0.1 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.32 -177.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' A' ' 46' ' ' HIS . 0.0 OUTLIER 50.96 65.07 1.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.666 ' CB ' ' HG3' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -127.41 -2.49 6.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 176.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 7.8 ttt180 55.4 116.91 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.668 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 20.3 t 98.56 -62.12 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.668 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.5 Cg_endo -79.22 -179.2 5.21 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.624 1.549 . . . . 0.0 111.944 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 51.7 Cg_exo -54.32 80.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.012 1.808 . . . . 0.0 111.842 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.727 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 23.6 mm-40 -135.84 -107.3 0.21 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.138 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.546 HG13 ' HA ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -108.3 -24.01 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.428 ' HB2' ' OG1' ' A' ' 22' ' ' THR . 5.9 mt 41.75 31.61 0.21 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.779 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HA ' ' C ' ' A' ' 63' ' ' LYS . . . 50.31 21.13 0.75 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' THR . 2.7 ttm 74.67 -56.57 0.63 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.19 23.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 8.8 mp0 -127.46 -24.19 3.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.403 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 24.7 m-20 64.18 76.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.724 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.424 ' HA ' ' HG3' ' A' ' 49' ' ' ARG . 9.9 p -170.83 29.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.563 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 49' ' ' ARG . 0.3 OUTLIER 64.31 1.73 1.34 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.28 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' C ' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.554 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 74.91 -66.99 0.27 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.765 0.317 . . . . 0.0 111.794 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.2 p -130.23 88.08 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.589 ' HB3' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -74.94 176.41 7.18 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 111.278 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.72 ' H ' ' HA ' ' A' ' 40' ' ' SER . 20.8 t -112.83 -42.03 0.08 OUTLIER Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.558 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.599 ' HD3' ' HA ' ' A' ' 40' ' ' SER . 98.6 Cg_exo -46.18 92.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.268 1.979 . . . . 0.0 113.795 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.538 ' HB ' HD21 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -124.04 171.76 6.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.472 178.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 93.2 Cg_exo -45.49 89.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.26 1.973 . . . . 0.0 112.24 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.724 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . 134.67 -60.87 0.64 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.861 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.9 t -48.78 151.63 1.16 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -103.89 -45.7 4.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.666 0.269 . . . . 0.0 111.648 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 84.41 47.85 5.27 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.74 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.637 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -157.0 120.08 4.08 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.041 -0.579 . . . . 0.0 110.934 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 97.03 24.8 12.15 Favored Glycine 0 C--O 1.223 -0.549 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.63 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.737 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.3 t-80 21.78 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 1.06 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 8.4 p -60.14 -35.63 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.049 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.489 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 8.3 p -119.45 6.24 11.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.092 -0.38 . . . . 0.0 111.73 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.23 14.61 62.0 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.733 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.489 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 13.6 mt -106.03 3.67 28.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.375 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.697 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.18 161.04 33.26 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' CG ' ' A' ' 37' ' ' HIS . 6.5 Cg_exo -71.87 47.54 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.589 1.526 . . . . 0.0 110.857 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.637 ' HB3' ' HA ' ' A' ' 28' ' ' THR . 0.3 OUTLIER 78.11 174.08 0.18 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.967 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 49.9 p-80 -123.9 -43.16 2.13 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.607 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.73 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 40.15 23.97 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.9 179.084 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.73 ' OG ' ' O ' ' A' ' 39' ' ' ARG . 58.0 m 145.57 30.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.724 0.64 . . . . 0.0 112.109 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 38' ' ' HIS . 12.0 mt -126.88 -179.42 4.82 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.101 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.3 p -73.94 -1.87 21.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.565 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -71.28 -96.28 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 1.06 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 3.6 t 66.55 124.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 56.3 Cg_endo -99.35 22.63 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.295 2.663 . . . . 0.0 113.908 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.595 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 18.6 m-70 -105.31 -84.3 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.697 -178.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HG3' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 70.94 68.68 0.18 Allowed 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.831 -0.543 . . . . 0.0 110.339 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -116.01 -8.47 11.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.022 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.816 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 8.6 mmp_? 65.17 38.23 6.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.235 0.541 . . . . 0.0 111.118 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -158.4 170.93 8.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.159 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 84.6 Cg_exo -41.32 -46.89 5.63 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.25 1.967 . . . . 0.0 114.179 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.724 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 66.3 Cg_endo -86.35 84.21 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.391 2.061 . . . . 0.0 115.182 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER 172.62 -100.55 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.339 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.642 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -122.54 -8.68 8.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.435 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.538 HD21 ' HB ' ' A' ' 22' ' ' THR . 0.6 OUTLIER 37.58 32.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.035 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 57' ' ' MET . . . 79.74 -30.36 0.13 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.419 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 79.3 -72.58 0.07 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.728 0.299 . . . . 0.0 110.296 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.46 29.51 7.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.541 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -146.12 174.91 10.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -80.72 80.42 7.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.621 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 2.7 t 57.48 165.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.323 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.816 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER 42.84 -118.69 0.5 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.868 0.105 . . . . 0.0 110.922 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.72 179.607 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.932 0.396 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -59.16 -85.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.179 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.95 152.59 24.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.773 0.32 . . . . 0.0 111.389 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 39' ' ' ARG . 23.9 mmtt -141.03 -173.84 3.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.596 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' ' N ' ' A' ' 22' ' ' THR . 44.2 t -80.28 -45.05 1.41 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.497 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 6.7 Cg_endo -51.71 70.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.801 1.668 . . . . 0.0 111.754 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.749 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 82.8 p -98.85 175.57 2.4 Favored Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.749 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -47.07 -21.75 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.509 1.473 . . . . 0.0 110.928 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' GLU . . . -100.52 20.01 50.13 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.935 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.1 t -163.79 158.89 20.65 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.041 0.421 . . . . 0.0 111.631 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.82 -44.78 6.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 77.59 39.67 24.85 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.888 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.612 ' CG2' ' O ' ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.51 46.81 1.29 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.359 0.599 . . . . 0.0 111.315 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.977 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -177.76 48.97 0.1 OUTLIER Glycine 0 C--O 1.218 -0.867 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.79 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.977 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 -6.33 -179.39 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.583 ' C ' ' HB3' ' A' ' 45' ' ' PRO . 10.2 p -54.88 -25.48 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.405 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 21.3 p -125.73 -3.31 7.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.51 66.32 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.405 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 14.2 mt -99.49 2.73 45.2 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.472 0.653 . . . . 0.0 109.404 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.657 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -113.23 157.23 41.58 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 57.2 Cg_endo -71.97 51.31 1.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.22 1.28 . . . . 0.0 111.234 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.573 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.0 m170 90.24 -176.01 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.481 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 26.2 p-80 -130.07 119.52 23.22 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.824 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.495 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -51.85 -30.96 25.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.6 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 6.4 t 160.96 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 O-C-N 123.054 0.221 . . . . 0.0 111.329 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.601 ' CD2' ' HG2' ' A' ' 57' ' ' MET . 2.2 mt 78.35 -27.41 0.17 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -49.64 -23.87 1.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.344 179.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.541 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -133.49 -88.03 0.33 Allowed Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.528 ' O ' ' O ' ' A' ' 43' ' ' GLY . 1.2 t 42.71 109.72 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.522 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.694 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -102.54 -2.29 0.35 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.795 2.997 . . . . 0.0 113.288 -179.324 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.658 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 44.3 m-70 -63.64 -80.01 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.765 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 12.2 pttt 57.25 57.1 4.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.46 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -120.17 -10.82 9.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.573 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 20.0 ttp180 46.66 48.24 14.49 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.726 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -159.61 -57.72 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 120.64 0.257 . . . . 0.0 110.71 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.726 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 21.2 Cg_endo -97.03 -171.99 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.933 3.089 . . . . 0.0 110.217 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.681 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 12.5 Cg_endo -56.5 79.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.25 1.3 . . . . 0.0 110.737 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.658 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.0 OUTLIER -124.16 -107.75 0.33 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.813 -178.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.5 ' CG1' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -140.58 13.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 110.328 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.573 ' HB3' ' HA ' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -46.35 -35.44 5.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.095 -179.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.09 44.79 1.21 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.235 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.601 ' HG2' ' CD2' ' A' ' 41' ' ' LEU . 2.0 mtt -65.18 -74.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.006 0.431 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -172.85 -68.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.239 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.21 -28.25 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.268 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -170.3 1.92 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.008 0.433 . . . . 0.0 111.3 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.477 ' HB ' ' HG3' ' A' ' 49' ' ' ARG . 4.1 m -140.58 153.62 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.638 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER 34.17 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.948 0.404 . . . . 0.0 111.735 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.679 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.844 0.354 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.81 -171.0 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.715 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 p -85.2 167.42 15.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.47 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -77.59 -174.16 3.28 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.892 0.377 . . . . 0.0 110.746 -179.849 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.7 t -118.15 26.61 0.11 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 28.5 Cg_endo -62.9 69.97 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.088 1.192 . . . . 0.0 112.181 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 20' ' ' CYS . 21.7 m -80.33 135.88 53.5 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.443 ' HD2' HG23 ' A' ' 22' ' ' THR . 97.4 Cg_exo -42.33 -26.51 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 111.667 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.658 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -103.76 -50.33 1.03 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.887 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.502 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 46.2 t -42.81 155.33 0.05 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.487 0.644 . . . . 0.0 111.228 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -101.77 -34.88 9.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 81.15 38.21 15.96 Favored Glycine 0 CA--C 1.502 -0.75 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.654 ' CG2' ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -159.57 62.85 0.38 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.85 -1.175 . . . . 0.0 108.572 -179.17 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 177.99 54.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.608 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.608 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.8 t-80 -37.52 176.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 45' ' ' PRO . 13.1 p -47.0 -30.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.502 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.44 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 15.0 p -126.63 -2.52 6.7 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.074 -0.391 . . . . 0.0 109.966 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.82 14.94 66.14 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 15.5 mt -100.96 4.7 42.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.715 0.769 . . . . 0.0 109.119 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -111.48 159.53 32.73 Favored Pre-proline 0 N--CA 1.448 -0.548 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.142 179.472 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 37' ' ' HIS . 61.1 Cg_endo -73.21 49.08 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.222 1.282 . . . . 0.0 111.113 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.518 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.6 m170 88.64 -173.97 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.514 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 29.6 p-80 -139.26 -50.94 0.52 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.335 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.497 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.1 OUTLIER 41.05 20.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.506 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 4.8 p -161.09 18.27 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 40' ' ' SER . 2.7 mt 71.62 5.72 5.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.892 0.314 . . . . 0.0 111.576 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.478 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 12.9 m -67.97 -4.43 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -156.92 -72.29 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.436 ' SG ' ' CG2' ' A' ' 54' ' ' ILE . 4.7 t 20.31 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.066 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.608 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 3.4 Cg_endo -105.7 5.88 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.703 3.602 . . . . 0.0 112.097 178.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.746 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 86.1 m-70 -39.01 -67.85 0.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.982 -177.135 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.704 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER 54.62 69.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.568 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -127.82 -8.79 5.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.563 179.629 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.637 ' C ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER 46.02 33.23 1.59 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.173 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.637 HG22 ' C ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -171.37 -75.33 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.624 177.834 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.526 ' CD ' HG21 ' A' ' 50' ' ' VAL . 49.9 Cg_endo -67.8 178.1 3.66 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 111.581 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.658 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 2.0 Cg_endo -41.77 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.364 2.043 . . . . 0.0 111.576 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.746 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.9 OUTLIER -150.1 -110.75 0.06 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.633 ' H ' ' CG ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -146.85 11.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.049 0.939 . . . . 0.0 108.883 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.403 ' CD1' ' HG ' ' A' ' 62' ' ' LEU . 19.7 tp -56.0 -12.48 1.46 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' CB ' HG22 ' A' ' 22' ' ' THR . . . -129.53 58.58 1.62 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.464 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 31.7 tpp -177.27 132.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.489 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 62.35 140.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.125 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.1 -29.3 3.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.888 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -76.41 63.45 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.591 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 63' ' ' LYS . 2.6 m -104.19 160.31 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.084 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 49' ' ' ARG . 1.4 mp 66.5 -67.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.126 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 1.506 ' CA ' ' CG ' ' A' ' 19' ' ' LYS 0.789 0.4 OUTLIER . . . . . 1 N--CA 0.861 -29.895 1 N-CA-C 129.976 7.028 . . . . 4.23 129.976 . . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 1.093 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 48.9 t -86.73 -22.85 0.29 Allowed Pre-proline 2 C--O 1.002 -11.945 1 CA-C-O 130.826 5.108 . . . . 0.88 112.712 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 1.093 ' HD2' ' N ' ' A' ' 20' ' ' CYS 0.288 14.8 Cg_exo -52.21 81.69 0.02 OUTLIER 'Trans proline' 3 C--N 1.0 -17.806 2 O-C-N 105.253 -8.341 . . . . 2.74 121.264 -178.869 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 1.345 ' CG2' ' CA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -92.84 167.62 14.05 Favored Pre-proline 2 C--N 1.143 -8.406 0 CA-C-N 114.023 -1.444 . . . . 2.05 114.559 -179.675 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.728 ' HD2' HG22 ' A' ' 22' ' ' THR . 27.9 Cg_exo -43.77 -21.96 0.39 Allowed 'Trans proline' 2 C--O 1.084 -7.205 0 C-N-CA 123.532 2.821 . . . . 1.57 113.082 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.758 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -107.49 -54.83 0.64 Allowed Glycine 3 C--O 1.083 -9.328 0 O-C-N 118.409 -2.682 . . . . 1.34 114.177 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 42.4 t -54.72 155.18 4.38 Favored 'General case' 1 C--N 1.198 -5.98 1 O-C-N 115.373 -4.604 . . . . 0.49 110.856 -179.69 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 1.01 ' OD2' ' CB ' ' A' ' 26' ' ' ASP . 26.5 t0 -102.11 -40.26 6.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.061 0.458 . . . . 1.58 111.494 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 48.43 4.72 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.626 -0.797 . . . . 0.45 111.636 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -154.66 113.67 3.65 Favored 'General case' 1 C--O 1.05 -9.428 0 CA-C-O 124.055 1.883 . . . . 0.99 110.621 -179.6 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 1.011 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 113.11 29.37 3.04 Favored Glycine 2 C--N 1.162 -9.094 1 O-C-N 113.307 -5.871 . . . . 0.92 113.099 179.66 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 1.011 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 11.51 -167.24 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.377 0 O-C-N 119.95 -1.912 . . . . 0.34 112.885 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG13 HG22 ' A' ' 32' ' ' THR . 14.1 p -59.73 -32.59 49.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.415 0.894 . . . . 0.4 113.415 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.633 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -125.18 8.07 7.9 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.85 -0.531 . . . . 1.25 111.259 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.35 15.0 62.88 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.645 -0.788 . . . . 0.49 111.163 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.633 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 15.7 mt -101.96 3.98 39.52 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.266 0.555 . . . . 0.73 110.379 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.78 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.2 160.23 36.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.387 -0.824 . . . . 0.58 109.387 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.536 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 9.8 Cg_endo -72.69 46.66 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.573 1.515 . . . . 0.65 111.239 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.634 ' HA ' ' H ' ' A' ' 29' ' ' GLY . 4.0 m-70 89.65 -177.65 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.697 -0.853 . . . . 0.57 108.697 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 1.281 ' C ' ' CA ' ' A' ' 39' ' ' ARG . 42.1 p-80 -133.08 19.62 4.08 Favored 'General case' 1 C--O 0.634 -31.304 1 CA-C-O 176.774 26.988 . . . . 1.18 110.38 178.696 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 1.443 ' CG ' ' CA ' ' A' ' 39' ' ' ARG . 22.3 mtt180 -1.92 10.1 0.0 OUTLIER 'General case' 2 C--N 0.573 -33.156 3 O-C-N 8.928 -71.108 . . . . 5.36 118.508 177.803 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 1.413 ' OG ' ' CA ' ' A' ' 40' ' ' SER . 7.9 p -173.82 30.46 0.01 OUTLIER 'General case' 2 N--CA 1.318 -7.064 0 N-CA-C 118.899 2.925 . . . . 2.17 118.899 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.025 HD12 ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 87.76 -43.86 0.03 OUTLIER 'General case' 1 C--O 0.833 -20.858 0 CA-C-O 127.14 3.353 . . . . 2.28 116.281 179.143 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 1.113 ' OG ' ' HB2' ' A' ' 42' ' ' SER . 0.1 OUTLIER -35.48 -25.78 0.01 OUTLIER 'General case' 1 C--N 0.987 -15.179 3 O-C-N 100.76 -13.713 . . . . 1.68 111.608 179.396 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . -123.6 -88.99 0.87 Allowed Glycine 1 C--N 1.248 -4.333 0 O-C-N 120.365 -1.46 . . . . 0.39 110.731 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.786 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.1 t 48.9 109.8 0.01 OUTLIER Pre-proline 0 C--O 1.191 -1.977 0 CA-C-N 115.366 -0.417 . . . . 0.74 111.167 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.659 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 42.6 Cg_endo -96.83 18.45 0.56 Allowed 'Trans proline' 0 C--O 1.169 -2.926 0 C-N-CA 123.821 3.014 . . . . 1.3 115.383 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.716 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 12.6 m80 -94.18 -83.09 0.34 Allowed 'General case' 1 C--N 1.207 -5.605 0 O-C-N 118.876 -2.39 . . . . 0.92 111.734 -177.539 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.551 ' CE ' ' CG ' ' A' ' 47' ' ' LYS 0.273 0.6 OUTLIER 67.59 62.14 0.44 Allowed 'General case' 2 CA--C 1.316 -8.043 0 N-CA-C 118.336 2.717 . . . . 3.59 118.336 179.938 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 1.34 ' OD1' ' CB ' ' A' ' 48' ' ' ASP 0.322 1.5 t0 -135.94 6.9 3.17 Favored 'General case' 2 N--CA 1.275 -9.215 1 CA-C-O 129.55 4.5 . . . . 3.5 120.243 178.955 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 1.251 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.2 ptt180 56.53 87.27 0.06 Allowed 'General case' 2 C--O 0.679 -28.96 2 O-C-N 114.286 -5.259 . . . . 5.32 118.085 179.431 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.251 HG23 ' O ' ' A' ' 49' ' ' ARG . 1.9 t 142.54 -113.12 0.0 OUTLIER Pre-proline 3 C--N 0.943 -17.065 4 O-C-N 90.607 -20.058 . . . . 2.92 115.5 177.269 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.287 ' HB2' ' CD ' ' A' ' 52' ' ' PRO 0.445 2.2 Cg_endo -56.64 -139.95 0.0 OUTLIER 'Trans proline' 4 C--N 0.752 -30.857 3 O-C-N 93.03 -14.774 . . . . 3.16 126.842 -179.35 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 1.287 ' CD ' ' HB2' ' A' ' 51' ' ' PRO . 1.6 Cg_endo -62.47 79.13 0.1 Allowed 'Trans proline' 2 C--N 1.129 -11.013 0 O-C-N 118.441 -1.4 . . . . 1.79 114.319 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 1.319 ' CD ' ' CB ' ' A' ' 53' ' ' GLU . 3.8 mp0 -151.55 -103.64 0.06 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.33 -0.857 . . . . 2.29 111.665 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.786 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -132.82 2.16 1.55 Allowed 'Isoleucine or valine' 1 C--O 1.142 -4.586 0 CA-C-O 118.712 -0.661 . . . . 1.18 109.583 -179.712 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.56 ' CD2' ' CB ' ' A' ' 55' ' ' LEU . 1.1 tp . . . . . 2 CA--C 1.351 -6.69 1 CA-C-O 136.579 7.847 . . . . 2.64 117.136 -178.959 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 3.4 mttt . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 121.22 0.533 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.702 ' O ' ' N ' ' A' ' 22' ' ' THR . 50.9 t -74.68 -36.64 2.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.335 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 72.4 Cg_exo -48.56 73.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.931 1.754 . . . . 0.0 111.822 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.702 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -79.53 172.99 8.46 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.323 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 94.9 Cg_exo -41.84 -28.15 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.191 1.927 . . . . 0.0 111.31 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.509 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -94.73 -70.35 1.09 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.095 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 22.7 t -50.97 159.39 0.58 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.891 0.346 . . . . 0.0 110.95 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -109.76 -41.61 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 92.53 60.55 1.22 Allowed Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.42 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.72 129.38 8.46 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.249 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.689 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.16 22.36 32.7 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.125 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.801 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 23.42 -160.9 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 123.436 0.695 . . . . 0.0 112.585 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.53 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.5 p -62.25 -33.41 58.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.884 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.4 t -133.89 21.76 3.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.412 0.551 . . . . 0.0 111.415 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.31 16.84 44.32 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.884 HD12 ' CG2' ' A' ' 32' ' ' THR . 20.5 mt -99.48 4.53 46.09 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.14 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.801 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.41 157.45 58.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.444 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 56.1 Cg_endo -70.96 47.11 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.427 1.418 . . . . 0.0 111.041 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 36' ' ' PRO . 6.9 m-70 88.47 -179.39 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.968 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 52.9 p-80 -130.61 104.14 7.03 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.188 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' SER . 4.5 mtt180 -71.16 -1.85 13.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.718 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.637 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 72.7 p 175.03 61.1 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 43' ' ' GLY . 0.5 OUTLIER 76.93 -161.3 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.398 178.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.437 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER 64.57 -2.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -147.27 -98.32 0.21 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.968 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.5 t 52.9 105.87 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.571 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.613 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 93.3 Cg_endo -90.6 34.89 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.142 2.562 . . . . 0.0 114.367 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.855 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 5.3 m80 -121.12 -92.07 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.961 -0.695 . . . . 0.0 112.507 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 75.25 67.74 0.08 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.26 0.482 . . . . 0.0 111.192 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.458 ' HB3' ' OE1' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -151.63 18.52 0.71 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.913 0.387 . . . . 0.0 111.012 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.508 ' O ' ' OE1' ' A' ' 53' ' ' GLU . 6.2 ptt-85 50.74 -177.64 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.914 ' HA ' HD22 ' A' ' 55' ' ' LEU . 70.2 t 26.72 -85.38 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.144 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 69.0 Cg_exo -46.34 168.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.269 0 CA-C-N 120.709 1.289 . . . . 0.0 111.872 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.509 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 7.6 Cg_endo -49.85 96.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.425 2.083 . . . . 0.0 112.173 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.855 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 3.8 mp0 -154.62 -102.43 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.84 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -147.58 19.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.995 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.914 HD22 ' HA ' ' A' ' 50' ' ' VAL . 15.3 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.284 0.564 . . . . 0.0 111.018 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.044 0.449 . . . . 0.0 110.027 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.661 ' O ' ' N ' ' A' ' 22' ' ' THR . 16.7 t -77.14 -54.78 1.48 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.158 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.573 ' HB3' ' HA3' ' A' ' 27' ' ' GLY . 9.7 Cg_endo -53.09 70.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.072 1.848 . . . . 0.0 112.051 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.661 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -110.4 -177.45 0.46 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.997 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.507 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 83.9 Cg_exo -46.86 -18.75 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.719 1.613 . . . . 0.0 112.691 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.41 ' H ' HG23 ' A' ' 22' ' ' THR . . . -103.92 12.44 52.92 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.884 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 26' ' ' ASP . 41.7 t -153.65 162.81 40.92 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.854 0.327 . . . . 0.0 110.57 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 25.4 t0 -103.94 -41.94 5.72 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.975 0.417 . . . . 0.0 109.883 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.573 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 86.79 54.21 2.69 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.944 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -156.75 131.79 9.06 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.362 -0.419 . . . . 0.0 111.487 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.6 21.29 34.73 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.425 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.802 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.9 t-80 24.36 -159.19 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 122.996 0.518 . . . . 0.0 112.189 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.952 HG13 HG23 ' A' ' 32' ' ' THR . 10.5 p -70.03 -34.51 59.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.952 HG23 HG13 ' A' ' 31' ' ' VAL . 10.7 p -116.72 6.53 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.204 -0.31 . . . . 0.0 111.557 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 65.03 14.4 58.95 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.812 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.639 HD12 ' OG1' ' A' ' 32' ' ' THR . 18.8 mt -102.58 1.77 35.26 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.802 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.14 158.32 41.34 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.373 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.9 Cg_endo -71.32 46.43 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.457 1.438 . . . . 0.0 111.329 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m-70 89.11 -179.44 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.963 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 51.5 p-80 -130.73 108.52 9.94 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.875 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -56.06 -22.83 29.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.668 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.702 ' O ' HD12 ' A' ' 41' ' ' LEU . 4.4 p 168.61 86.83 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER 79.24 -170.79 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.502 0.191 . . . . 0.0 110.511 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.475 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 68.7 m 66.35 -8.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.554 ' O ' ' HB ' ' A' ' 31' ' ' VAL . . . -145.99 -101.3 0.3 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.963 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 55.24 104.92 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.615 -0.293 . . . . 0.0 111.246 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.595 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 70.3 Cg_endo -92.16 34.72 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.13 2.554 . . . . 0.0 114.207 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.694 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 4.1 m80 -122.16 -83.02 0.66 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.356 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 71.92 65.17 0.14 Allowed 'General case' 0 N--CA 1.461 0.119 0 O-C-N 122.156 -0.34 . . . . 0.0 111.199 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB3' ' CD ' ' A' ' 53' ' ' GLU . 2.3 t0 -152.81 15.79 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.401 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' O ' ' OE1' ' A' ' 53' ' ' GLU . 2.6 ttm180 43.67 -169.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.712 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 88.7 t 37.45 -91.07 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.114 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 10.1 Cg_endo -54.09 -175.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.254 1.303 . . . . 0.0 112.109 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 27.6 Cg_exo -62.19 95.84 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.283 1.988 . . . . 0.0 111.536 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.694 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 19.4 mp0 -152.11 -103.23 0.05 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.929 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.75 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -136.14 7.94 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.066 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 50' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 121.151 0.5 . . . . 0.0 110.965 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 121.249 0.547 . . . . 0.0 111.899 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 22' ' ' THR . 49.5 t -72.13 -26.58 0.86 Allowed Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 71.9 Cg_exo -50.51 74.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.558 1.505 . . . . 0.0 112.388 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -83.78 172.54 9.0 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 88.1 Cg_exo -44.49 -27.93 2.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.243 1.962 . . . . 0.0 111.839 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . -97.42 -69.1 0.97 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.357 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 24.0 t -46.04 157.52 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 111.716 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -112.51 -30.72 7.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.81 58.75 2.08 Favored Glycine 0 CA--C 1.506 -0.512 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.452 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.51 128.67 4.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.426 -0.887 . . . . 0.0 109.738 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.979 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.62 50.33 3.6 Favored Glycine 0 C--O 1.219 -0.801 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.03 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.979 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 -12.3 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 32' ' ' THR . 13.1 p -52.39 -37.36 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.888 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.947 HG23 HG13 ' A' ' 31' ' ' VAL . 17.9 p -114.02 -7.28 13.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.819 0.342 . . . . 0.0 110.156 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.79 80.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.628 HD12 ' OG1' ' A' ' 32' ' ' THR . 12.1 mt -97.06 1.38 50.05 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.702 0.763 . . . . 0.0 109.163 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.79 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -110.33 161.21 25.46 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.771 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 74.2 Cg_endo -76.63 49.32 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.261 1.308 . . . . 0.0 111.265 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.3 m170 90.46 -176.4 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 48.3 p-80 -134.98 -53.96 0.8 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.511 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 39.96 33.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.463 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.677 ' O ' HD23 ' A' ' 41' ' ' LEU . 28.3 p -143.95 -68.46 0.33 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.792 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 40' ' ' SER . 0.4 OUTLIER 157.72 -52.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.548 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.49 ' N ' HD12 ' A' ' 41' ' ' LEU . 13.3 p -41.55 -30.32 0.21 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.796 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.5 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -100.41 -106.06 2.79 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.822 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.0 t 49.77 108.07 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.954 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.731 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 9.2 Cg_endo -96.29 2.0 2.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.143 2.562 . . . . 0.0 113.373 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.67 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 16.6 m80 -70.2 -80.29 0.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.758 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 53.82 61.72 2.95 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.455 0.645 . . . . 0.0 110.853 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.591 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.16 -6.25 12.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.902 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 0.4 OUTLIER 47.81 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.742 ' HB ' ' CD ' ' A' ' 51' ' ' PRO . 88.8 t 107.44 -81.76 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.351 1.061 . . . . 0.0 110.518 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.742 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 12.7 Cg_endo -56.41 -171.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.767 1.645 . . . . 0.0 111.115 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.508 ' CD ' ' HB2' ' A' ' 51' ' ' PRO . 25.1 Cg_exo -65.83 108.63 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.224 1.949 . . . . 0.0 111.768 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.67 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 2.0 pm0 -158.84 -103.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.822 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -120.52 -8.73 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.949 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 11.4 mmtm . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.154 0.502 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.6 t -88.48 -42.08 0.47 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.355 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 74.2 Cg_exo -48.35 76.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.991 1.794 . . . . 0.0 112.212 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -90.63 175.64 3.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.67 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.586 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 64.6 Cg_exo -40.57 -27.97 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 112.622 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.631 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -93.8 -72.96 1.2 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.542 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.422 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 48.8 t -46.13 158.8 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 111.499 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -103.64 -37.52 7.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.791 0.329 . . . . 0.0 110.901 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 85.04 40.9 7.79 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.744 HG22 ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -158.16 62.44 0.45 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.864 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 176.59 57.24 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.632 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.5 t-80 -37.92 173.91 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.372 0.606 . . . . 0.0 112.298 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.913 HG13 HG23 ' A' ' 32' ' ' THR . 13.6 p -48.44 -33.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.519 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.913 HG23 HG13 ' A' ' 31' ' ' VAL . 7.9 p -122.84 -1.79 8.86 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.155 -0.341 . . . . 0.0 110.16 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.57 15.63 64.28 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.576 HD12 ' OG1' ' A' ' 32' ' ' THR . 23.7 mt -99.93 6.07 45.22 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.948 0.88 . . . . 0.0 108.747 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.616 ' HE1' ' HG1' ' A' ' 32' ' ' THR . 0.1 OUTLIER -115.42 155.96 46.45 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.165 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.493 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 3.0 Cg_exo -73.48 51.39 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.658 1.572 . . . . 0.0 110.574 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.501 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 7.9 m-70 89.47 -174.36 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 26.5 p-80 -130.5 124.69 32.53 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.323 0.582 . . . . 0.0 111.121 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -54.47 -35.67 63.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.404 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 23.0 p 169.43 84.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD2' HG22 ' A' ' 54' ' ' ILE . 7.6 mt 75.04 -8.33 1.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -53.06 -27.21 18.85 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.382 0.611 . . . . 0.0 109.376 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.477 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -133.15 -77.17 0.11 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.841 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.6 t 26.81 92.58 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 6.2 Cg_endo -105.16 2.46 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.448 3.432 . . . . 0.0 112.959 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.691 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 38.5 m80 -37.19 -57.39 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.74 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.67 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 6.0 mttt -175.1 -62.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.263 0.554 . . . . 0.0 110.626 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 26.1 t70 132.03 -14.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.032 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.461 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 3.5 ttp180 -70.59 145.95 50.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.318 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.912 HG13 ' HD3' ' A' ' 51' ' ' PRO . 1.7 p -42.15 -46.37 10.44 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.912 ' HD3' HG13 ' A' ' 50' ' ' VAL . 7.6 Cg_endo -49.15 178.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.769 1.646 . . . . 0.0 111.235 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 4.1 Cg_endo -46.21 69.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.661 2.241 . . . . 0.0 112.845 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.725 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.5 mt-10 -145.11 -106.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.841 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -126.41 -6.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.727 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.577 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 4.8 mmtp . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.397 0.618 . . . . 0.0 111.742 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 22' ' ' THR . 51.0 t -87.94 -35.21 0.44 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.957 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HD2' ' CB ' ' A' ' 19' ' ' LYS . 94.8 Cg_exo -44.45 73.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.268 1.979 . . . . 0.0 112.803 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -81.17 171.66 11.68 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.162 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 96.2 Cg_exo -41.08 -28.51 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.394 2.063 . . . . 0.0 111.891 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -96.44 -64.1 0.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.195 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.6 t -56.15 158.58 3.93 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.836 0.35 . . . . 0.0 111.272 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -110.46 -35.73 5.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.608 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 89.23 56.48 1.92 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.856 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.409 ' HG1' ' CG ' ' A' ' 37' ' ' HIS . 0.8 OUTLIER -158.96 131.46 6.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.985 -0.607 . . . . 0.0 111.082 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 94.94 20.6 27.93 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.246 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 23.2 -163.21 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 123.647 0.779 . . . . 0.0 112.798 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 32' ' ' THR . 13.8 p -63.23 -33.68 62.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.801 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.3 t -130.05 18.25 5.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.016 -0.427 . . . . 0.0 111.348 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.97 15.22 48.74 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.351 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.801 HD12 ' CG2' ' A' ' 32' ' ' THR . 18.7 mt -97.88 4.85 49.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 120.99 0.424 . . . . 0.0 110.068 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.786 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.8 158.05 58.14 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.877 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.553 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 8.3 Cg_exo -71.37 46.83 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.8 1.667 . . . . 0.0 111.078 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.553 ' CD2' ' O ' ' A' ' 36' ' ' PRO . 9.1 m-70 91.9 -176.24 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.671 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 26.9 p-80 -128.42 121.7 29.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.281 0.562 . . . . 0.0 110.528 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.41 -29.22 67.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.202 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.748 ' O ' HD12 ' A' ' 41' ' ' LEU . 24.1 p 175.51 73.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 ' CG2' ' A' ' 54' ' ' ILE . 0.5 OUTLIER 78.84 -15.54 0.75 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 178.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -22.99 1.29 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.226 0.536 . . . . 0.0 109.894 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.655 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.52 -82.6 0.15 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.671 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 47.76 110.08 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 114.874 -0.663 . . . . 0.0 111.315 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.604 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 14.6 Cg_endo -102.69 30.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.492 2.795 . . . . 0.0 113.179 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.84 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 24.1 m80 -98.18 -90.87 0.27 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.692 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 40.0 mmtt -161.07 -74.77 0.06 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 110.988 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.692 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 22.7 t0 158.21 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.073 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.483 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -56.42 129.56 41.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.258 -179.324 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 2.4 t -29.83 -50.66 0.32 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.92 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.9 Cg_exo -51.67 -170.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.24 1.96 . . . . 0.0 111.873 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 74.9 Cg_exo -50.47 64.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.679 2.253 . . . . 0.0 113.645 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.84 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.9 mm-40 -139.7 -106.21 0.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 119.918 -0.087 . . . . 0.0 111.091 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.753 ' CG2' HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -129.69 -21.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.916 -0.49 . . . . 0.0 111.547 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.897 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.7 tt . . . . . 0 CA--C 1.533 0.318 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.827 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 111.547 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' THR . 42.5 t -89.5 -41.46 0.43 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.06 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.827 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 85.6 Cg_exo -43.37 81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.418 2.078 . . . . 0.0 112.96 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -91.97 171.6 7.55 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.204 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.4 Cg_endo -47.5 -27.71 7.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.892 1.728 . . . . 0.0 110.368 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.574 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -91.3 -67.62 1.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.751 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -53.39 154.84 3.15 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.23 -40.16 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.027 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.482 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 83.65 44.25 6.94 Favored Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.109 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.64 129.96 8.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.146 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 99.59 19.45 20.27 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.43 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.761 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.6 t-80 24.19 -157.0 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 123.462 0.705 . . . . 0.0 112.261 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG13 HG22 ' A' ' 32' ' ' THR . 14.6 p -66.27 -33.68 65.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.88 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.1 t -132.47 21.49 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.484 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.6 15.02 45.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.604 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.88 HD12 ' CG2' ' A' ' 32' ' ' THR . 17.4 mt -98.95 3.83 47.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.987 0.422 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.761 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.68 161.4 44.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.259 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.543 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.5 Cg_exo -72.29 45.07 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.041 1.828 . . . . 0.0 111.629 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.5 m-70 90.58 -176.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.852 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 31.3 p-80 -129.49 120.35 25.26 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.159 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.22 -17.66 63.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.267 -178.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.766 ' O ' HD12 ' A' ' 41' ' ' LEU . 35.3 t 173.83 68.73 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.907 HD23 HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER 78.5 -12.87 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.09 -29.53 0.91 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.411 0.624 . . . . 0.0 109.401 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.741 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.83 -77.77 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.088 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.852 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 51.23 109.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.587 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 76.1 Cg_endo -94.07 22.49 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.914 2.409 . . . . 0.0 113.98 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.707 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 6.8 m80 -105.29 -93.32 0.36 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.432 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.528 ' HG3' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 74.48 69.08 0.09 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.556 0.616 . . . . 0.0 111.472 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.632 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -136.17 8.38 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.071 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 1.0 OUTLIER 55.5 38.73 30.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.074 0.464 . . . . 0.0 111.984 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.642 HG12 ' HD2' ' A' ' 52' ' ' PRO . 5.8 t -142.72 143.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.921 ' HD3' HD23 ' A' ' 55' ' ' LEU . 12.7 Cg_exo -27.01 -59.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.56 2.84 . . . . 0.0 113.677 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.642 ' HD2' HG12 ' A' ' 50' ' ' VAL . 70.5 Cg_endo -73.46 57.61 3.58 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.48 2.12 . . . . 0.0 113.69 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.707 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 20.2 mp0 -164.88 -102.29 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.907 HG22 HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -131.9 0.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.914 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.921 HD23 ' HD3' ' A' ' 51' ' ' PRO . 12.7 tp . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.906 0.384 . . . . 0.0 111.205 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HB2' ' N ' ' A' ' 41' ' ' LEU . 47.4 t -104.28 67.61 0.13 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.27 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.476 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 85.5 Cg_endo -78.9 75.22 5.15 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.927 1.752 . . . . 0.0 113.272 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.586 ' HB ' ' CB ' ' A' ' 25' ' ' CYS . 91.7 m -87.34 145.19 37.15 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 22' ' ' THR . 61.2 Cg_exo -36.93 -27.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.726 2.284 . . . . 0.0 112.987 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -144.15 -9.95 0.38 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.996 -1.097 . . . . 0.0 114.74 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.586 ' CB ' ' HB ' ' A' ' 22' ' ' THR . 23.6 t -48.09 151.78 0.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.811 1.306 . . . . 0.0 110.712 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -102.76 -44.06 5.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.795 0.331 . . . . 0.0 111.301 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 55.65 1.52 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.657 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.71 129.74 8.69 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.66 -0.77 . . . . 0.0 110.557 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.825 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 93.78 23.75 22.39 Favored Glycine 0 C--O 1.226 -0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.222 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.825 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 t-80 17.72 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.05 0.94 . . . . 0.0 113.179 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.889 HG13 HG23 ' A' ' 32' ' ' THR . 9.5 p -63.88 -33.31 61.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.889 HG23 HG13 ' A' ' 31' ' ' VAL . 12.0 p -117.65 0.23 12.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.866 0.303 . . . . 0.0 110.837 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 69.27 13.66 67.78 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.098 -1.049 . . . . 0.0 110.649 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.594 HD12 ' OG1' ' A' ' 32' ' ' THR . 16.9 mt -101.06 3.5 41.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.218 0.532 . . . . 0.0 109.77 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.813 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.51 159.46 36.82 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.101 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 60.5 Cg_endo -73.34 47.69 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.329 1.352 . . . . 0.0 110.872 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.7 m-70 91.36 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.655 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 34.7 p-80 -132.75 -51.18 0.91 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.402 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 36.73 28.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.646 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 2.2 p -158.03 5.01 0.12 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.7 HD11 ' O ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 82.26 -23.61 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.1 p -48.89 -27.01 2.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.115 0.484 . . . . 0.0 110.164 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -124.71 -88.84 0.79 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.849 ' SG ' HG23 ' A' ' 54' ' ' ILE . 3.3 t 52.72 111.62 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.513 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 30' ' ' HIS . 28.8 Cg_endo -98.95 14.4 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.204 2.603 . . . . 0.0 113.45 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.713 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 14.5 m80 -86.72 -72.97 0.48 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.594 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 50.29 62.13 2.83 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.082 0.468 . . . . 0.0 111.644 -179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.63 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 5.9 t70 -141.44 9.75 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.606 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.651 ' HG3' HG23 ' A' ' 50' ' ' VAL . 1.9 ptt180 59.96 -170.73 0.14 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.278 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.651 HG23 ' HG3' ' A' ' 49' ' ' ARG . 56.4 t 23.65 -80.2 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 124.972 1.309 . . . . 0.0 114.156 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.623 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 9.1 Cg_endo -50.88 176.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.669 1.579 . . . . 0.0 112.056 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 44.3 Cg_exo -56.79 77.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.14 1.894 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.713 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.9 mm-40 -132.32 -105.62 0.26 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.849 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -145.99 18.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.592 ' HB2' ' N ' ' A' ' 50' ' ' VAL . 2.6 tm? . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.38 0.61 . . . . 0.0 111.615 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.851 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 5.3 mmtt . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 121.665 0.745 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 35.2 t -72.16 -35.78 3.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.53 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 88.6 Cg_exo -47.05 82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.987 1.791 . . . . 0.0 112.796 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -87.44 177.79 2.54 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 72.1 Cg_exo -41.7 -23.71 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.314 2.009 . . . . 0.0 112.775 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.493 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -105.14 -67.06 0.69 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 39.1 t -46.75 155.11 0.27 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.637 0.718 . . . . 0.0 110.749 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -107.9 -43.39 4.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 110.784 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 96.21 61.49 0.98 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.962 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -154.35 131.09 10.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.2 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.671 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 89.86 22.59 35.61 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.217 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.795 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 t-80 23.37 -158.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.448 0.699 . . . . 0.0 112.279 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.563 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 8.7 p -64.84 -35.83 76.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.851 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.4 t -129.85 21.01 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.438 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.08 16.2 39.73 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.193 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.851 HD12 ' CG2' ' A' ' 32' ' ' THR . 25.5 mt -97.3 2.57 50.86 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 110.048 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.795 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -121.52 158.19 54.47 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.602 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.556 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.17 45.74 0.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.741 1.627 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.9 m-70 89.97 179.44 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.961 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.6 p-80 -124.89 -52.85 1.66 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.705 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.463 ' CG ' ' HG2' ' A' ' 21' ' ' PRO . 47.3 ttt180 45.35 19.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.889 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.851 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -165.24 23.06 0.05 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 77.83 -161.07 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 71.77 -53.14 0.69 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.581 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -96.9 -91.17 1.86 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.961 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.88 108.7 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.259 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.573 ' N ' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -90.4 27.12 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.074 2.516 . . . . 0.0 114.431 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.797 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 7.9 m80 -111.61 -76.0 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.982 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.862 ' HB3' HD11 ' A' ' 54' ' ' ILE . 1.6 ptpt 53.8 68.59 0.82 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 110.917 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.818 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 2.2 t70 -132.74 10.58 4.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.432 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER 50.23 50.73 18.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.297 0.57 . . . . 0.0 112.229 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.921 HG12 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -149.16 153.55 38.02 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.921 ' HD2' HG12 ' A' ' 50' ' ' VAL . 79.6 Cg_exo -38.52 -56.38 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.769 1.646 . . . . 0.0 112.782 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 72.9 Cg_endo -73.44 56.37 3.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.678 2.252 . . . . 0.0 114.098 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.699 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 30.8 mp0 -162.84 -104.33 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.873 0.368 . . . . 0.0 110.985 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.862 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -131.85 4.56 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.702 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD13 ' HD3' ' A' ' 51' ' ' PRO . 2.5 tt . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.794 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 1.7 mmtm . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.185 0.517 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 22' ' ' THR . 41.9 t -55.16 -41.84 92.81 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.387 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 76.9 Cg_exo -43.05 77.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.367 2.045 . . . . 0.0 112.984 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.629 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -82.96 176.03 4.22 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.137 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 80.7 Cg_exo -46.9 -22.84 2.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.925 1.75 . . . . 0.0 111.663 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 52' ' ' PRO . . . -103.11 -69.22 0.8 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.904 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.9 t -42.1 150.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.043 0.422 . . . . 0.0 111.7 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -101.71 -47.14 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 100.38 53.44 1.07 Allowed Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.511 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.468 ' HG1' ' CE1' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -157.71 125.74 5.4 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.721 ' O ' ' CA ' ' A' ' 33' ' ' GLY . . . 111.25 -10.35 28.88 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.096 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.953 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 46.94 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.702 -0.881 . . . . 0.0 111.823 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.8 p -50.97 -31.6 10.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.877 HG23 HG13 ' A' ' 31' ' ' VAL . 9.5 p -116.47 4.28 13.29 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.574 1.079 . . . . 0.0 112.036 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.721 ' CA ' ' O ' ' A' ' 29' ' ' GLY . . . 71.57 17.38 76.38 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.351 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 32' ' ' THR . 3.2 mt -124.29 8.62 8.49 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.953 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -107.09 167.21 9.77 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.336 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.727 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 57.1 Cg_endo -72.12 37.63 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.263 1.309 . . . . 0.0 110.884 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 2.2 m-70 89.34 179.26 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.941 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.0 p-80 -128.68 -50.33 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.727 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HG3' ' HG2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER 40.95 27.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.422 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.564 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 2.4 m -174.09 18.98 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 43' ' ' GLY . 0.9 OUTLIER 76.33 -171.86 0.09 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.305 0.502 . . . . 0.0 110.36 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 18.8 m 73.28 -18.06 0.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.548 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -130.48 -94.33 0.68 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.941 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.5 t 55.77 121.62 0.01 OUTLIER Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.709 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.636 ' HD2' ' CE1' ' A' ' 46' ' ' HIS . 72.5 Cg_endo -95.21 24.97 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.006 2.471 . . . . 0.0 113.857 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.636 ' CE1' ' HD2' ' A' ' 45' ' ' PRO . 5.6 m80 -115.8 -95.46 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 78.62 67.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.346 0.521 . . . . 0.0 112.209 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.447 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 51.0 t0 -139.24 10.54 2.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.374 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 27.11 43.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.806 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 96.0 t -157.65 -57.32 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.207 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.806 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.4 Cg_endo -96.42 -179.41 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.198 2.599 . . . . 0.0 111.171 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 9.3 Cg_endo -50.88 84.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 121.977 1.785 . . . . 0.0 110.736 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.624 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.2 mt-10 -140.37 -96.85 0.15 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.595 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -146.43 25.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' ' 50' ' ' VAL . 7.6 tt . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.607 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.712 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.717 0.294 . . . . 0.0 111.324 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.646 ' N ' ' HA ' ' A' ' 40' ' ' SER . 48.8 t -111.6 68.8 0.77 Allowed Pre-proline 0 C--N 1.334 -0.067 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 94.9 Cg_endo -88.9 71.98 2.12 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.857 1.705 . . . . 0.0 111.123 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.626 ' HB ' ' H ' ' A' ' 25' ' ' CYS . 2.1 m -81.99 141.8 47.54 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.284 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 22' ' ' THR . 84.4 Cg_exo -46.69 -21.6 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.217 1.944 . . . . 0.0 111.869 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' C ' ' HB3' ' A' ' 52' ' ' PRO . . . -123.15 -37.23 0.61 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.622 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.626 ' H ' ' HB ' ' A' ' 22' ' ' THR . 13.0 t -44.4 152.13 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.868 0.834 . . . . 0.0 111.046 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -108.47 -34.36 6.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.31 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' HA3' ' HG2' ' A' ' 39' ' ' ARG . . . 83.63 54.83 2.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.211 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -157.8 127.43 5.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.443 -0.879 . . . . 0.0 110.154 -179.316 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.782 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 95.78 24.52 15.28 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.978 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.782 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 17.71 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.921 0.889 . . . . 0.0 113.049 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.864 HG13 HG23 ' A' ' 32' ' ' THR . 7.8 p -67.9 -35.57 72.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.864 HG23 HG13 ' A' ' 31' ' ' VAL . 11.5 p -113.62 -3.96 13.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.328 -0.233 . . . . 0.0 110.637 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 72.96 12.62 79.12 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.564 HD12 ' OG1' ' A' ' 32' ' ' THR . 13.7 mt -101.35 5.0 42.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 109.942 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.733 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.97 164.34 17.01 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.565 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 2.8 Cg_exo -74.09 45.21 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.945 1.763 . . . . 0.0 110.884 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m170 87.54 179.25 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.807 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 47.4 p-80 -129.23 -53.08 1.19 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.195 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 45.42 20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.607 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.69 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.4 p -143.21 -53.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER 157.6 -53.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.03 0.377 . . . . 0.0 111.459 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.483 ' N ' HD12 ' A' ' 41' ' ' LEU . 56.6 p -33.2 -36.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.235 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.598 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -104.48 -98.91 2.54 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.826 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.8 t 55.0 109.04 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.262 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.1 Cg_endo -95.01 24.65 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.903 2.402 . . . . 0.0 113.7 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.777 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 6.9 m80 -107.13 -76.84 0.61 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.793 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.859 ' HB3' HD11 ' A' ' 54' ' ' ILE . 4.4 pttt 54.07 66.23 1.29 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 1.5 t0 -131.34 -10.52 3.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.498 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER 53.21 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.011 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 28.0 t 99.55 -68.94 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.452 1.101 . . . . 0.0 110.449 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.011 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 2.9 Cg_exo -73.92 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.818 1.679 . . . . 0.0 110.498 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.634 ' HD2' ' CB ' ' A' ' 51' ' ' PRO . 44.1 Cg_endo -67.11 99.32 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.8 1.667 . . . . 0.0 111.647 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 21.8 mp0 -152.2 -103.16 0.05 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.52 7.74 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.083 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.575 ' C ' HD23 ' A' ' 55' ' ' LEU . 3.0 tt . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.884 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.798 0.332 . . . . 0.0 111.318 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.552 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 16.7 t -110.18 33.27 0.1 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 97.0 Cg_endo -77.35 80.03 3.01 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.484 1.456 . . . . 0.0 111.732 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' A' ' 25' ' ' CYS . 1.1 m -85.97 142.14 36.13 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.017 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 22' ' ' THR . 98.1 Cg_exo -43.43 -30.19 2.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.188 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.617 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -112.44 -26.61 4.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.965 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.603 ' H ' ' HB ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -51.83 144.18 11.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.512 ' H ' ' CE1' ' A' ' 46' ' ' HIS . 16.2 t0 -82.27 -46.77 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.34 23.72 77.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.568 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.48 43.95 1.29 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.388 0.614 . . . . 0.0 110.671 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.869 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -170.55 29.81 0.13 Allowed Glycine 0 C--O 1.22 -0.772 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.325 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.869 ' O ' ' O ' ' A' ' 29' ' ' GLY . 3.1 t-80 15.64 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.835 HG13 HG23 ' A' ' 32' ' ' THR . 10.3 p -59.01 -21.1 18.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.835 HG23 HG13 ' A' ' 31' ' ' VAL . 3.2 p -132.37 6.77 4.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.017 0.826 . . . . 0.0 110.216 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 64.18 18.62 62.95 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.7 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.672 HD12 ' OG1' ' A' ' 32' ' ' THR . 9.3 mt -117.06 10.42 13.93 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.711 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -113.39 171.4 4.38 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.003 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.546 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 2.7 Cg_exo -74.89 43.3 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.971 1.781 . . . . 0.0 112.01 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 36' ' ' PRO . 8.4 m-70 85.11 -176.37 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.25 0.547 . . . . 0.0 110.405 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.93 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 29.4 p-80 -152.01 153.71 34.57 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.601 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mtt180 -149.22 38.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.082 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.755 ' O ' HD12 ' A' ' 41' ' ' LEU . 60.3 p -170.42 20.54 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.011 HD23 HG22 ' A' ' 54' ' ' ILE . 0.7 OUTLIER 77.42 -36.84 0.24 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.46 0.573 . . . . 0.0 112.195 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 41' ' ' LEU . 64.6 m -36.46 -35.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.193 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.509 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.1 -93.05 2.26 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.981 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.93 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.1 t 48.67 111.08 0.01 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 115.256 -0.472 . . . . 0.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.577 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.9 Cg_endo -86.4 18.39 1.58 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.951 2.434 . . . . 0.0 113.943 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.747 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 5.8 m80 -105.0 -89.33 0.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.466 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.53 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER 77.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 178.346 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.718 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 1.4 t70 -146.13 24.9 1.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.259 0.552 . . . . 0.0 109.812 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.419 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER 34.23 43.12 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.95 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.647 HG23 ' HD2' ' A' ' 52' ' ' PRO . 6.7 m -135.99 153.78 77.18 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.681 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 27.9 Cg_exo -27.33 -48.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.039 3.159 . . . . 0.0 113.822 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 50' ' ' VAL . 96.7 Cg_endo -92.62 39.06 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.406 2.071 . . . . 0.0 114.461 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.747 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 8.8 mm-40 -144.42 -102.39 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.011 HG22 HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -128.9 3.71 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -178.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 49' ' ' ARG . 31.2 tp . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.656 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 22.5 mttt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 121.367 0.603 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.691 ' O ' ' N ' ' A' ' 22' ' ' THR . 48.1 t -56.21 -40.51 85.28 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.59 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.656 ' HD3' ' HA ' ' A' ' 39' ' ' ARG . 86.2 Cg_exo -48.51 72.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.118 1.879 . . . . 0.0 112.678 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.691 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -81.14 173.49 7.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 4.6 Cg_exo -37.5 -27.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.752 2.301 . . . . 0.0 112.644 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' THR . . . -97.28 -75.81 1.26 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.914 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 34.2 t -39.5 156.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.055 0.455 . . . . 0.0 112.212 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.77 -36.96 6.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.82 57.99 1.55 Allowed Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.126 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.64 135.46 9.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.808 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 90.68 21.75 35.96 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.452 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.759 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 21.63 -158.61 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.396 0.679 . . . . 0.0 112.448 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.857 HG13 HG23 ' A' ' 32' ' ' THR . 6.9 p -70.73 -34.52 56.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.857 HG23 HG13 ' A' ' 31' ' ' VAL . 5.9 p -117.46 5.81 12.53 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.025 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.54 13.76 61.31 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.132 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.625 HD12 ' OG1' ' A' ' 32' ' ' THR . 19.8 mt -101.63 2.56 38.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.759 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.25 158.78 40.33 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.335 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.6 Cg_endo -71.9 48.26 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.354 1.37 . . . . 0.0 111.302 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.55 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 4.3 m-70 90.2 -179.33 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.912 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 33.1 p-80 -129.33 -55.07 1.18 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.426 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 91.4 mtt-85 41.92 30.5 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.656 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 38.3 t -155.12 -1.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.673 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 82.73 -35.78 0.09 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.0 p -39.77 -37.34 0.52 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.241 0.543 . . . . 0.0 110.485 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.504 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.49 -90.69 2.09 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.912 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 59.1 112.24 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.859 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.5 Cg_endo -92.31 27.08 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.013 2.475 . . . . 0.0 114.105 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.739 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 5.8 m80 -114.7 -74.91 0.6 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.025 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.793 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 54.61 65.48 1.49 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.92 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t70 -133.88 -7.06 2.76 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.718 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.569 ' HD2' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER 48.69 135.22 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.961 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 33.6 t 96.21 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.551 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.961 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 4.7 Cg_exo -76.95 -167.51 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.646 1.564 . . . . 0.0 110.706 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.502 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 24.9 Cg_exo -64.93 100.74 0.36 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 121.989 1.793 . . . . 0.0 112.28 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.739 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 26.3 mp0 -155.85 -104.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -132.36 11.15 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.195 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD13 ' H ' ' A' ' 50' ' ' VAL . 17.7 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.369 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.048 0 CA-C-O 121.142 0.496 . . . . 0.0 111.854 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.685 ' O ' ' N ' ' A' ' 22' ' ' THR . 52.3 t -88.72 -32.96 0.4 Allowed Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 49.9 Cg_exo -38.47 76.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.229 1.953 . . . . 0.0 113.31 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -84.77 170.21 14.24 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.11 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HD2' HG22 ' A' ' 22' ' ' THR . 9.3 Cg_endo -52.58 -19.22 9.85 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.285 1.99 . . . . 0.0 112.207 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' ' C ' ' A' ' 51' ' ' PRO . . . -108.95 -51.0 0.7 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.483 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.3 t -51.74 156.27 1.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.339 0.569 . . . . 0.0 110.304 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -98.75 -42.9 7.0 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.23 53.69 2.44 Favored Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.919 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.436 ' HG1' ' CE1' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -156.19 131.57 9.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.922 -0.639 . . . . 0.0 111.162 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.71 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 92.66 20.87 33.03 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.439 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.812 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t-80 22.08 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.6 p -61.76 -33.69 58.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.836 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.5 t -132.4 19.94 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.268 0.485 . . . . 0.0 111.475 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.17 16.75 49.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.176 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.836 HD12 ' CG2' ' A' ' 32' ' ' THR . 22.3 mt -99.57 3.9 45.6 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.227 0.537 . . . . 0.0 110.055 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.812 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.75 158.49 51.8 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.822 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.15 44.33 0.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.945 1.763 . . . . 0.0 111.268 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 4.5 m-70 93.01 -175.63 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.926 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 43.2 p-80 -141.09 140.27 34.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.434 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 9.3 mtt180 -131.82 33.06 4.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.746 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 38.6 p -165.42 12.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.59 HD23 HG22 ' A' ' 54' ' ' ILE . 0.4 OUTLIER 81.31 -32.63 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.525 0.602 . . . . 0.0 111.633 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -39.78 -31.44 0.11 Allowed 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.208 0.528 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.562 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -109.57 -92.81 2.22 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.926 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.37 108.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 115.151 -0.524 . . . . 0.0 111.089 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.552 ' CB ' ' O ' ' A' ' 30' ' ' HIS . 97.3 Cg_endo -87.53 23.21 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.85 2.366 . . . . 0.0 114.084 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.705 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 6.2 m80 -110.56 -96.47 0.41 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.571 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.602 ' CB ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.98 68.09 0.1 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.962 0.801 . . . . 0.0 110.492 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.55 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -133.64 9.32 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.443 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? 60.96 42.41 12.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.108 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.787 HG23 ' CD ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -152.94 148.6 20.48 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.43 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 50.7 Cg_exo -36.66 -58.18 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.36 2.04 . . . . 0.0 113.044 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.745 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 13.5 Cg_exo -69.0 62.03 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.077 1.851 . . . . 0.0 112.6 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.787 ' CD ' HG23 ' A' ' 50' ' ' VAL . 18.8 mp0 -166.58 -102.65 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.008 0.433 . . . . 0.0 110.559 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.649 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -117.09 -32.05 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 51' ' ' PRO . 11.8 tp . . . . . 0 N--CA 1.466 0.334 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.509 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.5 mmmm . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 121.32 0.581 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 34.0 t -113.77 41.31 0.24 Allowed Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 41.1 Cg_endo -89.68 81.33 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.946 1.764 . . . . 0.0 113.296 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.843 HG23 ' H ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -96.53 152.64 38.74 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.787 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -44.34 -25.1 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -101.92 -51.54 1.08 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.843 ' H ' HG23 ' A' ' 22' ' ' THR . 47.9 t -51.1 148.53 4.37 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.053 0.926 . . . . 0.0 110.311 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -96.06 -46.18 6.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 92.63 42.72 4.41 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.429 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -152.94 131.35 12.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.566 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.752 ' O ' ' N ' ' A' ' 33' ' ' GLY . . . 103.62 -4.15 46.65 Favored Glycine 0 C--O 1.219 -0.842 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.453 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.991 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 46.77 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.494 -1.004 . . . . 0.0 111.494 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.51 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 8.1 p -52.28 -32.32 15.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.877 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.5 t -133.35 21.53 4.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.512 1.051 . . . . 0.0 112.499 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 66.58 15.68 64.38 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.264 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.877 HD12 ' CG2' ' A' ' 32' ' ' THR . 8.9 mt -112.2 6.85 19.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.991 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -117.85 163.14 25.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.054 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 Cg_endo -71.52 42.25 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.505 1.47 . . . . 0.0 111.388 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 2.2 m170 90.73 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 122.921 0.488 . . . . 0.0 109.896 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.723 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 35.5 p-80 -137.66 -54.74 0.67 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.436 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 15.9 mtt180 41.14 25.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.622 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 83.3 p -162.34 17.42 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.823 HD23 HG22 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 76.36 -33.1 0.21 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 85.5 p -38.62 -31.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.873 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.643 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -122.85 -84.15 0.67 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.723 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 45.96 112.32 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 114.865 -0.667 . . . . 0.0 111.013 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.7 Cg_endo -93.59 12.82 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.761 ' HB3' ' CD ' ' A' ' 53' ' ' GLU . 10.5 m80 -92.08 -69.63 0.73 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.859 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.583 ' HA ' HG13 ' A' ' 54' ' ' ILE . 1.7 ptpt 51.01 62.14 2.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.739 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -135.03 14.44 3.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.137 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 0.3 OUTLIER 41.52 38.86 0.95 Allowed 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.354 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 48' ' ' ASP . 2.5 m -130.7 153.46 81.56 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.541 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.489 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 87.7 Cg_exo -27.05 -46.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.988 3.125 . . . . 0.0 114.487 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.585 ' HD2' HG23 ' A' ' 50' ' ' VAL . 86.6 Cg_endo -98.43 46.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.877 2.385 . . . . 0.0 114.543 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.761 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 14.4 mm-40 -149.44 -98.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.823 HG22 HD23 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -129.64 5.36 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.612 0.365 . . . . 0.0 110.248 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.413 HD13 ' HD3' ' A' ' 51' ' ' PRO . 4.0 tt . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.6 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 11.4 mmtt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.374 0.607 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.3 t -72.8 -35.3 2.89 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.017 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 63.5 Cg_exo -37.57 77.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.682 2.255 . . . . 0.0 113.705 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -82.93 173.88 6.88 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -46.99 -20.22 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.46 2.106 . . . . 0.0 112.265 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.46 -58.27 0.55 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.696 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 37.7 t -54.77 156.75 3.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.985 0.422 . . . . 0.0 111.693 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.03 -43.41 6.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.117 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 82.26 34.5 23.23 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.769 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.78 ' O ' HG23 ' A' ' 28' ' ' THR . 0.6 OUTLIER -142.13 45.49 1.66 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.492 0.663 . . . . 0.0 110.68 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.956 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -178.58 57.81 0.09 OUTLIER Glycine 0 C--O 1.217 -0.944 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.775 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.956 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.3 t60 -12.82 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.549 HG12 ' HD2' ' A' ' 30' ' ' HIS . 10.0 p -56.25 -31.51 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.832 HG21 HD12 ' A' ' 34' ' ' LEU . 1.5 t -131.93 7.44 4.36 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.871 -0.518 . . . . 0.0 110.53 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.18 64.79 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.096 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.832 HD12 HG21 ' A' ' 32' ' ' THR . 38.0 mt -93.66 1.05 56.72 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.666 0.746 . . . . 0.0 109.331 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.709 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -116.01 156.86 46.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.286 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 59.2 Cg_endo -73.22 50.87 1.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.32 1.347 . . . . 0.0 111.604 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.577 ' CG ' ' HA ' ' A' ' 28' ' ' THR . 6.5 m-70 92.13 -176.67 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.555 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 27.4 p-80 -132.25 121.28 23.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.8 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.8 OUTLIER -59.74 -28.28 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.639 -178.098 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER 173.83 71.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.824 HD23 HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER 79.88 -17.75 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.694 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.02 1.04 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.273 0.558 . . . . 0.0 109.788 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.683 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -128.93 -85.47 0.45 Allowed Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.839 ' SG ' HG23 ' A' ' 54' ' ' ILE . 1.8 t 44.46 113.49 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.68 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.634 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 4.8 Cg_endo -101.61 1.28 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.808 3.005 . . . . 0.0 113.252 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.696 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 9.2 m80 -75.53 -92.03 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.145 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 63.71 65.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.091 -0.381 . . . . 0.0 111.935 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.501 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 7.2 t0 -129.63 -6.21 4.64 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.371 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.553 ' HG2' HG23 ' A' ' 50' ' ' VAL . 64.2 ttt-85 58.34 118.46 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.845 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 24.7 t 99.23 -72.43 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.886 0.874 . . . . 0.0 112.598 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.845 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 29.8 Cg_endo -74.4 -179.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.135 1.223 . . . . 0.0 111.955 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 60.9 Cg_exo -53.2 98.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.208 1.939 . . . . 0.0 112.478 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.696 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.1 mp0 -149.76 -105.03 0.07 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.839 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -118.39 -15.68 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.754 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' A' ' 22' ' ' THR . 14.3 mt . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.1 mttp . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.294 0.568 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -66.32 164.43 30.82 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.61 ' HD2' ' SG ' ' A' ' 20' ' ' CYS . 37.3 Cg_exo -25.18 -70.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.501 3.468 . . . . 0.0 114.06 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.808 HG23 ' H ' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -163.83 176.12 2.39 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.151 -178.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.625 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 81.4 Cg_exo -46.9 -27.56 5.95 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.949 1.766 . . . . 0.0 111.081 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.808 ' H ' HG23 ' A' ' 22' ' ' THR . . . -46.95 -57.36 6.95 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 42.3 t -55.91 157.6 4.31 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -84.06 -39.1 19.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.703 0.287 . . . . 0.0 111.311 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.489 ' HA2' ' NE2' ' A' ' 38' ' ' HIS . . . 69.3 43.91 68.23 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.29 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.2 133.64 16.5 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.782 -0.709 . . . . 0.0 111.017 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.623 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 88.61 24.9 31.75 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.926 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.837 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.2 t-80 24.55 -156.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.311 0.644 . . . . 0.0 112.07 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 15.0 p -70.11 -34.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.839 HG21 HD12 ' A' ' 34' ' ' LEU . 1.5 t -127.01 18.95 7.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.373 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.39 14.71 42.6 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.299 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.839 HD12 HG21 ' A' ' 32' ' ' THR . 21.1 mt -96.4 1.62 51.91 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.278 0.561 . . . . 0.0 110.172 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.837 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.52 156.82 55.31 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.734 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.8 Cg_exo -70.91 45.41 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.86 1.707 . . . . 0.0 111.72 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 6.6 m-70 95.72 -173.52 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.889 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 28.6 p-80 -140.31 -48.91 0.45 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.766 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.479 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 42.22 22.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.217 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.735 ' O ' HD12 ' A' ' 41' ' ' LEU . 52.6 p -163.48 17.13 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 40' ' ' SER . 0.3 OUTLIER 77.84 -7.53 1.81 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.045 0.384 . . . . 0.0 111.765 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -53.63 -22.87 9.54 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -146.15 -72.61 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.889 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.9 t 53.26 112.0 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.012 -0.594 . . . . 0.0 111.163 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.631 ' HD2' ' CE1' ' A' ' 46' ' ' HIS . 57.4 Cg_endo -98.16 35.51 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.234 2.623 . . . . 0.0 114.362 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.721 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 7.0 m80 -118.88 -99.83 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.249 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HG3' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.9 69.83 0.11 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-N 118.633 0.651 . . . . 0.0 110.243 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' A' ' 50' ' ' VAL . 17.5 t70 -136.33 10.81 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.155 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 49' ' ' ARG . 1.4 ttt85 57.18 43.96 23.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.175 0.512 . . . . 0.0 111.737 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.885 HG12 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -141.86 152.85 63.43 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.885 ' HD2' HG12 ' A' ' 50' ' ' VAL . 3.6 Cg_exo -35.28 -58.64 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.767 2.311 . . . . 0.0 112.817 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 94.3 Cg_endo -79.85 65.79 8.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.605 2.203 . . . . 0.0 113.764 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.721 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 20.5 mp0 -163.15 -101.93 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 112.22 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.716 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -165.16 29.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.7 pt? . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.001 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 22' ' ' THR . 30.2 t -81.31 -34.97 0.75 Allowed Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 75.9 Cg_exo -44.34 82.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.138 1.892 . . . . 0.0 113.091 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -89.63 173.79 5.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.889 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 3.6 Cg_endo -45.51 -23.13 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.615 2.21 . . . . 0.0 112.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.482 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -106.32 -61.35 0.6 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.62 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.5 t -50.95 158.82 0.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.681 0.241 . . . . 0.0 111.071 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -108.42 -29.42 8.83 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.81 44.24 7.86 Favored Glycine 0 CA--C 1.503 -0.664 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -153.75 129.87 10.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.72 -1.24 . . . . 0.0 108.947 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.879 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.31 59.45 1.74 Allowed Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.431 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.879 ' O ' ' O ' ' A' ' 29' ' ' GLY . 4.1 t60 -24.09 -167.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.879 1.272 . . . . 0.0 113.783 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.552 HG13 HG22 ' A' ' 32' ' ' THR . 10.9 p -51.51 -32.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.621 HG21 HD12 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -129.24 1.73 5.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.963 0.347 . . . . 0.0 110.326 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.89 13.94 78.66 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.621 HD12 HG21 ' A' ' 32' ' ' THR . 43.6 mt -95.13 2.01 54.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.834 0.826 . . . . 0.0 109.398 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.763 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.24 160.53 33.78 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.15 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 73.7 Cg_endo -75.71 49.18 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.161 1.241 . . . . 0.0 111.359 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.5 m170 91.03 -176.65 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 44.8 p-80 -136.26 134.78 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.538 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -111.71 15.65 20.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.492 ' O ' HD12 ' A' ' 41' ' ' LEU . 49.7 p -172.76 28.05 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 HG22 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 78.59 -24.31 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.57 0.623 . . . . 0.0 111.784 178.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -42.27 -28.48 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.547 . . . . 0.0 109.894 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.639 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -112.15 -90.51 1.93 Allowed Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.832 ' SG ' HG23 ' A' ' 54' ' ' ILE . 3.7 t 41.61 112.26 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 115.248 -0.476 . . . . 0.0 110.898 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.722 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 3.3 Cg_endo -99.88 1.18 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.489 2.793 . . . . 0.0 113.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.775 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 14.2 m80 -72.53 -77.22 0.1 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.32 -177.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 50.96 65.07 1.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.67 ' CB ' ' HG3' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -127.41 -2.49 6.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 176.672 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.528 ' C ' ' HD2' ' A' ' 51' ' ' PRO . 7.8 ttt180 55.4 116.91 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.702 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 20.3 t 98.56 -62.12 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.5 Cg_endo -79.22 -179.2 5.21 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.624 1.549 . . . . 0.0 111.944 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 51.7 Cg_exo -54.32 80.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.012 1.808 . . . . 0.0 111.842 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.775 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 23.6 mm-40 -135.84 -107.3 0.21 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.138 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.864 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -108.3 -24.01 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD13 ' HB ' ' A' ' 22' ' ' THR . 5.9 mt . . . . . 0 N--CA 1.467 0.417 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.779 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.603 ' HB3' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.44 -0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 111.278 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.775 ' H ' ' HA ' ' A' ' 40' ' ' SER . 20.8 t -112.83 -42.03 0.08 OUTLIER Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.558 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HD3' ' HA ' ' A' ' 40' ' ' SER . 98.6 Cg_exo -46.18 92.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.268 1.979 . . . . 0.0 113.795 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.793 HG22 HD22 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -124.04 171.76 6.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.472 178.684 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 93.2 Cg_exo -45.49 89.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.26 1.973 . . . . 0.0 112.24 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . 134.67 -60.87 0.64 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.861 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.9 t -48.78 151.63 1.16 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.621 ' H ' ' CE1' ' A' ' 46' ' ' HIS . 15.1 t70 -103.89 -45.7 4.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.666 0.269 . . . . 0.0 111.648 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.603 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 84.41 47.85 5.27 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.74 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -157.0 120.08 4.08 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.041 -0.579 . . . . 0.0 110.934 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 97.03 24.8 12.15 Favored Glycine 0 C--O 1.223 -0.549 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.63 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.3 t-80 21.78 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.076 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 8.4 p -60.14 -35.63 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.049 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.937 HG23 HG13 ' A' ' 31' ' ' VAL . 8.3 p -119.45 6.24 11.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.092 -0.38 . . . . 0.0 111.73 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.23 14.61 62.0 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.733 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 32' ' ' THR . 13.6 mt -106.03 3.67 28.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.375 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.745 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.18 161.04 33.26 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' CG ' ' A' ' 37' ' ' HIS . 6.5 Cg_exo -71.87 47.54 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.589 1.526 . . . . 0.0 110.857 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 28' ' ' THR . 0.6 OUTLIER 78.11 174.08 0.18 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.973 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 49.9 p-80 -123.9 -43.16 2.13 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.607 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.723 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 40.15 23.97 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.9 179.084 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.775 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 58.0 m 145.57 30.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.724 0.64 . . . . 0.0 112.109 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 40' ' ' SER . 12.0 mt -126.88 -179.42 4.82 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.101 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.3 p -73.94 -1.87 21.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.583 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -71.28 -96.28 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 1.076 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 3.6 t 66.55 124.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.658 ' HD2' ' CE1' ' A' ' 46' ' ' HIS . 56.3 Cg_endo -99.35 22.63 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.295 2.663 . . . . 0.0 113.908 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.658 ' CE1' ' HD2' ' A' ' 45' ' ' PRO . 9.6 m80 -105.31 -84.3 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.697 -178.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 0.0 OUTLIER 70.94 68.68 0.18 Allowed 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.831 -0.543 . . . . 0.0 110.339 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -116.01 -8.47 11.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.022 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? 65.17 38.23 6.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.235 0.541 . . . . 0.0 111.118 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.617 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -158.4 170.93 8.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.159 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 84.6 Cg_exo -41.32 -46.89 5.63 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.25 1.967 . . . . 0.0 114.179 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.646 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 66.3 Cg_endo -86.35 84.21 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.391 2.061 . . . . 0.0 115.182 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.686 ' CD ' ' H ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER 172.62 -100.55 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.339 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.769 HG23 ' CB ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -122.54 -8.68 8.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.435 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.793 HD22 HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.035 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 39' ' ' ARG . 23.9 mmtt . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' ' N ' ' A' ' 22' ' ' THR . 44.2 t -80.28 -45.05 1.41 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.497 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 6.7 Cg_endo -51.71 70.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.801 1.668 . . . . 0.0 111.754 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.813 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 82.8 p -98.85 175.57 2.4 Favored Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -47.07 -21.75 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.509 1.473 . . . . 0.0 110.928 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.652 ' CA ' HD21 ' A' ' 55' ' ' LEU . . . -100.52 20.01 50.13 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.935 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.1 t -163.79 158.89 20.65 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.041 0.421 . . . . 0.0 111.631 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.82 -44.78 6.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 77.59 39.67 24.85 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.888 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.796 ' O ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.51 46.81 1.29 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.359 0.599 . . . . 0.0 111.315 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.977 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -177.76 48.97 0.1 OUTLIER Glycine 0 C--O 1.218 -0.867 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.79 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.977 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 -6.33 -179.39 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.894 HG13 HG23 ' A' ' 32' ' ' THR . 10.2 p -54.88 -25.48 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.894 HG23 HG13 ' A' ' 31' ' ' VAL . 21.3 p -125.73 -3.31 7.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.51 66.32 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.623 HD12 ' OG1' ' A' ' 32' ' ' THR . 14.2 mt -99.49 2.73 45.2 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.472 0.653 . . . . 0.0 109.404 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.66 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -113.23 157.23 41.58 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 57.2 Cg_endo -71.97 51.31 1.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.22 1.28 . . . . 0.0 111.234 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.567 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 6.1 m-70 90.24 -176.01 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.488 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 26.2 p-80 -130.07 119.52 23.22 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.824 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -51.85 -30.96 25.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.6 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.518 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 6.4 t 160.96 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 O-C-N 123.054 0.221 . . . . 0.0 111.329 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' HG ' ' C ' ' A' ' 40' ' ' SER . 2.2 mt 78.35 -27.41 0.17 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.64 -23.87 1.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.344 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.571 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -133.49 -88.03 0.33 Allowed Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.913 ' SG ' HG23 ' A' ' 54' ' ' ILE . 1.2 t 42.71 109.72 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.522 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.698 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -102.54 -2.29 0.35 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.795 2.997 . . . . 0.0 113.288 -179.324 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.698 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 15.7 m80 -63.64 -80.01 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.765 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.582 ' H ' ' CG1' ' A' ' 54' ' ' ILE . 12.2 pttt 57.25 57.1 4.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.49 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -120.17 -10.82 9.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.612 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 20.0 ttp180 46.66 48.24 14.49 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -159.61 -57.72 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 120.64 0.257 . . . . 0.0 110.71 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.75 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 21.2 Cg_endo -97.03 -171.99 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.933 3.089 . . . . 0.0 110.217 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 12.5 Cg_endo -56.5 79.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.25 1.3 . . . . 0.0 110.737 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.698 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.0 OUTLIER -124.16 -107.75 0.33 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.813 -178.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.913 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -140.58 13.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 110.328 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.652 HD21 ' CA ' ' A' ' 24' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.095 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 120.892 0.377 . . . . 0.0 110.746 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.7 t -118.15 26.61 0.11 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 28.5 Cg_endo -62.9 69.97 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.088 1.192 . . . . 0.0 112.181 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.758 HG22 ' H ' ' A' ' 24' ' ' GLY . 21.7 m -80.33 135.88 53.5 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.33 -26.51 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 111.667 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.758 ' H ' HG22 ' A' ' 22' ' ' THR . . . -103.76 -50.33 1.03 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.887 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.528 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 46.2 t -42.81 155.33 0.05 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.487 0.644 . . . . 0.0 111.228 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -101.77 -34.88 9.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 81.15 38.21 15.96 Favored Glycine 0 CA--C 1.502 -0.75 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.77 HG22 ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -159.57 62.85 0.38 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.85 -1.175 . . . . 0.0 108.572 -179.17 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 177.99 54.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.608 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.615 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.8 t-80 -37.52 176.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.948 HG13 HG23 ' A' ' 32' ' ' THR . 13.1 p -47.0 -30.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.502 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.948 HG23 HG13 ' A' ' 31' ' ' VAL . 15.0 p -126.63 -2.52 6.7 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.074 -0.391 . . . . 0.0 109.966 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.82 14.94 66.14 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.656 HD12 ' OG1' ' A' ' 32' ' ' THR . 15.5 mt -100.96 4.7 42.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.715 0.769 . . . . 0.0 109.119 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.561 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -111.48 159.53 32.73 Favored Pre-proline 0 N--CA 1.448 -0.548 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.142 179.472 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 37' ' ' HIS . 61.1 Cg_endo -73.21 49.08 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.222 1.282 . . . . 0.0 111.113 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 6.9 m-70 88.64 -173.97 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 29.6 p-80 -139.26 -50.94 0.52 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.335 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.497 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.1 OUTLIER 41.05 20.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.506 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 4.8 p -161.09 18.27 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.411 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 2.7 mt 71.62 5.72 5.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.892 0.314 . . . . 0.0 111.576 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.478 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 12.9 m -67.97 -4.43 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.506 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -156.92 -72.29 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.857 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.7 t 20.31 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.066 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 3.4 Cg_endo -105.7 5.88 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.703 3.602 . . . . 0.0 112.097 178.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.782 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 32.8 m80 -39.01 -67.85 0.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.982 -177.135 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.733 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER 54.62 69.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.583 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -127.82 -8.79 5.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.563 179.629 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.467 ' C ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER 46.02 33.23 1.59 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.173 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.638 HG23 ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -171.37 -75.33 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.624 177.834 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' A' ' 50' ' ' VAL . 49.9 Cg_endo -67.8 178.1 3.66 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 111.581 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.646 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 2.0 Cg_endo -41.77 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.364 2.043 . . . . 0.0 111.576 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.782 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.9 OUTLIER -150.1 -110.75 0.06 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.998 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.857 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -146.85 11.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.049 0.939 . . . . 0.0 108.883 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 50' ' ' VAL . 19.7 tp . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 1.47 ' C ' ' CA ' ' A' ' 17' ' ' GLU 1.061 0.0 OUTLIER . . . . . 3 C--O 0.325 -47.601 2 N-CA-C 145.341 12.719 . . . . 7.59 145.341 . . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 1.47 ' CA ' ' C ' ' A' ' 16' ' ' ARG 0.919 5.8 mt-10 97.52 -113.15 0.0 OUTLIER 'General case' 4 C--O 0.156 -56.472 5 O-C-N 61.523 -38.236 . . . . 7.1 144.321 -179.8 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.665 ' N ' ' HE2' ' A' ' 19' ' ' LYS 0.769 73.6 m -83.22 166.22 18.76 Favored 'General case' 4 C--O 0.255 -51.25 4 CA-C-N 169.722 23.874 . . . . 4.82 126.912 179.236 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.972 ' C ' ' HD2' ' A' ' 21' ' ' PRO 0.789 0.4 OUTLIER -129.05 -177.85 4.39 Favored 'General case' 2 N--CA 0.861 -29.895 4 O-C-N 83.215 -24.678 . . . . 4.23 129.976 179.947 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 1.093 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 48.9 t -86.73 -22.85 0.29 Allowed Pre-proline 2 C--O 1.002 -11.945 1 CA-C-O 130.826 5.108 . . . . 0.88 112.712 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 1.093 ' HD2' ' N ' ' A' ' 20' ' ' CYS 0.288 14.8 Cg_exo -52.21 81.69 0.02 OUTLIER 'Trans proline' 3 C--N 1.0 -17.806 2 O-C-N 105.253 -8.341 . . . . 2.74 121.264 -178.869 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 1.345 ' CG2' ' CA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -92.84 167.62 14.05 Favored Pre-proline 2 C--N 1.143 -8.406 0 CA-C-N 114.023 -1.444 . . . . 2.05 114.559 -179.675 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.728 ' HD2' HG22 ' A' ' 22' ' ' THR . 27.9 Cg_exo -43.77 -21.96 0.39 Allowed 'Trans proline' 2 C--O 1.084 -7.205 0 C-N-CA 123.532 2.821 . . . . 1.57 113.082 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.758 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -107.49 -54.83 0.64 Allowed Glycine 3 C--O 1.083 -9.328 0 O-C-N 118.409 -2.682 . . . . 1.34 114.177 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 42.4 t -54.72 155.18 4.38 Favored 'General case' 1 C--N 1.198 -5.98 1 O-C-N 115.373 -4.604 . . . . 0.49 110.856 -179.69 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 1.01 ' OD2' ' CB ' ' A' ' 26' ' ' ASP . 26.5 t0 -102.11 -40.26 6.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.061 0.458 . . . . 1.58 111.494 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 48.43 4.72 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.626 -0.797 . . . . 0.45 111.636 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -154.66 113.67 3.65 Favored 'General case' 1 C--O 1.05 -9.428 0 CA-C-O 124.055 1.883 . . . . 0.99 110.621 -179.6 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 1.011 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 113.11 29.37 3.04 Favored Glycine 2 C--N 1.162 -9.094 1 O-C-N 113.307 -5.871 . . . . 0.92 113.099 179.66 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 1.011 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 11.51 -167.24 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.377 0 O-C-N 119.95 -1.912 . . . . 0.34 112.885 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG13 HG22 ' A' ' 32' ' ' THR . 14.1 p -59.73 -32.59 49.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.415 0.894 . . . . 0.4 113.415 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.633 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -125.18 8.07 7.9 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.85 -0.531 . . . . 1.25 111.259 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.35 15.0 62.88 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.645 -0.788 . . . . 0.49 111.163 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.633 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 15.7 mt -101.96 3.98 39.52 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.266 0.555 . . . . 0.73 110.379 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.78 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.2 160.23 36.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.387 -0.824 . . . . 0.58 109.387 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.536 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 9.8 Cg_endo -72.69 46.66 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.573 1.515 . . . . 0.65 111.239 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.634 ' HA ' ' H ' ' A' ' 29' ' ' GLY . 4.0 m-70 89.65 -177.65 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.697 -0.853 . . . . 0.57 108.697 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 1.281 ' C ' ' CA ' ' A' ' 39' ' ' ARG . 42.1 p-80 -133.08 19.62 4.08 Favored 'General case' 1 C--O 0.634 -31.304 1 CA-C-O 176.774 26.988 . . . . 1.18 110.38 178.696 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 1.443 ' CG ' ' CA ' ' A' ' 39' ' ' ARG . 22.3 mtt180 -1.92 10.1 0.0 OUTLIER 'General case' 2 C--N 0.573 -33.156 3 O-C-N 8.928 -71.108 . . . . 5.36 118.508 177.803 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 1.413 ' OG ' ' CA ' ' A' ' 40' ' ' SER . 7.9 p -173.82 30.46 0.01 OUTLIER 'General case' 2 N--CA 1.318 -7.064 0 N-CA-C 118.899 2.925 . . . . 2.17 118.899 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.66 HD22 ' SD ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 87.76 -43.86 0.03 OUTLIER 'General case' 1 C--O 0.833 -20.858 0 CA-C-O 127.14 3.353 . . . . 2.28 116.281 179.143 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 1.113 ' OG ' ' HB2' ' A' ' 42' ' ' SER . 0.1 OUTLIER -35.48 -25.78 0.01 OUTLIER 'General case' 1 C--N 0.987 -15.179 3 O-C-N 100.76 -13.713 . . . . 1.68 111.608 179.396 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . -123.6 -88.99 0.87 Allowed Glycine 1 C--N 1.248 -4.333 0 O-C-N 120.365 -1.46 . . . . 0.39 110.731 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.786 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.1 t 48.9 109.8 0.01 OUTLIER Pre-proline 0 C--O 1.191 -1.977 0 CA-C-N 115.366 -0.417 . . . . 0.74 111.167 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.659 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 42.6 Cg_endo -96.83 18.45 0.56 Allowed 'Trans proline' 0 C--O 1.169 -2.926 0 C-N-CA 123.821 3.014 . . . . 1.3 115.383 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.716 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 12.6 m80 -94.18 -83.09 0.34 Allowed 'General case' 1 C--N 1.207 -5.605 0 O-C-N 118.876 -2.39 . . . . 0.92 111.734 -177.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.551 ' CE ' ' CG ' ' A' ' 47' ' ' LYS 0.273 0.6 OUTLIER 67.59 62.14 0.44 Allowed 'General case' 2 CA--C 1.316 -8.043 0 N-CA-C 118.336 2.717 . . . . 3.59 118.336 179.938 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 1.34 ' OD1' ' CB ' ' A' ' 48' ' ' ASP 0.322 1.5 t0 -135.94 6.9 3.17 Favored 'General case' 2 N--CA 1.275 -9.215 1 CA-C-O 129.55 4.5 . . . . 3.5 120.243 178.955 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 1.251 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.2 ptt180 56.53 87.27 0.06 Allowed 'General case' 2 C--O 0.679 -28.96 2 O-C-N 114.286 -5.259 . . . . 5.32 118.085 179.431 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.251 HG23 ' O ' ' A' ' 49' ' ' ARG . 1.9 t 142.54 -113.12 0.0 OUTLIER Pre-proline 3 C--N 0.943 -17.065 4 O-C-N 90.607 -20.058 . . . . 2.92 115.5 177.269 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.287 ' HB2' ' CD ' ' A' ' 52' ' ' PRO 0.445 2.2 Cg_endo -56.64 -139.95 0.0 OUTLIER 'Trans proline' 4 C--N 0.752 -30.857 3 O-C-N 93.03 -14.774 . . . . 3.16 126.842 -179.35 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 1.287 ' CD ' ' HB2' ' A' ' 51' ' ' PRO . 1.6 Cg_endo -62.47 79.13 0.1 Allowed 'Trans proline' 2 C--N 1.129 -11.013 0 O-C-N 118.441 -1.4 . . . . 1.79 114.319 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 1.319 ' CD ' ' CB ' ' A' ' 53' ' ' GLU . 3.8 mp0 -151.55 -103.64 0.06 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.33 -0.857 . . . . 2.29 111.665 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.028 ' O ' ' N ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -132.82 2.16 1.55 Allowed 'Isoleucine or valine' 1 C--O 1.142 -4.586 0 CA-C-O 118.712 -0.661 . . . . 1.18 109.583 -179.712 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.56 ' CD2' ' CB ' ' A' ' 55' ' ' LEU . 1.1 tp -17.71 -10.43 0.0 OUTLIER 'General case' 2 CA--C 1.351 -6.69 1 CA-C-O 136.579 7.847 . . . . 2.64 117.136 -178.959 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.028 ' N ' ' O ' ' A' ' 54' ' ' ILE 0.933 . . -133.42 6.5 3.82 Favored 'General case' 4 C--N 0.889 -19.454 4 N-CA-C 148.576 13.917 . . . . 3.24 148.576 -179.721 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 1.66 ' SD ' HD22 ' A' ' 41' ' ' LEU 0.336 0.0 OUTLIER -54.0 -163.71 0.0 OUTLIER 'General case' 4 C--O 0.462 -40.357 2 O-C-N 106.839 -9.913 . . . . 4.67 106.539 -179.973 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.57 ' NE2' ' HE1' ' A' ' 58' ' ' HIS 0.687 0.6 OUTLIER -89.94 -36.3 15.08 Favored 'General case' 4 C--O 0.411 -43.074 5 CA-C-O 158.019 18.057 . . . . 5.8 131.318 -179.485 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.477 ' C ' ' CA ' ' A' ' 60' ' ' ASN 0.529 2.0 mt-10 -116.75 -35.92 4.04 Favored 'General case' 4 C--N 0.551 -34.113 4 O-C-N 40.191 -51.568 . . . . 5.66 109.746 -179.892 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 1.477 ' CA ' ' C ' ' A' ' 59' ' ' GLU 0.766 1.4 m-20 -124.13 105.32 9.44 Favored 'General case' 4 C--N 0.702 -27.572 5 O-C-N 84.301 -23.999 . . . . 6.08 135.775 179.894 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.435 ' CA ' ' C ' ' A' ' 60' ' ' ASN 0.443 27.1 m -84.19 152.64 3.74 Favored 'Isoleucine or valine' 4 C--N 0.761 -25.01 3 O-C-N 92.275 -19.016 . . . . 3.29 114.079 179.982 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.288 ' CD1' ' CA ' ' A' ' 62' ' ' LEU 0.402 7.5 tt 57.19 -40.67 0.04 OUTLIER 'General case' 4 C--O 0.433 -41.914 2 CA-C-O 137.146 8.117 . . . . 4.03 108.571 179.82 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.831 ' CD ' ' HG2' ' A' ' 63' ' ' LYS 0.751 4.7 tttm . . . . . 4 C--O 0.55 -35.739 4 O-C-N 70.002 -32.936 . . . . 6.51 118.484 179.828 . . . . . . . . 4 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 18' ' ' SER . 0.7 OUTLIER -132.83 65.62 1.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 3.4 t 85.34 -14.84 0.55 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.851 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 3.4 mttt 57.82 156.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.22 0.533 . . . . 0.0 111.364 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.702 ' O ' ' N ' ' A' ' 22' ' ' THR . 50.9 t -74.68 -36.64 2.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.335 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 72.4 Cg_exo -48.56 73.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.931 1.754 . . . . 0.0 111.822 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 1.02 HG21 ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -79.53 172.99 8.46 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.323 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 94.9 Cg_exo -41.84 -28.15 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.191 1.927 . . . . 0.0 111.31 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.509 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -94.73 -70.35 1.09 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.095 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 22.7 t -50.97 159.39 0.58 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.891 0.346 . . . . 0.0 110.95 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -109.76 -41.61 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 92.53 60.55 1.22 Allowed Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.42 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.72 129.38 8.46 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.249 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.689 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.16 22.36 32.7 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.125 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.801 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 23.42 -160.9 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 123.436 0.695 . . . . 0.0 112.585 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.53 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.5 p -62.25 -33.41 58.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.884 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.4 t -133.89 21.76 3.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.412 0.551 . . . . 0.0 111.415 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.31 16.84 44.32 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.884 HD12 ' CG2' ' A' ' 32' ' ' THR . 20.5 mt -99.48 4.53 46.09 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.14 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.801 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.41 157.45 58.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.444 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 56.1 Cg_endo -70.96 47.11 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.427 1.418 . . . . 0.0 111.041 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 36' ' ' PRO . 6.9 m-70 88.47 -179.39 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.968 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 52.9 p-80 -130.61 104.14 7.03 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.188 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' SER . 4.5 mtt180 -71.16 -1.85 13.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.718 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.637 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 72.7 p 175.03 61.1 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.664 HD22 ' CG ' ' A' ' 57' ' ' MET . 0.5 OUTLIER 76.93 -161.3 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.398 178.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.437 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER 64.57 -2.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -147.27 -98.32 0.21 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.968 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.5 t 52.9 105.87 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.571 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.613 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 93.3 Cg_endo -90.6 34.89 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.142 2.562 . . . . 0.0 114.367 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.855 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 5.3 m80 -121.12 -92.07 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.961 -0.695 . . . . 0.0 112.507 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 75.25 67.74 0.08 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.26 0.482 . . . . 0.0 111.192 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.458 ' HB3' ' OE1' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -151.63 18.52 0.71 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.913 0.387 . . . . 0.0 111.012 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.633 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 6.2 ptt-85 50.74 -177.64 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.914 ' HA ' HD22 ' A' ' 55' ' ' LEU . 70.2 t 26.72 -85.38 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.144 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 69.0 Cg_exo -46.34 168.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.269 0 CA-C-N 120.709 1.289 . . . . 0.0 111.872 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.509 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 7.6 Cg_endo -49.85 96.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.425 2.083 . . . . 0.0 112.173 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.855 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 3.8 mp0 -154.62 -102.43 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.84 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -147.58 19.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.995 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.914 HD22 ' HA ' ' A' ' 50' ' ' VAL . 15.3 tp -46.92 -29.0 1.8 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.284 0.564 . . . . 0.0 111.018 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.02 ' HB3' HG21 ' A' ' 22' ' ' THR . . . -109.67 42.61 1.46 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.276 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.737 ' H ' HG12 ' A' ' 61' ' ' VAL . 9.8 ttt -66.03 -80.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.482 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 57' ' ' MET . 33.7 p80 173.64 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.012 0.434 . . . . 0.0 110.488 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 9.7 tt0 -133.92 -40.22 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.546 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.88 40.01 1.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.773 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.737 HG12 ' H ' ' A' ' 57' ' ' MET . 31.0 m -71.81 158.7 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.741 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.633 ' HA ' ' HB3' ' A' ' 49' ' ' ARG . 6.9 mp 62.52 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.897 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.924 0.392 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 62.05 113.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.524 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 p 63.81 115.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.603 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -90.32 -176.27 4.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.044 0.449 . . . . 0.0 110.027 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.661 ' O ' ' N ' ' A' ' 22' ' ' THR . 16.7 t -77.14 -54.78 1.48 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.158 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.573 ' HB3' ' HA3' ' A' ' 27' ' ' GLY . 9.7 Cg_endo -53.09 70.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.072 1.848 . . . . 0.0 112.051 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.689 HG22 ' HB2' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -110.4 -177.45 0.46 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.997 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.507 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 83.9 Cg_exo -46.86 -18.75 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.719 1.613 . . . . 0.0 112.691 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.41 ' H ' HG23 ' A' ' 22' ' ' THR . . . -103.92 12.44 52.92 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.884 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 26' ' ' ASP . 41.7 t -153.65 162.81 40.92 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.854 0.327 . . . . 0.0 110.57 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 25.4 t0 -103.94 -41.94 5.72 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.975 0.417 . . . . 0.0 109.883 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.573 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 86.79 54.21 2.69 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.944 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -156.75 131.79 9.06 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.362 -0.419 . . . . 0.0 111.487 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.6 21.29 34.73 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.425 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.802 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.9 t-80 24.36 -159.19 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 122.996 0.518 . . . . 0.0 112.189 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.952 HG13 HG23 ' A' ' 32' ' ' THR . 10.5 p -70.03 -34.51 59.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.952 HG23 HG13 ' A' ' 31' ' ' VAL . 10.7 p -116.72 6.53 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.204 -0.31 . . . . 0.0 111.557 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 65.03 14.4 58.95 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.812 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.639 HD12 ' OG1' ' A' ' 32' ' ' THR . 18.8 mt -102.58 1.77 35.26 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.802 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.14 158.32 41.34 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.373 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.9 Cg_endo -71.32 46.43 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.457 1.438 . . . . 0.0 111.329 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m-70 89.11 -179.44 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.963 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 51.5 p-80 -130.73 108.52 9.94 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.875 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -56.06 -22.83 29.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.668 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.702 ' O ' HD12 ' A' ' 41' ' ' LEU . 4.4 p 168.61 86.83 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER 79.24 -170.79 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.502 0.191 . . . . 0.0 110.511 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.475 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 68.7 m 66.35 -8.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.554 ' O ' ' HB ' ' A' ' 31' ' ' VAL . . . -145.99 -101.3 0.3 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.963 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 55.24 104.92 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.615 -0.293 . . . . 0.0 111.246 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.595 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 70.3 Cg_endo -92.16 34.72 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.13 2.554 . . . . 0.0 114.207 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.694 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 4.1 m80 -122.16 -83.02 0.66 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.356 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 71.92 65.17 0.14 Allowed 'General case' 0 N--CA 1.461 0.119 0 O-C-N 122.156 -0.34 . . . . 0.0 111.199 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB3' ' CD ' ' A' ' 53' ' ' GLU . 2.3 t0 -152.81 15.79 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.401 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' O ' ' OE1' ' A' ' 53' ' ' GLU . 2.6 ttm180 43.67 -169.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.712 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 88.7 t 37.45 -91.07 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.114 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 10.1 Cg_endo -54.09 -175.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.254 1.303 . . . . 0.0 112.109 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 27.6 Cg_exo -62.19 95.84 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.283 1.988 . . . . 0.0 111.536 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.694 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 19.4 mp0 -152.11 -103.23 0.05 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.929 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.75 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -136.14 7.94 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.066 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 50' ' ' VAL . 0.8 OUTLIER -46.58 -30.11 2.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.151 0.5 . . . . 0.0 110.965 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.689 ' HB2' HG22 ' A' ' 22' ' ' THR . . . -47.83 -29.65 3.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.153 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.683 ' HG3' HG22 ' A' ' 54' ' ' ILE . 40.4 mtp -61.66 102.77 0.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.913 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.97 -34.24 71.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -67.02 -53.82 27.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -136.15 96.28 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.025 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 35.6 m -76.3 151.84 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.261 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 0.7 OUTLIER 83.76 -24.42 0.16 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.855 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.824 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 120.71 0.291 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -75.68 154.16 36.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.003 0.43 . . . . 0.0 111.806 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.76 129.28 39.8 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.508 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' O ' ' HE1' ' A' ' 57' ' ' MET . 0.3 OUTLIER -143.97 -52.02 0.32 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.249 0.547 . . . . 0.0 111.899 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 22' ' ' THR . 49.5 t -72.13 -26.58 0.86 Allowed Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 71.9 Cg_exo -50.51 74.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.558 1.505 . . . . 0.0 112.388 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -83.78 172.54 9.0 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 88.1 Cg_exo -44.49 -27.93 2.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.243 1.962 . . . . 0.0 111.839 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . -97.42 -69.1 0.97 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.357 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 24.0 t -46.04 157.52 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 111.716 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -112.51 -30.72 7.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.81 58.75 2.08 Favored Glycine 0 CA--C 1.506 -0.512 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.452 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.51 128.67 4.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.426 -0.887 . . . . 0.0 109.738 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.979 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.62 50.33 3.6 Favored Glycine 0 C--O 1.219 -0.801 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.03 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.979 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 -12.3 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 32' ' ' THR . 13.1 p -52.39 -37.36 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.888 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.947 HG23 HG13 ' A' ' 31' ' ' VAL . 17.9 p -114.02 -7.28 13.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.819 0.342 . . . . 0.0 110.156 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.79 80.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.628 HD12 ' OG1' ' A' ' 32' ' ' THR . 12.1 mt -97.06 1.38 50.05 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.702 0.763 . . . . 0.0 109.163 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.79 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -110.33 161.21 25.46 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.771 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 74.2 Cg_endo -76.63 49.32 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.261 1.308 . . . . 0.0 111.265 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.3 m170 90.46 -176.4 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 48.3 p-80 -134.98 -53.96 0.8 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.511 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 39.96 33.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.463 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.677 ' O ' HD23 ' A' ' 41' ' ' LEU . 28.3 p -143.95 -68.46 0.33 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.792 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 40' ' ' SER . 0.4 OUTLIER 157.72 -52.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.548 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.49 ' N ' HD12 ' A' ' 41' ' ' LEU . 13.3 p -41.55 -30.32 0.21 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.796 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.5 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -100.41 -106.06 2.79 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.822 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.0 t 49.77 108.07 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.954 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.731 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 9.2 Cg_endo -96.29 2.0 2.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.143 2.562 . . . . 0.0 113.373 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.67 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 16.6 m80 -70.2 -80.29 0.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.758 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 53.82 61.72 2.95 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.455 0.645 . . . . 0.0 110.853 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.591 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.16 -6.25 12.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.902 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.803 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.4 OUTLIER 47.81 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.742 ' HB ' ' CD ' ' A' ' 51' ' ' PRO . 88.8 t 107.44 -81.76 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.351 1.061 . . . . 0.0 110.518 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.742 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 12.7 Cg_endo -56.41 -171.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.767 1.645 . . . . 0.0 111.115 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.508 ' CD ' ' HB2' ' A' ' 51' ' ' PRO . 25.1 Cg_exo -65.83 108.63 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.224 1.949 . . . . 0.0 111.768 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.67 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 2.0 pm0 -158.84 -103.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.822 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -120.52 -8.73 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 42.07 27.1 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.949 -179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . 70.3 -24.36 0.16 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.503 ' HE1' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER 68.16 -81.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.59 0.233 . . . . 0.0 111.109 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -83.58 -46.96 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.66 -170.45 1.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -110.77 102.53 11.06 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.851 0.357 . . . . 0.0 111.217 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.803 HG12 ' HB2' ' A' ' 49' ' ' ARG . 6.8 t 68.79 127.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.554 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 49' ' ' ARG . 17.0 tp 75.21 -80.38 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.646 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.784 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.865 0.364 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -148.97 -79.32 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.528 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.07 131.29 54.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.175 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 11.4 mmtm -97.66 -170.07 1.94 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.154 0.502 . . . . 0.0 111.391 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.6 t -88.48 -42.08 0.47 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.355 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 74.2 Cg_exo -48.35 76.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.991 1.794 . . . . 0.0 112.212 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -90.63 175.64 3.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.67 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.586 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 64.6 Cg_exo -40.57 -27.97 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 112.622 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.631 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -93.8 -72.96 1.2 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.542 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.422 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 48.8 t -46.13 158.8 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 111.499 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -103.64 -37.52 7.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.791 0.329 . . . . 0.0 110.901 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 85.04 40.9 7.79 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.744 HG22 ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -158.16 62.44 0.45 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.864 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 176.59 57.24 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.632 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.5 t-80 -37.92 173.91 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.372 0.606 . . . . 0.0 112.298 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.913 HG13 HG23 ' A' ' 32' ' ' THR . 13.6 p -48.44 -33.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.519 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.913 HG23 HG13 ' A' ' 31' ' ' VAL . 7.9 p -122.84 -1.79 8.86 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.155 -0.341 . . . . 0.0 110.16 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.57 15.63 64.28 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.576 HD12 ' OG1' ' A' ' 32' ' ' THR . 23.7 mt -99.93 6.07 45.22 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.948 0.88 . . . . 0.0 108.747 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.616 ' HE1' ' HG1' ' A' ' 32' ' ' THR . 0.1 OUTLIER -115.42 155.96 46.45 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.165 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.493 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 3.0 Cg_exo -73.48 51.39 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.658 1.572 . . . . 0.0 110.574 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.501 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 7.9 m-70 89.47 -174.36 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 26.5 p-80 -130.5 124.69 32.53 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.323 0.582 . . . . 0.0 111.121 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -54.47 -35.67 63.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.404 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 23.0 p 169.43 84.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD2' HG22 ' A' ' 54' ' ' ILE . 7.6 mt 75.04 -8.33 1.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -53.06 -27.21 18.85 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.382 0.611 . . . . 0.0 109.376 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -133.15 -77.17 0.11 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.841 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.6 t 26.81 92.58 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 6.2 Cg_endo -105.16 2.46 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.448 3.432 . . . . 0.0 112.959 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.691 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 38.5 m80 -37.19 -57.39 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.74 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.67 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 6.0 mttt -175.1 -62.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.263 0.554 . . . . 0.0 110.626 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 26.1 t70 132.03 -14.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.032 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.461 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 3.5 ttp180 -70.59 145.95 50.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.318 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.912 HG13 ' HD3' ' A' ' 51' ' ' PRO . 1.7 p -42.15 -46.37 10.44 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.912 ' HD3' HG13 ' A' ' 50' ' ' VAL . 7.6 Cg_endo -49.15 178.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.769 1.646 . . . . 0.0 111.235 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 4.1 Cg_endo -46.21 69.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.661 2.241 . . . . 0.0 112.845 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.725 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.5 mt-10 -145.11 -106.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.841 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -126.41 -6.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.805 ' CD2' HG12 ' A' ' 61' ' ' VAL . 0.8 OUTLIER 53.13 26.3 4.86 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.727 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 60' ' ' ASN . . . 61.91 22.06 12.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.563 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.568 ' CG ' HD22 ' A' ' 41' ' ' LEU . 20.7 mtt 65.34 -73.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.865 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.11 -177.86 3.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.77 -28.25 3.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.574 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 83.7 m-20 -61.01 171.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.722 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.805 HG12 ' CD2' ' A' ' 55' ' ' LEU . 18.5 m -134.62 137.06 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.471 HD23 HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 63.34 176.63 0.16 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.712 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 tptp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.883 179.751 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.029 0.442 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -141.52 -60.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.126 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -137.46 174.77 10.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.527 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.577 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 4.8 mmtp -129.91 179.04 6.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.397 0.618 . . . . 0.0 111.742 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 22' ' ' THR . 51.0 t -87.94 -35.21 0.44 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.957 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HD2' ' CB ' ' A' ' 19' ' ' LYS . 94.8 Cg_exo -44.45 73.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.268 1.979 . . . . 0.0 112.803 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -81.17 171.66 11.68 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.162 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 96.2 Cg_exo -41.08 -28.51 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.394 2.063 . . . . 0.0 111.891 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -96.44 -64.1 0.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.195 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.6 t -56.15 158.58 3.93 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.836 0.35 . . . . 0.0 111.272 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -110.46 -35.73 5.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.608 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 89.23 56.48 1.92 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.856 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.409 ' HG1' ' CG ' ' A' ' 37' ' ' HIS . 0.8 OUTLIER -158.96 131.46 6.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.985 -0.607 . . . . 0.0 111.082 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 94.94 20.6 27.93 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.246 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 23.2 -163.21 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 123.647 0.779 . . . . 0.0 112.798 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 32' ' ' THR . 13.8 p -63.23 -33.68 62.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.801 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.3 t -130.05 18.25 5.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.016 -0.427 . . . . 0.0 111.348 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.97 15.22 48.74 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.351 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.801 HD12 ' CG2' ' A' ' 32' ' ' THR . 18.7 mt -97.88 4.85 49.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 120.99 0.424 . . . . 0.0 110.068 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.786 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.8 158.05 58.14 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.877 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.553 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 8.3 Cg_exo -71.37 46.83 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.8 1.667 . . . . 0.0 111.078 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.553 ' CD2' ' O ' ' A' ' 36' ' ' PRO . 9.1 m-70 91.9 -176.24 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.671 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 26.9 p-80 -128.42 121.7 29.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.281 0.562 . . . . 0.0 110.528 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.41 -29.22 67.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.202 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.748 ' O ' HD12 ' A' ' 41' ' ' LEU . 24.1 p 175.51 73.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 ' CG2' ' A' ' 54' ' ' ILE . 0.5 OUTLIER 78.84 -15.54 0.75 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 178.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -22.99 1.29 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.226 0.536 . . . . 0.0 109.894 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.655 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.52 -82.6 0.15 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.671 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 47.76 110.08 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 114.874 -0.663 . . . . 0.0 111.315 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.604 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 14.6 Cg_endo -102.69 30.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.492 2.795 . . . . 0.0 113.179 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.84 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 24.1 m80 -98.18 -90.87 0.27 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.692 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 40.0 mmtt -161.07 -74.77 0.06 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 110.988 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.692 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 22.7 t0 158.21 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.073 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.828 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -56.42 129.56 41.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.258 -179.324 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 2.4 t -29.83 -50.66 0.32 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.92 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.9 Cg_exo -51.67 -170.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.24 1.96 . . . . 0.0 111.873 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 74.9 Cg_exo -50.47 64.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.679 2.253 . . . . 0.0 113.645 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.84 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.9 mm-40 -139.7 -106.21 0.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 119.918 -0.087 . . . . 0.0 111.091 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.753 ' CG2' HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -129.69 -21.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.916 -0.49 . . . . 0.0 111.547 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.897 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.7 tt 56.24 14.65 1.61 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' HIS . . . 45.17 25.87 0.21 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.749 ' HG3' HD11 ' A' ' 41' ' ' LEU . 1.7 mtp 44.36 -87.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.496 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' ALA . 11.3 p80 -124.98 165.22 18.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.727 0.298 . . . . 0.0 110.593 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 58.84 99.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.029 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.9 t30 60.59 167.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.638 HG23 ' C ' ' A' ' 55' ' ' LEU . 11.2 p -168.87 166.56 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.431 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.828 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 2.2 tt 62.9 123.94 0.01 OUTLIER 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.48 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.09 175.04 8.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.868 0.366 . . . . 0.0 111.162 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -163.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.296 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.827 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -143.5 173.96 11.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 111.547 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' THR . 42.5 t -89.5 -41.46 0.43 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.06 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.827 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 85.6 Cg_exo -43.37 81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.418 2.078 . . . . 0.0 112.96 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -91.97 171.6 7.55 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.204 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.4 Cg_endo -47.5 -27.71 7.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.892 1.728 . . . . 0.0 110.368 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.574 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -91.3 -67.62 1.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.751 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -53.39 154.84 3.15 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.23 -40.16 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.027 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.482 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 83.65 44.25 6.94 Favored Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.109 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.64 129.96 8.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.146 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 99.59 19.45 20.27 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.43 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.761 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.6 t-80 24.19 -157.0 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 123.462 0.705 . . . . 0.0 112.261 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG13 HG22 ' A' ' 32' ' ' THR . 14.6 p -66.27 -33.68 65.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.88 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.1 t -132.47 21.49 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.484 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.6 15.02 45.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.604 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.88 HD12 ' CG2' ' A' ' 32' ' ' THR . 17.4 mt -98.95 3.83 47.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.987 0.422 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.761 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.68 161.4 44.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.259 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.543 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.5 Cg_exo -72.29 45.07 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.041 1.828 . . . . 0.0 111.629 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.5 m-70 90.58 -176.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.852 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 31.3 p-80 -129.49 120.35 25.26 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.159 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.22 -17.66 63.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.267 -178.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.766 ' O ' HD12 ' A' ' 41' ' ' LEU . 35.3 t 173.83 68.73 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.966 HD11 ' HG3' ' A' ' 57' ' ' MET . 0.3 OUTLIER 78.5 -12.87 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.09 -29.53 0.91 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.411 0.624 . . . . 0.0 109.401 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.741 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.83 -77.77 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.088 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.852 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 51.23 109.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.587 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 76.1 Cg_endo -94.07 22.49 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.914 2.409 . . . . 0.0 113.98 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.707 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 6.8 m80 -105.29 -93.32 0.36 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.432 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.528 ' HG3' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 74.48 69.08 0.09 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.556 0.616 . . . . 0.0 111.472 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.632 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -136.17 8.38 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.071 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.505 ' HB2' HD23 ' A' ' 62' ' ' LEU . 1.0 OUTLIER 55.5 38.73 30.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.074 0.464 . . . . 0.0 111.984 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.642 HG12 ' HD2' ' A' ' 52' ' ' PRO . 5.8 t -142.72 143.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.921 ' HD3' HD23 ' A' ' 55' ' ' LEU . 12.7 Cg_exo -27.01 -59.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.56 2.84 . . . . 0.0 113.677 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.642 ' HD2' HG12 ' A' ' 50' ' ' VAL . 70.5 Cg_endo -73.46 57.61 3.58 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.48 2.12 . . . . 0.0 113.69 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.707 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 20.2 mp0 -164.88 -102.29 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.907 HG22 HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -131.9 0.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.914 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.921 HD23 ' HD3' ' A' ' 51' ' ' PRO . 12.7 tp -47.6 -16.4 0.07 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.555 ' HA ' HG21 ' A' ' 22' ' ' THR . . . -37.54 -60.72 0.67 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.966 ' HG3' HD11 ' A' ' 41' ' ' LEU . 70.1 mmm -98.94 -163.85 1.08 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.576 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -127.37 -36.24 2.12 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.647 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -45.31 -91.52 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.112 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.26 51.11 1.59 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.284 0.564 . . . . 0.0 109.564 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.721 HG21 ' C ' ' A' ' 57' ' ' MET . 67.3 t -120.19 167.74 13.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.892 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.574 ' N ' HG12 ' A' ' 61' ' ' VAL . 2.0 mp 60.88 19.61 9.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.723 0.297 . . . . 0.0 110.778 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.908 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.842 0.353 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -95.8 85.2 4.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.2 t -149.92 167.47 26.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -163.27 -174.33 3.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.205 179.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HB2' ' N ' ' A' ' 41' ' ' LEU . 47.4 t -104.28 67.61 0.13 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.27 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.476 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 85.5 Cg_endo -78.9 75.22 5.15 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.927 1.752 . . . . 0.0 113.272 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.586 ' HB ' ' CB ' ' A' ' 25' ' ' CYS . 91.7 m -87.34 145.19 37.15 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 22' ' ' THR . 61.2 Cg_exo -36.93 -27.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.726 2.284 . . . . 0.0 112.987 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -144.15 -9.95 0.38 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.996 -1.097 . . . . 0.0 114.74 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.586 ' CB ' ' HB ' ' A' ' 22' ' ' THR . 23.6 t -48.09 151.78 0.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.811 1.306 . . . . 0.0 110.712 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -102.76 -44.06 5.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.795 0.331 . . . . 0.0 111.301 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 55.65 1.52 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.657 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.71 129.74 8.69 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.66 -0.77 . . . . 0.0 110.557 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.825 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 93.78 23.75 22.39 Favored Glycine 0 C--O 1.226 -0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.222 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.825 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 t-80 17.72 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.05 0.94 . . . . 0.0 113.179 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.889 HG13 HG23 ' A' ' 32' ' ' THR . 9.5 p -63.88 -33.31 61.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.889 HG23 HG13 ' A' ' 31' ' ' VAL . 12.0 p -117.65 0.23 12.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.866 0.303 . . . . 0.0 110.837 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 69.27 13.66 67.78 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.098 -1.049 . . . . 0.0 110.649 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.594 HD12 ' OG1' ' A' ' 32' ' ' THR . 16.9 mt -101.06 3.5 41.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.218 0.532 . . . . 0.0 109.77 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.813 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.51 159.46 36.82 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.101 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 60.5 Cg_endo -73.34 47.69 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.329 1.352 . . . . 0.0 110.872 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.7 m-70 91.36 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.655 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 34.7 p-80 -132.75 -51.18 0.91 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.402 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 36.73 28.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.646 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 2.2 p -158.03 5.01 0.12 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.7 HD11 ' O ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 82.26 -23.61 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.1 p -48.89 -27.01 2.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.115 0.484 . . . . 0.0 110.164 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -124.71 -88.84 0.79 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.849 ' SG ' HG23 ' A' ' 54' ' ' ILE . 3.3 t 52.72 111.62 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.513 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 30' ' ' HIS . 28.8 Cg_endo -98.95 14.4 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.204 2.603 . . . . 0.0 113.45 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.713 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 14.5 m80 -86.72 -72.97 0.48 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.594 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 50.29 62.13 2.83 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.082 0.468 . . . . 0.0 111.644 -179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.63 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 5.9 t70 -141.44 9.75 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.606 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.83 ' HB2' HD23 ' A' ' 62' ' ' LEU . 1.9 ptt180 59.96 -170.73 0.14 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.278 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.651 HG23 ' HG3' ' A' ' 49' ' ' ARG . 56.4 t 23.65 -80.2 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 124.972 1.309 . . . . 0.0 114.156 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.623 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 9.1 Cg_endo -50.88 176.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.669 1.579 . . . . 0.0 112.056 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 44.3 Cg_exo -56.79 77.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.14 1.894 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.713 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.9 mm-40 -132.32 -105.62 0.26 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.849 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -145.99 18.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.592 ' HB2' ' N ' ' A' ' 50' ' ' VAL . 2.6 tm? -40.65 -32.41 0.21 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.38 0.61 . . . . 0.0 111.615 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 22' ' ' THR . . . -99.14 58.65 1.12 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.541 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.629 ' HA ' HD22 ' A' ' 41' ' ' LEU . 1.5 ttt -102.21 171.25 7.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.847 0.356 . . . . 0.0 110.884 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -117.14 -20.2 9.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.384 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -106.64 -52.17 2.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.708 0.289 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -131.93 77.17 1.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.206 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 62' ' ' LEU . 28.5 m -70.25 148.13 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.83 HD23 ' HB2' ' A' ' 49' ' ' ARG . 0.5 OUTLIER 69.28 -66.33 0.26 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.907 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.947 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.777 0.322 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.23 -173.46 3.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.963 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.9 m -134.28 176.58 8.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.851 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 5.3 mmtt -80.03 131.75 35.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.665 0.745 . . . . 0.0 111.181 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 35.2 t -72.16 -35.78 3.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.53 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 88.6 Cg_exo -47.05 82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.987 1.791 . . . . 0.0 112.796 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.829 ' HB ' ' HB2' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -87.44 177.79 2.54 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 72.1 Cg_exo -41.7 -23.71 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.314 2.009 . . . . 0.0 112.775 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.493 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -105.14 -67.06 0.69 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 39.1 t -46.75 155.11 0.27 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.637 0.718 . . . . 0.0 110.749 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -107.9 -43.39 4.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 110.784 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 96.21 61.49 0.98 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.962 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -154.35 131.09 10.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.2 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.671 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 89.86 22.59 35.61 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.217 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.795 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 t-80 23.37 -158.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.448 0.699 . . . . 0.0 112.279 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.563 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 8.7 p -64.84 -35.83 76.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.851 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.4 t -129.85 21.01 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.438 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.08 16.2 39.73 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.193 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.851 HD12 ' CG2' ' A' ' 32' ' ' THR . 25.5 mt -97.3 2.57 50.86 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 110.048 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.795 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -121.52 158.19 54.47 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.602 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.556 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.17 45.74 0.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.741 1.627 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.9 m-70 89.97 179.44 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.961 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.6 p-80 -124.89 -52.85 1.66 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.705 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.463 ' CG ' ' HG2' ' A' ' 21' ' ' PRO . 47.3 ttt180 45.35 19.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.889 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.851 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -165.24 23.06 0.05 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.954 HD22 ' CG ' ' A' ' 57' ' ' MET . 0.6 OUTLIER 77.83 -161.07 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 71.77 -53.14 0.69 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.581 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -96.9 -91.17 1.86 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.961 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.88 108.7 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.259 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.573 ' N ' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -90.4 27.12 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.074 2.516 . . . . 0.0 114.431 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.797 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 7.9 m80 -111.61 -76.0 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.982 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.862 ' HB3' HD11 ' A' ' 54' ' ' ILE . 1.6 ptpt 53.8 68.59 0.82 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 110.917 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.818 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 2.2 t70 -132.74 10.58 4.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.432 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.873 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER 50.23 50.73 18.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.297 0.57 . . . . 0.0 112.229 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.921 HG12 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -149.16 153.55 38.02 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.921 ' HD2' HG12 ' A' ' 50' ' ' VAL . 79.6 Cg_exo -38.52 -56.38 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.769 1.646 . . . . 0.0 112.782 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 72.9 Cg_endo -73.44 56.37 3.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.678 2.252 . . . . 0.0 114.098 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.699 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 30.8 mp0 -162.84 -104.33 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.873 0.368 . . . . 0.0 110.985 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.862 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -131.85 4.56 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.702 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 ' HA ' ' CB ' ' A' ' 62' ' ' LEU . 2.5 tt -39.25 -30.92 0.07 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.794 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.829 ' HB2' ' HB ' ' A' ' 22' ' ' THR . . . -64.51 -42.3 95.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.237 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.977 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.9 tmm? -58.71 173.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.603 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.552 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 1.9 m-70 -134.41 -173.13 3.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.806 0.336 . . . . 0.0 111.459 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' A' ' 58' ' ' HIS . 33.8 mm-40 75.37 -86.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.412 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -119.62 64.76 0.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.106 0.479 . . . . 0.0 110.904 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.977 HG21 ' HB3' ' A' ' 57' ' ' MET . 33.5 m -158.18 -172.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.633 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.873 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER 42.58 -165.46 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.919 0.39 . . . . 0.0 111.742 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.555 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.878 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.941 0.401 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.19 159.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.344 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.81 125.58 25.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.944 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 1.7 mmtm -112.93 -78.34 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.185 0.517 . . . . 0.0 110.622 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 22' ' ' THR . 41.9 t -55.16 -41.84 92.81 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.387 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 76.9 Cg_exo -43.05 77.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.367 2.045 . . . . 0.0 112.984 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 1.014 HG21 ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -82.96 176.03 4.22 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.137 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 80.7 Cg_exo -46.9 -22.84 2.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.925 1.75 . . . . 0.0 111.663 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 52' ' ' PRO . . . -103.11 -69.22 0.8 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.904 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.9 t -42.1 150.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.043 0.422 . . . . 0.0 111.7 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -101.71 -47.14 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 100.38 53.44 1.07 Allowed Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.511 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.468 ' HG1' ' CE1' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -157.71 125.74 5.4 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.721 ' O ' ' CA ' ' A' ' 33' ' ' GLY . . . 111.25 -10.35 28.88 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.096 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.953 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 46.94 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.702 -0.881 . . . . 0.0 111.823 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.8 p -50.97 -31.6 10.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.877 HG23 HG13 ' A' ' 31' ' ' VAL . 9.5 p -116.47 4.28 13.29 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.574 1.079 . . . . 0.0 112.036 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.721 ' CA ' ' O ' ' A' ' 29' ' ' GLY . . . 71.57 17.38 76.38 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.351 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 32' ' ' THR . 3.2 mt -124.29 8.62 8.49 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.953 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -107.09 167.21 9.77 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.336 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.727 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 57.1 Cg_endo -72.12 37.63 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.263 1.309 . . . . 0.0 110.884 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 2.2 m-70 89.34 179.26 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.941 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.0 p-80 -128.68 -50.33 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.727 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HG3' ' HG2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER 40.95 27.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.422 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.564 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 2.4 m -174.09 18.98 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.684 HD22 ' SD ' ' A' ' 57' ' ' MET . 0.9 OUTLIER 76.33 -171.86 0.09 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.305 0.502 . . . . 0.0 110.36 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 18.8 m 73.28 -18.06 0.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.548 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -130.48 -94.33 0.68 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.941 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.5 t 55.77 121.62 0.01 OUTLIER Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.709 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.636 ' HD2' ' CE1' ' A' ' 46' ' ' HIS . 72.5 Cg_endo -95.21 24.97 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.006 2.471 . . . . 0.0 113.857 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.636 ' CE1' ' HD2' ' A' ' 45' ' ' PRO . 5.6 m80 -115.8 -95.46 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 78.62 67.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.346 0.521 . . . . 0.0 112.209 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.447 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 51.0 t0 -139.24 10.54 2.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.374 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 27.11 43.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.806 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 96.0 t -157.65 -57.32 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.207 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.806 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.4 Cg_endo -96.42 -179.41 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.198 2.599 . . . . 0.0 111.171 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 9.3 Cg_endo -50.88 84.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 121.977 1.785 . . . . 0.0 110.736 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.624 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.2 mt-10 -140.37 -96.85 0.15 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.595 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -146.43 25.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' ' 50' ' ' VAL . 7.6 tt -48.82 -18.8 0.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.607 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.014 ' HB3' HG21 ' A' ' 22' ' ' THR . . . -133.6 54.77 1.93 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.367 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.684 ' SD ' HD22 ' A' ' 41' ' ' LEU . 8.2 tmm? -61.37 -76.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.871 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.482 ' HB2' ' HE1' ' A' ' 57' ' ' MET . 2.2 t-80 -121.37 -73.42 0.65 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.727 0.298 . . . . 0.0 110.991 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -75.2 -67.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 61' ' ' VAL . 1.4 m-20 176.32 147.15 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 60' ' ' ASN . 15.8 m 44.25 105.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.484 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.497 HD13 ' HG2' ' A' ' 49' ' ' ARG . 0.3 OUTLIER 68.78 -171.34 0.18 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.982 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 tttp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.853 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 mmp_? . . . . . 0 C--O 1.231 0.098 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.85 37.24 4.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.226 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 m -95.82 159.9 14.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.578 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.712 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -108.79 -166.56 1.13 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.324 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.646 ' N ' ' HA ' ' A' ' 40' ' ' SER . 48.8 t -111.6 68.8 0.77 Allowed Pre-proline 0 C--N 1.334 -0.067 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.749 ' HD2' ' HB1' ' A' ' 56' ' ' ALA . 94.9 Cg_endo -88.9 71.98 2.12 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.857 1.705 . . . . 0.0 111.123 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.626 ' HB ' ' H ' ' A' ' 25' ' ' CYS . 2.1 m -81.99 141.8 47.54 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.284 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 22' ' ' THR . 84.4 Cg_exo -46.69 -21.6 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.217 1.944 . . . . 0.0 111.869 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' C ' ' HB3' ' A' ' 52' ' ' PRO . . . -123.15 -37.23 0.61 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.622 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.626 ' H ' ' HB ' ' A' ' 22' ' ' THR . 13.0 t -44.4 152.13 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.868 0.834 . . . . 0.0 111.046 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -108.47 -34.36 6.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.31 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' HA3' ' HG2' ' A' ' 39' ' ' ARG . . . 83.63 54.83 2.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.211 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -157.8 127.43 5.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.443 -0.879 . . . . 0.0 110.154 -179.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.782 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 95.78 24.52 15.28 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.978 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.782 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 17.71 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.921 0.889 . . . . 0.0 113.049 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.864 HG13 HG23 ' A' ' 32' ' ' THR . 7.8 p -67.9 -35.57 72.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.864 HG23 HG13 ' A' ' 31' ' ' VAL . 11.5 p -113.62 -3.96 13.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.328 -0.233 . . . . 0.0 110.637 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 72.96 12.62 79.12 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.564 HD12 ' OG1' ' A' ' 32' ' ' THR . 13.7 mt -101.35 5.0 42.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 109.942 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.733 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.97 164.34 17.01 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.565 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 2.8 Cg_exo -74.09 45.21 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.945 1.763 . . . . 0.0 110.884 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m170 87.54 179.25 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.807 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 47.4 p-80 -129.23 -53.08 1.19 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.195 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 45.42 20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.607 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.69 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.4 p -143.21 -53.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER 157.6 -53.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.03 0.377 . . . . 0.0 111.459 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.483 ' N ' HD12 ' A' ' 41' ' ' LEU . 56.6 p -33.2 -36.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.235 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.598 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -104.48 -98.91 2.54 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.826 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.8 t 55.0 109.04 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.262 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.1 Cg_endo -95.01 24.65 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.903 2.402 . . . . 0.0 113.7 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.777 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 6.9 m80 -107.13 -76.84 0.61 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.793 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.859 ' HB3' HD11 ' A' ' 54' ' ' ILE . 4.4 pttt 54.07 66.23 1.29 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 1.5 t0 -131.34 -10.52 3.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.498 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER 53.21 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.011 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 28.0 t 99.55 -68.94 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.452 1.101 . . . . 0.0 110.449 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.011 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 2.9 Cg_exo -73.92 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.818 1.679 . . . . 0.0 110.498 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.634 ' HD2' ' CB ' ' A' ' 51' ' ' PRO . 44.1 Cg_endo -67.11 99.32 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.8 1.667 . . . . 0.0 111.647 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 21.8 mp0 -152.2 -103.16 0.05 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.52 7.74 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.083 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.575 ' C ' HD23 ' A' ' 55' ' ' LEU . 3.0 tt -46.78 -26.58 0.98 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.884 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.749 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -53.19 -46.74 69.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.672 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -61.54 82.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -46.38 -29.38 1.66 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.419 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.421 ' H ' ' HE2' ' A' ' 57' ' ' MET . 0.1 OUTLIER -84.52 -51.01 7.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.88 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -103.73 57.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.343 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 57' ' ' MET . 17.1 m -81.23 146.92 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.891 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 49' ' ' ARG . 0.4 OUTLIER 67.51 -66.94 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.884 0.374 . . . . 0.0 111.189 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' VAL . 1.7 tptt . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.813 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.897 0.38 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.25 157.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.9 p -75.89 151.36 37.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -122.02 -26.87 4.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 111.318 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.552 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 16.7 t -110.18 33.27 0.1 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 97.0 Cg_endo -77.35 80.03 3.01 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.484 1.456 . . . . 0.0 111.732 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.833 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 1.1 m -85.97 142.14 36.13 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.017 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 22' ' ' THR . 98.1 Cg_exo -43.43 -30.19 2.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.188 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.617 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -112.44 -26.61 4.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.965 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.603 ' H ' ' HB ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -51.83 144.18 11.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.512 ' H ' ' CE1' ' A' ' 46' ' ' HIS . 16.2 t0 -82.27 -46.77 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.34 23.72 77.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.568 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.48 43.95 1.29 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.388 0.614 . . . . 0.0 110.671 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.869 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -170.55 29.81 0.13 Allowed Glycine 0 C--O 1.22 -0.772 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.325 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.869 ' O ' ' O ' ' A' ' 29' ' ' GLY . 3.1 t-80 15.64 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.835 HG13 HG23 ' A' ' 32' ' ' THR . 10.3 p -59.01 -21.1 18.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.835 HG23 HG13 ' A' ' 31' ' ' VAL . 3.2 p -132.37 6.77 4.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.017 0.826 . . . . 0.0 110.216 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 64.18 18.62 62.95 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.7 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.672 HD12 ' OG1' ' A' ' 32' ' ' THR . 9.3 mt -117.06 10.42 13.93 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.711 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -113.39 171.4 4.38 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.003 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.546 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 2.7 Cg_exo -74.89 43.3 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.971 1.781 . . . . 0.0 112.01 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 36' ' ' PRO . 8.4 m-70 85.11 -176.37 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.25 0.547 . . . . 0.0 110.405 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.93 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 29.4 p-80 -152.01 153.71 34.57 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.601 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mtt180 -149.22 38.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.082 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.755 ' O ' HD12 ' A' ' 41' ' ' LEU . 60.3 p -170.42 20.54 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.011 HD23 HG22 ' A' ' 54' ' ' ILE . 0.7 OUTLIER 77.42 -36.84 0.24 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.46 0.573 . . . . 0.0 112.195 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 41' ' ' LEU . 64.6 m -36.46 -35.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.193 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.509 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.1 -93.05 2.26 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.981 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.93 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.1 t 48.67 111.08 0.01 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 115.256 -0.472 . . . . 0.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.9 Cg_endo -86.4 18.39 1.58 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.951 2.434 . . . . 0.0 113.943 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.747 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 5.8 m80 -105.0 -89.33 0.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.466 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.638 ' HE2' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER 77.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 178.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.718 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 1.4 t70 -146.13 24.9 1.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.259 0.552 . . . . 0.0 109.812 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.757 ' CZ ' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER 34.23 43.12 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.95 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.647 HG23 ' HD2' ' A' ' 52' ' ' PRO . 6.7 m -135.99 153.78 77.18 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.681 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 27.9 Cg_exo -27.33 -48.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.039 3.159 . . . . 0.0 113.822 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 50' ' ' VAL . 96.7 Cg_endo -92.62 39.06 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.406 2.071 . . . . 0.0 114.461 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.747 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 8.8 mm-40 -144.42 -102.39 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.011 HG22 HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -128.9 3.71 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -178.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 49' ' ' ARG . 31.2 tp -53.85 -15.58 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.833 ' HB2' ' OG1' ' A' ' 22' ' ' THR . . . -31.2 -61.77 0.19 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.837 ' HG3' HD11 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -63.64 146.88 52.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.476 -178.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.38 142.2 29.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.563 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 73.89 -61.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.654 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -68.85 83.44 0.3 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 110.512 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 49' ' ' ARG . 21.0 m -83.04 139.92 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.208 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.757 HD13 ' CZ ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER 68.48 -66.73 0.22 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.968 0.414 . . . . 0.0 111.017 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.781 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.766 0.317 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.22 -33.77 63.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.5 p -160.84 116.83 2.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.656 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 22.5 mttt -99.99 -73.64 0.63 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.367 0.603 . . . . 0.0 111.064 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.691 ' O ' ' N ' ' A' ' 22' ' ' THR . 48.1 t -56.21 -40.51 85.28 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.59 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.656 ' HD3' ' HA ' ' A' ' 39' ' ' ARG . 86.2 Cg_exo -48.51 72.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.118 1.879 . . . . 0.0 112.678 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.851 ' HB ' ' HB2' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -81.14 173.49 7.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 4.6 Cg_exo -37.5 -27.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.752 2.301 . . . . 0.0 112.644 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' THR . . . -97.28 -75.81 1.26 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.914 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 34.2 t -39.5 156.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.055 0.455 . . . . 0.0 112.212 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.77 -36.96 6.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.82 57.99 1.55 Allowed Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.126 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.64 135.46 9.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.808 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 90.68 21.75 35.96 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.452 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.759 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 21.63 -158.61 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.396 0.679 . . . . 0.0 112.448 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.857 HG13 HG23 ' A' ' 32' ' ' THR . 6.9 p -70.73 -34.52 56.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.857 HG23 HG13 ' A' ' 31' ' ' VAL . 5.9 p -117.46 5.81 12.53 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.025 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.54 13.76 61.31 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.132 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.625 HD12 ' OG1' ' A' ' 32' ' ' THR . 19.8 mt -101.63 2.56 38.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.759 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.25 158.78 40.33 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.335 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.6 Cg_endo -71.9 48.26 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.354 1.37 . . . . 0.0 111.302 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.55 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 4.3 m-70 90.2 -179.33 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.912 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 33.1 p-80 -129.33 -55.07 1.18 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.426 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 91.4 mtt-85 41.92 30.5 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.656 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 38.3 t -155.12 -1.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.836 HD22 ' HG3' ' A' ' 57' ' ' MET . 0.3 OUTLIER 82.73 -35.78 0.09 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.0 p -39.77 -37.34 0.52 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.241 0.543 . . . . 0.0 110.485 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.504 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.49 -90.69 2.09 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.912 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 59.1 112.24 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.859 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.5 Cg_endo -92.31 27.08 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.013 2.475 . . . . 0.0 114.105 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.739 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 5.8 m80 -114.7 -74.91 0.6 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.025 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.793 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 54.61 65.48 1.49 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.92 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t70 -133.88 -7.06 2.76 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.718 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.569 ' HD2' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER 48.69 135.22 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.961 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 33.6 t 96.21 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.551 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.961 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 4.7 Cg_exo -76.95 -167.51 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.646 1.564 . . . . 0.0 110.706 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.502 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 24.9 Cg_exo -64.93 100.74 0.36 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 121.989 1.793 . . . . 0.0 112.28 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.739 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 26.3 mp0 -155.85 -104.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -132.36 11.15 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.195 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD13 ' H ' ' A' ' 50' ' ' VAL . 17.7 tp -45.64 -25.64 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.369 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.851 ' HB2' ' HB ' ' A' ' 22' ' ' THR . . . -54.18 -48.15 71.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.442 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.836 ' HG3' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -52.22 108.16 0.27 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.54 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -66.19 136.69 56.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.745 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.9 25.38 12.03 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.081 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -157.38 48.99 0.43 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.985 0.421 . . . . 0.0 110.77 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 29.6 m -60.87 156.01 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.123 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.608 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER 42.2 40.08 1.62 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.266 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 tptm . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.127 179.411 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.743 0.306 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.79 39.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -178.68 153.86 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -168.4 145.74 4.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.142 0.496 . . . . 0.0 111.854 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.685 ' O ' ' N ' ' A' ' 22' ' ' THR . 52.3 t -88.72 -32.96 0.4 Allowed Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 49.9 Cg_exo -38.47 76.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.229 1.953 . . . . 0.0 113.31 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -84.77 170.21 14.24 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.11 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HD2' HG22 ' A' ' 22' ' ' THR . 9.3 Cg_endo -52.58 -19.22 9.85 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.285 1.99 . . . . 0.0 112.207 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' ' C ' ' A' ' 51' ' ' PRO . . . -108.95 -51.0 0.7 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.483 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.3 t -51.74 156.27 1.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.339 0.569 . . . . 0.0 110.304 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -98.75 -42.9 7.0 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.23 53.69 2.44 Favored Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.919 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.436 ' HG1' ' CE1' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -156.19 131.57 9.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.922 -0.639 . . . . 0.0 111.162 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.71 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 92.66 20.87 33.03 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.439 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.812 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t-80 22.08 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.6 p -61.76 -33.69 58.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.836 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.5 t -132.4 19.94 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.268 0.485 . . . . 0.0 111.475 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.17 16.75 49.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.176 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.836 HD12 ' CG2' ' A' ' 32' ' ' THR . 22.3 mt -99.57 3.9 45.6 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.227 0.537 . . . . 0.0 110.055 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.812 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.75 158.49 51.8 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.822 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.15 44.33 0.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.945 1.763 . . . . 0.0 111.268 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 4.5 m-70 93.01 -175.63 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.926 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 43.2 p-80 -141.09 140.27 34.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.434 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 9.3 mtt180 -131.82 33.06 4.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.746 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 38.6 p -165.42 12.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.59 HD23 HG22 ' A' ' 54' ' ' ILE . 0.4 OUTLIER 81.31 -32.63 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.525 0.602 . . . . 0.0 111.633 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -39.78 -31.44 0.11 Allowed 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.208 0.528 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.562 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -109.57 -92.81 2.22 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.926 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.37 108.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 115.151 -0.524 . . . . 0.0 111.089 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' CB ' ' O ' ' A' ' 30' ' ' HIS . 97.3 Cg_endo -87.53 23.21 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.85 2.366 . . . . 0.0 114.084 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.705 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 6.2 m80 -110.56 -96.47 0.41 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.571 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.602 ' CB ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.98 68.09 0.1 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.962 0.801 . . . . 0.0 110.492 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.55 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -133.64 9.32 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.443 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.944 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 3.5 mpp_? 60.96 42.41 12.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.108 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.787 HG23 ' CD ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -152.94 148.6 20.48 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.43 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 50.7 Cg_exo -36.66 -58.18 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.36 2.04 . . . . 0.0 113.044 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.745 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 13.5 Cg_exo -69.0 62.03 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.077 1.851 . . . . 0.0 112.6 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.787 ' CD ' HG23 ' A' ' 50' ' ' VAL . 18.8 mp0 -166.58 -102.65 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.008 0.433 . . . . 0.0 110.559 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.845 HG21 ' CG ' ' A' ' 57' ' ' MET . 0.4 OUTLIER -117.09 -32.05 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.759 HD12 HD11 ' A' ' 62' ' ' LEU . 11.8 tp 31.24 32.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.509 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.926 ' HA ' HG12 ' A' ' 61' ' ' VAL . . . 172.0 29.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.845 ' CG ' HG21 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -82.2 125.14 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.561 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 57.16 -163.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.05 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -93.33 42.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.797 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.7 50.92 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.328 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.926 HG12 ' HA ' ' A' ' 56' ' ' ALA . 8.1 m -42.86 132.71 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.711 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.944 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 2.3 mp 44.77 34.29 1.15 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.052 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.15 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.938 0.399 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.47 -168.55 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.608 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.26 12.16 21.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.5 mmmm 71.38 172.67 0.31 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.32 0.581 . . . . 0.0 111.269 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 34.0 t -113.77 41.31 0.24 Allowed Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 41.1 Cg_endo -89.68 81.33 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.946 1.764 . . . . 0.0 113.296 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.843 HG23 ' H ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -96.53 152.64 38.74 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.787 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -44.34 -25.1 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -101.92 -51.54 1.08 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.843 ' H ' HG23 ' A' ' 22' ' ' THR . 47.9 t -51.1 148.53 4.37 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.053 0.926 . . . . 0.0 110.311 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -96.06 -46.18 6.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 92.63 42.72 4.41 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.429 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -152.94 131.35 12.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.566 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.752 ' O ' ' N ' ' A' ' 33' ' ' GLY . . . 103.62 -4.15 46.65 Favored Glycine 0 C--O 1.219 -0.842 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.453 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.991 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 46.77 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.494 -1.004 . . . . 0.0 111.494 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.51 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 8.1 p -52.28 -32.32 15.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.877 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.5 t -133.35 21.53 4.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.512 1.051 . . . . 0.0 112.499 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 66.58 15.68 64.38 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.264 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.877 HD12 ' CG2' ' A' ' 32' ' ' THR . 8.9 mt -112.2 6.85 19.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.991 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -117.85 163.14 25.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.054 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 Cg_endo -71.52 42.25 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.505 1.47 . . . . 0.0 111.388 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 2.2 m170 90.73 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 122.921 0.488 . . . . 0.0 109.896 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.723 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 35.5 p-80 -137.66 -54.74 0.67 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.436 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 15.9 mtt180 41.14 25.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.622 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 83.3 p -162.34 17.42 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.823 HD23 HG22 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 76.36 -33.1 0.21 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 85.5 p -38.62 -31.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.873 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.643 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -122.85 -84.15 0.67 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.723 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 45.96 112.32 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 114.865 -0.667 . . . . 0.0 111.013 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.7 Cg_endo -93.59 12.82 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.761 ' HB3' ' CD ' ' A' ' 53' ' ' GLU . 10.5 m80 -92.08 -69.63 0.73 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.859 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.583 ' HA ' HG13 ' A' ' 54' ' ' ILE . 1.7 ptpt 51.01 62.14 2.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.739 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -135.03 14.44 3.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.137 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 0.3 OUTLIER 41.52 38.86 0.95 Allowed 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.354 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 48' ' ' ASP . 2.5 m -130.7 153.46 81.56 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.541 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.489 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 87.7 Cg_exo -27.05 -46.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.988 3.125 . . . . 0.0 114.487 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.585 ' HD2' HG23 ' A' ' 50' ' ' VAL . 86.6 Cg_endo -98.43 46.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.877 2.385 . . . . 0.0 114.543 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.761 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 14.4 mm-40 -149.44 -98.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.823 HG22 HD23 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -129.64 5.36 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.612 0.365 . . . . 0.0 110.248 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.413 HD13 ' HD3' ' A' ' 51' ' ' PRO . 4.0 tt -56.48 -13.46 2.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.658 ' CA ' ' HB ' ' A' ' 22' ' ' THR . . . -42.71 -57.51 2.71 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.819 ' HG3' HD11 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -63.12 115.64 4.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.003 0.43 . . . . 0.0 111.182 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -78.3 -34.13 48.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.801 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -61.3 -52.26 65.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.69 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.03 92.82 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.7 m -66.8 173.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.18 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 63' ' ' LYS . 2.7 tt 62.41 -80.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.822 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' N ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.911 0.386 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.58 178.33 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.655 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.3 m -91.85 20.57 5.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.6 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 11.4 mmtt 62.73 167.93 0.13 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.374 0.607 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.3 t -72.8 -35.3 2.89 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.017 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 63.5 Cg_exo -37.57 77.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.682 2.255 . . . . 0.0 113.705 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -82.93 173.88 6.88 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -46.99 -20.22 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.46 2.106 . . . . 0.0 112.265 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.46 -58.27 0.55 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.696 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 37.7 t -54.77 156.75 3.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.985 0.422 . . . . 0.0 111.693 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.03 -43.41 6.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.117 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 82.26 34.5 23.23 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.769 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.78 ' O ' HG23 ' A' ' 28' ' ' THR . 0.6 OUTLIER -142.13 45.49 1.66 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.492 0.663 . . . . 0.0 110.68 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.956 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -178.58 57.81 0.09 OUTLIER Glycine 0 C--O 1.217 -0.944 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.775 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.956 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.3 t60 -12.82 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.549 HG12 ' HD2' ' A' ' 30' ' ' HIS . 10.0 p -56.25 -31.51 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.832 HG21 HD12 ' A' ' 34' ' ' LEU . 1.5 t -131.93 7.44 4.36 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.871 -0.518 . . . . 0.0 110.53 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.18 64.79 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.096 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.832 HD12 HG21 ' A' ' 32' ' ' THR . 38.0 mt -93.66 1.05 56.72 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.666 0.746 . . . . 0.0 109.331 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.709 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -116.01 156.86 46.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.286 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 59.2 Cg_endo -73.22 50.87 1.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.32 1.347 . . . . 0.0 111.604 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.577 ' CG ' ' HA ' ' A' ' 28' ' ' THR . 6.5 m-70 92.13 -176.67 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.555 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 27.4 p-80 -132.25 121.28 23.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.8 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.8 OUTLIER -59.74 -28.28 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.639 -178.098 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER 173.83 71.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.824 HD23 HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER 79.88 -17.75 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.694 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.02 1.04 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.273 0.558 . . . . 0.0 109.788 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.683 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -128.93 -85.47 0.45 Allowed Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.839 ' SG ' HG23 ' A' ' 54' ' ' ILE . 1.8 t 44.46 113.49 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.68 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.634 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 4.8 Cg_endo -101.61 1.28 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.808 3.005 . . . . 0.0 113.252 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.696 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 9.2 m80 -75.53 -92.03 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.145 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 63.71 65.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.091 -0.381 . . . . 0.0 111.935 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.501 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 7.2 t0 -129.63 -6.21 4.64 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.371 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.553 ' HG2' HG23 ' A' ' 50' ' ' VAL . 64.2 ttt-85 58.34 118.46 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.845 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 24.7 t 99.23 -72.43 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.886 0.874 . . . . 0.0 112.598 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.845 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 29.8 Cg_endo -74.4 -179.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.135 1.223 . . . . 0.0 111.955 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 60.9 Cg_exo -53.2 98.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.208 1.939 . . . . 0.0 112.478 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.696 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.1 mp0 -149.76 -105.03 0.07 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.839 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -118.39 -15.68 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.754 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.758 HD23 HG23 ' A' ' 61' ' ' VAL . 14.3 mt 34.06 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.858 ' HB3' ' O ' ' A' ' 60' ' ' ASN . . . 55.45 2.03 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.638 ' HG3' HD11 ' A' ' 41' ' ' LEU . 0.0 OUTLIER 70.25 -65.92 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.734 0.302 . . . . 0.0 111.649 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -109.67 143.03 40.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.18 0.514 . . . . 0.0 112.328 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 33.84 -88.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.377 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.858 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 3.9 p30 -48.48 167.63 0.03 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.188 0.518 . . . . 0.0 112.152 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.758 HG23 HD23 ' A' ' 55' ' ' LEU . 14.6 p -127.9 155.28 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.163 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.745 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.3 OUTLIER 83.58 5.48 0.78 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.776 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 10.6 tptm . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.129 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.891 0.377 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -73.67 159.32 33.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 p -68.7 178.07 2.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.447 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.1 mttp -86.65 -174.94 5.23 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.294 0.568 . . . . 0.0 111.08 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -66.32 164.43 30.82 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.857 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 37.3 Cg_exo -25.18 -70.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.501 3.468 . . . . 0.0 114.06 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.808 HG23 ' H ' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -163.83 176.12 2.39 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.151 -178.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.625 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 81.4 Cg_exo -46.9 -27.56 5.95 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.949 1.766 . . . . 0.0 111.081 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.808 ' H ' HG23 ' A' ' 22' ' ' THR . . . -46.95 -57.36 6.95 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 42.3 t -55.91 157.6 4.31 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -84.06 -39.1 19.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.703 0.287 . . . . 0.0 111.311 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.489 ' HA2' ' NE2' ' A' ' 38' ' ' HIS . . . 69.3 43.91 68.23 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.29 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.2 133.64 16.5 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.782 -0.709 . . . . 0.0 111.017 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.623 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 88.61 24.9 31.75 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.926 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.837 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.2 t-80 24.55 -156.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.311 0.644 . . . . 0.0 112.07 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 15.0 p -70.11 -34.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.839 HG21 HD12 ' A' ' 34' ' ' LEU . 1.5 t -127.01 18.95 7.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.373 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.39 14.71 42.6 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.299 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.839 HD12 HG21 ' A' ' 32' ' ' THR . 21.1 mt -96.4 1.62 51.91 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.278 0.561 . . . . 0.0 110.172 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.837 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.52 156.82 55.31 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.734 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.8 Cg_exo -70.91 45.41 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.86 1.707 . . . . 0.0 111.72 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 6.6 m-70 95.72 -173.52 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.889 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 28.6 p-80 -140.31 -48.91 0.45 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.766 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.479 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 42.22 22.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.217 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.735 ' O ' HD12 ' A' ' 41' ' ' LEU . 52.6 p -163.48 17.13 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 40' ' ' SER . 0.3 OUTLIER 77.84 -7.53 1.81 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.045 0.384 . . . . 0.0 111.765 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -53.63 -22.87 9.54 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -146.15 -72.61 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.889 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.9 t 53.26 112.0 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.012 -0.594 . . . . 0.0 111.163 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.631 ' HD2' ' CE1' ' A' ' 46' ' ' HIS . 57.4 Cg_endo -98.16 35.51 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.234 2.623 . . . . 0.0 114.362 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.721 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 7.0 m80 -118.88 -99.83 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.249 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HG3' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.9 69.83 0.11 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-N 118.633 0.651 . . . . 0.0 110.243 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' A' ' 50' ' ' VAL . 17.5 t70 -136.33 10.81 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.155 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.705 ' HD3' HD12 ' A' ' 62' ' ' LEU . 1.4 ttt85 57.18 43.96 23.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.175 0.512 . . . . 0.0 111.737 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.885 HG12 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -141.86 152.85 63.43 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.885 ' HD2' HG12 ' A' ' 50' ' ' VAL . 3.6 Cg_exo -35.28 -58.64 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.767 2.311 . . . . 0.0 112.817 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 94.3 Cg_endo -79.85 65.79 8.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.605 2.203 . . . . 0.0 113.764 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.721 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 20.5 mp0 -163.15 -101.93 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 112.22 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.716 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -165.16 29.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 61' ' ' VAL . 2.7 pt? -48.81 -32.42 8.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.001 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.857 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . . . -114.91 64.47 0.68 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.729 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.53 ' HG3' HD23 ' A' ' 41' ' ' LEU . 19.6 ttp -89.63 154.77 19.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.553 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.406 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -52.47 -23.8 6.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.449 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -123.09 87.14 2.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.882 0.373 . . . . 0.0 111.793 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 61.03 160.46 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 55' ' ' LEU . 2.1 p -91.26 151.01 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.465 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 63' ' ' LYS . 4.7 tt 62.31 148.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.924 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.759 ' N ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.043 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.818 0.342 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.32 155.01 41.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.036 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.526 ' HA ' ' HB3' ' A' ' 39' ' ' ARG . 2.2 p -87.59 165.41 15.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.366 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 57' ' ' MET . 0.0 OUTLIER -129.85 -26.74 2.39 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 22' ' ' THR . 30.2 t -81.31 -34.97 0.75 Allowed Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 75.9 Cg_exo -44.34 82.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.138 1.892 . . . . 0.0 113.091 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -89.63 173.79 5.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.889 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 3.6 Cg_endo -45.51 -23.13 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.615 2.21 . . . . 0.0 112.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.482 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -106.32 -61.35 0.6 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.62 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.5 t -50.95 158.82 0.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.681 0.241 . . . . 0.0 111.071 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -108.42 -29.42 8.83 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.81 44.24 7.86 Favored Glycine 0 CA--C 1.503 -0.664 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -153.75 129.87 10.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.72 -1.24 . . . . 0.0 108.947 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.879 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.31 59.45 1.74 Allowed Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.431 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.879 ' O ' ' O ' ' A' ' 29' ' ' GLY . 4.1 t60 -24.09 -167.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.879 1.272 . . . . 0.0 113.783 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.552 HG13 HG22 ' A' ' 32' ' ' THR . 10.9 p -51.51 -32.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.621 HG21 HD12 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -129.24 1.73 5.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.963 0.347 . . . . 0.0 110.326 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.89 13.94 78.66 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.621 HD12 HG21 ' A' ' 32' ' ' THR . 43.6 mt -95.13 2.01 54.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.834 0.826 . . . . 0.0 109.398 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.763 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.24 160.53 33.78 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.15 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 73.7 Cg_endo -75.71 49.18 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.161 1.241 . . . . 0.0 111.359 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.5 m170 91.03 -176.65 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 44.8 p-80 -136.26 134.78 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.538 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.526 ' HB3' ' HA ' ' A' ' 18' ' ' SER . 7.0 mtt180 -111.71 15.65 20.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.492 ' O ' HD12 ' A' ' 41' ' ' LEU . 49.7 p -172.76 28.05 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 HG22 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 78.59 -24.31 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.57 0.623 . . . . 0.0 111.784 178.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -42.27 -28.48 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.547 . . . . 0.0 109.894 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.639 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -112.15 -90.51 1.93 Allowed Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.832 ' SG ' HG23 ' A' ' 54' ' ' ILE . 3.7 t 41.61 112.26 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 115.248 -0.476 . . . . 0.0 110.898 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.722 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 3.3 Cg_endo -99.88 1.18 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.489 2.793 . . . . 0.0 113.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.775 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 14.2 m80 -72.53 -77.22 0.1 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.32 -177.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 50.96 65.07 1.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.67 ' CB ' ' HG3' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -127.41 -2.49 6.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 176.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HB2' HD12 ' A' ' 62' ' ' LEU . 7.8 ttt180 55.4 116.91 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.702 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 20.3 t 98.56 -62.12 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.5 Cg_endo -79.22 -179.2 5.21 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.624 1.549 . . . . 0.0 111.944 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 51.7 Cg_exo -54.32 80.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.012 1.808 . . . . 0.0 111.842 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.775 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 23.6 mm-40 -135.84 -107.3 0.21 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.138 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.864 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -108.3 -24.01 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.534 HD22 ' OD1' ' A' ' 60' ' ' ASN . 5.9 mt 41.75 31.61 0.21 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.779 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.669 ' HB1' ' O ' ' A' ' 63' ' ' LYS . . . 50.31 21.13 0.75 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.478 ' HB2' HD21 ' A' ' 41' ' ' LEU . 2.7 ttm 74.67 -56.57 0.63 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.19 23.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -127.46 -24.19 3.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.537 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 24.7 m-20 64.18 76.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.724 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.463 ' HA ' ' HG3' ' A' ' 49' ' ' ARG . 9.9 p -170.83 29.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.563 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 47' ' ' LYS . 0.3 OUTLIER 64.31 1.73 1.34 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.28 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.669 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.554 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 74.91 -66.99 0.27 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.765 0.317 . . . . 0.0 111.794 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.2 p -130.23 88.08 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.603 ' HB3' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -74.94 176.41 7.18 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 111.278 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.775 ' H ' ' HA ' ' A' ' 40' ' ' SER . 20.8 t -112.83 -42.03 0.08 OUTLIER Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.558 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HD3' ' HA ' ' A' ' 40' ' ' SER . 98.6 Cg_exo -46.18 92.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.268 1.979 . . . . 0.0 113.795 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.793 HG22 HD22 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -124.04 171.76 6.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.472 178.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 93.2 Cg_exo -45.49 89.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.26 1.973 . . . . 0.0 112.24 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . 134.67 -60.87 0.64 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.861 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.9 t -48.78 151.63 1.16 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.621 ' H ' ' CE1' ' A' ' 46' ' ' HIS . 15.1 t70 -103.89 -45.7 4.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.666 0.269 . . . . 0.0 111.648 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.603 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 84.41 47.85 5.27 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.74 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -157.0 120.08 4.08 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.041 -0.579 . . . . 0.0 110.934 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 97.03 24.8 12.15 Favored Glycine 0 C--O 1.223 -0.549 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.63 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.3 t-80 21.78 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.076 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 8.4 p -60.14 -35.63 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.049 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.937 HG23 HG13 ' A' ' 31' ' ' VAL . 8.3 p -119.45 6.24 11.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.092 -0.38 . . . . 0.0 111.73 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.23 14.61 62.0 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.733 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 32' ' ' THR . 13.6 mt -106.03 3.67 28.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.375 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.745 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.18 161.04 33.26 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' CG ' ' A' ' 37' ' ' HIS . 6.5 Cg_exo -71.87 47.54 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.589 1.526 . . . . 0.0 110.857 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 28' ' ' THR . 0.6 OUTLIER 78.11 174.08 0.18 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.973 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 49.9 p-80 -123.9 -43.16 2.13 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.607 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.723 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 40.15 23.97 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.9 179.084 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.775 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 58.0 m 145.57 30.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.724 0.64 . . . . 0.0 112.109 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 40' ' ' SER . 12.0 mt -126.88 -179.42 4.82 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.101 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.3 p -73.94 -1.87 21.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.583 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -71.28 -96.28 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 1.076 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 3.6 t 66.55 124.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.658 ' HD2' ' CE1' ' A' ' 46' ' ' HIS . 56.3 Cg_endo -99.35 22.63 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.295 2.663 . . . . 0.0 113.908 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.658 ' CE1' ' HD2' ' A' ' 45' ' ' PRO . 9.6 m80 -105.31 -84.3 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.697 -178.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 0.0 OUTLIER 70.94 68.68 0.18 Allowed 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.831 -0.543 . . . . 0.0 110.339 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -116.01 -8.47 11.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.022 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.842 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 8.6 mmp_? 65.17 38.23 6.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.235 0.541 . . . . 0.0 111.118 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.617 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -158.4 170.93 8.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.159 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 84.6 Cg_exo -41.32 -46.89 5.63 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.25 1.967 . . . . 0.0 114.179 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.646 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 66.3 Cg_endo -86.35 84.21 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.391 2.061 . . . . 0.0 115.182 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.686 ' CD ' ' H ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER 172.62 -100.55 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.339 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.769 HG23 ' CB ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -122.54 -8.68 8.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.435 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.793 HD22 HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER 37.58 32.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.035 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.952 ' HB1' ' HB2' ' A' ' 59' ' ' GLU . . . 79.74 -30.36 0.13 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.419 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 79.3 -72.58 0.07 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.728 0.299 . . . . 0.0 110.296 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.46 29.51 7.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.541 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.952 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 1.9 mt-10 -146.12 174.91 10.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.472 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -80.72 80.42 7.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.794 ' HB ' HD23 ' A' ' 62' ' ' LEU . 2.7 t 57.48 165.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.323 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.842 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER 42.84 -118.69 0.5 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.868 0.105 . . . . 0.0 110.922 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.72 179.607 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.932 0.396 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -59.16 -85.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.179 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.95 152.59 24.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.773 0.32 . . . . 0.0 111.389 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 39' ' ' ARG . 23.9 mmtt -141.03 -173.84 3.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.596 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' ' N ' ' A' ' 22' ' ' THR . 44.2 t -80.28 -45.05 1.41 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.497 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 6.7 Cg_endo -51.71 70.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.801 1.668 . . . . 0.0 111.754 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.813 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 82.8 p -98.85 175.57 2.4 Favored Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -47.07 -21.75 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.509 1.473 . . . . 0.0 110.928 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.652 ' CA ' HD21 ' A' ' 55' ' ' LEU . . . -100.52 20.01 50.13 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.935 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.1 t -163.79 158.89 20.65 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.041 0.421 . . . . 0.0 111.631 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.82 -44.78 6.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 77.59 39.67 24.85 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.888 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.796 ' O ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.51 46.81 1.29 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.359 0.599 . . . . 0.0 111.315 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.977 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -177.76 48.97 0.1 OUTLIER Glycine 0 C--O 1.218 -0.867 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.79 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.977 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 -6.33 -179.39 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.894 HG13 HG23 ' A' ' 32' ' ' THR . 10.2 p -54.88 -25.48 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.894 HG23 HG13 ' A' ' 31' ' ' VAL . 21.3 p -125.73 -3.31 7.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.51 66.32 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.623 HD12 ' OG1' ' A' ' 32' ' ' THR . 14.2 mt -99.49 2.73 45.2 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.472 0.653 . . . . 0.0 109.404 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.66 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -113.23 157.23 41.58 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 57.2 Cg_endo -71.97 51.31 1.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.22 1.28 . . . . 0.0 111.234 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.567 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 6.1 m-70 90.24 -176.01 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.488 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 26.2 p-80 -130.07 119.52 23.22 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.824 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -51.85 -30.96 25.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.6 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.518 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 6.4 t 160.96 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 O-C-N 123.054 0.221 . . . . 0.0 111.329 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.639 HD21 ' HA ' ' A' ' 57' ' ' MET . 2.2 mt 78.35 -27.41 0.17 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.64 -23.87 1.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.344 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.571 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -133.49 -88.03 0.33 Allowed Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.913 ' SG ' HG23 ' A' ' 54' ' ' ILE . 1.2 t 42.71 109.72 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.522 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.698 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -102.54 -2.29 0.35 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.795 2.997 . . . . 0.0 113.288 -179.324 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.698 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 15.7 m80 -63.64 -80.01 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.765 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.582 ' H ' ' CG1' ' A' ' 54' ' ' ILE . 12.2 pttt 57.25 57.1 4.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.49 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -120.17 -10.82 9.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.612 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 20.0 ttp180 46.66 48.24 14.49 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -159.61 -57.72 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 120.64 0.257 . . . . 0.0 110.71 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.75 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 21.2 Cg_endo -97.03 -171.99 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.933 3.089 . . . . 0.0 110.217 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 12.5 Cg_endo -56.5 79.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.25 1.3 . . . . 0.0 110.737 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.698 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.0 OUTLIER -124.16 -107.75 0.33 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.813 -178.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.913 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -140.58 13.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 110.328 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.652 HD21 ' CA ' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -46.35 -35.44 5.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.095 -179.078 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.646 ' HB3' ' OG1' ' A' ' 22' ' ' THR . . . -91.09 44.79 1.21 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.235 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.639 ' HA ' HD21 ' A' ' 41' ' ' LEU . 2.0 mtt -65.18 -74.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.006 0.431 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -172.85 -68.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.239 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.21 -28.25 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.268 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -170.3 1.92 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.008 0.433 . . . . 0.0 111.3 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' HB ' ' HG3' ' A' ' 49' ' ' ARG . 4.1 m -140.58 153.62 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.638 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER 34.17 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.948 0.404 . . . . 0.0 111.735 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.679 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.844 0.354 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.81 -171.0 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.715 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 p -85.2 167.42 15.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.47 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -77.59 -174.16 3.28 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.892 0.377 . . . . 0.0 110.746 -179.849 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.7 t -118.15 26.61 0.11 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 28.5 Cg_endo -62.9 69.97 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.088 1.192 . . . . 0.0 112.181 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . 1.025 HG23 ' HB3' ' A' ' 56' ' ' ALA . 21.7 m -80.33 135.88 53.5 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 56' ' ' ALA . 97.4 Cg_exo -42.33 -26.51 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 111.667 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.758 ' H ' HG22 ' A' ' 22' ' ' THR . . . -103.76 -50.33 1.03 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.887 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.528 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 46.2 t -42.81 155.33 0.05 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.487 0.644 . . . . 0.0 111.228 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -101.77 -34.88 9.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 81.15 38.21 15.96 Favored Glycine 0 CA--C 1.502 -0.75 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.77 HG22 ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -159.57 62.85 0.38 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.85 -1.175 . . . . 0.0 108.572 -179.17 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 177.99 54.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.608 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.615 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.8 t-80 -37.52 176.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.948 HG13 HG23 ' A' ' 32' ' ' THR . 13.1 p -47.0 -30.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.502 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.948 HG23 HG13 ' A' ' 31' ' ' VAL . 15.0 p -126.63 -2.52 6.7 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.074 -0.391 . . . . 0.0 109.966 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.82 14.94 66.14 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.656 HD12 ' OG1' ' A' ' 32' ' ' THR . 15.5 mt -100.96 4.7 42.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.715 0.769 . . . . 0.0 109.119 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.561 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -111.48 159.53 32.73 Favored Pre-proline 0 N--CA 1.448 -0.548 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.142 179.472 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 37' ' ' HIS . 61.1 Cg_endo -73.21 49.08 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.222 1.282 . . . . 0.0 111.113 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 6.9 m-70 88.64 -173.97 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 29.6 p-80 -139.26 -50.94 0.52 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.335 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.497 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.1 OUTLIER 41.05 20.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.506 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 4.8 p -161.09 18.27 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.798 HD11 ' CG ' ' A' ' 57' ' ' MET . 2.7 mt 71.62 5.72 5.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.892 0.314 . . . . 0.0 111.576 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.478 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 12.9 m -67.97 -4.43 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.506 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -156.92 -72.29 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.857 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.7 t 20.31 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.066 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 3.4 Cg_endo -105.7 5.88 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.703 3.602 . . . . 0.0 112.097 178.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.782 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 32.8 m80 -39.01 -67.85 0.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.982 -177.135 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.733 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER 54.62 69.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.583 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -127.82 -8.79 5.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.563 179.629 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HB2' HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER 46.02 33.23 1.59 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.173 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.638 HG23 ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -171.37 -75.33 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.624 177.834 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' A' ' 50' ' ' VAL . 49.9 Cg_endo -67.8 178.1 3.66 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 111.581 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.646 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 2.0 Cg_endo -41.77 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.364 2.043 . . . . 0.0 111.576 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.782 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.9 OUTLIER -150.1 -110.75 0.06 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.998 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.857 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -146.85 11.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.049 0.939 . . . . 0.0 108.883 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 50' ' ' VAL . 19.7 tp -56.0 -12.48 1.46 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.025 ' HB3' HG23 ' A' ' 22' ' ' THR . . . -129.53 58.58 1.62 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.798 ' CG ' HD11 ' A' ' 41' ' ' LEU . 31.7 tpp -177.27 132.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.489 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.703 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.5 OUTLIER 62.35 140.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.125 179.61 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.1 -29.3 3.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.888 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -76.41 63.45 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.591 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.772 HG23 HD12 ' A' ' 62' ' ' LEU . 2.6 m -104.19 160.31 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.084 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.772 HD12 HG23 ' A' ' 61' ' ' VAL . 1.4 mp 66.5 -67.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.126 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 1.506 ' CA ' ' CG ' ' A' ' 19' ' ' LYS 0.789 0.4 OUTLIER . . . . . 1 N--CA 0.861 -29.895 1 N-CA-C 129.976 7.028 . . . . 4.23 129.976 . . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 1.093 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 48.9 t -86.73 -22.85 0.29 Allowed Pre-proline 2 C--O 1.002 -11.945 1 CA-C-O 130.826 5.108 . . . . 0.88 112.712 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 1.093 ' HD2' ' N ' ' A' ' 20' ' ' CYS 0.288 14.8 Cg_exo -52.21 81.69 0.02 OUTLIER 'Trans proline' 3 C--N 1.0 -17.806 2 O-C-N 105.253 -8.341 . . . . 2.74 121.264 -178.869 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 1.345 ' CG2' ' CA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -92.84 167.62 14.05 Favored Pre-proline 2 C--N 1.143 -8.406 0 CA-C-N 114.023 -1.444 . . . . 2.05 114.559 -179.675 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.728 ' HD2' HG22 ' A' ' 22' ' ' THR . 27.9 Cg_exo -43.77 -21.96 0.39 Allowed 'Trans proline' 2 C--O 1.084 -7.205 0 C-N-CA 123.532 2.821 . . . . 1.57 113.082 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.758 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -107.49 -54.83 0.64 Allowed Glycine 3 C--O 1.083 -9.328 0 O-C-N 118.409 -2.682 . . . . 1.34 114.177 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 42.4 t -54.72 155.18 4.38 Favored 'General case' 1 C--N 1.198 -5.98 1 O-C-N 115.373 -4.604 . . . . 0.49 110.856 -179.69 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 1.01 ' OD2' ' CB ' ' A' ' 26' ' ' ASP . 26.5 t0 -102.11 -40.26 6.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.061 0.458 . . . . 1.58 111.494 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 48.43 4.72 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.626 -0.797 . . . . 0.45 111.636 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -154.66 113.67 3.65 Favored 'General case' 1 C--O 1.05 -9.428 0 CA-C-O 124.055 1.883 . . . . 0.99 110.621 -179.6 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 1.011 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 113.11 29.37 3.04 Favored Glycine 2 C--N 1.162 -9.094 1 O-C-N 113.307 -5.871 . . . . 0.92 113.099 179.66 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 1.011 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 11.51 -167.24 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.377 0 O-C-N 119.95 -1.912 . . . . 0.34 112.885 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG13 HG22 ' A' ' 32' ' ' THR . 14.1 p -59.73 -32.59 49.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.415 0.894 . . . . 0.4 113.415 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.633 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -125.18 8.07 7.9 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.85 -0.531 . . . . 1.25 111.259 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.35 15.0 62.88 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.645 -0.788 . . . . 0.49 111.163 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.633 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 15.7 mt -101.96 3.98 39.52 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.266 0.555 . . . . 0.73 110.379 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.78 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.2 160.23 36.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.387 -0.824 . . . . 0.58 109.387 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.536 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 9.8 Cg_endo -72.69 46.66 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.573 1.515 . . . . 0.65 111.239 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.634 ' HA ' ' H ' ' A' ' 29' ' ' GLY . 3.0 m170 89.65 -177.65 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.697 -0.853 . . . . 0.57 108.697 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 1.281 ' C ' ' CA ' ' A' ' 39' ' ' ARG . 42.1 p-80 -133.08 19.62 4.08 Favored 'General case' 1 C--O 0.634 -31.304 1 CA-C-O 176.774 26.988 . . . . 1.18 110.38 178.696 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 1.443 ' CG ' ' CA ' ' A' ' 39' ' ' ARG . 22.3 mtt180 -1.92 10.1 0.0 OUTLIER 'General case' 2 C--N 0.573 -33.156 3 O-C-N 8.928 -71.108 . . . . 5.36 118.508 177.803 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 1.413 ' OG ' ' CA ' ' A' ' 40' ' ' SER . 7.9 p -173.82 30.46 0.01 OUTLIER 'General case' 2 N--CA 1.318 -7.064 0 N-CA-C 118.899 2.925 . . . . 2.17 118.899 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.025 HD12 ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 87.76 -43.86 0.03 OUTLIER 'General case' 1 C--O 0.833 -20.858 0 CA-C-O 127.14 3.353 . . . . 2.28 116.281 179.143 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 1.113 ' OG ' ' HB2' ' A' ' 42' ' ' SER . 0.1 OUTLIER -35.48 -25.78 0.01 OUTLIER 'General case' 1 C--N 0.987 -15.179 3 O-C-N 100.76 -13.713 . . . . 1.68 111.608 179.396 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . -123.6 -88.99 0.87 Allowed Glycine 1 C--N 1.248 -4.333 0 O-C-N 120.365 -1.46 . . . . 0.39 110.731 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.786 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.1 t 48.9 109.8 0.01 OUTLIER Pre-proline 0 C--O 1.191 -1.977 0 CA-C-N 115.366 -0.417 . . . . 0.74 111.167 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.659 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 42.6 Cg_endo -96.83 18.45 0.56 Allowed 'Trans proline' 0 C--O 1.169 -2.926 0 C-N-CA 123.821 3.014 . . . . 1.3 115.383 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.716 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 33.9 m-70 -94.18 -83.09 0.34 Allowed 'General case' 1 C--N 1.207 -5.605 0 O-C-N 118.876 -2.39 . . . . 0.92 111.734 -177.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.551 ' CE ' ' CG ' ' A' ' 47' ' ' LYS 0.273 0.6 OUTLIER 67.59 62.14 0.44 Allowed 'General case' 2 CA--C 1.316 -8.043 0 N-CA-C 118.336 2.717 . . . . 3.59 118.336 179.938 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 1.34 ' OD1' ' CB ' ' A' ' 48' ' ' ASP 0.322 1.5 t0 -135.94 6.9 3.17 Favored 'General case' 2 N--CA 1.275 -9.215 1 CA-C-O 129.55 4.5 . . . . 3.5 120.243 178.955 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 1.251 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.2 ptt180 56.53 87.27 0.06 Allowed 'General case' 2 C--O 0.679 -28.96 2 O-C-N 114.286 -5.259 . . . . 5.32 118.085 179.431 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.251 HG23 ' O ' ' A' ' 49' ' ' ARG . 1.9 t 142.54 -113.12 0.0 OUTLIER Pre-proline 3 C--N 0.943 -17.065 4 O-C-N 90.607 -20.058 . . . . 2.92 115.5 177.269 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.287 ' HB2' ' CD ' ' A' ' 52' ' ' PRO 0.445 2.2 Cg_endo -56.64 -139.95 0.0 OUTLIER 'Trans proline' 4 C--N 0.752 -30.857 3 O-C-N 93.03 -14.774 . . . . 3.16 126.842 -179.35 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 1.287 ' CD ' ' HB2' ' A' ' 51' ' ' PRO . 1.6 Cg_endo -62.47 79.13 0.1 Allowed 'Trans proline' 2 C--N 1.129 -11.013 0 O-C-N 118.441 -1.4 . . . . 1.79 114.319 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 1.319 ' CD ' ' CB ' ' A' ' 53' ' ' GLU . 3.8 mp0 -151.55 -103.64 0.06 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.33 -0.857 . . . . 2.29 111.665 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.786 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -132.82 2.16 1.55 Allowed 'Isoleucine or valine' 1 C--O 1.142 -4.586 0 CA-C-O 118.712 -0.661 . . . . 1.18 109.583 -179.712 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.56 ' CD2' ' CB ' ' A' ' 55' ' ' LEU . 1.1 tp . . . . . 2 CA--C 1.351 -6.69 1 CA-C-O 136.579 7.847 . . . . 2.64 117.136 -178.959 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 3.4 mttt . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 121.22 0.533 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.702 ' O ' ' N ' ' A' ' 22' ' ' THR . 50.9 t -74.68 -36.64 2.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.335 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 72.4 Cg_exo -48.56 73.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.931 1.754 . . . . 0.0 111.822 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.702 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -79.53 172.99 8.46 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.323 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 94.9 Cg_exo -41.84 -28.15 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.191 1.927 . . . . 0.0 111.31 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.509 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -94.73 -70.35 1.09 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.095 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 22.7 t -50.97 159.39 0.58 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.891 0.346 . . . . 0.0 110.95 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -109.76 -41.61 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 92.53 60.55 1.22 Allowed Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.42 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.72 129.38 8.46 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.249 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.689 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.16 22.36 32.7 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.125 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.801 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 23.42 -160.9 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 123.436 0.695 . . . . 0.0 112.585 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.53 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.5 p -62.25 -33.41 58.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.884 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.4 t -133.89 21.76 3.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.412 0.551 . . . . 0.0 111.415 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.31 16.84 44.32 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.884 HD12 ' CG2' ' A' ' 32' ' ' THR . 20.5 mt -99.48 4.53 46.09 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.14 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.801 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.41 157.45 58.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.444 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.1 Cg_endo -70.96 47.11 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.427 1.418 . . . . 0.0 111.041 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.513 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 5.1 m80 88.47 -179.39 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.968 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 52.9 p-80 -130.61 104.14 7.03 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.188 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' SER . 4.5 mtt180 -71.16 -1.85 13.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.718 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.637 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 72.7 p 175.03 61.1 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 43' ' ' GLY . 0.5 OUTLIER 76.93 -161.3 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.398 178.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.437 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER 64.57 -2.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -147.27 -98.32 0.21 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.968 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.5 t 52.9 105.87 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.571 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.613 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 93.3 Cg_endo -90.6 34.89 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.142 2.562 . . . . 0.0 114.367 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.855 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.8 m-70 -121.12 -92.07 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.961 -0.695 . . . . 0.0 112.507 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 75.25 67.74 0.08 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.26 0.482 . . . . 0.0 111.192 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.458 ' HB3' ' OE1' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -151.63 18.52 0.71 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.913 0.387 . . . . 0.0 111.012 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.508 ' O ' ' OE1' ' A' ' 53' ' ' GLU . 6.2 ptt-85 50.74 -177.64 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.914 ' HA ' HD22 ' A' ' 55' ' ' LEU . 70.2 t 26.72 -85.38 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.144 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 69.0 Cg_exo -46.34 168.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.269 0 CA-C-N 120.709 1.289 . . . . 0.0 111.872 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.509 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 7.6 Cg_endo -49.85 96.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.425 2.083 . . . . 0.0 112.173 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.855 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 3.8 mp0 -154.62 -102.43 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.84 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -147.58 19.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.995 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.914 HD22 ' HA ' ' A' ' 50' ' ' VAL . 15.3 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.284 0.564 . . . . 0.0 111.018 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.044 0.449 . . . . 0.0 110.027 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.661 ' O ' ' N ' ' A' ' 22' ' ' THR . 16.7 t -77.14 -54.78 1.48 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.158 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.573 ' HB3' ' HA3' ' A' ' 27' ' ' GLY . 9.7 Cg_endo -53.09 70.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.072 1.848 . . . . 0.0 112.051 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.661 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -110.4 -177.45 0.46 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.997 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.507 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 83.9 Cg_exo -46.86 -18.75 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.719 1.613 . . . . 0.0 112.691 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.41 ' H ' HG23 ' A' ' 22' ' ' THR . . . -103.92 12.44 52.92 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.884 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 26' ' ' ASP . 41.7 t -153.65 162.81 40.92 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.854 0.327 . . . . 0.0 110.57 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 25.4 t0 -103.94 -41.94 5.72 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.975 0.417 . . . . 0.0 109.883 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.573 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 86.79 54.21 2.69 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.944 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -156.75 131.79 9.06 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.362 -0.419 . . . . 0.0 111.487 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.6 21.29 34.73 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.425 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.802 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.9 t-80 24.36 -159.19 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 122.996 0.518 . . . . 0.0 112.189 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.952 HG13 HG23 ' A' ' 32' ' ' THR . 10.5 p -70.03 -34.51 59.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.952 HG23 HG13 ' A' ' 31' ' ' VAL . 10.7 p -116.72 6.53 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.204 -0.31 . . . . 0.0 111.557 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 65.03 14.4 58.95 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.812 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.639 HD12 ' OG1' ' A' ' 32' ' ' THR . 18.8 mt -102.58 1.77 35.26 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.802 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.14 158.32 41.34 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.373 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.9 Cg_endo -71.32 46.43 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.457 1.438 . . . . 0.0 111.329 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m170 89.11 -179.44 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.963 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 51.5 p-80 -130.73 108.52 9.94 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.875 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -56.06 -22.83 29.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.668 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.702 ' O ' HD12 ' A' ' 41' ' ' LEU . 4.4 p 168.61 86.83 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER 79.24 -170.79 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.502 0.191 . . . . 0.0 110.511 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.475 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 68.7 m 66.35 -8.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.554 ' O ' ' HB ' ' A' ' 31' ' ' VAL . . . -145.99 -101.3 0.3 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.963 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 55.24 104.92 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.615 -0.293 . . . . 0.0 111.246 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.595 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 70.3 Cg_endo -92.16 34.72 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.13 2.554 . . . . 0.0 114.207 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.694 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 11.2 m-70 -122.16 -83.02 0.66 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.356 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 71.92 65.17 0.14 Allowed 'General case' 0 N--CA 1.461 0.119 0 O-C-N 122.156 -0.34 . . . . 0.0 111.199 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB3' ' CD ' ' A' ' 53' ' ' GLU . 2.3 t0 -152.81 15.79 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.401 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' O ' ' OE1' ' A' ' 53' ' ' GLU . 2.6 ttm180 43.67 -169.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.712 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 88.7 t 37.45 -91.07 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.114 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 10.1 Cg_endo -54.09 -175.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.254 1.303 . . . . 0.0 112.109 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 27.6 Cg_exo -62.19 95.84 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.283 1.988 . . . . 0.0 111.536 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.694 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 19.4 mp0 -152.11 -103.23 0.05 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.929 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.75 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -136.14 7.94 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 50' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 121.151 0.5 . . . . 0.0 110.965 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 121.249 0.547 . . . . 0.0 111.899 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 22' ' ' THR . 49.5 t -72.13 -26.58 0.86 Allowed Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 71.9 Cg_exo -50.51 74.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.558 1.505 . . . . 0.0 112.388 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -83.78 172.54 9.0 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 88.1 Cg_exo -44.49 -27.93 2.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.243 1.962 . . . . 0.0 111.839 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . -97.42 -69.1 0.97 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.357 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 24.0 t -46.04 157.52 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 111.716 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -112.51 -30.72 7.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.81 58.75 2.08 Favored Glycine 0 CA--C 1.506 -0.512 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.452 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.51 128.67 4.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.426 -0.887 . . . . 0.0 109.738 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.979 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.62 50.33 3.6 Favored Glycine 0 C--O 1.219 -0.801 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.03 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.979 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 -12.3 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 32' ' ' THR . 13.1 p -52.39 -37.36 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.888 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.947 HG23 HG13 ' A' ' 31' ' ' VAL . 17.9 p -114.02 -7.28 13.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.819 0.342 . . . . 0.0 110.156 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.79 80.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.628 HD12 ' OG1' ' A' ' 32' ' ' THR . 12.1 mt -97.06 1.38 50.05 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.702 0.763 . . . . 0.0 109.163 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.79 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -110.33 161.21 25.46 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.771 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 74.2 Cg_endo -76.63 49.32 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.261 1.308 . . . . 0.0 111.265 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.3 m170 90.46 -176.4 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 48.3 p-80 -134.98 -53.96 0.8 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.511 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 39.96 33.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.463 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.677 ' O ' HD23 ' A' ' 41' ' ' LEU . 28.3 p -143.95 -68.46 0.33 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.792 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 40' ' ' SER . 0.4 OUTLIER 157.72 -52.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.548 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.49 ' N ' HD12 ' A' ' 41' ' ' LEU . 13.3 p -41.55 -30.32 0.21 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.796 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.5 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -100.41 -106.06 2.79 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.822 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.0 t 49.77 108.07 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.954 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.731 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 9.2 Cg_endo -96.29 2.0 2.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.143 2.562 . . . . 0.0 113.373 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.67 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 47.1 m-70 -70.2 -80.29 0.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.758 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 53.82 61.72 2.95 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.455 0.645 . . . . 0.0 110.853 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.591 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.16 -6.25 12.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.902 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 0.4 OUTLIER 47.81 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.742 ' HB ' ' CD ' ' A' ' 51' ' ' PRO . 88.8 t 107.44 -81.76 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.351 1.061 . . . . 0.0 110.518 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.742 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 12.7 Cg_endo -56.41 -171.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.767 1.645 . . . . 0.0 111.115 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.508 ' CD ' ' HB2' ' A' ' 51' ' ' PRO . 25.1 Cg_exo -65.83 108.63 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.224 1.949 . . . . 0.0 111.768 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.67 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 2.0 pm0 -158.84 -103.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.822 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -120.52 -8.73 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.949 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 11.4 mmtm . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.154 0.502 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.6 t -88.48 -42.08 0.47 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.355 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 74.2 Cg_exo -48.35 76.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.991 1.794 . . . . 0.0 112.212 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -90.63 175.64 3.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.67 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.586 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 64.6 Cg_exo -40.57 -27.97 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 112.622 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.631 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -93.8 -72.96 1.2 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.542 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.422 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 48.8 t -46.13 158.8 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 111.499 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -103.64 -37.52 7.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.791 0.329 . . . . 0.0 110.901 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 85.04 40.9 7.79 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.744 HG22 ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -158.16 62.44 0.45 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.864 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 176.59 57.24 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.632 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.5 t-80 -37.92 173.91 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.372 0.606 . . . . 0.0 112.298 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.913 HG13 HG23 ' A' ' 32' ' ' THR . 13.6 p -48.44 -33.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.519 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.913 HG23 HG13 ' A' ' 31' ' ' VAL . 7.9 p -122.84 -1.79 8.86 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.155 -0.341 . . . . 0.0 110.16 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.57 15.63 64.28 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.576 HD12 ' OG1' ' A' ' 32' ' ' THR . 23.7 mt -99.93 6.07 45.22 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.948 0.88 . . . . 0.0 108.747 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.616 ' HE1' ' HG1' ' A' ' 32' ' ' THR . 0.1 OUTLIER -115.42 155.96 46.45 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.165 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.493 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 3.0 Cg_exo -73.48 51.39 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.658 1.572 . . . . 0.0 110.574 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.536 ' CD2' ' HA ' ' A' ' 28' ' ' THR . 6.3 m170 89.47 -174.36 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 26.5 p-80 -130.5 124.69 32.53 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.323 0.582 . . . . 0.0 111.121 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -54.47 -35.67 63.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.404 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 23.0 p 169.43 84.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD2' HG22 ' A' ' 54' ' ' ILE . 7.6 mt 75.04 -8.33 1.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -53.06 -27.21 18.85 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.382 0.611 . . . . 0.0 109.376 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.477 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -133.15 -77.17 0.11 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.841 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.6 t 26.81 92.58 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 6.2 Cg_endo -105.16 2.46 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.448 3.432 . . . . 0.0 112.959 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.691 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 92.6 m-70 -37.19 -57.39 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.74 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.67 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 6.0 mttt -175.1 -62.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.263 0.554 . . . . 0.0 110.626 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 26.1 t70 132.03 -14.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.032 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.461 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 3.5 ttp180 -70.59 145.95 50.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.318 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.912 HG13 ' HD3' ' A' ' 51' ' ' PRO . 1.7 p -42.15 -46.37 10.44 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.912 ' HD3' HG13 ' A' ' 50' ' ' VAL . 7.6 Cg_endo -49.15 178.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.769 1.646 . . . . 0.0 111.235 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 4.1 Cg_endo -46.21 69.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.661 2.241 . . . . 0.0 112.845 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.725 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.5 mt-10 -145.11 -106.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.841 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -126.41 -6.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.727 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.577 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 4.8 mmtp . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.397 0.618 . . . . 0.0 111.742 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 22' ' ' THR . 51.0 t -87.94 -35.21 0.44 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.957 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HD2' ' CB ' ' A' ' 19' ' ' LYS . 94.8 Cg_exo -44.45 73.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.268 1.979 . . . . 0.0 112.803 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -81.17 171.66 11.68 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.162 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 96.2 Cg_exo -41.08 -28.51 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.394 2.063 . . . . 0.0 111.891 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -96.44 -64.1 0.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.195 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.6 t -56.15 158.58 3.93 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.836 0.35 . . . . 0.0 111.272 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -110.46 -35.73 5.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.608 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 89.23 56.48 1.92 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.856 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.8 OUTLIER -158.96 131.46 6.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.985 -0.607 . . . . 0.0 111.082 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 94.94 20.6 27.93 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.246 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 23.2 -163.21 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 123.647 0.779 . . . . 0.0 112.798 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 32' ' ' THR . 13.8 p -63.23 -33.68 62.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.801 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.3 t -130.05 18.25 5.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.016 -0.427 . . . . 0.0 111.348 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.97 15.22 48.74 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.351 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.801 HD12 ' CG2' ' A' ' 32' ' ' THR . 18.7 mt -97.88 4.85 49.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 120.99 0.424 . . . . 0.0 110.068 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.786 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.8 158.05 58.14 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.877 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.3 Cg_exo -71.37 46.83 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.8 1.667 . . . . 0.0 111.078 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 6.6 m170 91.9 -176.24 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.671 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 26.9 p-80 -128.42 121.7 29.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.281 0.562 . . . . 0.0 110.528 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.41 -29.22 67.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.202 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.748 ' O ' HD12 ' A' ' 41' ' ' LEU . 24.1 p 175.51 73.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 ' CG2' ' A' ' 54' ' ' ILE . 0.5 OUTLIER 78.84 -15.54 0.75 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 178.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -22.99 1.29 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.226 0.536 . . . . 0.0 109.894 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.655 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.52 -82.6 0.15 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.671 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 47.76 110.08 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 114.874 -0.663 . . . . 0.0 111.315 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.604 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 14.6 Cg_endo -102.69 30.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.492 2.795 . . . . 0.0 113.179 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.84 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 67.3 m-70 -98.18 -90.87 0.27 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.692 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 40.0 mmtt -161.07 -74.77 0.06 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 110.988 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.692 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 22.7 t0 158.21 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.073 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.483 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -56.42 129.56 41.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.258 -179.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 2.4 t -29.83 -50.66 0.32 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.92 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.9 Cg_exo -51.67 -170.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.24 1.96 . . . . 0.0 111.873 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 74.9 Cg_exo -50.47 64.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.679 2.253 . . . . 0.0 113.645 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.84 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.9 mm-40 -139.7 -106.21 0.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 119.918 -0.087 . . . . 0.0 111.091 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.753 ' CG2' HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -129.69 -21.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.916 -0.49 . . . . 0.0 111.547 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.897 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.7 tt . . . . . 0 CA--C 1.533 0.318 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.827 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 111.547 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' THR . 42.5 t -89.5 -41.46 0.43 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.06 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.827 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 85.6 Cg_exo -43.37 81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.418 2.078 . . . . 0.0 112.96 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -91.97 171.6 7.55 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.204 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.4 Cg_endo -47.5 -27.71 7.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.892 1.728 . . . . 0.0 110.368 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.574 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -91.3 -67.62 1.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.751 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -53.39 154.84 3.15 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.23 -40.16 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.027 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.482 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 83.65 44.25 6.94 Favored Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.109 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.435 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -155.64 129.96 8.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.146 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 99.59 19.45 20.27 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.43 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.761 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.6 t-80 24.19 -157.0 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 123.462 0.705 . . . . 0.0 112.261 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG13 HG22 ' A' ' 32' ' ' THR . 14.6 p -66.27 -33.68 65.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.88 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.1 t -132.47 21.49 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.484 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.6 15.02 45.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.604 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.88 HD12 ' CG2' ' A' ' 32' ' ' THR . 17.4 mt -98.95 3.83 47.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.987 0.422 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.761 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.68 161.4 44.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.259 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.543 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.5 Cg_exo -72.29 45.07 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.041 1.828 . . . . 0.0 111.629 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.0 m170 90.58 -176.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.852 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 31.3 p-80 -129.49 120.35 25.26 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.159 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.22 -17.66 63.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.267 -178.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.766 ' O ' HD12 ' A' ' 41' ' ' LEU . 35.3 t 173.83 68.73 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.907 HD23 HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER 78.5 -12.87 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.09 -29.53 0.91 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.411 0.624 . . . . 0.0 109.401 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.741 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.83 -77.77 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.088 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.852 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 51.23 109.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.587 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 76.1 Cg_endo -94.07 22.49 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.914 2.409 . . . . 0.0 113.98 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.707 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.6 m-70 -105.29 -93.32 0.36 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.432 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.528 ' HG3' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 74.48 69.08 0.09 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.556 0.616 . . . . 0.0 111.472 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.632 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -136.17 8.38 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.071 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 1.0 OUTLIER 55.5 38.73 30.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.074 0.464 . . . . 0.0 111.984 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.642 HG12 ' HD2' ' A' ' 52' ' ' PRO . 5.8 t -142.72 143.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.921 ' HD3' HD23 ' A' ' 55' ' ' LEU . 12.7 Cg_exo -27.01 -59.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.56 2.84 . . . . 0.0 113.677 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.642 ' HD2' HG12 ' A' ' 50' ' ' VAL . 70.5 Cg_endo -73.46 57.61 3.58 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.48 2.12 . . . . 0.0 113.69 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.707 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 20.2 mp0 -164.88 -102.29 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.907 HG22 HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -131.9 0.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.914 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.921 HD23 ' HD3' ' A' ' 51' ' ' PRO . 12.7 tp . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.906 0.384 . . . . 0.0 111.205 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HB2' ' N ' ' A' ' 41' ' ' LEU . 47.4 t -104.28 67.61 0.13 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.27 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.476 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 85.5 Cg_endo -78.9 75.22 5.15 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.927 1.752 . . . . 0.0 113.272 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.586 ' HB ' ' CB ' ' A' ' 25' ' ' CYS . 91.7 m -87.34 145.19 37.15 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 22' ' ' THR . 61.2 Cg_exo -36.93 -27.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.726 2.284 . . . . 0.0 112.987 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -144.15 -9.95 0.38 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.996 -1.097 . . . . 0.0 114.74 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.586 ' CB ' ' HB ' ' A' ' 22' ' ' THR . 23.6 t -48.09 151.78 0.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.811 1.306 . . . . 0.0 110.712 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -102.76 -44.06 5.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.795 0.331 . . . . 0.0 111.301 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 55.65 1.52 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.657 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.71 129.74 8.69 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.66 -0.77 . . . . 0.0 110.557 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.825 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 93.78 23.75 22.39 Favored Glycine 0 C--O 1.226 -0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.222 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.825 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 t-80 17.72 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.05 0.94 . . . . 0.0 113.179 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.889 HG13 HG23 ' A' ' 32' ' ' THR . 9.5 p -63.88 -33.31 61.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.889 HG23 HG13 ' A' ' 31' ' ' VAL . 12.0 p -117.65 0.23 12.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.866 0.303 . . . . 0.0 110.837 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 69.27 13.66 67.78 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.098 -1.049 . . . . 0.0 110.649 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.594 HD12 ' OG1' ' A' ' 32' ' ' THR . 16.9 mt -101.06 3.5 41.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.218 0.532 . . . . 0.0 109.77 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.813 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.51 159.46 36.82 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.101 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 60.5 Cg_endo -73.34 47.69 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.329 1.352 . . . . 0.0 110.872 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.1 m170 91.36 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.655 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 34.7 p-80 -132.75 -51.18 0.91 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.402 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 36.73 28.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.646 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 2.2 p -158.03 5.01 0.12 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.7 HD11 ' O ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 82.26 -23.61 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.1 p -48.89 -27.01 2.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.115 0.484 . . . . 0.0 110.164 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -124.71 -88.84 0.79 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.849 ' SG ' HG23 ' A' ' 54' ' ' ILE . 3.3 t 52.72 111.62 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.513 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 30' ' ' HIS . 28.8 Cg_endo -98.95 14.4 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.204 2.603 . . . . 0.0 113.45 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.713 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 38.1 m-70 -86.72 -72.97 0.48 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.594 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 50.29 62.13 2.83 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.082 0.468 . . . . 0.0 111.644 -179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.63 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 5.9 t70 -141.44 9.75 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.606 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.651 ' HG3' HG23 ' A' ' 50' ' ' VAL . 1.9 ptt180 59.96 -170.73 0.14 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.278 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.651 HG23 ' HG3' ' A' ' 49' ' ' ARG . 56.4 t 23.65 -80.2 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 124.972 1.309 . . . . 0.0 114.156 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.623 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 9.1 Cg_endo -50.88 176.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.669 1.579 . . . . 0.0 112.056 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 44.3 Cg_exo -56.79 77.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.14 1.894 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.713 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.9 mm-40 -132.32 -105.62 0.26 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.849 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -145.99 18.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.592 ' HB2' ' N ' ' A' ' 50' ' ' VAL . 2.6 tm? . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.38 0.61 . . . . 0.0 111.615 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.851 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 5.3 mmtt . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 121.665 0.745 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 35.2 t -72.16 -35.78 3.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.53 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 88.6 Cg_exo -47.05 82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.987 1.791 . . . . 0.0 112.796 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -87.44 177.79 2.54 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 72.1 Cg_exo -41.7 -23.71 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.314 2.009 . . . . 0.0 112.775 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.493 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -105.14 -67.06 0.69 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 39.1 t -46.75 155.11 0.27 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.637 0.718 . . . . 0.0 110.749 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -107.9 -43.39 4.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 110.784 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 96.21 61.49 0.98 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.962 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -154.35 131.09 10.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.2 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.671 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 89.86 22.59 35.61 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.217 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.795 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 t-80 23.37 -158.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.448 0.699 . . . . 0.0 112.279 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.563 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 8.7 p -64.84 -35.83 76.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.851 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.4 t -129.85 21.01 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.438 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.08 16.2 39.73 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.193 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.851 HD12 ' CG2' ' A' ' 32' ' ' THR . 25.5 mt -97.3 2.57 50.86 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 110.048 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.795 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -121.52 158.19 54.47 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.602 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.556 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.17 45.74 0.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.741 1.627 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m170 89.97 179.44 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.961 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.6 p-80 -124.89 -52.85 1.66 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.705 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.463 ' CG ' ' HG2' ' A' ' 21' ' ' PRO . 47.3 ttt180 45.35 19.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.889 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.851 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -165.24 23.06 0.05 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 77.83 -161.07 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 71.77 -53.14 0.69 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.581 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -96.9 -91.17 1.86 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.961 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.88 108.7 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.259 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.573 ' N ' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -90.4 27.12 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.074 2.516 . . . . 0.0 114.431 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.797 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 19.2 m-70 -111.61 -76.0 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.982 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.862 ' HB3' HD11 ' A' ' 54' ' ' ILE . 1.6 ptpt 53.8 68.59 0.82 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 110.917 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.818 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 2.2 t70 -132.74 10.58 4.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.432 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER 50.23 50.73 18.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.297 0.57 . . . . 0.0 112.229 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.921 HG12 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -149.16 153.55 38.02 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.921 ' HD2' HG12 ' A' ' 50' ' ' VAL . 79.6 Cg_exo -38.52 -56.38 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.769 1.646 . . . . 0.0 112.782 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 72.9 Cg_endo -73.44 56.37 3.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.678 2.252 . . . . 0.0 114.098 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.699 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 30.8 mp0 -162.84 -104.33 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.873 0.368 . . . . 0.0 110.985 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.862 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -131.85 4.56 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.702 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD13 ' HD3' ' A' ' 51' ' ' PRO . 2.5 tt . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.794 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 1.7 mmtm . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.185 0.517 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 22' ' ' THR . 41.9 t -55.16 -41.84 92.81 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.387 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 76.9 Cg_exo -43.05 77.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.367 2.045 . . . . 0.0 112.984 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.629 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -82.96 176.03 4.22 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.137 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 80.7 Cg_exo -46.9 -22.84 2.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.925 1.75 . . . . 0.0 111.663 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 52' ' ' PRO . . . -103.11 -69.22 0.8 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.904 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.9 t -42.1 150.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.043 0.422 . . . . 0.0 111.7 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -101.71 -47.14 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 100.38 53.44 1.07 Allowed Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.511 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -157.71 125.74 5.4 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.721 ' O ' ' CA ' ' A' ' 33' ' ' GLY . . . 111.25 -10.35 28.88 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.096 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.953 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 46.94 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.702 -0.881 . . . . 0.0 111.823 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.8 p -50.97 -31.6 10.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.877 HG23 HG13 ' A' ' 31' ' ' VAL . 9.5 p -116.47 4.28 13.29 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.574 1.079 . . . . 0.0 112.036 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.721 ' CA ' ' O ' ' A' ' 29' ' ' GLY . . . 71.57 17.38 76.38 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.351 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 32' ' ' THR . 3.2 mt -124.29 8.62 8.49 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.953 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -107.09 167.21 9.77 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.336 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.727 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 57.1 Cg_endo -72.12 37.63 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.263 1.309 . . . . 0.0 110.884 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m170 89.34 179.26 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.941 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.0 p-80 -128.68 -50.33 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.727 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HG3' ' HG2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER 40.95 27.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.422 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.564 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 2.4 m -174.09 18.98 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 43' ' ' GLY . 0.9 OUTLIER 76.33 -171.86 0.09 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.305 0.502 . . . . 0.0 110.36 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 18.8 m 73.28 -18.06 0.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.548 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -130.48 -94.33 0.68 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.941 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.5 t 55.77 121.62 0.01 OUTLIER Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.709 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.586 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 72.5 Cg_endo -95.21 24.97 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.006 2.471 . . . . 0.0 113.857 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.624 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 11.1 m-70 -115.8 -95.46 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 78.62 67.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.346 0.521 . . . . 0.0 112.209 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.447 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 51.0 t0 -139.24 10.54 2.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.374 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 27.11 43.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.806 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 96.0 t -157.65 -57.32 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.207 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.806 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.4 Cg_endo -96.42 -179.41 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.198 2.599 . . . . 0.0 111.171 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 9.3 Cg_endo -50.88 84.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 121.977 1.785 . . . . 0.0 110.736 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.624 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.2 mt-10 -140.37 -96.85 0.15 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.595 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -146.43 25.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' ' 50' ' ' VAL . 7.6 tt . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.607 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.712 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.717 0.294 . . . . 0.0 111.324 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.646 ' N ' ' HA ' ' A' ' 40' ' ' SER . 48.8 t -111.6 68.8 0.77 Allowed Pre-proline 0 C--N 1.334 -0.067 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 94.9 Cg_endo -88.9 71.98 2.12 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.857 1.705 . . . . 0.0 111.123 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.626 ' HB ' ' H ' ' A' ' 25' ' ' CYS . 2.1 m -81.99 141.8 47.54 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.284 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 22' ' ' THR . 84.4 Cg_exo -46.69 -21.6 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.217 1.944 . . . . 0.0 111.869 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' C ' ' HB3' ' A' ' 52' ' ' PRO . . . -123.15 -37.23 0.61 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.622 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.626 ' H ' ' HB ' ' A' ' 22' ' ' THR . 13.0 t -44.4 152.13 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.868 0.834 . . . . 0.0 111.046 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -108.47 -34.36 6.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.31 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' HA3' ' HG2' ' A' ' 39' ' ' ARG . . . 83.63 54.83 2.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.211 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -157.8 127.43 5.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.443 -0.879 . . . . 0.0 110.154 -179.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.782 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 95.78 24.52 15.28 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.978 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.782 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 17.71 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.921 0.889 . . . . 0.0 113.049 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.864 HG13 HG23 ' A' ' 32' ' ' THR . 7.8 p -67.9 -35.57 72.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.864 HG23 HG13 ' A' ' 31' ' ' VAL . 11.5 p -113.62 -3.96 13.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.328 -0.233 . . . . 0.0 110.637 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 72.96 12.62 79.12 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.564 HD12 ' OG1' ' A' ' 32' ' ' THR . 13.7 mt -101.35 5.0 42.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 109.942 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.733 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.97 164.34 17.01 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.565 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 2.8 Cg_exo -74.09 45.21 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.945 1.763 . . . . 0.0 110.884 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m170 87.54 179.25 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.807 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 47.4 p-80 -129.23 -53.08 1.19 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.195 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 45.42 20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.607 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.69 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.4 p -143.21 -53.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER 157.6 -53.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.03 0.377 . . . . 0.0 111.459 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.483 ' N ' HD12 ' A' ' 41' ' ' LEU . 56.6 p -33.2 -36.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.235 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.598 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -104.48 -98.91 2.54 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.826 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.8 t 55.0 109.04 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.262 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.1 Cg_endo -95.01 24.65 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.903 2.402 . . . . 0.0 113.7 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.777 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 15.6 m-70 -107.13 -76.84 0.61 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.793 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.859 ' HB3' HD11 ' A' ' 54' ' ' ILE . 4.4 pttt 54.07 66.23 1.29 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 1.5 t0 -131.34 -10.52 3.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.498 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER 53.21 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.011 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 28.0 t 99.55 -68.94 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.452 1.101 . . . . 0.0 110.449 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.011 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 2.9 Cg_exo -73.92 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.818 1.679 . . . . 0.0 110.498 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.634 ' HD2' ' CB ' ' A' ' 51' ' ' PRO . 44.1 Cg_endo -67.11 99.32 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.8 1.667 . . . . 0.0 111.647 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 21.8 mp0 -152.2 -103.16 0.05 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.52 7.74 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.575 ' C ' HD23 ' A' ' 55' ' ' LEU . 3.0 tt . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.884 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.798 0.332 . . . . 0.0 111.318 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.552 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 16.7 t -110.18 33.27 0.1 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 97.0 Cg_endo -77.35 80.03 3.01 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.484 1.456 . . . . 0.0 111.732 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' A' ' 25' ' ' CYS . 1.1 m -85.97 142.14 36.13 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.017 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 22' ' ' THR . 98.1 Cg_exo -43.43 -30.19 2.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.188 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.617 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -112.44 -26.61 4.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.965 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.603 ' H ' ' HB ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -51.83 144.18 11.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -82.27 -46.77 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.34 23.72 77.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.568 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.48 43.95 1.29 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.388 0.614 . . . . 0.0 110.671 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.869 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -170.55 29.81 0.13 Allowed Glycine 0 C--O 1.22 -0.772 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.325 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.869 ' O ' ' O ' ' A' ' 29' ' ' GLY . 3.1 t-80 15.64 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.835 HG13 HG23 ' A' ' 32' ' ' THR . 10.3 p -59.01 -21.1 18.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.835 HG23 HG13 ' A' ' 31' ' ' VAL . 3.2 p -132.37 6.77 4.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.017 0.826 . . . . 0.0 110.216 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 64.18 18.62 62.95 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.7 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.672 HD12 ' OG1' ' A' ' 32' ' ' THR . 9.3 mt -117.06 10.42 13.93 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.711 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -113.39 171.4 4.38 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.003 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.516 ' CD ' ' HB3' ' A' ' 35' ' ' TYR . 2.7 Cg_exo -74.89 43.3 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.971 1.781 . . . . 0.0 112.01 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.526 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.8 m80 85.11 -176.37 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.25 0.547 . . . . 0.0 110.405 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.93 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 29.4 p-80 -152.01 153.71 34.57 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.601 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mtt180 -149.22 38.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.082 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.755 ' O ' HD12 ' A' ' 41' ' ' LEU . 60.3 p -170.42 20.54 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.011 HD23 HG22 ' A' ' 54' ' ' ILE . 0.7 OUTLIER 77.42 -36.84 0.24 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.46 0.573 . . . . 0.0 112.195 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 41' ' ' LEU . 64.6 m -36.46 -35.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.193 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.509 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.1 -93.05 2.26 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.981 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.93 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.1 t 48.67 111.08 0.01 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 115.256 -0.472 . . . . 0.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.577 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.9 Cg_endo -86.4 18.39 1.58 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.951 2.434 . . . . 0.0 113.943 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.747 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 9.3 m-70 -105.0 -89.33 0.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.466 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.53 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER 77.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 178.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.718 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 1.4 t70 -146.13 24.9 1.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.259 0.552 . . . . 0.0 109.812 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.419 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER 34.23 43.12 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.95 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.647 HG23 ' HD2' ' A' ' 52' ' ' PRO . 6.7 m -135.99 153.78 77.18 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.681 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 27.9 Cg_exo -27.33 -48.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.039 3.159 . . . . 0.0 113.822 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 50' ' ' VAL . 96.7 Cg_endo -92.62 39.06 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.406 2.071 . . . . 0.0 114.461 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.747 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 8.8 mm-40 -144.42 -102.39 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.011 HG22 HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -128.9 3.71 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -178.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 49' ' ' ARG . 31.2 tp . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.656 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 22.5 mttt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 121.367 0.603 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.691 ' O ' ' N ' ' A' ' 22' ' ' THR . 48.1 t -56.21 -40.51 85.28 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.59 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.656 ' HD3' ' HA ' ' A' ' 39' ' ' ARG . 86.2 Cg_exo -48.51 72.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.118 1.879 . . . . 0.0 112.678 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.691 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -81.14 173.49 7.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 4.6 Cg_exo -37.5 -27.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.752 2.301 . . . . 0.0 112.644 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' THR . . . -97.28 -75.81 1.26 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.914 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 34.2 t -39.5 156.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.055 0.455 . . . . 0.0 112.212 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.77 -36.96 6.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.82 57.99 1.55 Allowed Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.126 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.64 135.46 9.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.808 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 90.68 21.75 35.96 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.452 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.759 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 21.63 -158.61 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.396 0.679 . . . . 0.0 112.448 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.857 HG13 HG23 ' A' ' 32' ' ' THR . 6.9 p -70.73 -34.52 56.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.857 HG23 HG13 ' A' ' 31' ' ' VAL . 5.9 p -117.46 5.81 12.53 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.025 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.54 13.76 61.31 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.132 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.625 HD12 ' OG1' ' A' ' 32' ' ' THR . 19.8 mt -101.63 2.56 38.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.759 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.25 158.78 40.33 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.335 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.6 Cg_endo -71.9 48.26 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.354 1.37 . . . . 0.0 111.302 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.55 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.1 m170 90.2 -179.33 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.912 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 33.1 p-80 -129.33 -55.07 1.18 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.426 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 91.4 mtt-85 41.92 30.5 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.656 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 38.3 t -155.12 -1.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.673 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 82.73 -35.78 0.09 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.0 p -39.77 -37.34 0.52 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.241 0.543 . . . . 0.0 110.485 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.504 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.49 -90.69 2.09 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.912 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 59.1 112.24 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.859 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.5 Cg_endo -92.31 27.08 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.013 2.475 . . . . 0.0 114.105 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.739 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.8 m-70 -114.7 -74.91 0.6 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.025 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.793 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 54.61 65.48 1.49 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.92 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t70 -133.88 -7.06 2.76 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.718 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.569 ' HD2' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER 48.69 135.22 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.961 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 33.6 t 96.21 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.551 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.961 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 4.7 Cg_exo -76.95 -167.51 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.646 1.564 . . . . 0.0 110.706 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.502 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 24.9 Cg_exo -64.93 100.74 0.36 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 121.989 1.793 . . . . 0.0 112.28 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.739 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 26.3 mp0 -155.85 -104.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -132.36 11.15 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.195 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD13 ' H ' ' A' ' 50' ' ' VAL . 17.7 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.369 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.048 0 CA-C-O 121.142 0.496 . . . . 0.0 111.854 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.685 ' O ' ' N ' ' A' ' 22' ' ' THR . 52.3 t -88.72 -32.96 0.4 Allowed Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 49.9 Cg_exo -38.47 76.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.229 1.953 . . . . 0.0 113.31 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -84.77 170.21 14.24 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.11 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HD2' HG22 ' A' ' 22' ' ' THR . 9.3 Cg_endo -52.58 -19.22 9.85 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.285 1.99 . . . . 0.0 112.207 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' ' C ' ' A' ' 51' ' ' PRO . . . -108.95 -51.0 0.7 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.483 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.3 t -51.74 156.27 1.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.339 0.569 . . . . 0.0 110.304 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -98.75 -42.9 7.0 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.23 53.69 2.44 Favored Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.919 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.19 131.57 9.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.922 -0.639 . . . . 0.0 111.162 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.71 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 92.66 20.87 33.03 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.439 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.812 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t-80 22.08 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.6 p -61.76 -33.69 58.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.836 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.5 t -132.4 19.94 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.268 0.485 . . . . 0.0 111.475 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.17 16.75 49.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.176 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.836 HD12 ' CG2' ' A' ' 32' ' ' THR . 22.3 mt -99.57 3.9 45.6 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.227 0.537 . . . . 0.0 110.055 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.812 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.75 158.49 51.8 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.822 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.15 44.33 0.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.945 1.763 . . . . 0.0 111.268 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.9 m170 93.01 -175.63 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.926 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 43.2 p-80 -141.09 140.27 34.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.434 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 9.3 mtt180 -131.82 33.06 4.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.746 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 38.6 p -165.42 12.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.59 HD23 HG22 ' A' ' 54' ' ' ILE . 0.4 OUTLIER 81.31 -32.63 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.525 0.602 . . . . 0.0 111.633 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -39.78 -31.44 0.11 Allowed 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.208 0.528 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.562 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -109.57 -92.81 2.22 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.926 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.37 108.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 115.151 -0.524 . . . . 0.0 111.089 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.552 ' CB ' ' O ' ' A' ' 30' ' ' HIS . 97.3 Cg_endo -87.53 23.21 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.85 2.366 . . . . 0.0 114.084 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.705 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 14.4 m-70 -110.56 -96.47 0.41 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.571 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.602 ' CB ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.98 68.09 0.1 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.962 0.801 . . . . 0.0 110.492 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.55 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -133.64 9.32 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.443 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? 60.96 42.41 12.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.108 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.787 HG23 ' CD ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -152.94 148.6 20.48 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.43 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 50.7 Cg_exo -36.66 -58.18 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.36 2.04 . . . . 0.0 113.044 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.745 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 13.5 Cg_exo -69.0 62.03 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.077 1.851 . . . . 0.0 112.6 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.787 ' CD ' HG23 ' A' ' 50' ' ' VAL . 18.8 mp0 -166.58 -102.65 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.008 0.433 . . . . 0.0 110.559 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.649 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -117.09 -32.05 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 51' ' ' PRO . 11.8 tp . . . . . 0 N--CA 1.466 0.334 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.509 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.5 mmmm . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 121.32 0.581 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 34.0 t -113.77 41.31 0.24 Allowed Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 41.1 Cg_endo -89.68 81.33 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.946 1.764 . . . . 0.0 113.296 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.843 HG23 ' H ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -96.53 152.64 38.74 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.787 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -44.34 -25.1 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -101.92 -51.54 1.08 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.843 ' H ' HG23 ' A' ' 22' ' ' THR . 47.9 t -51.1 148.53 4.37 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.053 0.926 . . . . 0.0 110.311 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -96.06 -46.18 6.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 92.63 42.72 4.41 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.429 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -152.94 131.35 12.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.566 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.752 ' O ' ' N ' ' A' ' 33' ' ' GLY . . . 103.62 -4.15 46.65 Favored Glycine 0 C--O 1.219 -0.842 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.453 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.991 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 46.77 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.494 -1.004 . . . . 0.0 111.494 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.51 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 8.1 p -52.28 -32.32 15.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.877 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.5 t -133.35 21.53 4.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.512 1.051 . . . . 0.0 112.499 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 66.58 15.68 64.38 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.264 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.877 HD12 ' CG2' ' A' ' 32' ' ' THR . 8.9 mt -112.2 6.85 19.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.991 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -117.85 163.14 25.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.054 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 Cg_endo -71.52 42.25 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.505 1.47 . . . . 0.0 111.388 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 2.2 m170 90.73 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 122.921 0.488 . . . . 0.0 109.896 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.723 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 35.5 p-80 -137.66 -54.74 0.67 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.436 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 15.9 mtt180 41.14 25.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.622 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 83.3 p -162.34 17.42 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.823 HD23 HG22 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 76.36 -33.1 0.21 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 85.5 p -38.62 -31.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.873 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.643 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -122.85 -84.15 0.67 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.723 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 45.96 112.32 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 114.865 -0.667 . . . . 0.0 111.013 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.7 Cg_endo -93.59 12.82 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.761 ' HB3' ' CD ' ' A' ' 53' ' ' GLU . 18.7 m-70 -92.08 -69.63 0.73 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.859 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.583 ' HA ' HG13 ' A' ' 54' ' ' ILE . 1.7 ptpt 51.01 62.14 2.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.739 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -135.03 14.44 3.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.137 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 0.3 OUTLIER 41.52 38.86 0.95 Allowed 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.354 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 48' ' ' ASP . 2.5 m -130.7 153.46 81.56 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.541 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.489 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 87.7 Cg_exo -27.05 -46.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.988 3.125 . . . . 0.0 114.487 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.585 ' HD2' HG23 ' A' ' 50' ' ' VAL . 86.6 Cg_endo -98.43 46.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.877 2.385 . . . . 0.0 114.543 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.761 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 14.4 mm-40 -149.44 -98.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.823 HG22 HD23 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -129.64 5.36 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.612 0.365 . . . . 0.0 110.248 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.413 HD13 ' HD3' ' A' ' 51' ' ' PRO . 4.0 tt . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.6 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 11.4 mmtt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.374 0.607 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.3 t -72.8 -35.3 2.89 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.017 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 63.5 Cg_exo -37.57 77.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.682 2.255 . . . . 0.0 113.705 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -82.93 173.88 6.88 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -46.99 -20.22 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.46 2.106 . . . . 0.0 112.265 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.46 -58.27 0.55 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.696 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 37.7 t -54.77 156.75 3.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.985 0.422 . . . . 0.0 111.693 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.03 -43.41 6.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.117 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 82.26 34.5 23.23 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.769 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.78 ' O ' HG23 ' A' ' 28' ' ' THR . 0.6 OUTLIER -142.13 45.49 1.66 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.492 0.663 . . . . 0.0 110.68 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.956 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -178.58 57.81 0.09 OUTLIER Glycine 0 C--O 1.217 -0.944 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.775 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.956 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -12.82 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.177 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.512 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 10.0 p -56.25 -31.51 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.832 HG21 HD12 ' A' ' 34' ' ' LEU . 1.5 t -131.93 7.44 4.36 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.871 -0.518 . . . . 0.0 110.53 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.18 64.79 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.096 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.832 HD12 HG21 ' A' ' 32' ' ' THR . 38.0 mt -93.66 1.05 56.72 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.666 0.746 . . . . 0.0 109.331 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.709 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -116.01 156.86 46.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.286 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 59.2 Cg_endo -73.22 50.87 1.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.32 1.347 . . . . 0.0 111.604 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.582 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.3 m170 92.13 -176.67 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.555 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 27.4 p-80 -132.25 121.28 23.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.8 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.8 OUTLIER -59.74 -28.28 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.639 -178.098 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER 173.83 71.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.824 HD23 HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER 79.88 -17.75 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.694 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.02 1.04 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.273 0.558 . . . . 0.0 109.788 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.683 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -128.93 -85.47 0.45 Allowed Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.839 ' SG ' HG23 ' A' ' 54' ' ' ILE . 1.8 t 44.46 113.49 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.68 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.634 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 4.8 Cg_endo -101.61 1.28 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.808 3.005 . . . . 0.0 113.252 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.696 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 22.5 m-70 -75.53 -92.03 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.145 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 63.71 65.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.091 -0.381 . . . . 0.0 111.935 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.501 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 7.2 t0 -129.63 -6.21 4.64 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.371 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.553 ' HG2' HG23 ' A' ' 50' ' ' VAL . 64.2 ttt-85 58.34 118.46 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.845 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 24.7 t 99.23 -72.43 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.886 0.874 . . . . 0.0 112.598 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.845 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 29.8 Cg_endo -74.4 -179.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.135 1.223 . . . . 0.0 111.955 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 60.9 Cg_exo -53.2 98.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.208 1.939 . . . . 0.0 112.478 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.696 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.1 mp0 -149.76 -105.03 0.07 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.839 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -118.39 -15.68 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.754 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' A' ' 22' ' ' THR . 14.3 mt . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.1 mttp . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.294 0.568 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -66.32 164.43 30.82 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.61 ' HD2' ' SG ' ' A' ' 20' ' ' CYS . 37.3 Cg_exo -25.18 -70.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.501 3.468 . . . . 0.0 114.06 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.808 HG23 ' H ' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -163.83 176.12 2.39 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.151 -178.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.625 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 81.4 Cg_exo -46.9 -27.56 5.95 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.949 1.766 . . . . 0.0 111.081 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.808 ' H ' HG23 ' A' ' 22' ' ' THR . . . -46.95 -57.36 6.95 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 42.3 t -55.91 157.6 4.31 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -84.06 -39.1 19.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.703 0.287 . . . . 0.0 111.311 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.489 ' HA2' ' NE2' ' A' ' 38' ' ' HIS . . . 69.3 43.91 68.23 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.29 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.2 133.64 16.5 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.782 -0.709 . . . . 0.0 111.017 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.623 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 88.61 24.9 31.75 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.926 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.837 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.2 t-80 24.55 -156.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.311 0.644 . . . . 0.0 112.07 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 15.0 p -70.11 -34.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.839 HG21 HD12 ' A' ' 34' ' ' LEU . 1.5 t -127.01 18.95 7.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.373 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.39 14.71 42.6 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.299 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.839 HD12 HG21 ' A' ' 32' ' ' THR . 21.1 mt -96.4 1.62 51.91 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.278 0.561 . . . . 0.0 110.172 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.837 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.52 156.82 55.31 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.734 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.8 Cg_exo -70.91 45.41 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.86 1.707 . . . . 0.0 111.72 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 6.1 m170 95.72 -173.52 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.889 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 28.6 p-80 -140.31 -48.91 0.45 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.766 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.479 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 42.22 22.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.217 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.735 ' O ' HD12 ' A' ' 41' ' ' LEU . 52.6 p -163.48 17.13 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 40' ' ' SER . 0.3 OUTLIER 77.84 -7.53 1.81 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.045 0.384 . . . . 0.0 111.765 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -53.63 -22.87 9.54 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -146.15 -72.61 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.889 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.9 t 53.26 112.0 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.012 -0.594 . . . . 0.0 111.163 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.603 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 57.4 Cg_endo -98.16 35.51 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.234 2.623 . . . . 0.0 114.362 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.721 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 18.7 m-70 -118.88 -99.83 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.249 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HG3' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.9 69.83 0.11 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-N 118.633 0.651 . . . . 0.0 110.243 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' A' ' 50' ' ' VAL . 17.5 t70 -136.33 10.81 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.155 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 49' ' ' ARG . 1.4 ttt85 57.18 43.96 23.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.175 0.512 . . . . 0.0 111.737 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.885 HG12 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -141.86 152.85 63.43 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.885 ' HD2' HG12 ' A' ' 50' ' ' VAL . 3.6 Cg_exo -35.28 -58.64 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.767 2.311 . . . . 0.0 112.817 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 94.3 Cg_endo -79.85 65.79 8.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.605 2.203 . . . . 0.0 113.764 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.721 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 20.5 mp0 -163.15 -101.93 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 112.22 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.716 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -165.16 29.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.7 pt? . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.001 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 22' ' ' THR . 30.2 t -81.31 -34.97 0.75 Allowed Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 75.9 Cg_exo -44.34 82.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.138 1.892 . . . . 0.0 113.091 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -89.63 173.79 5.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.889 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 3.6 Cg_endo -45.51 -23.13 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.615 2.21 . . . . 0.0 112.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.482 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -106.32 -61.35 0.6 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.62 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.5 t -50.95 158.82 0.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.681 0.241 . . . . 0.0 111.071 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -108.42 -29.42 8.83 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.81 44.24 7.86 Favored Glycine 0 CA--C 1.503 -0.664 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -153.75 129.87 10.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.72 -1.24 . . . . 0.0 108.947 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.879 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.31 59.45 1.74 Allowed Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.431 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.879 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.5 t-80 -24.09 -167.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.879 1.272 . . . . 0.0 113.783 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.552 HG13 HG22 ' A' ' 32' ' ' THR . 10.9 p -51.51 -32.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.621 HG21 HD12 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -129.24 1.73 5.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.963 0.347 . . . . 0.0 110.326 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.89 13.94 78.66 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.621 HD12 HG21 ' A' ' 32' ' ' THR . 43.6 mt -95.13 2.01 54.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.834 0.826 . . . . 0.0 109.398 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.763 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.24 160.53 33.78 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.15 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 73.7 Cg_endo -75.71 49.18 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.161 1.241 . . . . 0.0 111.359 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.5 m170 91.03 -176.65 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.594 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 44.8 p-80 -136.26 134.78 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.538 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -111.71 15.65 20.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.492 ' O ' HD12 ' A' ' 41' ' ' LEU . 49.7 p -172.76 28.05 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 HG22 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 78.59 -24.31 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.57 0.623 . . . . 0.0 111.784 178.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -42.27 -28.48 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.547 . . . . 0.0 109.894 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.639 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -112.15 -90.51 1.93 Allowed Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.832 ' SG ' HG23 ' A' ' 54' ' ' ILE . 3.7 t 41.61 112.26 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 115.248 -0.476 . . . . 0.0 110.898 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.722 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 3.3 Cg_endo -99.88 1.18 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.489 2.793 . . . . 0.0 113.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.775 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 38.7 m-70 -72.53 -77.22 0.1 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.32 -177.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 50.96 65.07 1.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.67 ' CB ' ' HG3' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -127.41 -2.49 6.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 176.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.528 ' C ' ' HD2' ' A' ' 51' ' ' PRO . 7.8 ttt180 55.4 116.91 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.702 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 20.3 t 98.56 -62.12 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.5 Cg_endo -79.22 -179.2 5.21 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.624 1.549 . . . . 0.0 111.944 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 51.7 Cg_exo -54.32 80.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.012 1.808 . . . . 0.0 111.842 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.775 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 23.6 mm-40 -135.84 -107.3 0.21 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.138 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.864 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -108.3 -24.01 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD13 ' HB ' ' A' ' 22' ' ' THR . 5.9 mt . . . . . 0 N--CA 1.467 0.417 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.779 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.603 ' HB3' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.44 -0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 111.278 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.775 ' H ' ' HA ' ' A' ' 40' ' ' SER . 20.8 t -112.83 -42.03 0.08 OUTLIER Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.558 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HD3' ' HA ' ' A' ' 40' ' ' SER . 98.6 Cg_exo -46.18 92.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.268 1.979 . . . . 0.0 113.795 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.793 HG22 HD22 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -124.04 171.76 6.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.472 178.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 93.2 Cg_exo -45.49 89.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.26 1.973 . . . . 0.0 112.24 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . 134.67 -60.87 0.64 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.861 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.9 t -48.78 151.63 1.16 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -103.89 -45.7 4.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.666 0.269 . . . . 0.0 111.648 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.603 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 84.41 47.85 5.27 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.74 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -157.0 120.08 4.08 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.041 -0.579 . . . . 0.0 110.934 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 97.03 24.8 12.15 Favored Glycine 0 C--O 1.223 -0.549 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.63 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.3 t-80 21.78 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.076 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 8.4 p -60.14 -35.63 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.049 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.937 HG23 HG13 ' A' ' 31' ' ' VAL . 8.3 p -119.45 6.24 11.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.092 -0.38 . . . . 0.0 111.73 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.23 14.61 62.0 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.733 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 32' ' ' THR . 13.6 mt -106.03 3.67 28.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.375 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.745 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.18 161.04 33.26 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' CG ' ' A' ' 37' ' ' HIS . 6.5 Cg_exo -71.87 47.54 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.589 1.526 . . . . 0.0 110.857 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 28' ' ' THR . 0.3 OUTLIER 78.11 174.08 0.18 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.973 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 49.9 p-80 -123.9 -43.16 2.13 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.607 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.723 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 40.15 23.97 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.9 179.084 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.775 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 58.0 m 145.57 30.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.724 0.64 . . . . 0.0 112.109 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 40' ' ' SER . 12.0 mt -126.88 -179.42 4.82 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.101 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.3 p -73.94 -1.87 21.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.583 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -71.28 -96.28 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 1.076 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 3.6 t 66.55 124.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.581 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 56.3 Cg_endo -99.35 22.63 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.295 2.663 . . . . 0.0 113.908 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.627 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 18.6 m-70 -105.31 -84.3 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.697 -178.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 0.0 OUTLIER 70.94 68.68 0.18 Allowed 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.831 -0.543 . . . . 0.0 110.339 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -116.01 -8.47 11.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.022 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? 65.17 38.23 6.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.235 0.541 . . . . 0.0 111.118 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.617 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -158.4 170.93 8.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.159 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 84.6 Cg_exo -41.32 -46.89 5.63 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.25 1.967 . . . . 0.0 114.179 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.646 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 66.3 Cg_endo -86.35 84.21 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.391 2.061 . . . . 0.0 115.182 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.686 ' CD ' ' H ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER 172.62 -100.55 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.339 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.769 HG23 ' CB ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -122.54 -8.68 8.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.435 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.793 HD22 HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.035 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 39' ' ' ARG . 23.9 mmtt . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' ' N ' ' A' ' 22' ' ' THR . 44.2 t -80.28 -45.05 1.41 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.497 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 6.7 Cg_endo -51.71 70.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.801 1.668 . . . . 0.0 111.754 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.813 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 82.8 p -98.85 175.57 2.4 Favored Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -47.07 -21.75 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.509 1.473 . . . . 0.0 110.928 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.652 ' CA ' HD21 ' A' ' 55' ' ' LEU . . . -100.52 20.01 50.13 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.935 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.1 t -163.79 158.89 20.65 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.041 0.421 . . . . 0.0 111.631 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.82 -44.78 6.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 77.59 39.67 24.85 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.888 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.796 ' O ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.51 46.81 1.29 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.359 0.599 . . . . 0.0 111.315 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.977 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -177.76 48.97 0.1 OUTLIER Glycine 0 C--O 1.218 -0.867 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.79 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.977 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 -6.33 -179.39 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.894 HG13 HG23 ' A' ' 32' ' ' THR . 10.2 p -54.88 -25.48 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.894 HG23 HG13 ' A' ' 31' ' ' VAL . 21.3 p -125.73 -3.31 7.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.51 66.32 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.623 HD12 ' OG1' ' A' ' 32' ' ' THR . 14.2 mt -99.49 2.73 45.2 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.472 0.653 . . . . 0.0 109.404 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.66 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -113.23 157.23 41.58 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 57.2 Cg_endo -71.97 51.31 1.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.22 1.28 . . . . 0.0 111.234 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.567 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.0 m170 90.24 -176.01 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.488 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 26.2 p-80 -130.07 119.52 23.22 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.824 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -51.85 -30.96 25.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.6 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.518 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 6.4 t 160.96 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 O-C-N 123.054 0.221 . . . . 0.0 111.329 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' HG ' ' C ' ' A' ' 40' ' ' SER . 2.2 mt 78.35 -27.41 0.17 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.64 -23.87 1.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.344 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.571 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -133.49 -88.03 0.33 Allowed Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.913 ' SG ' HG23 ' A' ' 54' ' ' ILE . 1.2 t 42.71 109.72 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.522 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.698 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -102.54 -2.29 0.35 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.795 2.997 . . . . 0.0 113.288 -179.324 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.698 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 44.3 m-70 -63.64 -80.01 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.765 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.582 ' H ' ' CG1' ' A' ' 54' ' ' ILE . 12.2 pttt 57.25 57.1 4.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.49 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -120.17 -10.82 9.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.612 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 20.0 ttp180 46.66 48.24 14.49 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -159.61 -57.72 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 120.64 0.257 . . . . 0.0 110.71 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.75 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 21.2 Cg_endo -97.03 -171.99 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.933 3.089 . . . . 0.0 110.217 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 12.5 Cg_endo -56.5 79.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.25 1.3 . . . . 0.0 110.737 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.698 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.0 OUTLIER -124.16 -107.75 0.33 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.813 -178.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.913 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -140.58 13.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 110.328 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.652 HD21 ' CA ' ' A' ' 24' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.095 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 120.892 0.377 . . . . 0.0 110.746 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.7 t -118.15 26.61 0.11 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 28.5 Cg_endo -62.9 69.97 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.088 1.192 . . . . 0.0 112.181 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.758 HG22 ' H ' ' A' ' 24' ' ' GLY . 21.7 m -80.33 135.88 53.5 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.33 -26.51 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 111.667 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.758 ' H ' HG22 ' A' ' 22' ' ' THR . . . -103.76 -50.33 1.03 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.887 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.528 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 46.2 t -42.81 155.33 0.05 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.487 0.644 . . . . 0.0 111.228 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -101.77 -34.88 9.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 81.15 38.21 15.96 Favored Glycine 0 CA--C 1.502 -0.75 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.77 HG22 ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -159.57 62.85 0.38 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.85 -1.175 . . . . 0.0 108.572 -179.17 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 177.99 54.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.608 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.615 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.8 t-80 -37.52 176.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.948 HG13 HG23 ' A' ' 32' ' ' THR . 13.1 p -47.0 -30.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.502 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.948 HG23 HG13 ' A' ' 31' ' ' VAL . 15.0 p -126.63 -2.52 6.7 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.074 -0.391 . . . . 0.0 109.966 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.82 14.94 66.14 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.656 HD12 ' OG1' ' A' ' 32' ' ' THR . 15.5 mt -100.96 4.7 42.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.715 0.769 . . . . 0.0 109.119 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.561 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -111.48 159.53 32.73 Favored Pre-proline 0 N--CA 1.448 -0.548 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.142 179.472 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 37' ' ' HIS . 61.1 Cg_endo -73.21 49.08 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.222 1.282 . . . . 0.0 111.113 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.521 ' CD2' ' HA ' ' A' ' 28' ' ' THR . 5.6 m170 88.64 -173.97 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 29.6 p-80 -139.26 -50.94 0.52 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.335 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.497 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.1 OUTLIER 41.05 20.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.506 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 4.8 p -161.09 18.27 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.411 ' HG ' ' HB2' ' A' ' 20' ' ' CYS . 2.7 mt 71.62 5.72 5.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.892 0.314 . . . . 0.0 111.576 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.478 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 12.9 m -67.97 -4.43 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.506 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -156.92 -72.29 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.857 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.7 t 20.31 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.066 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 3.4 Cg_endo -105.7 5.88 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.703 3.602 . . . . 0.0 112.097 178.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.782 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 86.1 m-70 -39.01 -67.85 0.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.982 -177.135 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.733 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER 54.62 69.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.583 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -127.82 -8.79 5.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.563 179.629 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.467 ' C ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER 46.02 33.23 1.59 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.173 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.638 HG23 ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -171.37 -75.33 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.624 177.834 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' A' ' 50' ' ' VAL . 49.9 Cg_endo -67.8 178.1 3.66 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 111.581 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.646 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 2.0 Cg_endo -41.77 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.364 2.043 . . . . 0.0 111.576 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.782 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.9 OUTLIER -150.1 -110.75 0.06 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.857 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -146.85 11.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.049 0.939 . . . . 0.0 108.883 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 50' ' ' VAL . 19.7 tp . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 1.47 ' C ' ' CA ' ' A' ' 17' ' ' GLU 1.061 0.0 OUTLIER . . . . . 3 C--O 0.325 -47.601 2 N-CA-C 145.341 12.719 . . . . 7.59 145.341 . . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 1.47 ' CA ' ' C ' ' A' ' 16' ' ' ARG 0.919 5.8 mt-10 97.52 -113.15 0.0 OUTLIER 'General case' 4 C--O 0.156 -56.472 5 O-C-N 61.523 -38.236 . . . . 7.1 144.321 -179.8 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.665 ' N ' ' HE2' ' A' ' 19' ' ' LYS 0.769 73.6 m -83.22 166.22 18.76 Favored 'General case' 4 C--O 0.255 -51.25 4 CA-C-N 169.722 23.874 . . . . 4.82 126.912 179.236 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.972 ' C ' ' HD2' ' A' ' 21' ' ' PRO 0.789 0.4 OUTLIER -129.05 -177.85 4.39 Favored 'General case' 2 N--CA 0.861 -29.895 4 O-C-N 83.215 -24.678 . . . . 4.23 129.976 179.947 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 1.093 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 48.9 t -86.73 -22.85 0.29 Allowed Pre-proline 2 C--O 1.002 -11.945 1 CA-C-O 130.826 5.108 . . . . 0.88 112.712 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 1.093 ' HD2' ' N ' ' A' ' 20' ' ' CYS 0.288 14.8 Cg_exo -52.21 81.69 0.02 OUTLIER 'Trans proline' 3 C--N 1.0 -17.806 2 O-C-N 105.253 -8.341 . . . . 2.74 121.264 -178.869 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 1.345 ' CG2' ' CA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -92.84 167.62 14.05 Favored Pre-proline 2 C--N 1.143 -8.406 0 CA-C-N 114.023 -1.444 . . . . 2.05 114.559 -179.675 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.728 ' HD2' HG22 ' A' ' 22' ' ' THR . 27.9 Cg_exo -43.77 -21.96 0.39 Allowed 'Trans proline' 2 C--O 1.084 -7.205 0 C-N-CA 123.532 2.821 . . . . 1.57 113.082 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.758 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -107.49 -54.83 0.64 Allowed Glycine 3 C--O 1.083 -9.328 0 O-C-N 118.409 -2.682 . . . . 1.34 114.177 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 42.4 t -54.72 155.18 4.38 Favored 'General case' 1 C--N 1.198 -5.98 1 O-C-N 115.373 -4.604 . . . . 0.49 110.856 -179.69 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 1.01 ' OD2' ' CB ' ' A' ' 26' ' ' ASP . 26.5 t0 -102.11 -40.26 6.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.061 0.458 . . . . 1.58 111.494 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 48.43 4.72 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.626 -0.797 . . . . 0.45 111.636 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 28' ' ' THR . 0.6 OUTLIER -154.66 113.67 3.65 Favored 'General case' 1 C--O 1.05 -9.428 0 CA-C-O 124.055 1.883 . . . . 0.99 110.621 -179.6 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 1.011 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 113.11 29.37 3.04 Favored Glycine 2 C--N 1.162 -9.094 1 O-C-N 113.307 -5.871 . . . . 0.92 113.099 179.66 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 1.011 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 11.51 -167.24 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.377 0 O-C-N 119.95 -1.912 . . . . 0.34 112.885 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG13 HG22 ' A' ' 32' ' ' THR . 14.1 p -59.73 -32.59 49.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.415 0.894 . . . . 0.4 113.415 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.633 ' OG1' ' CD1' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -125.18 8.07 7.9 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.85 -0.531 . . . . 1.25 111.259 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.35 15.0 62.88 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.645 -0.788 . . . . 0.49 111.163 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.633 ' CD1' ' OG1' ' A' ' 32' ' ' THR . 15.7 mt -101.96 3.98 39.52 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.266 0.555 . . . . 0.73 110.379 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.78 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.2 160.23 36.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.387 -0.824 . . . . 0.58 109.387 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.536 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 9.8 Cg_endo -72.69 46.66 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.573 1.515 . . . . 0.65 111.239 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.634 ' HA ' ' H ' ' A' ' 29' ' ' GLY . 3.0 m170 89.65 -177.65 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.697 -0.853 . . . . 0.57 108.697 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 1.281 ' C ' ' CA ' ' A' ' 39' ' ' ARG . 42.1 p-80 -133.08 19.62 4.08 Favored 'General case' 1 C--O 0.634 -31.304 1 CA-C-O 176.774 26.988 . . . . 1.18 110.38 178.696 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 1.443 ' CG ' ' CA ' ' A' ' 39' ' ' ARG . 22.3 mtt180 -1.92 10.1 0.0 OUTLIER 'General case' 2 C--N 0.573 -33.156 3 O-C-N 8.928 -71.108 . . . . 5.36 118.508 177.803 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 1.413 ' OG ' ' CA ' ' A' ' 40' ' ' SER . 7.9 p -173.82 30.46 0.01 OUTLIER 'General case' 2 N--CA 1.318 -7.064 0 N-CA-C 118.899 2.925 . . . . 2.17 118.899 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.66 HD22 ' SD ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 87.76 -43.86 0.03 OUTLIER 'General case' 1 C--O 0.833 -20.858 0 CA-C-O 127.14 3.353 . . . . 2.28 116.281 179.143 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 1.113 ' OG ' ' HB2' ' A' ' 42' ' ' SER . 0.1 OUTLIER -35.48 -25.78 0.01 OUTLIER 'General case' 1 C--N 0.987 -15.179 3 O-C-N 100.76 -13.713 . . . . 1.68 111.608 179.396 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . -123.6 -88.99 0.87 Allowed Glycine 1 C--N 1.248 -4.333 0 O-C-N 120.365 -1.46 . . . . 0.39 110.731 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.786 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.1 t 48.9 109.8 0.01 OUTLIER Pre-proline 0 C--O 1.191 -1.977 0 CA-C-N 115.366 -0.417 . . . . 0.74 111.167 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.659 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 42.6 Cg_endo -96.83 18.45 0.56 Allowed 'Trans proline' 0 C--O 1.169 -2.926 0 C-N-CA 123.821 3.014 . . . . 1.3 115.383 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.716 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 33.9 m-70 -94.18 -83.09 0.34 Allowed 'General case' 1 C--N 1.207 -5.605 0 O-C-N 118.876 -2.39 . . . . 0.92 111.734 -177.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.551 ' CE ' ' CG ' ' A' ' 47' ' ' LYS 0.273 0.6 OUTLIER 67.59 62.14 0.44 Allowed 'General case' 2 CA--C 1.316 -8.043 0 N-CA-C 118.336 2.717 . . . . 3.59 118.336 179.938 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 1.34 ' OD1' ' CB ' ' A' ' 48' ' ' ASP 0.322 1.5 t0 -135.94 6.9 3.17 Favored 'General case' 2 N--CA 1.275 -9.215 1 CA-C-O 129.55 4.5 . . . . 3.5 120.243 178.955 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 1.251 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.2 ptt180 56.53 87.27 0.06 Allowed 'General case' 2 C--O 0.679 -28.96 2 O-C-N 114.286 -5.259 . . . . 5.32 118.085 179.431 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.251 HG23 ' O ' ' A' ' 49' ' ' ARG . 1.9 t 142.54 -113.12 0.0 OUTLIER Pre-proline 3 C--N 0.943 -17.065 4 O-C-N 90.607 -20.058 . . . . 2.92 115.5 177.269 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.287 ' HB2' ' CD ' ' A' ' 52' ' ' PRO 0.445 2.2 Cg_endo -56.64 -139.95 0.0 OUTLIER 'Trans proline' 4 C--N 0.752 -30.857 3 O-C-N 93.03 -14.774 . . . . 3.16 126.842 -179.35 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 1.287 ' CD ' ' HB2' ' A' ' 51' ' ' PRO . 1.6 Cg_endo -62.47 79.13 0.1 Allowed 'Trans proline' 2 C--N 1.129 -11.013 0 O-C-N 118.441 -1.4 . . . . 1.79 114.319 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 1.319 ' CD ' ' CB ' ' A' ' 53' ' ' GLU . 3.8 mp0 -151.55 -103.64 0.06 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.33 -0.857 . . . . 2.29 111.665 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.028 ' O ' ' N ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -132.82 2.16 1.55 Allowed 'Isoleucine or valine' 1 C--O 1.142 -4.586 0 CA-C-O 118.712 -0.661 . . . . 1.18 109.583 -179.712 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.56 ' CD2' ' CB ' ' A' ' 55' ' ' LEU . 1.1 tp -17.71 -10.43 0.0 OUTLIER 'General case' 2 CA--C 1.351 -6.69 1 CA-C-O 136.579 7.847 . . . . 2.64 117.136 -178.959 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.028 ' N ' ' O ' ' A' ' 54' ' ' ILE 0.933 . . -133.42 6.5 3.82 Favored 'General case' 4 C--N 0.889 -19.454 4 N-CA-C 148.576 13.917 . . . . 3.24 148.576 -179.721 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 1.66 ' SD ' HD22 ' A' ' 41' ' ' LEU 0.336 0.0 OUTLIER -54.0 -163.71 0.0 OUTLIER 'General case' 4 C--O 0.462 -40.357 2 O-C-N 106.839 -9.913 . . . . 4.67 106.539 -179.973 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.718 ' ND1' ' HE1' ' A' ' 58' ' ' HIS 0.687 14.0 m170 -89.94 -36.3 15.08 Favored 'General case' 4 C--O 0.411 -43.074 5 CA-C-O 158.019 18.057 . . . . 5.8 131.318 -179.485 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.477 ' C ' ' CA ' ' A' ' 60' ' ' ASN 0.529 2.0 mt-10 -116.75 -35.92 4.04 Favored 'General case' 4 C--N 0.551 -34.113 4 O-C-N 40.191 -51.568 . . . . 5.66 109.746 -179.892 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 1.477 ' CA ' ' C ' ' A' ' 59' ' ' GLU 0.766 1.4 m-20 -124.13 105.32 9.44 Favored 'General case' 4 C--N 0.702 -27.572 5 O-C-N 84.301 -23.999 . . . . 6.08 135.775 179.894 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.435 ' CA ' ' C ' ' A' ' 60' ' ' ASN 0.443 27.1 m -84.19 152.64 3.74 Favored 'Isoleucine or valine' 4 C--N 0.761 -25.01 3 O-C-N 92.275 -19.016 . . . . 3.29 114.079 179.982 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.288 ' CD1' ' CA ' ' A' ' 62' ' ' LEU 0.402 7.5 tt 57.19 -40.67 0.04 OUTLIER 'General case' 4 C--O 0.433 -41.914 2 CA-C-O 137.146 8.117 . . . . 4.03 108.571 179.82 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.831 ' CD ' ' HG2' ' A' ' 63' ' ' LYS 0.751 4.7 tttm . . . . . 4 C--O 0.55 -35.739 4 O-C-N 70.002 -32.936 . . . . 6.51 118.484 179.828 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 18' ' ' SER . 0.7 OUTLIER -132.83 65.62 1.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 3.4 t 85.34 -14.84 0.55 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.851 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 3.4 mttt 57.82 156.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.22 0.533 . . . . 0.0 111.364 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.702 ' O ' ' N ' ' A' ' 22' ' ' THR . 50.9 t -74.68 -36.64 2.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.335 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 72.4 Cg_exo -48.56 73.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.931 1.754 . . . . 0.0 111.822 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 1.02 HG21 ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -79.53 172.99 8.46 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.323 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 94.9 Cg_exo -41.84 -28.15 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.191 1.927 . . . . 0.0 111.31 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.509 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -94.73 -70.35 1.09 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.095 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 22.7 t -50.97 159.39 0.58 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.891 0.346 . . . . 0.0 110.95 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -109.76 -41.61 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 92.53 60.55 1.22 Allowed Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.42 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.72 129.38 8.46 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.249 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.689 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.16 22.36 32.7 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.125 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.801 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 23.42 -160.9 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 123.436 0.695 . . . . 0.0 112.585 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.53 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.5 p -62.25 -33.41 58.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.884 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.4 t -133.89 21.76 3.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.412 0.551 . . . . 0.0 111.415 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.31 16.84 44.32 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.884 HD12 ' CG2' ' A' ' 32' ' ' THR . 20.5 mt -99.48 4.53 46.09 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.14 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.801 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.41 157.45 58.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.444 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.1 Cg_endo -70.96 47.11 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.427 1.418 . . . . 0.0 111.041 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.513 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 5.1 m80 88.47 -179.39 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.968 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 52.9 p-80 -130.61 104.14 7.03 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.188 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' SER . 4.5 mtt180 -71.16 -1.85 13.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.718 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.637 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 72.7 p 175.03 61.1 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.664 HD22 ' CG ' ' A' ' 57' ' ' MET . 0.5 OUTLIER 76.93 -161.3 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.398 178.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.437 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER 64.57 -2.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -147.27 -98.32 0.21 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.968 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.5 t 52.9 105.87 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.571 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.613 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 93.3 Cg_endo -90.6 34.89 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.142 2.562 . . . . 0.0 114.367 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.855 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.8 m-70 -121.12 -92.07 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.961 -0.695 . . . . 0.0 112.507 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 75.25 67.74 0.08 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.26 0.482 . . . . 0.0 111.192 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.458 ' HB3' ' OE1' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -151.63 18.52 0.71 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.913 0.387 . . . . 0.0 111.012 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.633 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 6.2 ptt-85 50.74 -177.64 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.914 ' HA ' HD22 ' A' ' 55' ' ' LEU . 70.2 t 26.72 -85.38 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.144 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 69.0 Cg_exo -46.34 168.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.269 0 CA-C-N 120.709 1.289 . . . . 0.0 111.872 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.509 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 7.6 Cg_endo -49.85 96.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.425 2.083 . . . . 0.0 112.173 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.855 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 3.8 mp0 -154.62 -102.43 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.84 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -147.58 19.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.995 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.914 HD22 ' HA ' ' A' ' 50' ' ' VAL . 15.3 tp -46.92 -29.0 1.8 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.284 0.564 . . . . 0.0 111.018 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.02 ' HB3' HG21 ' A' ' 22' ' ' THR . . . -109.67 42.61 1.46 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.276 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.737 ' H ' HG12 ' A' ' 61' ' ' VAL . 9.8 ttt -66.03 -80.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.482 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 57' ' ' MET . 33.7 p80 173.64 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.012 0.434 . . . . 0.0 110.488 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 9.7 tt0 -133.92 -40.22 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.546 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.88 40.01 1.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.773 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.737 HG12 ' H ' ' A' ' 57' ' ' MET . 31.0 m -71.81 158.7 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.741 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.633 ' HA ' ' HB3' ' A' ' 49' ' ' ARG . 6.9 mp 62.52 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.897 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.924 0.392 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 62.05 113.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.524 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 p 63.81 115.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.603 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -90.32 -176.27 4.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.044 0.449 . . . . 0.0 110.027 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.661 ' O ' ' N ' ' A' ' 22' ' ' THR . 16.7 t -77.14 -54.78 1.48 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.158 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.573 ' HB3' ' HA3' ' A' ' 27' ' ' GLY . 9.7 Cg_endo -53.09 70.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.072 1.848 . . . . 0.0 112.051 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.689 HG22 ' HB2' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -110.4 -177.45 0.46 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.997 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.507 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 83.9 Cg_exo -46.86 -18.75 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.719 1.613 . . . . 0.0 112.691 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.41 ' H ' HG23 ' A' ' 22' ' ' THR . . . -103.92 12.44 52.92 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.884 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 26' ' ' ASP . 41.7 t -153.65 162.81 40.92 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.854 0.327 . . . . 0.0 110.57 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 25.4 t0 -103.94 -41.94 5.72 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.975 0.417 . . . . 0.0 109.883 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.573 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 86.79 54.21 2.69 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.944 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -156.75 131.79 9.06 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.362 -0.419 . . . . 0.0 111.487 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 91.6 21.29 34.73 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.425 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.802 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.9 t-80 24.36 -159.19 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 122.996 0.518 . . . . 0.0 112.189 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.952 HG13 HG23 ' A' ' 32' ' ' THR . 10.5 p -70.03 -34.51 59.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.952 HG23 HG13 ' A' ' 31' ' ' VAL . 10.7 p -116.72 6.53 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.204 -0.31 . . . . 0.0 111.557 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 65.03 14.4 58.95 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.812 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.639 HD12 ' OG1' ' A' ' 32' ' ' THR . 18.8 mt -102.58 1.77 35.26 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.802 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.14 158.32 41.34 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.373 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.9 Cg_endo -71.32 46.43 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.457 1.438 . . . . 0.0 111.329 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m170 89.11 -179.44 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.963 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 51.5 p-80 -130.73 108.52 9.94 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.875 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -56.06 -22.83 29.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.668 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.702 ' O ' HD12 ' A' ' 41' ' ' LEU . 4.4 p 168.61 86.83 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER 79.24 -170.79 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.502 0.191 . . . . 0.0 110.511 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.475 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 68.7 m 66.35 -8.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.554 ' O ' ' HB ' ' A' ' 31' ' ' VAL . . . -145.99 -101.3 0.3 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.963 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 55.24 104.92 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.615 -0.293 . . . . 0.0 111.246 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.595 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 70.3 Cg_endo -92.16 34.72 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.13 2.554 . . . . 0.0 114.207 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.694 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 11.2 m-70 -122.16 -83.02 0.66 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.356 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 71.92 65.17 0.14 Allowed 'General case' 0 N--CA 1.461 0.119 0 O-C-N 122.156 -0.34 . . . . 0.0 111.199 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB3' ' CD ' ' A' ' 53' ' ' GLU . 2.3 t0 -152.81 15.79 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.401 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' O ' ' OE1' ' A' ' 53' ' ' GLU . 2.6 ttm180 43.67 -169.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.712 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 88.7 t 37.45 -91.07 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.114 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 10.1 Cg_endo -54.09 -175.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.254 1.303 . . . . 0.0 112.109 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 27.6 Cg_exo -62.19 95.84 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.283 1.988 . . . . 0.0 111.536 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.694 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 19.4 mp0 -152.11 -103.23 0.05 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.929 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.75 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -136.14 7.94 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 50' ' ' VAL . 0.8 OUTLIER -46.58 -30.11 2.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.151 0.5 . . . . 0.0 110.965 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.689 ' HB2' HG22 ' A' ' 22' ' ' THR . . . -47.83 -29.65 3.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.153 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.683 ' HG3' HG22 ' A' ' 54' ' ' ILE . 40.4 mtp -61.66 102.77 0.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.913 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.97 -34.24 71.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -67.02 -53.82 27.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -136.15 96.28 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.025 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 35.6 m -76.3 151.84 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.261 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 0.7 OUTLIER 83.76 -24.42 0.16 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.855 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.824 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 120.71 0.291 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -75.68 154.16 36.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.003 0.43 . . . . 0.0 111.806 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.76 129.28 39.8 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.508 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' O ' ' HE1' ' A' ' 57' ' ' MET . 0.3 OUTLIER -143.97 -52.02 0.32 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.249 0.547 . . . . 0.0 111.899 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 22' ' ' THR . 49.5 t -72.13 -26.58 0.86 Allowed Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 71.9 Cg_exo -50.51 74.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.558 1.505 . . . . 0.0 112.388 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -83.78 172.54 9.0 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 88.1 Cg_exo -44.49 -27.93 2.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.243 1.962 . . . . 0.0 111.839 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . -97.42 -69.1 0.97 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.357 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 24.0 t -46.04 157.52 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 111.716 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -112.51 -30.72 7.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.81 58.75 2.08 Favored Glycine 0 CA--C 1.506 -0.512 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.452 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.51 128.67 4.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.426 -0.887 . . . . 0.0 109.738 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.979 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.62 50.33 3.6 Favored Glycine 0 C--O 1.219 -0.801 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.03 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.979 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.8 t-80 -12.3 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 32' ' ' THR . 13.1 p -52.39 -37.36 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.888 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.947 HG23 HG13 ' A' ' 31' ' ' VAL . 17.9 p -114.02 -7.28 13.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.819 0.342 . . . . 0.0 110.156 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.79 80.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.628 HD12 ' OG1' ' A' ' 32' ' ' THR . 12.1 mt -97.06 1.38 50.05 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.702 0.763 . . . . 0.0 109.163 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.79 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -110.33 161.21 25.46 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.771 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 74.2 Cg_endo -76.63 49.32 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.261 1.308 . . . . 0.0 111.265 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.3 m170 90.46 -176.4 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 48.3 p-80 -134.98 -53.96 0.8 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.511 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 39.96 33.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.463 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.677 ' O ' HD23 ' A' ' 41' ' ' LEU . 28.3 p -143.95 -68.46 0.33 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.792 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 40' ' ' SER . 0.4 OUTLIER 157.72 -52.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.548 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.49 ' N ' HD12 ' A' ' 41' ' ' LEU . 13.3 p -41.55 -30.32 0.21 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.796 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.5 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -100.41 -106.06 2.79 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.822 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.0 t 49.77 108.07 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.745 -0.227 . . . . 0.0 110.954 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.731 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 9.2 Cg_endo -96.29 2.0 2.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.143 2.562 . . . . 0.0 113.373 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.67 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 47.1 m-70 -70.2 -80.29 0.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.758 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 53.82 61.72 2.95 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.455 0.645 . . . . 0.0 110.853 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.591 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.16 -6.25 12.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.902 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.803 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.4 OUTLIER 47.81 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.742 ' HB ' ' CD ' ' A' ' 51' ' ' PRO . 88.8 t 107.44 -81.76 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.351 1.061 . . . . 0.0 110.518 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.742 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 12.7 Cg_endo -56.41 -171.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.767 1.645 . . . . 0.0 111.115 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.508 ' CD ' ' HB2' ' A' ' 51' ' ' PRO . 25.1 Cg_exo -65.83 108.63 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.224 1.949 . . . . 0.0 111.768 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.67 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 2.0 pm0 -158.84 -103.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.822 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -120.52 -8.73 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 42.07 27.1 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.949 -179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . 70.3 -24.36 0.16 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.503 ' HE1' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER 68.16 -81.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.59 0.233 . . . . 0.0 111.109 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -83.58 -46.96 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.66 -170.45 1.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -110.77 102.53 11.06 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.851 0.357 . . . . 0.0 111.217 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.803 HG12 ' HB2' ' A' ' 49' ' ' ARG . 6.8 t 68.79 127.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.554 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 49' ' ' ARG . 17.0 tp 75.21 -80.38 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.646 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.784 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.865 0.364 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -148.97 -79.32 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.528 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.07 131.29 54.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.175 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 11.4 mmtm -97.66 -170.07 1.94 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.154 0.502 . . . . 0.0 111.391 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.6 t -88.48 -42.08 0.47 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.355 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 74.2 Cg_exo -48.35 76.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.991 1.794 . . . . 0.0 112.212 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -90.63 175.64 3.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.67 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.586 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 64.6 Cg_exo -40.57 -27.97 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 112.622 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.631 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -93.8 -72.96 1.2 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.542 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.422 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 48.8 t -46.13 158.8 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 111.499 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -103.64 -37.52 7.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.791 0.329 . . . . 0.0 110.901 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 85.04 40.9 7.79 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.744 HG22 ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -158.16 62.44 0.45 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.864 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 176.59 57.24 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.465 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.632 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.5 t-80 -37.92 173.91 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.372 0.606 . . . . 0.0 112.298 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.913 HG13 HG23 ' A' ' 32' ' ' THR . 13.6 p -48.44 -33.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.519 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.913 HG23 HG13 ' A' ' 31' ' ' VAL . 7.9 p -122.84 -1.79 8.86 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.155 -0.341 . . . . 0.0 110.16 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.57 15.63 64.28 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.576 HD12 ' OG1' ' A' ' 32' ' ' THR . 23.7 mt -99.93 6.07 45.22 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.948 0.88 . . . . 0.0 108.747 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.616 ' HE1' ' HG1' ' A' ' 32' ' ' THR . 0.1 OUTLIER -115.42 155.96 46.45 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.165 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.493 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 3.0 Cg_exo -73.48 51.39 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.658 1.572 . . . . 0.0 110.574 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.536 ' CD2' ' HA ' ' A' ' 28' ' ' THR . 6.3 m170 89.47 -174.36 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 26.5 p-80 -130.5 124.69 32.53 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.323 0.582 . . . . 0.0 111.121 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -54.47 -35.67 63.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.404 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 23.0 p 169.43 84.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD2' HG22 ' A' ' 54' ' ' ILE . 7.6 mt 75.04 -8.33 1.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 p -53.06 -27.21 18.85 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.382 0.611 . . . . 0.0 109.376 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -133.15 -77.17 0.11 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.841 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.6 t 26.81 92.58 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 6.2 Cg_endo -105.16 2.46 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.448 3.432 . . . . 0.0 112.959 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.691 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 92.6 m-70 -37.19 -57.39 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.74 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.67 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 6.0 mttt -175.1 -62.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.263 0.554 . . . . 0.0 110.626 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 26.1 t70 132.03 -14.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.032 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.461 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . 3.5 ttp180 -70.59 145.95 50.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.318 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.912 HG13 ' HD3' ' A' ' 51' ' ' PRO . 1.7 p -42.15 -46.37 10.44 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.912 ' HD3' HG13 ' A' ' 50' ' ' VAL . 7.6 Cg_endo -49.15 178.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.769 1.646 . . . . 0.0 111.235 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 4.1 Cg_endo -46.21 69.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.661 2.241 . . . . 0.0 112.845 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.725 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.5 mt-10 -145.11 -106.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.841 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -126.41 -6.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.805 ' CD2' HG12 ' A' ' 61' ' ' VAL . 0.8 OUTLIER 53.13 26.3 4.86 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.727 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 60' ' ' ASN . . . 61.91 22.06 12.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.563 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.568 ' CG ' HD22 ' A' ' 41' ' ' LEU . 20.7 mtt 65.34 -73.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.865 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.11 -177.86 3.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.77 -28.25 3.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.574 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 83.7 m-20 -61.01 171.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.722 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.805 HG12 ' CD2' ' A' ' 55' ' ' LEU . 18.5 m -134.62 137.06 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.471 HD23 HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 63.34 176.63 0.16 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.712 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 tptp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.883 179.751 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.029 0.442 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -141.52 -60.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.126 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -137.46 174.77 10.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.527 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.577 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 4.8 mmtp -129.91 179.04 6.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.397 0.618 . . . . 0.0 111.742 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.708 ' O ' ' N ' ' A' ' 22' ' ' THR . 51.0 t -87.94 -35.21 0.44 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.957 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HD2' ' CB ' ' A' ' 19' ' ' LYS . 94.8 Cg_exo -44.45 73.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.268 1.979 . . . . 0.0 112.803 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -81.17 171.66 11.68 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.162 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 96.2 Cg_exo -41.08 -28.51 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.394 2.063 . . . . 0.0 111.891 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -96.44 -64.1 0.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.195 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.6 t -56.15 158.58 3.93 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.836 0.35 . . . . 0.0 111.272 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -110.46 -35.73 5.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.608 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 89.23 56.48 1.92 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.856 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.8 OUTLIER -158.96 131.46 6.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.985 -0.607 . . . . 0.0 111.082 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 94.94 20.6 27.93 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.246 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 23.2 -163.21 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 123.647 0.779 . . . . 0.0 112.798 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 32' ' ' THR . 13.8 p -63.23 -33.68 62.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.801 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.3 t -130.05 18.25 5.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.016 -0.427 . . . . 0.0 111.348 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.97 15.22 48.74 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.351 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.801 HD12 ' CG2' ' A' ' 32' ' ' THR . 18.7 mt -97.88 4.85 49.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 120.99 0.424 . . . . 0.0 110.068 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.786 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.8 158.05 58.14 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.877 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.3 Cg_exo -71.37 46.83 0.78 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.8 1.667 . . . . 0.0 111.078 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 6.6 m170 91.9 -176.24 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.671 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 26.9 p-80 -128.42 121.7 29.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.281 0.562 . . . . 0.0 110.528 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.41 -29.22 67.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.202 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.748 ' O ' HD12 ' A' ' 41' ' ' LEU . 24.1 p 175.51 73.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 ' CG2' ' A' ' 54' ' ' ILE . 0.5 OUTLIER 78.84 -15.54 0.75 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 178.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -22.99 1.29 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.226 0.536 . . . . 0.0 109.894 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.655 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.52 -82.6 0.15 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.671 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 2.7 t 47.76 110.08 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 114.874 -0.663 . . . . 0.0 111.315 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.604 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 14.6 Cg_endo -102.69 30.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.492 2.795 . . . . 0.0 113.179 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.84 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 67.3 m-70 -98.18 -90.87 0.27 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.692 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 40.0 mmtt -161.07 -74.77 0.06 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 110.988 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.692 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 22.7 t0 158.21 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.073 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.828 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -56.42 129.56 41.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.258 -179.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 2.4 t -29.83 -50.66 0.32 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.92 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.9 Cg_exo -51.67 -170.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.24 1.96 . . . . 0.0 111.873 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 74.9 Cg_exo -50.47 64.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.679 2.253 . . . . 0.0 113.645 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.84 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.9 mm-40 -139.7 -106.21 0.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 119.918 -0.087 . . . . 0.0 111.091 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.753 ' CG2' HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -129.69 -21.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.916 -0.49 . . . . 0.0 111.547 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.897 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.7 tt 56.24 14.65 1.61 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' HIS . . . 45.17 25.87 0.21 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.749 ' HG3' HD11 ' A' ' 41' ' ' LEU . 1.7 mtp 44.36 -87.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.496 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' ALA . 11.3 p80 -124.98 165.22 18.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.727 0.298 . . . . 0.0 110.593 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 58.84 99.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.029 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.9 t30 60.59 167.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.638 HG23 ' C ' ' A' ' 55' ' ' LEU . 11.2 p -168.87 166.56 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.431 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.828 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 2.2 tt 62.9 123.94 0.01 OUTLIER 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.48 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.09 175.04 8.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.868 0.366 . . . . 0.0 111.162 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -163.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.296 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.827 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -143.5 173.96 11.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 111.547 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' THR . 42.5 t -89.5 -41.46 0.43 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.06 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.827 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 85.6 Cg_exo -43.37 81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.418 2.078 . . . . 0.0 112.96 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -91.97 171.6 7.55 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.204 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.4 Cg_endo -47.5 -27.71 7.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.892 1.728 . . . . 0.0 110.368 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.574 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -91.3 -67.62 1.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.751 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -53.39 154.84 3.15 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.23 -40.16 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.696 0.284 . . . . 0.0 111.027 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.482 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 83.65 44.25 6.94 Favored Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.109 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.435 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -155.64 129.96 8.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.146 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 99.59 19.45 20.27 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.43 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.761 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.6 t-80 24.19 -157.0 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 123.462 0.705 . . . . 0.0 112.261 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG13 HG22 ' A' ' 32' ' ' THR . 14.6 p -66.27 -33.68 65.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.88 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.1 t -132.47 21.49 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.484 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.6 15.02 45.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.604 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.88 HD12 ' CG2' ' A' ' 32' ' ' THR . 17.4 mt -98.95 3.83 47.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.987 0.422 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.761 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -122.68 161.4 44.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.259 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.543 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.5 Cg_exo -72.29 45.07 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.041 1.828 . . . . 0.0 111.629 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.0 m170 90.58 -176.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.852 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 31.3 p-80 -129.49 120.35 25.26 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.159 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.22 -17.66 63.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.267 -178.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.766 ' O ' HD12 ' A' ' 41' ' ' LEU . 35.3 t 173.83 68.73 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.966 HD11 ' HG3' ' A' ' 57' ' ' MET . 0.3 OUTLIER 78.5 -12.87 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.09 -29.53 0.91 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.411 0.624 . . . . 0.0 109.401 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.741 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -135.83 -77.77 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.088 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.852 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 51.23 109.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.587 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 76.1 Cg_endo -94.07 22.49 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.914 2.409 . . . . 0.0 113.98 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.707 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.6 m-70 -105.29 -93.32 0.36 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.432 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.528 ' HG3' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 74.48 69.08 0.09 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.556 0.616 . . . . 0.0 111.472 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.632 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -136.17 8.38 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.071 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.505 ' HB2' HD23 ' A' ' 62' ' ' LEU . 1.0 OUTLIER 55.5 38.73 30.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.074 0.464 . . . . 0.0 111.984 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.642 HG12 ' HD2' ' A' ' 52' ' ' PRO . 5.8 t -142.72 143.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.921 ' HD3' HD23 ' A' ' 55' ' ' LEU . 12.7 Cg_exo -27.01 -59.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.56 2.84 . . . . 0.0 113.677 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.642 ' HD2' HG12 ' A' ' 50' ' ' VAL . 70.5 Cg_endo -73.46 57.61 3.58 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.48 2.12 . . . . 0.0 113.69 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.707 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 20.2 mp0 -164.88 -102.29 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.907 HG22 HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -131.9 0.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.914 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.921 HD23 ' HD3' ' A' ' 51' ' ' PRO . 12.7 tp -47.6 -16.4 0.07 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.555 ' HA ' HG21 ' A' ' 22' ' ' THR . . . -37.54 -60.72 0.67 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.966 ' HG3' HD11 ' A' ' 41' ' ' LEU . 70.1 mmm -98.94 -163.85 1.08 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.576 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -127.37 -36.24 2.12 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.647 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -45.31 -91.52 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.112 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.26 51.11 1.59 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.284 0.564 . . . . 0.0 109.564 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.721 HG21 ' C ' ' A' ' 57' ' ' MET . 67.3 t -120.19 167.74 13.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.892 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.574 ' N ' HG12 ' A' ' 61' ' ' VAL . 2.0 mp 60.88 19.61 9.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.723 0.297 . . . . 0.0 110.778 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.908 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.842 0.353 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -95.8 85.2 4.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.2 t -149.92 167.47 26.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -163.27 -174.33 3.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.205 179.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HB2' ' N ' ' A' ' 41' ' ' LEU . 47.4 t -104.28 67.61 0.13 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.27 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.476 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 85.5 Cg_endo -78.9 75.22 5.15 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.927 1.752 . . . . 0.0 113.272 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.586 ' HB ' ' CB ' ' A' ' 25' ' ' CYS . 91.7 m -87.34 145.19 37.15 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 22' ' ' THR . 61.2 Cg_exo -36.93 -27.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.726 2.284 . . . . 0.0 112.987 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -144.15 -9.95 0.38 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.996 -1.097 . . . . 0.0 114.74 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.586 ' CB ' ' HB ' ' A' ' 22' ' ' THR . 23.6 t -48.09 151.78 0.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.811 1.306 . . . . 0.0 110.712 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -102.76 -44.06 5.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.795 0.331 . . . . 0.0 111.301 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 55.65 1.52 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.657 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.71 129.74 8.69 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.66 -0.77 . . . . 0.0 110.557 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.825 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 93.78 23.75 22.39 Favored Glycine 0 C--O 1.226 -0.374 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.222 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.825 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 t-80 17.72 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.05 0.94 . . . . 0.0 113.179 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.889 HG13 HG23 ' A' ' 32' ' ' THR . 9.5 p -63.88 -33.31 61.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.889 HG23 HG13 ' A' ' 31' ' ' VAL . 12.0 p -117.65 0.23 12.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.866 0.303 . . . . 0.0 110.837 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 69.27 13.66 67.78 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.098 -1.049 . . . . 0.0 110.649 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.594 HD12 ' OG1' ' A' ' 32' ' ' THR . 16.9 mt -101.06 3.5 41.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.218 0.532 . . . . 0.0 109.77 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.813 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.51 159.46 36.82 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.101 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 60.5 Cg_endo -73.34 47.69 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.329 1.352 . . . . 0.0 110.872 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.1 m170 91.36 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.655 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 34.7 p-80 -132.75 -51.18 0.91 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.402 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 36.73 28.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.646 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 2.2 p -158.03 5.01 0.12 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.7 HD11 ' O ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 82.26 -23.61 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.1 p -48.89 -27.01 2.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.115 0.484 . . . . 0.0 110.164 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -124.71 -88.84 0.79 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.849 ' SG ' HG23 ' A' ' 54' ' ' ILE . 3.3 t 52.72 111.62 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.513 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 30' ' ' HIS . 28.8 Cg_endo -98.95 14.4 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.204 2.603 . . . . 0.0 113.45 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.713 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 38.1 m-70 -86.72 -72.97 0.48 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.594 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 50.29 62.13 2.83 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.082 0.468 . . . . 0.0 111.644 -179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.63 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 5.9 t70 -141.44 9.75 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.606 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.83 ' HB2' HD23 ' A' ' 62' ' ' LEU . 1.9 ptt180 59.96 -170.73 0.14 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.278 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.651 HG23 ' HG3' ' A' ' 49' ' ' ARG . 56.4 t 23.65 -80.2 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 124.972 1.309 . . . . 0.0 114.156 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.623 ' CD ' ' HB ' ' A' ' 50' ' ' VAL . 9.1 Cg_endo -50.88 176.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.669 1.579 . . . . 0.0 112.056 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 44.3 Cg_exo -56.79 77.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.14 1.894 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.713 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.9 mm-40 -132.32 -105.62 0.26 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.849 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -145.99 18.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.592 ' HB2' ' N ' ' A' ' 50' ' ' VAL . 2.6 tm? -40.65 -32.41 0.21 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.38 0.61 . . . . 0.0 111.615 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 22' ' ' THR . . . -99.14 58.65 1.12 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.541 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.629 ' HA ' HD22 ' A' ' 41' ' ' LEU . 1.5 ttt -102.21 171.25 7.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.847 0.356 . . . . 0.0 110.884 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -117.14 -20.2 9.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.384 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -106.64 -52.17 2.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.708 0.289 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -131.93 77.17 1.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.206 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 62' ' ' LEU . 28.5 m -70.25 148.13 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.83 HD23 ' HB2' ' A' ' 49' ' ' ARG . 0.5 OUTLIER 69.28 -66.33 0.26 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.907 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.947 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.777 0.322 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.23 -173.46 3.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.963 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.9 m -134.28 176.58 8.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.851 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 5.3 mmtt -80.03 131.75 35.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.665 0.745 . . . . 0.0 111.181 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 35.2 t -72.16 -35.78 3.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.53 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 88.6 Cg_exo -47.05 82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.987 1.791 . . . . 0.0 112.796 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.829 ' HB ' ' HB2' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -87.44 177.79 2.54 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 72.1 Cg_exo -41.7 -23.71 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.314 2.009 . . . . 0.0 112.775 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.493 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -105.14 -67.06 0.69 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 39.1 t -46.75 155.11 0.27 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.637 0.718 . . . . 0.0 110.749 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -107.9 -43.39 4.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 110.784 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 96.21 61.49 0.98 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.962 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -154.35 131.09 10.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.2 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.671 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 89.86 22.59 35.61 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.217 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.795 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 t-80 23.37 -158.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.448 0.699 . . . . 0.0 112.279 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.563 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 8.7 p -64.84 -35.83 76.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.851 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.4 t -129.85 21.01 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.438 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 60.08 16.2 39.73 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.193 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.851 HD12 ' CG2' ' A' ' 32' ' ' THR . 25.5 mt -97.3 2.57 50.86 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 110.048 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.795 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -121.52 158.19 54.47 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.602 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.556 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.17 45.74 0.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.741 1.627 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m170 89.97 179.44 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.961 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.6 p-80 -124.89 -52.85 1.66 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.705 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.463 ' CG ' ' HG2' ' A' ' 21' ' ' PRO . 47.3 ttt180 45.35 19.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.889 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.851 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -165.24 23.06 0.05 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.954 HD22 ' CG ' ' A' ' 57' ' ' MET . 0.6 OUTLIER 77.83 -161.07 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 71.77 -53.14 0.69 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.581 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -96.9 -91.17 1.86 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.961 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.88 108.7 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.259 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.573 ' N ' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -90.4 27.12 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.074 2.516 . . . . 0.0 114.431 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.797 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 19.2 m-70 -111.61 -76.0 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.982 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.862 ' HB3' HD11 ' A' ' 54' ' ' ILE . 1.6 ptpt 53.8 68.59 0.82 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 110.917 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.818 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 2.2 t70 -132.74 10.58 4.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.432 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.873 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER 50.23 50.73 18.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.297 0.57 . . . . 0.0 112.229 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.921 HG12 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -149.16 153.55 38.02 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.921 ' HD2' HG12 ' A' ' 50' ' ' VAL . 79.6 Cg_exo -38.52 -56.38 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.769 1.646 . . . . 0.0 112.782 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 72.9 Cg_endo -73.44 56.37 3.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.678 2.252 . . . . 0.0 114.098 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.699 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 30.8 mp0 -162.84 -104.33 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.873 0.368 . . . . 0.0 110.985 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.862 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -131.85 4.56 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.702 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 ' HA ' ' CB ' ' A' ' 62' ' ' LEU . 2.5 tt -39.25 -30.92 0.07 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.794 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.829 ' HB2' ' HB ' ' A' ' 22' ' ' THR . . . -64.51 -42.3 95.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.237 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.977 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.9 tmm? -58.71 173.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.603 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.552 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 5.6 m170 -134.41 -173.13 3.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.806 0.336 . . . . 0.0 111.459 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' A' ' 58' ' ' HIS . 33.8 mm-40 75.37 -86.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.412 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -119.62 64.76 0.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.106 0.479 . . . . 0.0 110.904 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.977 HG21 ' HB3' ' A' ' 57' ' ' MET . 33.5 m -158.18 -172.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.633 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.873 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER 42.58 -165.46 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.919 0.39 . . . . 0.0 111.742 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.555 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.878 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.941 0.401 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.19 159.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.344 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.81 125.58 25.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.944 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 1.7 mmtm -112.93 -78.34 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.185 0.517 . . . . 0.0 110.622 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' A' ' 22' ' ' THR . 41.9 t -55.16 -41.84 92.81 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.387 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 76.9 Cg_exo -43.05 77.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.367 2.045 . . . . 0.0 112.984 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 1.014 HG21 ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -82.96 176.03 4.22 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.137 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 80.7 Cg_exo -46.9 -22.84 2.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.925 1.75 . . . . 0.0 111.663 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 52' ' ' PRO . . . -103.11 -69.22 0.8 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.904 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.9 t -42.1 150.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.043 0.422 . . . . 0.0 111.7 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -101.71 -47.14 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.732 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 100.38 53.44 1.07 Allowed Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.511 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -157.71 125.74 5.4 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.721 ' O ' ' CA ' ' A' ' 33' ' ' GLY . . . 111.25 -10.35 28.88 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.096 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.953 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 46.94 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.702 -0.881 . . . . 0.0 111.823 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.8 p -50.97 -31.6 10.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.877 HG23 HG13 ' A' ' 31' ' ' VAL . 9.5 p -116.47 4.28 13.29 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.574 1.079 . . . . 0.0 112.036 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.721 ' CA ' ' O ' ' A' ' 29' ' ' GLY . . . 71.57 17.38 76.38 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.351 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 32' ' ' THR . 3.2 mt -124.29 8.62 8.49 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.953 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -107.09 167.21 9.77 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.336 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.727 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 57.1 Cg_endo -72.12 37.63 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.263 1.309 . . . . 0.0 110.884 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m170 89.34 179.26 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.941 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 45.0 p-80 -128.68 -50.33 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.727 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HG3' ' HG2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER 40.95 27.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.422 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.564 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 2.4 m -174.09 18.98 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.684 HD22 ' SD ' ' A' ' 57' ' ' MET . 0.9 OUTLIER 76.33 -171.86 0.09 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.305 0.502 . . . . 0.0 110.36 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 18.8 m 73.28 -18.06 0.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.548 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -130.48 -94.33 0.68 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.941 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.5 t 55.77 121.62 0.01 OUTLIER Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.709 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.586 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 72.5 Cg_endo -95.21 24.97 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.006 2.471 . . . . 0.0 113.857 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.624 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 11.1 m-70 -115.8 -95.46 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 78.62 67.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.346 0.521 . . . . 0.0 112.209 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.447 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 51.0 t0 -139.24 10.54 2.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.374 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 27.11 43.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.806 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 96.0 t -157.65 -57.32 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.207 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.806 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.4 Cg_endo -96.42 -179.41 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.198 2.599 . . . . 0.0 111.171 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 9.3 Cg_endo -50.88 84.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 121.977 1.785 . . . . 0.0 110.736 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.624 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 3.2 mt-10 -140.37 -96.85 0.15 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.595 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -146.43 25.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' ' 50' ' ' VAL . 7.6 tt -48.82 -18.8 0.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.607 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.014 ' HB3' HG21 ' A' ' 22' ' ' THR . . . -133.6 54.77 1.93 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.367 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.684 ' SD ' HD22 ' A' ' 41' ' ' LEU . 8.2 tmm? -61.37 -76.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.871 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.482 ' HB2' ' HE1' ' A' ' 57' ' ' MET . 2.2 t-80 -121.37 -73.42 0.65 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.727 0.298 . . . . 0.0 110.991 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -75.2 -67.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 61' ' ' VAL . 1.4 m-20 176.32 147.15 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 60' ' ' ASN . 15.8 m 44.25 105.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.484 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.497 HD13 ' HG2' ' A' ' 49' ' ' ARG . 0.3 OUTLIER 68.78 -171.34 0.18 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.982 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 tttp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.853 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 mmp_? . . . . . 0 C--O 1.231 0.098 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.85 37.24 4.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.226 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 m -95.82 159.9 14.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.578 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.712 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -108.79 -166.56 1.13 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.324 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.646 ' N ' ' HA ' ' A' ' 40' ' ' SER . 48.8 t -111.6 68.8 0.77 Allowed Pre-proline 0 C--N 1.334 -0.067 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.749 ' HD2' ' HB1' ' A' ' 56' ' ' ALA . 94.9 Cg_endo -88.9 71.98 2.12 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.857 1.705 . . . . 0.0 111.123 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.626 ' HB ' ' H ' ' A' ' 25' ' ' CYS . 2.1 m -81.99 141.8 47.54 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.284 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 22' ' ' THR . 84.4 Cg_exo -46.69 -21.6 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.217 1.944 . . . . 0.0 111.869 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' C ' ' HB3' ' A' ' 52' ' ' PRO . . . -123.15 -37.23 0.61 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.622 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.626 ' H ' ' HB ' ' A' ' 22' ' ' THR . 13.0 t -44.4 152.13 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.868 0.834 . . . . 0.0 111.046 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -108.47 -34.36 6.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.31 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' HA3' ' HG2' ' A' ' 39' ' ' ARG . . . 83.63 54.83 2.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.211 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -157.8 127.43 5.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.443 -0.879 . . . . 0.0 110.154 -179.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.782 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 95.78 24.52 15.28 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.978 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.782 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 17.71 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.921 0.889 . . . . 0.0 113.049 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.864 HG13 HG23 ' A' ' 32' ' ' THR . 7.8 p -67.9 -35.57 72.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.864 HG23 HG13 ' A' ' 31' ' ' VAL . 11.5 p -113.62 -3.96 13.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.328 -0.233 . . . . 0.0 110.637 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 72.96 12.62 79.12 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.564 HD12 ' OG1' ' A' ' 32' ' ' THR . 13.7 mt -101.35 5.0 42.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 109.942 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.733 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -114.97 164.34 17.01 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.565 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 2.8 Cg_exo -74.09 45.21 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.945 1.763 . . . . 0.0 110.884 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m170 87.54 179.25 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.807 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 47.4 p-80 -129.23 -53.08 1.19 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.195 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 45.42 20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.607 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.69 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.4 p -143.21 -53.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER 157.6 -53.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.03 0.377 . . . . 0.0 111.459 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.483 ' N ' HD12 ' A' ' 41' ' ' LEU . 56.6 p -33.2 -36.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.235 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.598 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -104.48 -98.91 2.54 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.826 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.8 t 55.0 109.04 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.262 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.1 Cg_endo -95.01 24.65 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.903 2.402 . . . . 0.0 113.7 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.777 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 15.6 m-70 -107.13 -76.84 0.61 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.793 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.859 ' HB3' HD11 ' A' ' 54' ' ' ILE . 4.4 pttt 54.07 66.23 1.29 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 1.5 t0 -131.34 -10.52 3.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.498 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER 53.21 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.011 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 28.0 t 99.55 -68.94 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.452 1.101 . . . . 0.0 110.449 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.011 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 2.9 Cg_exo -73.92 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.818 1.679 . . . . 0.0 110.498 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.634 ' HD2' ' CB ' ' A' ' 51' ' ' PRO . 44.1 Cg_endo -67.11 99.32 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.8 1.667 . . . . 0.0 111.647 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 21.8 mp0 -152.2 -103.16 0.05 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.52 7.74 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.575 ' C ' HD23 ' A' ' 55' ' ' LEU . 3.0 tt -46.78 -26.58 0.98 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.884 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.749 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -53.19 -46.74 69.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.672 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -61.54 82.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -46.38 -29.38 1.66 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.419 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.421 ' H ' ' HE2' ' A' ' 57' ' ' MET . 0.1 OUTLIER -84.52 -51.01 7.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.88 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -103.73 57.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.343 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 57' ' ' MET . 17.1 m -81.23 146.92 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.891 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 49' ' ' ARG . 0.4 OUTLIER 67.51 -66.94 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.884 0.374 . . . . 0.0 111.189 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' VAL . 1.7 tptt . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.813 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.897 0.38 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.25 157.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.9 p -75.89 151.36 37.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -122.02 -26.87 4.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 111.318 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.552 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 16.7 t -110.18 33.27 0.1 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 97.0 Cg_endo -77.35 80.03 3.01 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.484 1.456 . . . . 0.0 111.732 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.833 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 1.1 m -85.97 142.14 36.13 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.017 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 22' ' ' THR . 98.1 Cg_exo -43.43 -30.19 2.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.188 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.617 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -112.44 -26.61 4.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.965 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.603 ' H ' ' HB ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -51.83 144.18 11.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -82.27 -46.77 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.34 23.72 77.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.568 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.48 43.95 1.29 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.388 0.614 . . . . 0.0 110.671 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.869 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -170.55 29.81 0.13 Allowed Glycine 0 C--O 1.22 -0.772 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.325 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.869 ' O ' ' O ' ' A' ' 29' ' ' GLY . 3.1 t-80 15.64 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.835 HG13 HG23 ' A' ' 32' ' ' THR . 10.3 p -59.01 -21.1 18.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.835 HG23 HG13 ' A' ' 31' ' ' VAL . 3.2 p -132.37 6.77 4.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.017 0.826 . . . . 0.0 110.216 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 64.18 18.62 62.95 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.7 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.672 HD12 ' OG1' ' A' ' 32' ' ' THR . 9.3 mt -117.06 10.42 13.93 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.711 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -113.39 171.4 4.38 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.003 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.516 ' CD ' ' HB3' ' A' ' 35' ' ' TYR . 2.7 Cg_exo -74.89 43.3 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.971 1.781 . . . . 0.0 112.01 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.526 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.8 m80 85.11 -176.37 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.25 0.547 . . . . 0.0 110.405 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.93 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 29.4 p-80 -152.01 153.71 34.57 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.601 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mtt180 -149.22 38.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.082 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.755 ' O ' HD12 ' A' ' 41' ' ' LEU . 60.3 p -170.42 20.54 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.011 HD23 HG22 ' A' ' 54' ' ' ILE . 0.7 OUTLIER 77.42 -36.84 0.24 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.46 0.573 . . . . 0.0 112.195 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 41' ' ' LEU . 64.6 m -36.46 -35.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.193 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.509 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.1 -93.05 2.26 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.981 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.93 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 3.1 t 48.67 111.08 0.01 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 115.256 -0.472 . . . . 0.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.9 Cg_endo -86.4 18.39 1.58 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.951 2.434 . . . . 0.0 113.943 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.747 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 9.3 m-70 -105.0 -89.33 0.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.466 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.638 ' HE2' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER 77.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 178.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.718 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 1.4 t70 -146.13 24.9 1.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.259 0.552 . . . . 0.0 109.812 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.757 ' CZ ' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER 34.23 43.12 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.95 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.647 HG23 ' HD2' ' A' ' 52' ' ' PRO . 6.7 m -135.99 153.78 77.18 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.681 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 27.9 Cg_exo -27.33 -48.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.039 3.159 . . . . 0.0 113.822 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 50' ' ' VAL . 96.7 Cg_endo -92.62 39.06 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.406 2.071 . . . . 0.0 114.461 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.747 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 8.8 mm-40 -144.42 -102.39 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.011 HG22 HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -128.9 3.71 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -178.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 49' ' ' ARG . 31.2 tp -53.85 -15.58 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.833 ' HB2' ' OG1' ' A' ' 22' ' ' THR . . . -31.2 -61.77 0.19 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.837 ' HG3' HD11 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -63.64 146.88 52.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.476 -178.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.38 142.2 29.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.563 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 73.89 -61.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.654 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -68.85 83.44 0.3 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 110.512 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 49' ' ' ARG . 21.0 m -83.04 139.92 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.208 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.757 HD13 ' CZ ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER 68.48 -66.73 0.22 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.968 0.414 . . . . 0.0 111.017 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.781 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.766 0.317 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.22 -33.77 63.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.5 p -160.84 116.83 2.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.656 ' HB2' ' HA ' ' A' ' 40' ' ' SER . 22.5 mttt -99.99 -73.64 0.63 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.367 0.603 . . . . 0.0 111.064 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.691 ' O ' ' N ' ' A' ' 22' ' ' THR . 48.1 t -56.21 -40.51 85.28 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.59 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.656 ' HD3' ' HA ' ' A' ' 39' ' ' ARG . 86.2 Cg_exo -48.51 72.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.118 1.879 . . . . 0.0 112.678 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.851 ' HB ' ' HB2' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -81.14 173.49 7.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 4.6 Cg_exo -37.5 -27.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.752 2.301 . . . . 0.0 112.644 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' THR . . . -97.28 -75.81 1.26 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.914 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 34.2 t -39.5 156.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.055 0.455 . . . . 0.0 112.212 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.77 -36.96 6.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.82 57.99 1.55 Allowed Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.126 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.64 135.46 9.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.808 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 90.68 21.75 35.96 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.452 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.759 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.7 t-80 21.63 -158.61 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.396 0.679 . . . . 0.0 112.448 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.857 HG13 HG23 ' A' ' 32' ' ' THR . 6.9 p -70.73 -34.52 56.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.857 HG23 HG13 ' A' ' 31' ' ' VAL . 5.9 p -117.46 5.81 12.53 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.025 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.54 13.76 61.31 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.132 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.625 HD12 ' OG1' ' A' ' 32' ' ' THR . 19.8 mt -101.63 2.56 38.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.759 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -115.25 158.78 40.33 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.335 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 56.6 Cg_endo -71.9 48.26 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.354 1.37 . . . . 0.0 111.302 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.55 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.1 m170 90.2 -179.33 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.912 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 33.1 p-80 -129.33 -55.07 1.18 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.426 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 91.4 mtt-85 41.92 30.5 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.656 ' HA ' ' HB2' ' A' ' 19' ' ' LYS . 38.3 t -155.12 -1.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.836 HD22 ' HG3' ' A' ' 57' ' ' MET . 0.3 OUTLIER 82.73 -35.78 0.09 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.0 p -39.77 -37.34 0.52 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.241 0.543 . . . . 0.0 110.485 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.504 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -109.49 -90.69 2.09 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.912 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 59.1 112.24 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.859 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 30' ' ' HIS . 97.5 Cg_endo -92.31 27.08 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.013 2.475 . . . . 0.0 114.105 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.739 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 13.8 m-70 -114.7 -74.91 0.6 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.025 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.793 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 54.61 65.48 1.49 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.886 0.374 . . . . 0.0 111.92 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t70 -133.88 -7.06 2.76 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.718 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.569 ' HD2' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER 48.69 135.22 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.961 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 33.6 t 96.21 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.551 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.961 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 4.7 Cg_exo -76.95 -167.51 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.646 1.564 . . . . 0.0 110.706 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.502 ' CD ' ' CB ' ' A' ' 51' ' ' PRO . 24.9 Cg_exo -64.93 100.74 0.36 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 121.989 1.793 . . . . 0.0 112.28 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.739 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 26.3 mp0 -155.85 -104.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -132.36 11.15 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.195 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD13 ' H ' ' A' ' 50' ' ' VAL . 17.7 tp -45.64 -25.64 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.369 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.851 ' HB2' ' HB ' ' A' ' 22' ' ' THR . . . -54.18 -48.15 71.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.442 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.836 ' HG3' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -52.22 108.16 0.27 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.54 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -66.19 136.69 56.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.745 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.9 25.38 12.03 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.081 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -157.38 48.99 0.43 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.985 0.421 . . . . 0.0 110.77 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 29.6 m -60.87 156.01 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.123 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.608 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER 42.2 40.08 1.62 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.266 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 tptm . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.127 179.411 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.743 0.306 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.79 39.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -178.68 153.86 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -168.4 145.74 4.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.142 0.496 . . . . 0.0 111.854 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.685 ' O ' ' N ' ' A' ' 22' ' ' THR . 52.3 t -88.72 -32.96 0.4 Allowed Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 49.9 Cg_exo -38.47 76.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.229 1.953 . . . . 0.0 113.31 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -84.77 170.21 14.24 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.11 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HD2' HG22 ' A' ' 22' ' ' THR . 9.3 Cg_endo -52.58 -19.22 9.85 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.285 1.99 . . . . 0.0 112.207 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' ' C ' ' A' ' 51' ' ' PRO . . . -108.95 -51.0 0.7 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.483 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.3 t -51.74 156.27 1.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.339 0.569 . . . . 0.0 110.304 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -98.75 -42.9 7.0 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.23 53.69 2.44 Favored Glycine 0 CA--C 1.507 -0.466 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.919 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.19 131.57 9.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.922 -0.639 . . . . 0.0 111.162 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.71 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 92.66 20.87 33.03 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.439 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.812 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t-80 22.08 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HB ' ' HA2' ' A' ' 43' ' ' GLY . 7.6 p -61.76 -33.69 58.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.836 ' CG2' HD12 ' A' ' 34' ' ' LEU . 1.5 t -132.4 19.94 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.268 0.485 . . . . 0.0 111.475 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.17 16.75 49.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.176 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.836 HD12 ' CG2' ' A' ' 32' ' ' THR . 22.3 mt -99.57 3.9 45.6 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.227 0.537 . . . . 0.0 110.055 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.812 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.75 158.49 51.8 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.822 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 7.9 Cg_exo -71.15 44.33 0.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.945 1.763 . . . . 0.0 111.268 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.9 m170 93.01 -175.63 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.926 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 43.2 p-80 -141.09 140.27 34.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.434 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 9.3 mtt180 -131.82 33.06 4.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.746 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 38.6 p -165.42 12.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.59 HD23 HG22 ' A' ' 54' ' ' ILE . 0.4 OUTLIER 81.31 -32.63 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.525 0.602 . . . . 0.0 111.633 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -39.78 -31.44 0.11 Allowed 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.208 0.528 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.562 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -109.57 -92.81 2.22 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.926 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.6 t 53.37 108.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 115.151 -0.524 . . . . 0.0 111.089 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' CB ' ' O ' ' A' ' 30' ' ' HIS . 97.3 Cg_endo -87.53 23.21 0.82 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.85 2.366 . . . . 0.0 114.084 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.705 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 14.4 m-70 -110.56 -96.47 0.41 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.571 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.602 ' CB ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.98 68.09 0.1 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.962 0.801 . . . . 0.0 110.492 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.55 ' HB2' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -133.64 9.32 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.443 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.944 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 3.5 mpp_? 60.96 42.41 12.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.108 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.787 HG23 ' CD ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -152.94 148.6 20.48 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.43 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 50.7 Cg_exo -36.66 -58.18 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.36 2.04 . . . . 0.0 113.044 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.745 ' HD3' ' HB2' ' A' ' 51' ' ' PRO . 13.5 Cg_exo -69.0 62.03 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.077 1.851 . . . . 0.0 112.6 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.787 ' CD ' HG23 ' A' ' 50' ' ' VAL . 18.8 mp0 -166.58 -102.65 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.008 0.433 . . . . 0.0 110.559 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.845 HG21 ' CG ' ' A' ' 57' ' ' MET . 0.4 OUTLIER -117.09 -32.05 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.759 HD12 HD11 ' A' ' 62' ' ' LEU . 11.8 tp 31.24 32.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.509 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.926 ' HA ' HG12 ' A' ' 61' ' ' VAL . . . 172.0 29.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.845 ' CG ' HG21 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -82.2 125.14 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.561 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 57.16 -163.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.05 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -93.33 42.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.797 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.7 50.92 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.328 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.926 HG12 ' HA ' ' A' ' 56' ' ' ALA . 8.1 m -42.86 132.71 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.711 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.944 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 2.3 mp 44.77 34.29 1.15 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.052 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.15 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.938 0.399 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.47 -168.55 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.608 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.26 12.16 21.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.5 mmmm 71.38 172.67 0.31 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.32 0.581 . . . . 0.0 111.269 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 34.0 t -113.77 41.31 0.24 Allowed Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 41.1 Cg_endo -89.68 81.33 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.946 1.764 . . . . 0.0 113.296 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.843 HG23 ' H ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -96.53 152.64 38.74 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.787 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -44.34 -25.1 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -101.92 -51.54 1.08 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.573 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.843 ' H ' HG23 ' A' ' 22' ' ' THR . 47.9 t -51.1 148.53 4.37 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.053 0.926 . . . . 0.0 110.311 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -96.06 -46.18 6.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 92.63 42.72 4.41 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.429 ' OG1' ' CD2' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -152.94 131.35 12.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.566 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.752 ' O ' ' N ' ' A' ' 33' ' ' GLY . . . 103.62 -4.15 46.65 Favored Glycine 0 C--O 1.219 -0.842 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.453 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.991 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 2.0 t-80 46.77 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.494 -1.004 . . . . 0.0 111.494 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.51 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 8.1 p -52.28 -32.32 15.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.877 ' CG2' HD12 ' A' ' 34' ' ' LEU . 2.5 t -133.35 21.53 4.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.512 1.051 . . . . 0.0 112.499 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 66.58 15.68 64.38 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.264 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.877 HD12 ' CG2' ' A' ' 32' ' ' THR . 8.9 mt -112.2 6.85 19.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.991 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -117.85 163.14 25.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.054 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 Cg_endo -71.52 42.25 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.505 1.47 . . . . 0.0 111.388 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 2.2 m170 90.73 -176.83 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 122.921 0.488 . . . . 0.0 109.896 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.723 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 35.5 p-80 -137.66 -54.74 0.67 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.436 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 15.9 mtt180 41.14 25.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.622 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 83.3 p -162.34 17.42 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.823 HD23 HG22 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 76.36 -33.1 0.21 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 85.5 p -38.62 -31.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.873 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.643 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -122.85 -84.15 0.67 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.723 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 5.4 t 45.96 112.32 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 114.865 -0.667 . . . . 0.0 111.013 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 55.7 Cg_endo -93.59 12.82 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.761 ' HB3' ' CD ' ' A' ' 53' ' ' GLU . 18.7 m-70 -92.08 -69.63 0.73 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.859 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.583 ' HA ' HG13 ' A' ' 54' ' ' ILE . 1.7 ptpt 51.01 62.14 2.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.739 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -135.03 14.44 3.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.137 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 0.3 OUTLIER 41.52 38.86 0.95 Allowed 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.354 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 48' ' ' ASP . 2.5 m -130.7 153.46 81.56 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.541 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.489 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 87.7 Cg_exo -27.05 -46.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.988 3.125 . . . . 0.0 114.487 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.585 ' HD2' HG23 ' A' ' 50' ' ' VAL . 86.6 Cg_endo -98.43 46.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.877 2.385 . . . . 0.0 114.543 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.761 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 14.4 mm-40 -149.44 -98.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.823 HG22 HD23 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -129.64 5.36 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.612 0.365 . . . . 0.0 110.248 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.413 HD13 ' HD3' ' A' ' 51' ' ' PRO . 4.0 tt -56.48 -13.46 2.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.658 ' CA ' ' HB ' ' A' ' 22' ' ' THR . . . -42.71 -57.51 2.71 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.819 ' HG3' HD11 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -63.12 115.64 4.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.003 0.43 . . . . 0.0 111.182 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -78.3 -34.13 48.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.801 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -61.3 -52.26 65.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.69 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.03 92.82 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.7 m -66.8 173.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.18 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 63' ' ' LYS . 2.7 tt 62.41 -80.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.822 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' N ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.911 0.386 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.58 178.33 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.655 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.3 m -91.85 20.57 5.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.6 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . 11.4 mmtt 62.73 167.93 0.13 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.374 0.607 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 22' ' ' THR . 43.3 t -72.8 -35.3 2.89 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.017 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 63.5 Cg_exo -37.57 77.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.682 2.255 . . . . 0.0 113.705 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -82.93 173.88 6.88 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -46.99 -20.22 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.46 2.106 . . . . 0.0 112.265 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.46 -58.27 0.55 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.696 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 37.7 t -54.77 156.75 3.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.985 0.422 . . . . 0.0 111.693 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.03 -43.41 6.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.117 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 21' ' ' PRO . . . 82.26 34.5 23.23 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.769 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.78 ' O ' HG23 ' A' ' 28' ' ' THR . 0.6 OUTLIER -142.13 45.49 1.66 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.492 0.663 . . . . 0.0 110.68 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.956 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -178.58 57.81 0.09 OUTLIER Glycine 0 C--O 1.217 -0.944 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.775 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.956 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -12.82 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.177 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.512 ' HA ' ' C ' ' A' ' 44' ' ' CYS . 10.0 p -56.25 -31.51 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.832 HG21 HD12 ' A' ' 34' ' ' LEU . 1.5 t -131.93 7.44 4.36 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.871 -0.518 . . . . 0.0 110.53 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.18 64.79 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.096 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.832 HD12 HG21 ' A' ' 32' ' ' THR . 38.0 mt -93.66 1.05 56.72 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.666 0.746 . . . . 0.0 109.331 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.709 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -116.01 156.86 46.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.286 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 59.2 Cg_endo -73.22 50.87 1.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.32 1.347 . . . . 0.0 111.604 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.582 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.3 m170 92.13 -176.67 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.555 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 27.4 p-80 -132.25 121.28 23.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.8 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.8 OUTLIER -59.74 -28.28 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.639 -178.098 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER 173.83 71.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.824 HD23 HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER 79.88 -17.75 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.694 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.02 1.04 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.273 0.558 . . . . 0.0 109.788 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.683 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -128.93 -85.47 0.45 Allowed Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.839 ' SG ' HG23 ' A' ' 54' ' ' ILE . 1.8 t 44.46 113.49 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.68 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.634 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 4.8 Cg_endo -101.61 1.28 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.808 3.005 . . . . 0.0 113.252 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.696 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 22.5 m-70 -75.53 -92.03 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.145 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HA ' HG13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 63.71 65.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.091 -0.381 . . . . 0.0 111.935 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.501 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 7.2 t0 -129.63 -6.21 4.64 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.371 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.553 ' HG2' HG23 ' A' ' 50' ' ' VAL . 64.2 ttt-85 58.34 118.46 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.845 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 24.7 t 99.23 -72.43 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.886 0.874 . . . . 0.0 112.598 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.845 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 29.8 Cg_endo -74.4 -179.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.135 1.223 . . . . 0.0 111.955 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 60.9 Cg_exo -53.2 98.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.208 1.939 . . . . 0.0 112.478 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.696 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 6.1 mp0 -149.76 -105.03 0.07 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.839 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -118.39 -15.68 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.754 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.758 HD23 HG23 ' A' ' 61' ' ' VAL . 14.3 mt 34.06 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.858 ' HB3' ' O ' ' A' ' 60' ' ' ASN . . . 55.45 2.03 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.638 ' HG3' HD11 ' A' ' 41' ' ' LEU . 0.0 OUTLIER 70.25 -65.92 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.734 0.302 . . . . 0.0 111.649 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -109.67 143.03 40.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.18 0.514 . . . . 0.0 112.328 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 33.84 -88.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.377 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.858 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 3.9 p30 -48.48 167.63 0.03 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.188 0.518 . . . . 0.0 112.152 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.758 HG23 HD23 ' A' ' 55' ' ' LEU . 14.6 p -127.9 155.28 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.163 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.745 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.3 OUTLIER 83.58 5.48 0.78 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.776 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 10.6 tptm . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.129 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.891 0.377 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -73.67 159.32 33.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 p -68.7 178.07 2.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.447 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 2.1 mttp -86.65 -174.94 5.23 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.294 0.568 . . . . 0.0 111.08 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -66.32 164.43 30.82 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.857 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 37.3 Cg_exo -25.18 -70.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.501 3.468 . . . . 0.0 114.06 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.808 HG23 ' H ' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -163.83 176.12 2.39 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.151 -178.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.625 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 81.4 Cg_exo -46.9 -27.56 5.95 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.949 1.766 . . . . 0.0 111.081 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.808 ' H ' HG23 ' A' ' 22' ' ' THR . . . -46.95 -57.36 6.95 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 42.3 t -55.91 157.6 4.31 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -84.06 -39.1 19.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.703 0.287 . . . . 0.0 111.311 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.489 ' HA2' ' NE2' ' A' ' 38' ' ' HIS . . . 69.3 43.91 68.23 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.29 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.2 133.64 16.5 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.782 -0.709 . . . . 0.0 111.017 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.623 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 88.61 24.9 31.75 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.926 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.837 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.2 t-80 24.55 -156.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.311 0.644 . . . . 0.0 112.07 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 15.0 p -70.11 -34.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.839 HG21 HD12 ' A' ' 34' ' ' LEU . 1.5 t -127.01 18.95 7.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.373 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 61.39 14.71 42.6 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.299 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.839 HD12 HG21 ' A' ' 32' ' ' THR . 21.1 mt -96.4 1.62 51.91 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.278 0.561 . . . . 0.0 110.172 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.837 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -120.52 156.82 55.31 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.734 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.8 Cg_exo -70.91 45.41 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.86 1.707 . . . . 0.0 111.72 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 6.1 m170 95.72 -173.52 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.889 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 28.6 p-80 -140.31 -48.91 0.45 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.766 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.479 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER 42.22 22.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.217 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.735 ' O ' HD12 ' A' ' 41' ' ' LEU . 52.6 p -163.48 17.13 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 40' ' ' SER . 0.3 OUTLIER 77.84 -7.53 1.81 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.045 0.384 . . . . 0.0 111.765 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -53.63 -22.87 9.54 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -146.15 -72.61 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.889 ' HA ' ' CE1' ' A' ' 38' ' ' HIS . 4.9 t 53.26 112.0 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.012 -0.594 . . . . 0.0 111.163 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.603 ' CD ' ' O ' ' A' ' 30' ' ' HIS . 57.4 Cg_endo -98.16 35.51 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.234 2.623 . . . . 0.0 114.362 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.721 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 18.7 m-70 -118.88 -99.83 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.249 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HG3' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 73.9 69.83 0.11 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-N 118.633 0.651 . . . . 0.0 110.243 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' A' ' 50' ' ' VAL . 17.5 t70 -136.33 10.81 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.155 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.705 ' HD3' HD12 ' A' ' 62' ' ' LEU . 1.4 ttt85 57.18 43.96 23.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.175 0.512 . . . . 0.0 111.737 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.885 HG12 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -141.86 152.85 63.43 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.885 ' HD2' HG12 ' A' ' 50' ' ' VAL . 3.6 Cg_exo -35.28 -58.64 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.767 2.311 . . . . 0.0 112.817 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 94.3 Cg_endo -79.85 65.79 8.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.605 2.203 . . . . 0.0 113.764 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.721 ' HG3' ' HB3' ' A' ' 46' ' ' HIS . 20.5 mp0 -163.15 -101.93 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 112.22 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.716 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -165.16 29.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 61' ' ' VAL . 2.7 pt? -48.81 -32.42 8.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.001 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.857 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . . . -114.91 64.47 0.68 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.729 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.53 ' HG3' HD23 ' A' ' 41' ' ' LEU . 19.6 ttp -89.63 154.77 19.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.553 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.406 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -52.47 -23.8 6.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.449 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -123.09 87.14 2.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.882 0.373 . . . . 0.0 111.793 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 61.03 160.46 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 55' ' ' LEU . 2.1 p -91.26 151.01 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.465 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 63' ' ' LYS . 4.7 tt 62.31 148.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.924 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.759 ' N ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.043 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.818 0.342 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.32 155.01 41.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.036 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.526 ' HA ' ' HB3' ' A' ' 39' ' ' ARG . 2.2 p -87.59 165.41 15.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.366 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 57' ' ' MET . 0.0 OUTLIER -129.85 -26.74 2.39 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 22' ' ' THR . 30.2 t -81.31 -34.97 0.75 Allowed Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 75.9 Cg_exo -44.34 82.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.138 1.892 . . . . 0.0 113.091 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -89.63 173.79 5.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.889 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 22' ' ' THR . 3.6 Cg_endo -45.51 -23.13 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.615 2.21 . . . . 0.0 112.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.482 ' C ' ' HA ' ' A' ' 52' ' ' PRO . . . -106.32 -61.35 0.6 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.62 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 38.5 t -50.95 158.82 0.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.681 0.241 . . . . 0.0 111.071 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -108.42 -29.42 8.83 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.81 44.24 7.86 Favored Glycine 0 CA--C 1.503 -0.664 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -153.75 129.87 10.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.72 -1.24 . . . . 0.0 108.947 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.879 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 87.31 59.45 1.74 Allowed Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.431 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.879 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.5 t-80 -24.09 -167.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.879 1.272 . . . . 0.0 113.783 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.552 HG13 HG22 ' A' ' 32' ' ' THR . 10.9 p -51.51 -32.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.621 HG21 HD12 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -129.24 1.73 5.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.963 0.347 . . . . 0.0 110.326 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.89 13.94 78.66 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.621 HD12 HG21 ' A' ' 32' ' ' THR . 43.6 mt -95.13 2.01 54.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.834 0.826 . . . . 0.0 109.398 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.763 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.24 160.53 33.78 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.15 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 73.7 Cg_endo -75.71 49.18 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.161 1.241 . . . . 0.0 111.359 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 36' ' ' PRO . 3.5 m170 91.03 -176.65 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.594 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 44.8 p-80 -136.26 134.78 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.538 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.526 ' HB3' ' HA ' ' A' ' 18' ' ' SER . 7.0 mtt180 -111.71 15.65 20.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.492 ' O ' HD12 ' A' ' 41' ' ' LEU . 49.7 p -172.76 28.05 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.753 HD23 HG22 ' A' ' 54' ' ' ILE . 0.2 OUTLIER 78.59 -24.31 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.57 0.623 . . . . 0.0 111.784 178.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -42.27 -28.48 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.547 . . . . 0.0 109.894 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.639 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -112.15 -90.51 1.93 Allowed Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.832 ' SG ' HG23 ' A' ' 54' ' ' ILE . 3.7 t 41.61 112.26 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 115.248 -0.476 . . . . 0.0 110.898 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.722 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 3.3 Cg_endo -99.88 1.18 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.489 2.793 . . . . 0.0 113.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.775 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 38.7 m-70 -72.53 -77.22 0.1 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.32 -177.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HB3' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER 50.96 65.07 1.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.67 ' CB ' ' HG3' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -127.41 -2.49 6.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 176.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HB2' HD12 ' A' ' 62' ' ' LEU . 7.8 ttt180 55.4 116.91 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.702 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 20.3 t 98.56 -62.12 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 74.5 Cg_endo -79.22 -179.2 5.21 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.624 1.549 . . . . 0.0 111.944 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 51.7 Cg_exo -54.32 80.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.012 1.808 . . . . 0.0 111.842 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.775 ' HA ' ' CB ' ' A' ' 46' ' ' HIS . 23.6 mm-40 -135.84 -107.3 0.21 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.138 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.864 HD11 ' HB3' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -108.3 -24.01 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.534 HD22 ' OD1' ' A' ' 60' ' ' ASN . 5.9 mt 41.75 31.61 0.21 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.779 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.669 ' HB1' ' O ' ' A' ' 63' ' ' LYS . . . 50.31 21.13 0.75 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.478 ' HB2' HD21 ' A' ' 41' ' ' LEU . 2.7 ttm 74.67 -56.57 0.63 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.19 23.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -127.46 -24.19 3.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.537 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 24.7 m-20 64.18 76.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.724 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.463 ' HA ' ' HG3' ' A' ' 49' ' ' ARG . 9.9 p -170.83 29.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.563 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 47' ' ' LYS . 0.3 OUTLIER 64.31 1.73 1.34 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.669 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.554 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 74.91 -66.99 0.27 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.765 0.317 . . . . 0.0 111.794 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.2 p -130.23 88.08 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.603 ' HB3' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -74.94 176.41 7.18 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 111.278 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.775 ' H ' ' HA ' ' A' ' 40' ' ' SER . 20.8 t -112.83 -42.03 0.08 OUTLIER Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.558 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HD3' ' HA ' ' A' ' 40' ' ' SER . 98.6 Cg_exo -46.18 92.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.268 1.979 . . . . 0.0 113.795 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.793 HG22 HD22 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -124.04 171.76 6.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.472 178.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 93.2 Cg_exo -45.49 89.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.26 1.973 . . . . 0.0 112.24 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' A' ' 52' ' ' PRO . . . 134.67 -60.87 0.64 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.861 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.9 t -48.78 151.63 1.16 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -103.89 -45.7 4.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.666 0.269 . . . . 0.0 111.648 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.603 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 84.41 47.85 5.27 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.74 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -157.0 120.08 4.08 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.041 -0.579 . . . . 0.0 110.934 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 97.03 24.8 12.15 Favored Glycine 0 C--O 1.223 -0.549 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.63 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.3 t-80 21.78 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.076 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 8.4 p -60.14 -35.63 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.049 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.937 HG23 HG13 ' A' ' 31' ' ' VAL . 8.3 p -119.45 6.24 11.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.092 -0.38 . . . . 0.0 111.73 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 29' ' ' GLY . . . 66.23 14.61 62.0 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.733 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 32' ' ' THR . 13.6 mt -106.03 3.67 28.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.375 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.745 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -116.18 161.04 33.26 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' CG ' ' A' ' 37' ' ' HIS . 6.5 Cg_exo -71.87 47.54 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.589 1.526 . . . . 0.0 110.857 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 28' ' ' THR . 0.3 OUTLIER 78.11 174.08 0.18 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.973 ' CE1' ' HA ' ' A' ' 44' ' ' CYS . 49.9 p-80 -123.9 -43.16 2.13 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.607 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.723 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 40.15 23.97 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.9 179.084 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.775 ' HA ' ' H ' ' A' ' 20' ' ' CYS . 58.0 m 145.57 30.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.724 0.64 . . . . 0.0 112.109 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 40' ' ' SER . 12.0 mt -126.88 -179.42 4.82 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.101 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.3 p -73.94 -1.87 21.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.583 ' HA2' ' HB ' ' A' ' 31' ' ' VAL . . . -71.28 -96.28 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 1.076 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 3.6 t 66.55 124.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.581 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 56.3 Cg_endo -99.35 22.63 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.295 2.663 . . . . 0.0 113.908 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.627 ' CB ' ' HA ' ' A' ' 53' ' ' GLU . 18.6 m-70 -105.31 -84.3 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.697 -178.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 0.0 OUTLIER 70.94 68.68 0.18 Allowed 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.831 -0.543 . . . . 0.0 110.339 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -116.01 -8.47 11.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.022 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.842 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 8.6 mmp_? 65.17 38.23 6.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.235 0.541 . . . . 0.0 111.118 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.617 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -158.4 170.93 8.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.159 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 84.6 Cg_exo -41.32 -46.89 5.63 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.25 1.967 . . . . 0.0 114.179 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.646 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 66.3 Cg_endo -86.35 84.21 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.391 2.061 . . . . 0.0 115.182 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.686 ' CD ' ' H ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER 172.62 -100.55 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.339 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.769 HG23 ' CB ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -122.54 -8.68 8.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.435 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.793 HD22 HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER 37.58 32.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.035 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.952 ' HB1' ' HB2' ' A' ' 59' ' ' GLU . . . 79.74 -30.36 0.13 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.419 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 79.3 -72.58 0.07 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.728 0.299 . . . . 0.0 110.296 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.46 29.51 7.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.541 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.952 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 1.9 mt-10 -146.12 174.91 10.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.472 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -80.72 80.42 7.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.794 ' HB ' HD23 ' A' ' 62' ' ' LEU . 2.7 t 57.48 165.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.323 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.842 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER 42.84 -118.69 0.5 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.868 0.105 . . . . 0.0 110.922 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.72 179.607 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.932 0.396 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -59.16 -85.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.179 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.95 152.59 24.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.773 0.32 . . . . 0.0 111.389 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 39' ' ' ARG . 23.9 mmtt -141.03 -173.84 3.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.596 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' ' N ' ' A' ' 22' ' ' THR . 44.2 t -80.28 -45.05 1.41 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.497 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 20' ' ' CYS . 6.7 Cg_endo -51.71 70.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.801 1.668 . . . . 0.0 111.754 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.813 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 82.8 p -98.85 175.57 2.4 Favored Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 5.2 Cg_endo -47.07 -21.75 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.509 1.473 . . . . 0.0 110.928 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.652 ' CA ' HD21 ' A' ' 55' ' ' LEU . . . -100.52 20.01 50.13 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.935 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 53' ' ' GLU . 43.1 t -163.79 158.89 20.65 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.041 0.421 . . . . 0.0 111.631 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.82 -44.78 6.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 21' ' ' PRO . . . 77.59 39.67 24.85 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.888 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.796 ' O ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -145.51 46.81 1.29 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.359 0.599 . . . . 0.0 111.315 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.977 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . -177.76 48.97 0.1 OUTLIER Glycine 0 C--O 1.218 -0.867 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.79 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.977 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.7 t-80 -6.33 -179.39 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.894 HG13 HG23 ' A' ' 32' ' ' THR . 10.2 p -54.88 -25.48 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.894 HG23 HG13 ' A' ' 31' ' ' VAL . 21.3 p -125.73 -3.31 7.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.51 66.32 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.623 HD12 ' OG1' ' A' ' 32' ' ' THR . 14.2 mt -99.49 2.73 45.2 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.472 0.653 . . . . 0.0 109.404 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.66 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -113.23 157.23 41.58 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 57.2 Cg_endo -71.97 51.31 1.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.22 1.28 . . . . 0.0 111.234 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.567 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 5.0 m170 90.24 -176.01 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.488 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 26.2 p-80 -130.07 119.52 23.22 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.824 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -51.85 -30.96 25.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.6 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.518 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 6.4 t 160.96 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 O-C-N 123.054 0.221 . . . . 0.0 111.329 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.639 HD21 ' HA ' ' A' ' 57' ' ' MET . 2.2 mt 78.35 -27.41 0.17 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.64 -23.87 1.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.344 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.571 ' HA3' ' CG ' ' A' ' 30' ' ' HIS . . . -133.49 -88.03 0.33 Allowed Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.913 ' SG ' HG23 ' A' ' 54' ' ' ILE . 1.2 t 42.71 109.72 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 115.024 -0.588 . . . . 0.0 111.522 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.698 ' HG3' ' O ' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -102.54 -2.29 0.35 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.795 2.997 . . . . 0.0 113.288 -179.324 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.698 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 44.3 m-70 -63.64 -80.01 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.765 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.582 ' H ' ' CG1' ' A' ' 54' ' ' ILE . 12.2 pttt 57.25 57.1 4.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.49 ' CB ' ' HG2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -120.17 -10.82 9.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.612 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 20.0 ttp180 46.66 48.24 14.49 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -159.61 -57.72 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 120.64 0.257 . . . . 0.0 110.71 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.75 ' HD3' ' HB ' ' A' ' 50' ' ' VAL . 21.2 Cg_endo -97.03 -171.99 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.933 3.089 . . . . 0.0 110.217 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 12.5 Cg_endo -56.5 79.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.25 1.3 . . . . 0.0 110.737 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.698 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.0 OUTLIER -124.16 -107.75 0.33 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.813 -178.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.913 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -140.58 13.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 110.328 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.652 HD21 ' CA ' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -46.35 -35.44 5.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.095 -179.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.646 ' HB3' ' OG1' ' A' ' 22' ' ' THR . . . -91.09 44.79 1.21 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.235 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.639 ' HA ' HD21 ' A' ' 41' ' ' LEU . 2.0 mtt -65.18 -74.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.006 0.431 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -172.85 -68.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.239 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.21 -28.25 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.268 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -170.3 1.92 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.008 0.433 . . . . 0.0 111.3 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' HB ' ' HG3' ' A' ' 49' ' ' ARG . 4.1 m -140.58 153.62 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.638 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER 34.17 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.948 0.404 . . . . 0.0 111.735 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.679 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.844 0.354 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.81 -171.0 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.715 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 p -85.2 167.42 15.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.47 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -77.59 -174.16 3.28 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.892 0.377 . . . . 0.0 110.746 -179.849 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.7 t -118.15 26.61 0.11 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 20' ' ' CYS . 28.5 Cg_endo -62.9 69.97 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.088 1.192 . . . . 0.0 112.181 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 1.025 HG23 ' HB3' ' A' ' 56' ' ' ALA . 21.7 m -80.33 135.88 53.5 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 56' ' ' ALA . 97.4 Cg_exo -42.33 -26.51 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 111.667 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.758 ' H ' HG22 ' A' ' 22' ' ' THR . . . -103.76 -50.33 1.03 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.887 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.528 ' N ' ' HA ' ' A' ' 52' ' ' PRO . 46.2 t -42.81 155.33 0.05 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.487 0.644 . . . . 0.0 111.228 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -101.77 -34.88 9.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 37' ' ' HIS . . . 81.15 38.21 15.96 Favored Glycine 0 CA--C 1.502 -0.75 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.77 HG22 ' O ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -159.57 62.85 0.38 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.85 -1.175 . . . . 0.0 108.572 -179.17 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 30' ' ' HIS . . . 177.99 54.34 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.608 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.615 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 3.8 t-80 -37.52 176.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.948 HG13 HG23 ' A' ' 32' ' ' THR . 13.1 p -47.0 -30.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.502 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.948 HG23 HG13 ' A' ' 31' ' ' VAL . 15.0 p -126.63 -2.52 6.7 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.074 -0.391 . . . . 0.0 109.966 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.82 14.94 66.14 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.656 HD12 ' OG1' ' A' ' 32' ' ' THR . 15.5 mt -100.96 4.7 42.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.715 0.769 . . . . 0.0 109.119 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.561 ' HB2' ' CB ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -111.48 159.53 32.73 Favored Pre-proline 0 N--CA 1.448 -0.548 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.142 179.472 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 37' ' ' HIS . 61.1 Cg_endo -73.21 49.08 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.222 1.282 . . . . 0.0 111.113 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.521 ' CD2' ' HA ' ' A' ' 28' ' ' THR . 5.6 m170 88.64 -173.97 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 29.6 p-80 -139.26 -50.94 0.52 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.335 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.497 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 0.1 OUTLIER 41.05 20.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.506 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 4.8 p -161.09 18.27 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.798 HD11 ' CG ' ' A' ' 57' ' ' MET . 2.7 mt 71.62 5.72 5.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.892 0.314 . . . . 0.0 111.576 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.478 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 12.9 m -67.97 -4.43 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.506 ' HA3' ' H ' ' A' ' 31' ' ' VAL . . . -156.92 -72.29 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.857 ' SG ' HG23 ' A' ' 54' ' ' ILE . 4.7 t 20.31 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.066 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD3' ' C ' ' A' ' 30' ' ' HIS . 3.4 Cg_endo -105.7 5.88 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.703 3.602 . . . . 0.0 112.097 178.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.782 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 86.1 m-70 -39.01 -67.85 0.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.982 -177.135 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.733 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER 54.62 69.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.583 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -127.82 -8.79 5.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.563 179.629 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HB2' HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER 46.02 33.23 1.59 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.173 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.638 HG23 ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -171.37 -75.33 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.624 177.834 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' A' ' 50' ' ' VAL . 49.9 Cg_endo -67.8 178.1 3.66 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 111.581 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.646 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 2.0 Cg_endo -41.77 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.364 2.043 . . . . 0.0 111.576 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.782 ' HA ' ' CG ' ' A' ' 46' ' ' HIS . 0.9 OUTLIER -150.1 -110.75 0.06 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.857 HG23 ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -146.85 11.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.049 0.939 . . . . 0.0 108.883 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 50' ' ' VAL . 19.7 tp -56.0 -12.48 1.46 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.025 ' HB3' HG23 ' A' ' 22' ' ' THR . . . -129.53 58.58 1.62 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.798 ' CG ' HD11 ' A' ' 41' ' ' LEU . 31.7 tpp -177.27 132.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.489 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.703 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.5 OUTLIER 62.35 140.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.125 179.61 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.1 -29.3 3.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.888 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -76.41 63.45 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.591 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.772 HG23 HD12 ' A' ' 62' ' ' LEU . 2.6 m -104.19 160.31 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.084 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.772 HD12 HG23 ' A' ' 61' ' ' VAL . 1.4 mp 66.5 -67.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.126 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_